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Summary 
 
 
Despite being recognized as one of the most effective public health measures, vaccination has 
become increasingly controversial as more parents and doctors question the effectiveness and 
purpose of this preventive measure, with heightened emphasis on adverse events [Abrahamson 
and Pickering, 2002; Campion, 2002]. The goals of our study were to determine immunization 
coverage and examine factors influencing vaccination behaviors in 3 different age groups in each 
canton by collecting vaccination cards and questionnaires between 1999 and 2003. National 
coverage estimates for 3 doses of diphtheria (Di or D), tetanus (Te or T), pertussis (Per or P), 
poliomyelitis (Pol) and Haemophilus influenzae type B (Hib) and combined dose of measles (M), 
mumps (M), and rubella (R), or simply MMR, were: over 91% for Di, Te, Per, Pol and Hib and 
around 81% for MMR for toddlers; they were more than 92%, for 4 doses of Di, Te and Pol, 
60.9% and 26.6% for 4 doses of Per and Hib, respectively, and 87% for one dose of MMR for 
children at school entry. For children at school departure, coverage estimates at 5 doses of Di, Te 
and Pol was over 81% and around 50% for 2 doses of MMR (approximately 93% for 1 dose). 
Hepatitis B coverage ranged between 2.3% and 88.3% with the mean at 1 dose being 46.3%, for 
2 doses at 40.8%, and 3 doses at 25.9%. Due to methodological difficulties, comparison of 
coverage for schoolchildren among the cantons should be done with caution. Comparison of 
coverage for toddlers for MMR at one dose and Di, Te, and Pol at 3 doses with those from 1991 
and 1998 revealed that coverage has remained relatively unchanged. However, for Per and Hib at 
3 and 4 doses and 4 doses of Di, Te, and Pol, coverage levels have increased, with the uptake of 
Hib being most apparent, climbing from 77% in 1998 to 91% in our survey at 3 doses and from 
47% to 79% at 4 doses.  
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Vaccination coverage is significantly better in cantons where French or Italian is the predominant 
language spoken as compared to their German counterparts, particularly for MMR. Cantons 
supplementing their school health services with cantonally employed school nurses or 
“Lungenliga” nurses have improved vaccination coverage as compared to those working only 
with school doctors. Parental use of alternative medicine is found most often to be strongly 
associated with low vaccination coverage, cutting across cantonal differences and types of 
vaccines while being more influential by parents of younger kids. Nationality follows suit, with 
Swiss children having lower MMR and higher Di and Pol coverage levels than those of foreign 
background. Approximately 90% of all those who completed a questionnaire indicated that they 
have information concerning vaccination. Of these, 67% are satisfied with what they have, while 
17% are not happy, 7% remained undecided and 8% refrained from answering. Future 
vaccination campaigns should address the latter 3 groups to effectively increase immunization 
coverage.  
 
Finally, doctors are one of the most important resources for parents for obtaining information 
regarding vaccination; however, parents prefer that doctors actively share this information, rather 
than having to request for it from the doctors themselves. Parents of schoolchildren increasingly 
rely on school physicians for this information as their children get older. Health insurance should 
also share more information with parents while information distributed by the media is less 
desired. Parental attitudes towards vaccination and perception of the dangers of the childhood 
preventable diseases and vaccine safety and efficacy are significantly associated with coverage. 
Our results show that the most significant predictors of a child being UTD with the recommended 
vaccination plan is if parents agree that they follow the doctor’s recommendation, believe in the 
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effectiveness of vaccination, and think that as many children as possible should be vaccinated for 
the benefit of the community. In contrast, toddlers whose parents thought there was too much 
social pressure to vaccinate their children and have concerns about possible side effects from 
vaccines are less likely to be vaccinated as compared to those who disagree.  
 
In summary, children in Switzerland are sub-optimally vaccinated. Immunization coverage is 
affected by demographic and political factors, attitudes towards vaccination and perceptions of 
the dangers of the disease, as well as information available to the parents and healthcare 
providers. Future vaccination campaigns must address these factors, while providing clear and 
transparent resources to the parents and healthcare professionals. 
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Zusammenfassung 
 
Obwohl Impfungen als eine der wirksamsten Massnahmen zur Förderung der öffentlichen 
Gesundheit gelten, hat ein Teil der Bevölkerung diesbezüglich Bedenken [Abrahamson and 
Pickering, 2002; Campion, 2002]. Deshalb wurde das Institut für Sozial- und Präventivmedizin 
der Universität Zürich beauftragt die Durchimpfung von Kindern in drei verschiedenen 
Altersgruppen in allen Kantonen zwischen 1999 und 2003 anhand der Impfausweise zu erheben 
und die Faktoren, welche das Impfverhalten beeinflussen mittels Fragebogen zu untersuchen. Die 
durchschnittliche nationale Rate mit drei Dosen Diphtherie- (Di / D), Tetanus- (Te / T), Pertussis- 
(Per / P), Poliomyelitis- (Pol) und Haemophilus influenzae Typ b- (Hib) sowie einer Dosis 
Masern-, Mumps-, und Röteln- (MMR-) Impfung war wie folgt: über 91% bei Di, Te, Per, Pol 
und Hib und rund 81% bei MMR bei den Kleinkindern, und mit vier Dosen über 92% bei Di, Te 
und Pol, 60,9% bei Per, 26,6% bei Hib und 87% bei einer Dosis MMR bei Schuleintrittskindern. 
Bei den Schulaustretenden war das Impfniveau mit 5 Dosen Di, Te, und Pol über 81% und rund 
50% bei zwei Dosen MMR (rund 93% bei einer Dosis). Bei dieser Altersgruppe schwankte die 
Deckung für Hepatitis B zwischen  2,3% und 88,3% mit dem Mittelwert für eine Dosis bei 
46,3%, für zwei Dosen bei 40,8%, und drei Dosen bei 25,9%. Aufgrund methodischer 
Schwierigkeiten ist der Vergleich bei den Schulkindern zwischen den verschiedenen Kantonen 
mit Vorsicht zu betrachten. Der Vergleich der Durchimpfung von Kleinkindern mit einer Dosis 
MMR und je drei Dosen von Di, Te und Pol zwischen den Jahren 1999-2003 (diese Studie) und 
den Jahren 1991 und 1998 zeigt, dass der Impfgrad ungefähr gleich blieb. Für drei und vier 
Dosen Per und Hib und vier Dosen Di, Te, und Pol ist die Durchimpfung gestiegen, wobei Hib 
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am offensichtlichsten von 77% im Jahr 1998 auf 91% in unserer Erhebung bei 3 Dosen und von 
47% auf 79% bei 4 Dosen gestiegen ist. 
 
Im Vergleich zur Deutschschweiz ist die Durchimpfung in Kantonen in denen mehrheitlich 
französisch oder italienisch gesprochen wird signifikant höher, speziell für MMR. In Kantonen in 
welchen das Schulgesundheitssystem von kantonal angestellten Krankenschwestern oder 
Schwestern der Lungenliga unterstützt wird, ist das Impfniveau höher als in Kantonen die 
ausschliesslich mit Schulärzten arbeiten. Bei Anwendung von Alternativmedizin durch die 
Eltern, wird die Impfquote vor allem bei jüngeren Kindern stark beeinflusst, unabhängig von 
kantonalen Unterschieden und Art der Impfung. Schweizer Kinder haben eine tiefere MMR-, 
jedoch eine höhere Di- und Pol- Durchimpfung als ausländische Kinder. Etwa 90% der Personen 
die einen Fragebogen ausgefüllt haben gaben an, dass sie Informationen bezüglich Impfungen 
erhalten haben. Von diesen 90% sind 67% zufrieden mit den erhaltenen Informationen, 17% sind 
damit unzufrieden; 7% waren unentschlossen und 8% beantworteten diese Frage nicht. 
Zukünftige Impfkampagnen sollten die letzteren 3 Gruppen speziell ansprechen um den 
Durchimpfungsgrad zu erhöhen.  
 
Ärztinnen und Ärzte sind die wichtigsten Bezugspersonen der Eltern bezüglich Informationen 
über Impfungen; die Eltern bevorzugen jedoch, aktiv informiert werden und nicht selbst 
nachfragen zu müssen. Eltern von Schulkindern verlassen sich mit zunehmendem Alter der 
Kinder mehr und mehr darauf, dass sie von den Schulärzten mit Informationen versorgt werden. 
Die Eltern wünschen sich auch mehr Informationen von den Krankenkassen, während Infos 
durch die Medien weniger gefragt sind. Die elterliche Einstellung gegenüber Impfung im 
Allgemeinen, sowie die Einschätzung von Impfrisiken und Gefährlichkeit von 
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Kinderkrankheiten, haben den grössten Einfluss auf die Durchimpfungsraten. Gemäss den 
Resultaten unserer Studie sind die verlässlichsten Voraussetzungen für das Einhalten des 
empfohlenen Impfplans: Die Eltern folgen den Empfehlungen des Arztes, glauben an die 
Wirksamkeit der Impfung, und wissen, dass für das Erreichen einer „Herdenimmunität“ 
möglichst viele Individuen geimpft sein müssen. Kleinkinder, deren Eltern den sozialen Druck 
ihre Kinder impfen zu lassen als zu gross empfinden oder mögliche Nebeneffekte von Impfungen 
befürchten, haben eine geringere Durchimpfungsquote.   
 
Ein Vergleich der Daten der Jahre 1999 und 2003 im Kanton Wallis zeigt, dass bei den 
Kleinkindern die Durchimpfung mit 3 Dosen Di, Te, Per und Pol sowie einer Dosis MMR 
gesunken, jene mit 2 Dosen MMR jedoch gestiegen ist. Bei den Schulkindern ist die Impfniveau 
in diese Zeit signifikant gestiegen. Die Teilnahme an unserer Studie ist zwischen 1999 und 2003 
ebenfalls verbessert, wahrscheinlich wegen der verbesserten Datenerfassungsmethode sowie dem 
Verzicht auf den Fragebogen. In einem ähnlichen Rahmen hat sich die Teilnahme an der 
laufenden Studie (2005-2007) in allen Kantonen gestiegen. In 8 von den 9 Kantonen (AI, AG, 
BL, BS, NE, SH, SO, SZ, ZH) die im Jahr 2005 teilnahmen, ergab sich eine deutliche Erhöhung 
der Durchimpfung; einzig im Kanton Schwyz zeigte sich eine klare Reduktion. Ein deutlicher 
Anstieg der Durchimpfungsrate für alle Impfungen war auch bei den Schulkindern zu 
beobachten, dies könnte jedoch darauf zurückzuführen sein, dass eine andere Altersgruppe 
ausgewählt wurde. 
 
Zusammenfassend kann man feststellen, dass der Impfgrad der Kinder in der Schweiz zwischen 
1999 und 2005 zwar gestiegen, jedoch noch immer sub-optimal ist. Die Durchimpfung wird 
durch demographische und politische Faktoren, persönliche Einstellung gegenüber Impfung, 
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Einschätzung der Impfrisiken und Gefährlichkeit von Kinderkrankheiten, sowie der 
Verfügbarkeit von Informationen beeinflusst. Zukünftige Impfkampagnen sollten diese Faktoren 
in Betracht ziehen. Da ein möglichst hohes Impfniveau nötig ist um den Ausbruch von 
Krankheiten zu verhindern, wird empfohlen, dass die Impfraten der Kinder in der Schweiz 
regelmässig erhoben werden. Das laufende Erhebungsmodell sieht einen 3-Jahresrhythmus vor. 
Es sollten Strategien erarbeitet werden, um die grosse Bereitschaft der Kantone und Gemeinden 
an der Studie mitzumachen zu erhalten und die Antwortraten bei den ausgewählten Familien zu 
erhöhen. 
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Abbreviations
Cantons The 26 cantons in Switzerland are referred to by their
official abbreviations in this report.
CAM complementary / alternative medicine
CDC Centers for Disease Control and Prevention
CI Confidence interval (95%)
CMO Chief Medical Officer, "Kantonsarzt". For each canton
there is one CMO.
DTPPolHibMMR Immunization series where D, T, P, Pol, Hib, MMR are
analyzed together and the numbers represent the number
of doses for each vaccine, respectively.  For example,
33333111 indicates 3 doses of D, T, P, Pol, Hib and
combined dose of MMR. Used in the evaluation for toddlers
and children at school entry.
DTPPolMMR Immunization series where D, T, P, Pol and MMR are
analyzed together and the numbers represent the number
of doses for each vaccine, respectively.  For example,
5505111 indicates 5 doses of D, T, Pol, combined dose of
MMR and 0 dose of Per. Used in the evaluation for children at
school departure.
GSU Grenzsanitarische Untersuchungen. They are responsible for health
examinations and vaccinations for those seeking asylum in Switzerland.
University of Zurich
LL "Lungenliga".  Non-profit organization responsible for health aspects
associated with lungs and breathing problems.
MMWR Morbidity Mortality Weekly Report
SD Standard deviation
SFOPH Swiss Federal Office of Public Health
SFSO Swiss Federal Statistical Office
SKIF Swiss Advisory Committee on Immunisation
UTD Up to date
WHO World Health Organization
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Conditions for data analysis
Vaccination DTPPolHibMMR series DTPPolMMR series
Diphtheria (Di or D) Toddlers School entry School departure
Tetanus (Te or T) w/out Per/Hib with Per/Hib w/out Per/Hib with Per/Hib without Per with Per
Pertussis (Per or P) 33030111 33333111 33030111 33333111 3303111 3333111
Polio (Pol) 44040111 44443111 44040111 44443111 4403111 4433111
Haemophilus influenzae type B (Hib) 55050111 55553111 5505111 5535111
Measles 55050222 55553222 5505222 5535222
Mumps 6605111 6635111
Rubella 6605222 6635222
Hepatitis B (HepB) because Hib was recommended just recently, it was not considered in the analysis
for children at school departure.
Categories Cantons
Linguistic region
German-speaking AG, AI, AR, BE, BL, BS, GL, GR, LU, NW, OW, SG, SH, SO, SZ, TG, UR,  ZG, ZH
French-speaking FR, GE, JU, NE, VD, VS
Italian-speaking TI
Participation
Toddlers includes all cantons
< 60% AR, BS, FR, GR, JU, NE, LU, SG, SH, SO, TG, VS, ZG
60-70% AR, BL, GL, NW, OW, SZ, UR, VD, ZH
> 70% AI, BE, GE, TI
School entry does not include BE, JU, NE, TI
< 60% AR, GL, GR, LU, NW, OW, SG, SH, SO, TG, UR, VS, ZG
60-79% AG, BL, FR, SZ
≥ 80% AI, BS, GE, VD, ZH
School exit does not include BE, JU, NE, TI
< 60% BL, GR, LU, NW, OW, SG, SO, TG, ZG
60-79% AI, AR, BS, FR, GL, SH, SZ, UR, ZH
≥ 80% AG, GE, VD, VS
Data collection mode does not include BE, JU, NE, TI
School doctors AI, AR, GL, GR, SG, SH, UR, ZH
School / "Lungenliga" nurses AG, BL, BS, GE, SZ, VD, VS
School officials FR, LU, NW, OW, SO, TG, ZG
considering HepB campaign in the schools
School doctors AR, ZH
School / "Lungenliga" nurses AG, BS, GE, SZ, VD, VS
School officials FR, LU, SO, TG
no HepB campaign in the schools AI, BL, GL, GR, NW, OW, SG, SH, UR, ZG
considering HepB vax in the schools
School doctors AR, GL, GR, SG, SH, ZH
School / "Lungenliga" nurses AG, BL, BS, GE, VD, VS
School officials FR, NW, TG
does not vax in the schools AI, LU, OW, SO, SZ, UR, ZG
School vaccination policy does not include JU
use cantonally employed school
nurses or LungenLiga nurses:
Yes AG, BL, BS, GE, NW, SZ, VD, VS
No AI, AR, BE, FR, GL, GR, LU, NE, OW, SG, SH, SO,  TG, TI, UR, ZG, ZH
vaccination permitted in school
Yes AG, AR, BE, BS, FR, GL, GR, NE, NW, SG, SH, SZ, TG, VD, VS, ZH
No AI, BL, GE, LU, OW, SO, TI, UR, ZG
HepB campaign in the schools
Yes AG, AR, BE, BS, GE, FR, LU, SO, SZ, TI, TG, VD, VS, ZH
No AI, BL, GL, GR, NE, NW, OW, SG, SH, UR, ZG
HepB vax in the schools
Yes AG, AR, BE, BL, BS, FR, GE, GL, GR, NW, SG, SH, TG, VD, VS, ZH
No AI, LU, NE, OW, SO, SZ, TI, UR, ZG
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1. Introduction 
 
Since its inception, vaccination has prevented millions of deaths and sufferings, and has been 
documented as one of the most cost-effective public health measures [Chabot et al, 2004; 
Ulmer and Liu, 2002; CDC / MMWR, 1999(a); CDC / MMWR, 1999(b); WHO website]. 
Based on statistics for the United States, annual morbidity due to childhood vaccine 
preventable diseases has decreased 99-100% since 1900 [CDC / MMWR, 1999(a)]. For 
measles alone, global summaries by the World Health Organization (WHO) revealed that in 
1980, 3.9 million cases were registered worldwide; in 2002, only 586,000 cases. In the WHO 
designated European region, the number of measles reported cases decreased from 492,000 in 
1980 to 46,700 cases in 2002 [WHO: Global summaries, 2003]. Measles is responsible for 
nearly half of the estimated 1.7 million annual deaths due to childhood vaccine preventable 
diseases in 2000, and is one of the leading causes of childhood mortality [Henao-Restrepo et 
al, 2003]. Moreover, an estimated 1 million measles deaths have been prevented by 
vaccination in 2000, when assuming the same measles case-fatality ratios in the pre-vaccine 
era as those currently observed in the presence of vaccination programs [Henao-Restrepo et 
al, 2003]. The Measles Initiative announced recently that death as a result of measles has been 
reduced by 60% worldwide between 1999 and 2005, from an estimated 870,000 to 345,000 
[Editorial team, Euro Surveill, 2007; Wolfson et al, 2007].  
 
However, measles remains an extremely contagious disease, with outbreaks still common in 
Europe. Because vaccine-preventable diseases have become less prevalent, much of the 
attention from both healthcare providers and parents in the western communities has been 
shifted from dangerous consequences of the infections to the rare side effects of the vaccines 
[Offit and Coffin, 2003; Owens, 2002; Tickner, 2006]. Despite numerous studies that have 
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proved otherwise, speculations that the MMR vaccine is linked to autism, encephalitis or 
aseptic meningitis have reduced MMR coverage about 8.6 percentage points in the United 
Kingdom, with some areas having coverage as low as 65% [Wakefield et al, 1998; Taylor et 
al, 1999; Kaye et al, 2001; Madsen et al, 2002; Mäkelä et al, 2002; Owens, 2002; Ramsey et 
al, 2002; Wilson et al., 2003; DeStefano et al, 2004; Geier and Geier, 2004; Smeeth et al, 
2004; Demicheli et al, 2005; Elliman and Sengupta, 2005]. Additionally, concerns that 
vaccination may lead to atopy, asthma, or diabetes have also added fuel to the ongoing 
vaccination debate, although many large epidemiological studies have refuted this claim 
[Paunio et al, 2000; Grüber et al, 2002; Bager et al, 2003; Bernsen et al, 2003; Grüber et al, 
2003; Nilsson et al, 2003; Stehr-Green et al, 2003; Hviid et al, 2004; Koppen et al, 2004; 
Maitra et al, 2004; McKeever et al, 2004; Rottem and Shoenfeld, 2004; Adler, 2005; Flöistrup 
et al, 2006]. Furthermore, mistrust in government agencies and medical professions regarding 
vaccination, along with increase doubts in vaccine efficacy and safety, have negatively 
impacted vaccination campaign efforts [Evans et al, 2001; Cotter et al, 2003; Raithatha et al, 
2003; Salmon et al, 2005; Casiday et al, 2006; Cassell et al, 2006].  
 
Thus, it is becoming increasingly more difficult to maintain vaccination coverage levels high 
enough to interrupt circulation of the wild virus in the population, resulting in potentially 
dangerous epidemic outbreaks. For example, local measles outbreaks have been common in 
the past decade in many European countries. In The Netherlands, 2 measles epidemics 
occurred, one in 1999/2000 and one in 2002. Between June 1999 and May 2000, a large 
outbreak of 3,292 reported measles cases, with 3 measles-related deaths. It occurred in a 
community, where 83% of the 94% unvaccinated kids were religiously exempted [van den 
Hof et al, 2002]. Likewise, in Ireland, 1,407 cases of measles were notified, of which 111 
children were hospitalized, and a total of 3 deaths resulted between December 1999 and July 
2000 [McBrien et al, 2003]. A large outbreak occurred in London between December 2001 
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and May 2002 where a total of 580 cases (confirmed and suspected) were reported. From the 
70% of cases where vaccination history was available, 98% had no record of receiving any 
measles vaccine; the majority of confirmed cases lived in the more affluent area of London 
[Atkinson et al, 2005]. 
 
Two outbreaks plagued Italy within the last three years: one in 2002 where 1,571 cases were 
reported between January to July, affecting primarily unvaccinated school-aged children. Of 
the 1,543 cases where vaccination status was known, only 7% of the children were 
vaccinated. Subsequently, it has been shown that the number of cases reported is inversely 
proportional to the vaccination coverage of the afflicted areas [Ciofi degli Atti et al, 2002(a) 
and 2002(b)]. Exactly one year later, 1,217 cases were reported in Italy between January and 
May 2003. Again coverage estimates for measles were low in the affected regions: 71% in 
Abruzzo, 77% in Puglia, and 55% in Calabria [Ciofi degli Atti et al, 2003]. In Greece between 
September 2005 and February 2006, 171 measles cases were reported.  Epidemiological data 
showed that the majority of cases occurred in children under 14 years of age (45% in 0-4 
years), and of the 110 known vaccination status, 89% were not vaccinated while only 11% 
had a single dose of measles-containing vaccine [Georgakopoulou et al, 2006]. In Madrid, 
Spain, 59 cases of measles were notified during the first quarter of 2006.  Of the 19 cases who 
should have been vaccinated (between 15 months and younger than 21 years of age), 14 were 
not vaccinated; all vaccinated patients were born in Spain, and the non-vaccinated ones were 
born in other countries or belonged to minority ethnic groups [Garcia-Comas, 2006]. 
 
In Germany, there were regional variations in measles incidence and outbreaks, with the 
largest outbreak in Bavaria between November 2001 to April 2002 where 1,166 measles cases 
were reported; many parents in this region did not support vaccinating their children against 
childhood diseases due to anthroposophical beliefs. A more detailed investigation into an 
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outbreak in Nordfriesland between January to April 2001 showed that of the 133 confirmed 
clinical cases, 93% had never been vaccinated against measles [Hellenbrand et al, 2003]. 
Local measles outbreaks were repeated in the federal states of Hess and Bavaria in 2005 
[Siedler, 2006] and Nordrhein Westfalen [van Treeck, 2006] and Baden Württemberg in 2006 
[Editorial team, Eurosurveill, 2006].  Of the 223 cases in Hess, 95% were unvaccinated, with 
the highest age-specific attack rate in children aged 1- 4 years, with clustering observed in 
families and households. In Bavaria 98% of the 279 cases where not vaccinated, with the 
highest age –specific attack rate in children aged 5-9 years, indicating a clustering in schools 
or pre-school facilities.  Within the first half year of 2006, 1018 cases of measles were 
reported in Nordrhein Westfalen, where only 2.5% were fully vaccinated with 2 – doses 
against measles; schoolchildren were mainly affected. In Baden-Württemberg, all 58 cases 
reported during the first quarter of 2006 were not immunized; the patients belonged to a social 
group where measles vaccination is viewed as unnecessary. 
 
Finally, in Switzerland, there were two large measles outbreaks, one in 1997 and one in 2003. 
Two hundred and thirty five cases were reported in 1997 within Sentinella (estimated number 
of cases for Switzerland:  6,400), of which 16% of the patients were vaccinated, compared to 
30% in 1995, 32% in 1996 and 25% in 1998 [Paget et al, 2000]. In 2003, 614 cases were 
registered through the notification system, where 79% of the patients were under 16 years of 
age and 88% were not vaccinated against measles [Richard et al, 2003; Zimmermann, 
personal communication, 2004]. Between 2004 and 2006, there were two small local 
outbreaks of measles in cantons LU and VD, with many of the cases not vaccinated against 
measles [Masserey et al, 2006; Shang-Meier, 2007]. 
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Concerned with potential epidemic outbreaks, the Swiss Federal Office of Public Health 
(SFOPH) sponsored a national effort between 1999-2003 to determine vaccination coverage 
levels in each of the 26 cantons. The survey has two major goals:  
1. to determine vaccination coverage and factors affecting vaccination in three 
different age groups: toddlers 24-35 months of age, children at school entry and 
school departure, and  
2. to establish a feasible methodology that could be implemented in every canton 
 utilizing the existing infrastructure where possible.  
 
As it took 5 years to complete the study in all 26 cantons, the survey was repeated in the 
canton of Valais (VS, subsequently all cantons will be abbreviated) in 2003, taking into 
consideration the many changes to improve the methodology to ensure better data quality. A 
section is used to describe the changes implemented and its overall effect on vaccination 
coverage and participation in the canton of VS.  
 
A third section of this thesis will briefly summarize the ongoing Swiss National Vaccination 
Coverage Survey developed based on the results and experience from the survey 1999-2003.  
The current 3-year rolling cycle is an improvement of the previous methodology 
implementing many of the recommendations suggested by collaborators and results analysis 
to produce a sustainable surveillance system with outstanding and comparable data.  
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2. Methodology 
 
 
2.1 Target population 
 
As vaccination plays an important role in public health, a surveillance system to regularly 
monitor immunization coverage should be established. Three age groups were of interest: 
toddlers between 24-35 months of age (main target group), children at school entry and 
children at school departure. By the age of 2, children should be up to date with all the 
recommended infant and toddler vaccinations. If results indicate that immunization coverage 
for children at this age is low, then a program can be initiated to increase coverage before 
school entry in order to prevent disease outbreaks. Because vaccination behaviors of parents 
will change as children get older, it is important to continually monitor children's vaccination 
status. For examination of schoolchildren, the time of school entry is crucial, as well as the 
time of school departure, especially to determine Hepatitis B acceptance among the 
adolescents. If necessary, catch-up programs for children can also be implemented during 
these school years. 
 
 
2.2 Study design 
 
As it is important to have high coverage in all regions / cantons to effectively control or 
eliminate a disease, one of the major goals was to conduct the survey in every single canton. 
Due to limited resources and sampling frames, while hoping to gather support from the 
individual cantons, it was sought to adapt the survey to the existing infrastructure in each 
canton as much as possible. For the toddlers, a two stage sampling design with municipalities 
serving as the primary sampling units was employed (Levy and Lemeshow, 1999). Parents 
were contacted via two modes, mail and telephone. With the schoolchildren, random sampling 
of school classes with school classes serving as the primary sampling units was utilized. 
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Parents were only contacted via letters through the aid of teachers, school officials, school 
doctors or school nurses. In addition to submitting information on their child’s immunization 
status (via a copy of the immunization card), parents were also requested to complete a 
structured close-ended questionnaire regarding vaccination, perception of selected diseases, 
information about vaccination, and use of alternative medicine (Annex Questionnaire). 
 
The survey was repeated in canton VS in 2003 to determine the feasibility of the methodology 
with changes as recommended by the collaborators in canton VS to improve data quality. 
Although the basic methodology was still used, three major changes were implemented in 
2003:  
1) questionnaires were not utilized. Only vaccination status was examined, along with 
demographic variables such as gender and nationality. By the schoolchildren, 
2) children in the second grade were recruited to participate instead of those in the first 
grade, and  
3) vaccination summary forms were completed by the “Lungenliga” (LL) nurses. 
 
 
2.3 Statistical considerations 
 
Sample size calculation at 95% confidence interval and a precision of ±7% with a design 
effect of 2 due to sampling via clusters required a minimum of 400 samples. To take into 
account non-compliance of approximately 30-40%, a final sample size of 500- 600 per age 
group per canton was needed in this cross-sectional survey [Lemeshow et al, 1990]. 
 
 
2.4 Data collection 
 
Data collection methods for toddlers and schoolchildren were distinctly different due to 
available sampling frames, but remained similar among the cantons.  
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2.4.1  Toddlers 
 
For the toddlers, a list of the number of children born in a specified year in each municipality 
served as the sampling frame except for cantons AI, BS, NE, GE and VD where a single 
registry of all residents exists (Annex A). Supplied to ISPMZ by the Office of Statistics in the 
Canton of Zurich, this list is a compilation submitted by each canton to the Swiss Federal 
Statistical Office (SFSO) for the Statistical Yearbook for Switzerland [1999-2003]. By the 
time the list is used for the survey, the birth cohort is about 3 years old. Because of the 
tendency for families to remain at the same address for a relatively long period of time, the 
list remains fairly accurate. For BS and NE, simple random sampling was conducted to select 
the children. Due to their relatively small size, all children who were between 24-35 months 
of age and resided in cantons AI, GL, NW, OW and UR at the time of the study were 
recruited for the study. Because diphtheria vaccination is mandatory in GE, the Office of the 
Chief Medical Officer (CMO) regularly sends a letter requesting the immunization cards to all 
parents whose toddlers have reached the age of 28 months. Graciously, GE allowed ISPMZ to 
coordinate our study with this routine so as not to overburden the parents. In canton VD, 
sample selection was conducted by the “Bureau Vaudois d’Adresses” as they are responsible 
for maintaining the central registry for the canton. 
 
By the remaining cantons, the sampling procedure varied statistically as we tried to simplify 
the sampling technique (please refer to the cantonal assessment submitted to each canton for 
details describing the survey as implemented in the canton). In brief, municipalities were first 
selected, and then the children in these municipalities (Annex B). These municipalities were 
then requested to provide information (names of child and parents, date of birth, gender, 
address, nationality, telephone number) of the selected children. Children and their families 
were then invited to participate per mail, which included an introductory letter, the 
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questionnaire in the language of the region, and if necessary another questionnaire based on 
their nationality, and a pre-paid return envelope. Three to four weeks later a reminder was 
sent to all those who still have not responded, followed by a final telephone attempt, which 
included 3-4 calls at different hours during the week. Reasons for not participating in the 
survey were recorded in most cantons. The questionnaire exists in 8 different languages: 
German, French, Italian, Turkish, Albanian, Serbo-Croatian, English, and Portuguese. 
 
 
2.4.2   Schoolchildren 
 
An exhaustive list of schools and the number of classes with children in the target population 
served as the sampling frame for the schoolchildren, except in NE. From this list, between 30 
and 50 school classes were randomly chosen, depending on the average class size in the 
canton (Annex B). All children in these selected classes were recruited for the study. After the 
classes have been chosen, the data collection method diversified, depending on the existing 
infrastructure (Table 1). In cantons FR, LU, NW, OW, SO, TG and ZG, school directors and 
teachers were directly contacted to participate in the study. They were requested to distribute, 
collect and send the information (questionnaire and a copy of the vaccination card or the 
original) to ISPMZ. In AI, AR, GL, GR, SG, SH, TI, UR and ZH information were sent to the 
school doctors who coordinated the study with the routine school health exams. Because of 
their small size, all school doctors in cantons AI, GL and UR were requested to collect 
information from all classes at school entry and departure that were under their care. After 
collecting the questionnaires from the kids and either copying the vaccination booklets or 
completing a vaccination summary form (Annex Vaccination Summary Forms), all 
information were then sent to ISPMZ. When a school doctor refused to participate, the 
teachers or directors were directly contacted and the same procedure followed, as described 
above. In cantons AG, BL, BS, GE, JU, SZ, VD and VS the study was coordinated with the 
nurses in the school health services or the LL league who, like the aforementioned 
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collaborators, were responsible for all stages of data collection. Because the study was 
coordinated with the school health examinations, the selected grades varied- for school entry: 
children in kindergarten (second year), first, second or third grade were recruited, and by 
school departure, included were adolescents in the 6th, 7th, 8th or 9th grade. Finally, in cantons 
BE and NE, the method utilized for the toddlers were also used for the schoolchildren. 
Families were directly contacted to participate in the study. 
 
Table 1.  Data collection methods for schoolchildren 
    
Method     Canton 
Nurses      
  School health services   BS, GE, VD, SZ 
  Lungenliga   AG, BL, JU, VS 
School physicians   AI, AR, GL, GR, SG, SH, UR, TI, ZH 
School directors/ teachers   FR, LU, NW, OW, SO, TG, ZG 
Municipalities   BE, NE 
BE, TI: The survey was conducted independent of ISPM. 
 
 
As with the toddlers, each student in the selected classes received an envelope to bring home 
to their parents, which included an introductory letter and the questionnaire. The collected 
information was then returned to ISPMZ either via the school doctors, nurses, or school 
officials, with the original vaccination cards being returned within one week. 
 
In cantons BE, SO, TG and TI all phases of data collection were organized and conducted by 
the Office of the CMO; cantons SO and TG collected the data after sampling was conducted 
by ISPMZ, whereby in cantons BE and TI, all steps were performed independent of ISPMZ 
[Maurer, 2003; Galfetti, personal communication, 2003]. Data were graciously shared to 
ISPMZ for data analysis. 
 
In VS 2003, a revised vaccination summary form (Annex) was completed by the LL nurses 
for each class that was selected for the study. Children in the 2nd and 8th grades were recruited 
for the study. Regardless of whether or not they participated in the study, the nurses were 
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requested to include every single student in the class on the form. Data were collected 
between April and June 2003. Data entry and analysis were performed by ISPMZ.  
 
2.5   Data analysis 
 
Data for the toddlers and schoolchildren were weighted based on sampling probability, 
adjusted for nonresponse and poststratified by nationality (Swiss / non-Swiss), and sex. For 
toddlers, in addition to sex and nationality, urbanicity (city/ country, as defined by the SFSO) 
[1999-2003] was also used in poststratification so that totals matched estimates from the 
Statistical Yearbook with respect to the 3 aforementioned variables for generalization to the 
current population. Adjustment for nonresponse included distributing the weights of 
nonresponders to responders, under the assumption that the sample is representative of the 
general population and that behavior of those who do not respond will be similar to those who 
do respond. Imputation was conservatively done for missing information on gender and 
nationality for selected toddlers, where names were available. In the cantons of BE, VD and 
TI where the survey was independently conducted by the cantons themselves, questionnaires 
were not used with the schoolchildren. In addition to vaccination status, nationality and 
gender were also available for the children in the canton of BE, while only nationality was 
recorded for VD; for TI, only nonresponse adjustments were made since no other variables 
were collected.  
 
Age distribution was examined only for children submitting information from the vaccination 
card. For the schoolchildren in canton BL, dates of births were extracted from the 
questionnaires since this information was not supplied on the vaccination summary forms. 
Because data collection lasted for several months, to determine the age of the children, the 
point at which the majority of data were collected was selected as the time of reply for that 
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particular canton and that specific age group. When it was not possible to estimate this period, 
the middle point of data collection was designated as the time of participation. 
 
Only in cases where vaccination information were extracted from a vaccination card, 
descriptive Chi square analyses and logistic regression were conducted utilizing the statistical 
software Stata, Version 7.0 [2001]. Vaccination status and questionnaire were obtained for 
toddlers from all cantons; for the schoolchildren, vaccination information is missing from 
canton JU and questionnaires are missing from cantons BE, TI and VD. Due to 
misunderstandings in canton JU, immunization coverage by doses for the individual vaccines 
were not determined, although questionnaires were collected. 
 
For data analysis, ”up to date” (UTD) with the recommended childhood vaccination schedule 
was defined according to the 3 age groups at different number of doses for diphtheria (Di or 
D), tetanus (Te or T), pertussis (Per or P), poliomyelitis (Pol), Haemophilus influenzae type B 
(Hib), measles, mumps, rubella (MMR), and at the DTPPolHibMMR immunization series for 
toddlers and children at school entry and DTPPolMMR series for children at school departure. 
For toddlers, the DTPPolHibMMR immunization series was either 33333111 (i.e. 3 doses of 
D, T, P, Pol and Hib and combined dose of measles (M), mumps (M), and rubella (R)), or 
44443111, or without Per and Hib at 33030111 or 44040111; for children at school entry, it 
was held at 33333111, 44443111, 55553111 and 55553222, and without Per and Hib at 
33030111, 44040111, 55050111 and 55050222; and for children at school departure, we 
compared coverage  at various DTPPolMMR vaccination series, with and without 3 doses of 
Per. Hib was not analyzed for the children at school departure as it was only introduced into 
the vaccination plan recommended by the SFOPH and the Swiss Advisory Board on 
Immunisation (SKIF) in 1991. The DTPPolMMR series without Per included 3303111, 
4404111, 5505111, 5505222, 6605111 and 6605222; with Per, they were 3333111, 4434111, 
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5535111, 5535222, 6635111 and 6635222 (see list of Abbreivations). Hepatitis B (HepB) was 
analyzed only for children at school departure as it is recommended by the SFOPH for 
children between 11-15 years of age. 
 
Independent variables for the univariate logistic regression model included: demographic 
factors (nationality (Swiss vs. non-Swiss), sex (male vs. female), number of siblings (0 vs. ≥ 
1), number of older siblings (0 vs. ≥ 1), number of younger siblings (0 vs. ≥ 1), and highest 
educational level of the mother (low vs. middle vs. high), language of the region (German vs. 
French vs. Italian), alternative medicine use (no vs. yes), receipt of information regarding 
vaccination (no vs. yes), satisfaction with the available information (no vs. yes),  response rate 
(toddlers: < 60% vs. 60-70% vs. > 70%; schoolchildren: < 60% vs. 60-79% vs. ≥ 80%), 
parental perception of the dangers of childhood vaccine-preventable diseases, and parental 
attitudes toward immunization in general. Mode of data collection and school vaccination 
policy also served as independent variables for the schoolchildren. Dependent variables for 
the toddlers were coverage estimates for DTPPolHibMMR at series 3333111, Di at 3 doses, 
Hib at 3 doses and measles at one dose; for children at school entry, the dependent variables 
were coverage estimates for DTPPolHibMMR at series 44443111, Di at 4 doses, Hib at 3 
doses and measles at one dose; and by the children at school departure, the dependent 
variables were coverage estimates for DTPPolMMR at series 5505111, Di at 5 doses, Pol at 5 
doses and measles at one dose. Hib was not considered in the analysis for the school 
departure, as it was only recently recommended; many of the teenagers would not have been 
vaccinated for it. Significance was held at p-value less than 0.05, unless otherwise specified. 
 
Nationality was also examined in further detail, as collected in the questionnaire. Children of 
foreign background were further categorized into 4 regions: Europe  (countries in the 
European Union and Norway); Eastern Europe, including Turkey; Asia; and others. As canton 
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VD did not use identical nationality groupings in the vaccination summary form as those in 
our survey, schoolchildren from canton VD were not included in this analysis.  Because 
geographical location of some European countries may also influence vaccination coverage as 
determined by Bouvier et al in 1994, countries of origin were also regrouped into 7 regions: 
northern and western Europe (countries in the European Union and Norway), minus those 
categorized as Southern Europe; Eastern Europe, including Turkey; Southern Europe, which 
includes Portugal, Italy, France, Spain, and Greece; Asia; Latin and South American; Africa; 
North America, New Zealand and Australia. This latter re-grouping was only done for the 
toddlers, when the information was available; it did not include cantons BE, TI and TG. 
 
Educational level was partitioned into categories very similar to those from the Statistical 
Yearbook, as defined by the SFSO [2003]. The categories included: none (no formal 
education), first 9 years of schooling (obligatorische Schule), basic vocational training / 
Apprenticeship (Berufsschule / Berufslehre), high school diploma / teaching training 
(Maturitätsschule / Lehrerseminar), higher non-university diploma (Höhere 
Berufsausbildung), university (Universität / Hochschule), and others. Parents who provided a 
description as to their educational background when ”others” was checked, were re-grouped 
into one of the aforementioned categories when possible.  
 
The list of conditions for analysis found on pages ix-x summarizes the different categories 
used in the analysis and the subdivision of cantons within these variables. Cantons designated 
as French-speaking are FR, GE, JU, NE, VD and VS; the German-speaking region includes 
cantons AG, AI, AR, BE, BL, BS, GL, GR, LU, NW, OW, SG, SH, SO, SZ, TG, UR, ZG and 
ZH; TI is the only Italian-speaking canton.  For the logistic regression, response rates were 
divided into 3 groups: low, where participation was below 60%; medium, where participation 
was between 60-70% for toddlers and 60-79% for schoolchildren; and high, where 
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participation was more than 70% for toddlers and 80% or more for schoolchildren. For the 
toddlers, cantons falling into the group with low participation included AR, BS, FR, GR, JU, 
NE, LU, SG, SH, SO, TG, VS, ZG; medium included cantons AR, BL, GL, NW, OW, SZ, 
UR, VD, ZH; and high included 4 cantons AI, BE, GE, TI. For school entry, cantons with low 
participation included AR, GL, GR, LU, NW, OW, SG, SH, SO, TG, UR, VS and ZG; at the 
middle level are cantons AG, BL, FR and SZ; and those with high participation included 
cantons AI, BS, GE, VD and ZH. For school departure, cantons falling into the low 
participation group included BL, GR, LU, NW, OW, SG, SO, TG and ZG; at the middle level 
are cantons AI, AR, BS, FR, GL, SH, SZ, UR and ZH; and those with high participation are 
cantons AG, GE, VD and VS. The influence of the mode of data collection on vaccination 
coverage was also examined for schoolchildren where the methods used were similar for the 2 
age groups and did not include cantons BE, NE, JU and TI. Cantons where collaboration with 
school doctors were sought included AI, AR, GL, GR, SG, SH, UR, TI, and ZH; collaboration 
with cantonal employed school / LL nurses supplementing the school health services 
(thereafter referred to as school / LL nurses) included cantons AG, BL, BS, GE, SZ, VS and 
VD; and collaboration with school authorities included cantons FR, LU, NW, OW, SO, TG 
and ZG. Before this analysis could be done for HepB, the cantons were first categorized by 
their HepB vaccination policy (yes, vaccinate for HepB vs. no) or existence of a HepB 
campaign (yes vs. no) in the schools and then further subdivided into the different modes of 
data collection.  A HepB campaign is defined as one where additional HepB information was 
shared to supplement the standard disease / vaccination information given to the parents 
before the routine school health examinations. The final subsets for data collection method, in 
regards to HepB vaccination policy, are cantons where collaboration with school doctors were 
sought included AR, GL, GR, SG, SH and ZH; with school / LL nurses included cantons AG, 
BL, BS, GE, VS and VD; and with school authorities included cantons FR, NW, and TG. 
Cantons AI, LU, OW, SO, SZ, UR and ZG did not vaccinate against HepB during school 
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hours while cantons AI, BL, GL, GR, NW, OW, SG, SH, UR and ZG did not organize an 
official HepB campaign in the schools. In AR and ZH, HepB campaigns were conducted in 
the schools and help was sought from the school doctors; in cantons AG, BS, GE, SZ, VD and 
VS, school / LL nurses collected the data; and those where collaboration with school officials 
were requested included cantons FR, LU, SO and TG. 
 
Finally, immunization coverage levels for schoolchildren were further investigated by 
categorizing the cantons into those who do and do not vaccinate within the school health 
service, and those with and without school / LL nurses to supplement the school health 
services. Cantons who vaccinate in the schools (not considering HepB) include AG, AR, BE, 
BS, FR, GL, GR, JU, NE, NW, SG, SH, SZ, TG, VD, VS, and ZH; those who do not 
vaccinate in the school are AI, BL, GE, LU, OW, SO, TI, UR and ZG. Cantons AG, BL, BS, 
GE, JU, NW, SZ, VD and VS supplement their school health services with school / LL 
nurses; those without this additional help include cantons AI, AR, BE, FR, GL, GR, LU, NE, 
OW, SG, SH, SO, TG, TI, UR, ZG and ZH. As described earlier in the analysis of data 
collection modes in regard to HepB campaign and vaccination policy in the schools, the 
grouping of cantons within these two categories remain the same, but now also includes BE, 
NE and TI. HepB campaigns were also conducted in cantons BE and TI and not NE; HepB 
vaccination may be administered in the schools in BE, but not in NE and TI. 
 
Data analysis for VS 2003 is similar to those done for the cantons in 1999-2003. Additional 
information recorded includes reasons for nonresponse for schoolchildren, which were 
collected on the vaccination summary forms.   
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3. Results
3.1 Participation
Between 1999 and 2003, we have completed the study for all 3 age groups in every single canton.
Cantons participating in 1999 were VS and ZH, as part of the pilot study; throughout 2000 to 2002,
the remaining 24 cantons participated, averaging about 8 cantons per year [Annex C]. In 2003, data
collection was completed for canton VD and the study was once more repeated in canton VS, but
without the additional questionnaire. Cantons BE and TI conducted the survey in 2001 and 2002,
respectively, and shared the data with ISPMZ for analysis. Support for this study was given by all
CMO, except from cantons OW and ZG. However, a former president of the pediatric society in
canton ZG co-signed the letters sent to the parents in the name of all pediatricians in ZG. Most
cantons helped in some way during data collection, particularly with the schoolchildren, by
contributing financial and/ or personnel resources and written support such as letters to the parents,
municipalities, educational departments or offices of data protection. Cantons TG and SO were
alone responsible for the entire data collection process after ISPMZ performed the sampling; TI and
BE conducted the entire survey independently from ISPMZ, but utilized similar data collection
method for comparability purposes. In TI, all children were recruited through the schools, whereas
in BE the municipalities were used and parents were directly contacted by the Office of CMO.
3.1.1 Toddlers
For 25 cantons, toddlers between 24-35 months of age were selected, except in TI where data was
collected from children in the first year of kindergarten. Participation by the individual
municipalities was high at a mean of 97.1%, with a low of 89% in cantons TG and FR (Table 2).
These two cantons have many municipalities which, although politically integrated, were indicated as
separate entities on our sampling frame lists; consequently, some municipalities completed the
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requested information without incorporating the requests directed to the other municipalities
included in their district.
Examination of the age distribution of toddlers at the time when a vaccination card was submitted
revealed that the age ranged between 25.5 and 81.3 months, with the mean at 34.7 months of age
(standard deviation (SD) ±5.30), where 63.9% were between 25 and 35 months of age (data not
shown). When excluding toddlers from the canton of TI, the age distribution was between 25.5 and
42.4 months, 33.7 (SD ± 3.6), and 69.2%, respectively.
As indicated in Table 2, response rates from families of toddlers who submitted both vaccination
cards and questionnaires ranged from a low of 41.9% in TG to a high of 79.6% in AI with an
overall mean of 59.9%. Inclusion of information from vaccination cards based solely on parental
recalls can increase the participation to as high as 80% (data not shown). Response rates were also
increased at all 3 times of contact with the parents, with the first letter being most effective (25.7%),
followed by the telephone call (15.0%), and finally the recall letter (13.7%).
3. Results 19
Table 2.  Participation by the municipalities and the parents of toddlers, 1999-2003
          Municipalities Letters Response         Time of response (%)     Response (%)
  Canton selected (n) participated(%) sent (n) (%) 1st letter Recall Telephone VC+Q VC Q
AG 63 96.8 572 64.2 19.1 9.4 35.7 56.1 56.1 64.2
AI - - 230 80.4 31.7 21.7 27.0 79.6 80.4 80.4
AR 20 100.0 399 72.9 28.8 19.5 24.6 67.2 67.7 72.9
BE 60 100.0 567 81.1 49.4 21.9 9.9 81.1 81.1 81.1
BL 58 98.3 542 68.5 42.3 5.7 20.5 62.2 62.2 68.5
BS - - 600 55.5 27.8 11.5 16.2 47.8 48.5 54.8
FR 63 88.9 553 65.8 31.3 12.5 21.7 50.6 50.8 65.5
GE - - 848 84.7 - - - 69.0 82.8 70.9
GL 29 100.0 416 76.4 44.5 15.1 16.1 64.4 65.4 75.5
GR 57 100.0 472 70.3 28.0 19.3 22.7 58.5 58.9 69.9
JU 50 96.0 418 74.2 26.3 20.6 27.3 55.7 56.7 73.2
LU 60 98.3 630 65.1 35.9 14.1 15.1 55.9 56.5 65.1
NE - - 603 65.8 18.6 17.7 29.5 55.2 55.6 65.5
NW 11 100.0 426 78.4 43.0 18.8 16.2 69.0 69.5 77.9
OW 7 100.0 384 71.6 23.7 23.2 23.7 61.5 62.5 70.6
SG 60 100.0 496 61.7 28.0 16.3 16.5 55.2 56.0 60.9
SH 34 100.0 621 70.0 40.7 14.8 14.2 58.5 58.8 69.7
SO 62 100.0 552 56.2 - - - 53.1 53.4 55.8
SZ 30 100.0 586 73.4 41.8 14.2 17.2 65.5 66.0 72.9
TG 59 89.8 559 43.5 - - - 41.9 42.0 43.3
TI 48 95.8 930 75.5 - - - 57.2 73.5 59.1
UR 20 100.0 414 80.4 46.6 18.1 15.7 69.8 69.8 80.4
VD - - 600 69.8 27.5 24.0 17.3 60.5 63.7 66.7
VS 61 98.4 604 59.4 28.8 30.3 0.3 58.3 58.4 59.3
ZG 11 100.0 448 62.7 26.8 19.4 16.3 56.9 56.9 62.5
ZH 57 100.0 547 63.6 23.9 17.2 22.5 63.1 63.1 63.6
CH 9 2 0 9 7 . 1 1 4 0 1 7 6 8 . 7 2 5 . 7 1 3 . 7 1 5 . 0 5 9 . 9 6 2 . 3 6 6 . 4
AI, BS, NE, VD: as a central registry of all kids residing in the canton exists, it was not necessary to write to the individual municipalities.
BE, GE, SO, TG, TI: data collected by the cantons, and shared with ISPMZ.
SO, TG: one of the first cantons to participate. Hence, limited records of the nature of the responses and completeness of info.
TI: data collected via school doctors, school districts and school classes for children in first year of kindergarten.
GE: data collected from all children 28 months of age, for 2 months. BE: 2 additional recall letters instead of telephone contact.
GE, SO, TG, TI: time of response is not known; hence total (%) time of response is only 54.4%, and not 68.7%.
Language barrier (15.9%) was the most prominent reason for nonresponse once contact was made,
while not being able to reach the families by telephone (30.5%) and not locating the telephone
numbers (28.9%) were major hindrances to the response rate (Table 3). Very few parents expressed
strong feelings against vaccination as a reason for nonresponse (included in ”others”), whereas
many clearly stated that they simply did not want to participate in a survey.
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Table 3. Reasons for nonresponse (%) from parents of toddlers, 1999-2003
language Telephone nr. not does not no no wrong Total
Canton barrier not found reached moved want to time interest child others (n)
AG 23.4 23.4 38.5 2.4 5.9 3.9 2.0 0.5 0 205
AI 4.5 11.4 22.7 9.1 9.1 15.9 11.4 6.8 6.8 44
AR 18.1 30.5 16.2 5.7 11.4 11.4 4 0.0 2.9 105
BE - - - - - - - - - 107
BL 15.9 0 68.2 1.8 5.3 3.5 1.8 0 3.5 170
BS 25.3 42.4 16.0 6.3 4.1 1.5 0.7 1.1 1.1 269
FR 9.4 22.0 39.8 4.7 5.8 8.9 2.6 1.0 1.6 191
GE - - - - - - - - - 130
GL 23.3 26.2 16.5 6.8 15.5 5.8 1.0 0 0.0 103
GR 22.9 35.8 43.1 11.0 4.6 7.3 3.7 0.0 0.9 109
JU 6.7 47.2 29.2 7.9 2.2 14.6 11 0.0 1.1 89
LU 15.4 23.1 34.8 10.0 7.2 4.1 0.9 0.9 1.8 221
NE 9.7 42.7 18.4 6.3 3.4 6.8 5.3 3.4 2.9 206
NW 7.1 36.5 38.8 5.9 5.9 14.1 0 0 0 85
OW 18.7 26.7 50.7 9.3 0.0 21.3 16 1.3 1.3 75
SG 28.3 29.9 18.7 4.3 6.4 10.2 1.6 0.5 0.0 187
SH 20.2 31.9 28.7 3.7 6.4 3.2 1.6 0 0.5 188
SO - - - 1.0 - - - - - 1
SZ 19.7 28.7 22.9 3.8 7.0 6.4 0 1.3 0.0 157
TG - - - - - - - 7.0 - 7
TI - - - - - - - - - 228
UR 11.1 23.5 37.0 12.3 6.2 1.2 4.9 0 0.0 81
VD 3.1 33.8 13.3 1.5 25.1 7.2 1.0 4 3.1 195
VS - - - - - - - - - 245
ZG 19.3 32.9 25.5 4.3 5.0 9.3 1.2 0.0 2.5 100
ZH - - - - - - - - - 199
CH 1 5 . 9 2 8 . 9 3 0 . 5 6 . 2 7 . 2 8 . 2 3 . 7 1 . 4 1 . 6 3 6 9 7
Table 3.1 compares demographic characteristics between responders and nonresponders. Although
sex and language spoken in the region remain similar between these two groups, nationality and
urbanicity are significantly different, where Swiss tended to participate more than foreigners and
those from the urban regions, more than those from rural areas. Furthermore, a logistic regression
of the response rates with vaccination coverage levels at 3 doses of Di and Hib and one dose of
measles did not show any differences (data not shown); however, children residing in cantons that
achieved response rates of more than 70% have a higher chance of being up to date (UTD) at the
33333111 DTPPolHibMMR series and at 4 doses of Di, Hib, and Pol than those where response
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rates were lower than 60%, with the odds at 1.37 (confidence interval (CI): 1.09, 1.71), 1.31 (CI:
1.02, 1.67), 1.27 (CI: 1.03, 1.57) and 1.54 (CI: 1.22, 1.94), respectively (Table 3.2).
Table 3.1.  Comparison between responders and nonresponders of families with children aged
24-35 months for the survey without adjustments, 1999-2003
Responders Nonresponders
Categories N % n %
Language regions
   German-speaking 5512 71.4 2835 77.6
   French-speaking 2203 28.6 819 22.4
Nationality
   Swiss 6397 82.9 1861 55.8
   Foreigners 1318 17.1 1477 44.2
Urbanicity
   City 3508 50.1 1451 41.2
   Land 3489 49.9 2073 58.8
Gender
   Male 3712 48.1 1557 47.3
   Female 4003 51.9 1735 52.7
BE, TI, VS, ZH: not included since info on nonresponders were not collected. TG: no info on nationality and gender. GE: no info on urbanicity.
Table 3.2. Logistic regression of response rate and vaccination coverage for DTPPolHibMMR
for the number of doses at series 33333111, diphtheria at 4 doses, Haemophilus influenzae
type B (Hib) at 4 doses,  and polio at 4 doses for children 24-35 months of age living in
Switzerland, 1999-2003
Coverage for Odds Ratio Coverage Odds Ratio
series 33333111 33333111 Di (4 doses) Di (4 doses)
variable  n % %(±95%CI) (±95%CI) %(±95%CI) (±95%CI)
participation < 60% 3880 45.1 76.0 (73.9, 78.1) ref 83.0 (81.4, 84.7) ref
60-70% 2818 34.0 78.7 (76.1, 81.2) 1.16 (0.96, 1.41) 82.6 (79.7, 85.6) 0.97 (0.77, 1.23)
> 70% 2031 21.0 81.2 (78.3, 84.1) 1.37 (1.09, 1.71) 86.5 (84.0, 90.0) 1.31 (1.02, 1.67)
Coverage for Odds Ratio Coverage Odds Ratio
Hib (4 doses) Hib (4 doses) Pol (4 doses) Pol(4 doses)
variable  n % %(±95%CI) (±95%CI) %(±95%CI) (±95%CI)
participation < 60% 3880 45.1 78.6 (76.7, 80.4) ref 81.6 (79.8, 83.4) ref
60-70% 2818 34.0 78.3 (75.1, 81.5) 0.98 (0.79, 1.22) 81.3 (78.1, 84.4) 0.98 (0.77, 1.24)
> 70% 2031 21.0 83.3 (79.7, 85.0) 1.27 (1.03, 1.57) 87.2 (85.0, 89.4) 1.54 (1.22, 1.94)
CI: confidence interval. ref: reference group
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3.1.2  Schoolchildren
Participation by the schoolchildren varied dramatically, depending on the method of data collection
(via school directors, teachers, school doctors, or school health officials (Table 4, Annex D)). In
cantons where cantonal employed school nurses or school health services supplement the school
doctors at health examinations, participation rate was clearly better, ranging between 61.3% and
98.4%, with the mean being at 84.8% for children at school entry and 84.4% for those at school
departure. When working with school doctors, the response rate decreased about 20% with the
mean being 60.9% at school entry and 67.2% at school departure. Another 20-25% drop was seen
when we worked only with the school officials and teachers to reach the parents. On the other hand,
the response rates in NE where families of schoolchildren were directly contacted without aid from
the school doctors or officials were mediocre at 69.6% for school entry and 63.5% at school
departure;  in BE participation was high at 89.5% and 90.6%, respectively, after 4 contacts per mail
[Maurer, 2003]. Through the help of school doctors, response rates for the canton of TI were also
high at 84.2% and 83.7%, respectively  (Annex D.4) [Galfetti, personal communication, 2003] .
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The age distribution of the children at school entry submitting information from the vaccination card
ranged between 4.5 and 12.5 years, with the mean being 7.3 (SD±1.12) years, where 91.2% were
between ages 4 and 8. For those at school departure, the age ranged between 9.6 and 18.8 years,
with the mean being 15.0 (SD±1.06) years, where 96.7% were between ages 12 and 16 (data not
shown).    
The influence of the participation level and method of data collection (via school doctors, school/
“Lungenliga” (LL) nurses or school authorities) was also examined, in which cantons BE, NE, TI
and JU were excluded as parents in cantons BE and NE were directly contacted instead of via
schools, the canton TI constructed its own sampling frame and conducted data collection
independently from ISPMZ, and coverage estimates were not able to be assessed for canton JU. In
Table 4.1.1, it can be seen that response rates, as well as the method of data collection, for children at
school entry do not generally correlate with vaccination coverage, except for being UTD at 3 doses
Table 4. Participation by schoolchildren during school years 1999-2003, in collaboration with
cantonal employed school nurses, school doctors or school authorities.
School entry  Total           Total           Total
School nurses School doctors School authorities
n % n % n %
Number of classes 283 260 265
Number of students 4173 4280 4725
Number of participating classes 268 94.7 204 78.5 153 57.7
Number of vaccination cards 3303 79.2 2423 56.6 1754 37.1
Number of questionnaires 2547 61.0 2366 55.3 1905 40.3
Total response (VC or Q): 3540 84.8 2607 60.9 1915 40.5
Total nonresponse: 633 15.2 1673 39.1 2810 59.5
School departure School nurses School doctors School authorities
n % n % n %
Number of classes 243 252 248
Number of students 4476 4056 4714
Number of participating classes 234 96.3 189 75.0 111 44.8
Number of vaccination cards 3489 77.9 2558 63.1 1576 33.4
Number of questionnaires 2425 54.2 2084 51.4 1694 35.9
Total response (VC or Q): 3779 84.4 2724 67.2 1705 36.2
Total nonresponse: 697 15.6 1332 32.8 3009 63.8
Collaboration in cantons with school nurses: AG, BL, BS, GE, SZ, VD, VS
Collaboration in cantons with school doctors: AI, AR, GL, GR, SG, SH, UR, ZH
Collaboration in cantons with school authorities: FR, LU, NW, OW, SO, TG, ZG
BE, JU, NE, TI: not included.
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of Hib and at the 44443111 series. Children residing in cantons where participation was between
60-79% have an odds of being UTD for 3 doses of Hib of 0.65 (CI: 0.52, 0.80) times that of those
residing in cantons where participation was below 60%; for those residing in cantons where
participation was 80% or more, the odds is 0.57 (CI: 0.47, 0.69) times that of those where
participation was less than 60%. Children residing in cantons where school / LL nurses collected the
data have an odds of being UTD at the 44443111 DTPPolHibMMR series of 1.68 (CI: 1.40, 2.01)
times that of those residing in cantons where data were collected by the school doctors. In contrast,
children residing in cantons where school officials were sought to help with data collection have an
odds of 0.65 (CI: 0.53, 0.79) times that of those residing in cantons where data were collected by
the school doctors.
Table 4.1.1.  Logistic regression of response rates and data collection method and vaccination coverage
for DTPPolHibMMR for the number of doses at series 44443111, diphtheria at 4 doses, Haemophilus
influenzae type B (Hib) at 3 doses and measles at 1 dose for children at entry living in Switzerland,
1999-2003
Coverage for Odds Ratio Coverage Odds Ratio
variable series 44443111 44443111 Di (4 doses) Di (4 doses)
n % %(±95%CI) (±95%CI) %(±95%CI) (±95%CI)
participation < 60% 3418 40.8 48.8 (45.9, 51.6) ref 91.8 (90.6, 93.1) ref
60-79% 1713 22.4 50.9 (47.1, 54.6) 1.09 (0.90, 1.31) 92.0 (90.2. 93.8) 1.03 (0.76, 1.39)
≥ 80% 2337 36.7 48.5 (45.3, 51.8) 0.99 (0.83, 1.18) 92.9 (91.3, 94.4) 1.16 (0.87, 1.55)
data collection school doctors 2410 32.4 46.5 (43.1, 50.0) ref 92.6 (90.7, 94.4) ref
method school nurses 3304 41.8 59.3 (56.5, 62.2) 1.68 (1.40, 2.01) 92.4 (91.3, 93.5) 0.98 (0.72, 1.34)
school officials 1754 25.8  36.1 (32.9, 39.2) 0.65 (0.53, 0.79) 91.6 (89.9, 93.3) 0.87 (0.62, 1.24)
Coverage for Odds Ratio Coverage Odds Ratio
variable Hib (3 doses) Hib (3 doses) Measles (1 dose) Measles (1 dose)
n % %(±95%CI) (±95%CI) %(±95%CI) (±95%CI)
participation < 60% 3418 40.8 83.8 (82.2, 85.4) ref 88.7 (87.4, 90.0) ref
60-79% 1713 22.4 76.9 (73.9, 80.0) 0.65 (0.52, 0.80) 87.2 (84.7, 89.8) 0.87 (0.67, 1.14)
≥ 80% 2337 36.7 74.7 (71.8, 77.5) 0.57 (0.47, 0.69) 90.6 (88.8, 92.3) 1.23 (0.96, 1.57)
data collection school doctors 2410 32.4 77.2 (74.2, 80.2) ref 89.0 (86.9, 91.0) ref
method school nurses 3304 41.8 79.6 (77.8, 81.3) 1.15 (0.94, 1.41) 90.1 (88.8, 91.4) 1.12 (0.87, 1.46)
school officials 1754 25.8 80.0 (77.2, 82.8) 1.18 (0.93, 1.50) 87.4 (85.3, 89.5) 0.86 (0.65, 1.14)
CI: confidence interval. ref: reference group. BE, JU, NE, TI: not included in analysis.
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For children at school departure, Table 4.1.2 revealed that the method of data collection is more
associated with vaccination coverage than the response rate. For adolescents residing in cantons
where participation reached 80% or more, the odds of being UTD for 5 doses of Pol is 1.69 (CI:
1.33, 2.16) times that of those residing in cantons where participation was below 60%. Data
collection method is highly correlated with being UTD at the 5505111 DTPPolMMR series and 5
doses of Di and Pol where adolescents residing in cantons in which the help of school / LL nurses
was sought have an odds of 1.38 (CI: 1.10, 1.72), 1.36 (CI: 1.04, 1.77) and 1.76 (CI: 1.36, 2.27),
respectively, times that of those residing in cantons in which school doctors aided in data collection.
By HepB, there are significant associations between coverage estimate and participation and mode
of data collection (Table 4.1.2.1). Adolescents residing in cantons where participation ranged
between 60 and 79% had a significantly lower chance of being UTD (odds ratio: 0.54, CI: 0.38,
0.76) at 1 dose of HepB than those living in cantons where participation in the study was less than
60%. Teenagers living in cantons in which doctors aided in data collection and where there were
either HepB campaigns implemented or HepB vaccination permitted in the schools have a lower
chance of being UTD for 1 dose and 3 doses of HepB than those residing in cantons where there
were neither HepB campaigns nor were HepB vaccination permitted in the schools. In contrary,
adolescents residing in cantons where data collection were conducted by the school or LL nurses
and school authorities have a higher chance (odds ratio: 2.16 (CI: 1.60, 2.91) and 2.01 (CI: 1.31,
3.09), respectively), of being UTD at 1 dose of HepB when considering whether or not HepB
vaccination is permitted in the schools.
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Table 4.1.2.  Logistic regression of response rates and data collection method and vaccination
coverage for DTPPolMMR for the number of doses at series 5505111, diphtheria at 5 doses,
polio at 5 doses and measles at  1 dose for children at school departure living in Switzerland,
1999-2003
Coverage for Odds Ratio Coverage Odds Ratio
variable series 5505111 5505111 Di (5 doses) Di (5 doses)
n % %(±95%CI) (±95%CI) %(±95%CI) (±95%CI)
participation < 60% 2196 32.0 72.6 (69.8, 75.4) ref 80.5 (77.8, 83.3) ref
60-79% 3224 33.4 69.1 (65.1, 73.2) 0.85 (0.67, 1.07) 78.9 (75.2, 82.6) 0.91 (0.68, 1.20)
≥ 80% 2203 34.6 75.8 (73.4, 78.2) 1.19 (0.98, 1.44) 83.1 (80.8, 85.3) 1.18 (0.94, 1.50)
data collection school doctors 2558 35.2 69.6 (65.5, 73.7) ref 78.4 (74.6, 82.3) ref
method school nurses 3490 42.9 75.9 (73.9, 77.9) 1.38 (1.10, 1.72) 83.1 (81.2, 85.1) 1.36 (1.04, 1.77)
school officials 1575 22.0 70.7 (67.5, 73.8) 1.05 ( 0.83, 1.35) 80.4 (77.5, 83.2) 1.13 (0.84, 1.50)
Coverage for Odds Ratio Coverage Odds Ratio
variable Pol (5 doses) Pol (5 doses) Measles (1 dose) Measles (1 dose)
n % (±95%CI) %(±95%CI) %(±95%CI) (±95%CI)
participation < 60% 2196 32.0 78.1 (75.2, 81.1) ref 95.1 (94.0, 96.3) ref
60-79% 3224 33.4 75.4 (71.5, 79.2) 0.86 (0.65, 1.12) 93.8 (92.6, 95.1) 0.78 (0.56, 1.08)
≥ 80% 2203 34.6 85.8 (83.7, 87.9) 1.69 (1.33, 2.16) 94.3 (93.3, 95,3) 0.84 (0.62, 1.15)
data collection school doctors 2558 35.2 75.9 (72.0, 79.9) ref 94.5 (93.3, 95.8) ref
method school nurses 3490 42.9 84.7 (82.9, 86.5) 1.76 (1.36, 2.27) 94.5 (93.6, 95.3) 0.99 (0.73, 1.33)
school officials 1575 22.0 76.7 (73.4, 80.0) 1.05 (0.79, 1.39) 94.1 (92.8, 95.5) 0.93 (0.66, 1.31)
CI: confidence interval. ref: reference group. BE, JU, NE, TI: not included in analysis.
Table 4.1.2.1   Logistic regression of response rates and data collection method and vaccination
coverage for Hepatitis B (HepB) at one dose and three doses for children at school departure
living in Switzerland, 1999-2003
Coverages for Odds Ratio Coverages for Odds Ratio
variable HepB (1 dose) HepB (1 dose) HepB (3 doses) HepB (3 doses)
  n % %(±95%CI) (±95%CI) %(±95%CI) (±95%CI)
participation < 60% 2196 32.0 48.6 (42.4, 54.8) ref 26.8 (22.2, 31.3 ) ref
60-79% 3224 33.4 33.7 (28.6, 38.9) 0.54 (0.38, 0.76) 21.4 (17.6, 25.3) 0.75 (0.54, 1.03)
≥ 80% 2203 34.6 55.2 (50.0, 60.4) 1.30 (0.94, 1.81) 22.0 (18.1, 25.8) 0.77 (0.56, 1.06)
data collection no HepB campaign 2353 20.9 54.0 (46.1, 61.9) ref 23.2 (17.6, 28.7) ref
method school doctors 761 20.4 21.1 (13.7, 28.6) 0.23 (0.13, 0.40) 7.3 (2.3, 12.2) 0.26 (0.12, 0.57)
school nurses 3143 39.7 53.2 (48.6, 57.8) 0.97 (0.67, 1.40) 23.7 (20.2, 27.1) 1.03 (0.72, 1.48)
school officials 1366 19.0 48.7 (42.3, 55.0) 0.81 (0.54, 1.21) 40.0 (34.5, 45.4) 2.21 (1.51, 3.25)
data collection no HepB vaccination 1620 15.9 37.9 (32.4, 43.4) ref 31.3 (26.4, 36.2) ref
method school doctors 2128 34.1 34.2 (27.5, 41.0) 0.85 (0.58, 1.25) 12.2 (7.9, 16.5) 0.31 (0.19, 0.49)
school nurses 3049 40.3 56.8 (52.3, 61.4) 2.16 (1.60, 2.91) 25.4 (22.0, 28.9) 0.75 (0.56, 1.00)
school officials 826 9.8 55.1 (46.2, 64.0) 2.01 (1.31, 3.09) 40.2 (32.9, 47.6) 1.48 (1.01, 2.16)
CI: confidence interval. ref: reference group. BE, JU, NE, TI: not included in analysis.
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3.2 Demographic comparison of participants in the survey
Table 5 displays demographic comparison of the children participating in the survey with the data
from the SFSO, with and without weighting, nonresponse adjustments and poststratification. As it
can be seen by the toddlers, where no adjustments and weights were made, participants were similar
to the demographic statistics provided by the SFSO only in terms of gender. By nationality and
urbanicity, the differences were very apparent. After the application of sampling weights,
nonresponse adjustments and poststratification, the distribution of the demographic variables were
much more similar to those from the SFSO. By the schoolchildren the difference in demographic
background between the participants and the authorative figures from the SFSO varied very little.
Similar to the toddlers, with the necessary adjustments and poststratification, the demographic
background became more comparable (Annex E for cantonal details).
3. Results 28
Table 5.  Demographic comparison (%) of children participating in the survey in the German-,
French-, and Italian-speaking regions with and without weights, nonresponse adjustments and
poststratification, 1999-2003
a. Toddlers
  German French Italian Switzerland
 5755 2290 684 8729 77547
 Survey Survey Survey Survey SFSO
 n no adj. adj. n no adj. adj. n no adj. adj. n no adj. adj. n %
Nationality       
 Swiss 4981 86.6 74.4 1757 76.7 67.0 406 59.4 72.5 7144 81.8 72.4 56136 72.4
 Foreigners 774 13.4 25.6 533 23.3 33.0 278 40.6 27.5 1585 18.2 27.6 21411 27.6
       
Gender       
 Male 2993 52.0 51.6 1202 52.5 50.9 358 52.3 51.7 4553 52.2 51.4 39661 51.1
 Female 2762 48.0 48.4 1088 47.5 49.1 326 47.7 48.3 4176 47.8 48.6 37886 48.9
       
Urbanicity       
 City 2708 51.1 65.4 809 50.9 58.1 - - - 3517 51.1 63.4 39039 63.5
 Land 2587 48.9 34.6 779 49.1 41.9 - - - 3366 48.9 36.5 22479 36.5
b. School entry
  German French Switzerland
 6337 2323 8660 83794
 Survey Survey Survey SFSO
 n no adj. adj. n no adj. adj. n no adj. adj. n %
Nationality      
 Swiss 4934 77.9 79.0 1814 78.1 72.2 6748 77.9 77.3 64607 77.1
 Foreigners 1403 22.1 21.0 509 21.9 27.8 1912 22.1 22.7 19183 22.9
      
Gender      
 Male 3184 50.2 50.6 899 49.8 50.8 4083 50.2 50.6 42309 50.6
 Female 3153 49.8 49.4 905 50.1 49.2 4058 49.8 49.4 41435 49.4
c. School departure
  German French Switzerland
 6072 2739 8811 76603
 Survey Survey Survey SFSO
 n no adj. adj. n no adj. adj. n no adj. adj. n %
Nationality      
 Swiss 4906 80.8 79.0 2147 78.4 73.8 7053 80.0 77.6 59299 77.4
 Foreigners 1166 19.2 21.0 592 21.6 26.2 1758 20.0 22.3 17304 22.6
      
Gender      
 Male 3068 50.5 50.6 1018 51.6 49.2 4024 50.0 50.6 38750 50.6
 Female 3004 49.5 49.4 956 48.4 50.8 4022 50.0 49.4 37854 49.4
Note: not all information was available for all cantons. adj.: adjustments, includes weights, nonresponse adj., poststratification.
SFSO: Figures provided by the Swiss Federal Statistical Office and cantonal offices of statistics.
Total compiled for period between 1999-2003.
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3.3 Immunization coverage
Immunization coverage varies within all 3 different age groups (Table 6). 78.0% of the toddlers
living in Switzerland are UTD with the 33333111 DTPPolHibMMR series and 70.6% at the
44443111 series. More specifically, cantons SH, AR, AI are among the lowest to be vaccinated, at
49.4%, 66.4%, 66.7%, respectively, for the 33333111 series while TI at 90.7%, VS at 89.6%, and
GE at 87.4% are the highest (Annex F.1); for the 44443111 series, SH and AI remain as the
cantons with the lowest vaccination coverage while GE and TI as the highest. When analyzing
vaccination coverage by the different linguistic regions, toddlers residing in the German-speaking
region are only 74.6% UTD for the 33333111 series and 67.0% for the 44443111 series, whereby
toddlers in the French-speaking region have a coverage of 86.0% and 78.6%, respectively, and for
the canton of TI, coverage levels are even higher at 90.7% and 85.6%, respectively.
Only 69.2% of the children at school entry are UTD at the 33333111 series, 49.2% at the 44443111
series, 16.0% at the 55553111 series and 9.9% at the 55553222 series. The same trend can be
observed by the children at school entry as compared to the toddlers for all three series, with the
children in the German-speaking region having the lowest immunization coverage, followed by the
French-speaking region, with the Italian-speaking region having the highest coverage. Due to
missing information for Per and Hib from some school classes (total of 3 classes for children at
school entry and 6 for those at school departure), coverage estimates were also examined without
including Per and Hib for toddlers and children at school entry for comparative purposes. When not
considering Per and Hib, coverage estimates for toddlers remained similar to the series with Per and
Hib at 79.8% and 73.0% at the 33030111 and 44040111, respectively, DTPPolHibMMR series.
For children at school entry, there is a large difference where 84.8% are vaccinated at the 33030111
DTPPolHibMMR series, 81.7% at the 44040111 series, 52.6% at the 55050111 series, and 29.6%
at the 55050222 series. More specifically, the canton of SH is lowest at 56.7% for the 33333111
series and 25.1% for the 44443111 series while TI displays the highest coverage at 86.5% and
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83.9%, respectively (Annex F.2.1, F.2.2). Even when not considering Per and Hib in the
DTPPolHibMMMR immunization series, the same trends are seen at the cantonal level.
Finally, this pattern as observed in the two younger age groups, can also be seen by children at
school departure, with the DTPPolMMR series which included Per being slightly lower as
compared to the series examined without Per. Here the cantons of VS and OW have the lowest
coverage for the 6 different DTPPolMMR series while SZ has the highest coverage  (Annex F.3.1,
F.3.2), regardless if the series included Per or not. Additionally, cantons UR and ZG are often
among the cantons with the highest immunization coverage levels for the series requiring 3, 4 or 5
doses for Di and Te, i.e. 3333111, 4434111, 5535111 and 5535222, whereas cantons VD and AG
are among the highest for immunization series requiring 6 doses for Di and Te, i.e. 6635111 and
6635222.
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Table 6.  Vaccination coverage at different DTPPolHibMMR series, with and without pertussis
and Hib among toddlers 24-35 months of age and children at school entry and DTPPolMMR for
in the German-, French- and Italian-speaking regions of Switzerland, 1999-2003
       % coverage at different DTPPolHibMMR series
Age groups Regions n 33030111 44040111   
Toddlers German-speaking 5755 76.3 69.7  
(without pertussis French-speaking 2282 87.8 80.6  
and Hib) Italian-speaking 684 92.4 87.1  
 Switzerland 8721 79.8 73.0  
   
 n 33333111 44443111   
Toddlers German-speaking 5755 74.6 67.0  
(with pertussis French-speaking 2282 86.0 78.6  
and Hib) Italian-speaking 679 90.7 85.6  
 Switzerland 8716 78.0 70.6   
  % coverage at different DTPPolHibMMR series
Age groups Regions n 33030111 44040111 55050111 55050222
School entry German-speaking 6313 83.3 80.4 52.7 33.2
(without pertussis French-speaking 2019 87.8 84.5 53.5 18.1
and Hib) Italian-speaking 789 92.4 90.0 45.4 32.7
 Switzerland 9121 84.8 81.7 52.6 29.6
   
 n 33333111 44443111 55553111 55553222
School entry German-speaking 6275 67.1 44.8 11.9 9.1
(with pertussis French-speaking 2018 72.6 56.9 24.0 9.0
and Hib) Italian-speaking 787 86.5 83.9 42.1 30.9
 Switzerland 9080 69.2 49.2 16.0 9.9
   % coverage at different DTPPolMMR series
Age groups Regions n 3303111 4404111 5505111 5505222 6605111 6605222
School departure German-speaking 6043 83.7 81.3 72.0 40.9 47.4 31.8
(without pertussis) French-speaking 2320 84.9 82.1 71.8 49.0 44.7 36.9
 Italian-speaking 681 87.2 86.3 75.9 48.2 50.1 38.5
 Switzerland 9044 84.2 81.7 72.1 43.2 47.2 33.3
   
 n 3333111 4434111 5535111 5535222 6635111 6635222
School departure German-speaking 5931 75.7 75.0 67.7 38.6 45.0 30.2
(with pertussis) French-speaking 2320 78.3 76.8 68.4 46.6 44.7 35.7
 Italian-speaking 678 78.2 78.0 70.1 45.7 45.7 36.4
 Switzerland 8929 76.5 75.6 68.0 40.9 44.9 31.9
JU: not included for schoolchildren since vaccination cards were not collected. TI toddlers: data collected from children in Kindergarten via school classes.
"n"s for with and without Per and /or Hib do not equate as it was not possible to assess them from some vax cards. toddlers: missing info on Hib for 5 kids in TI.
school entry: in addition to single cases from TI, VD and ZG, Per and/or Hib were not assessed for 2 classes (13 kids) from AI and 24 kids from BS.
school exit: in addition to a couple of cases from SG, SH and TI, Per and /or Hib were not assessed for 3 classes (28 kids) from AI, 2 classes (21 kids) from GR,
and 57 kids from BS.
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Table 6.1 presents a summary of the coverage, along with the range, by vaccine per dose for all three
age groups. Coverage estimates for the first 3 doses of Di, Te, and Pol for all 3 age groups,
including Per and Hib for the toddlers, are relatively high (> 90%). After this, coverage declines, for
example to as low as 83.6% for 4 doses of Di for toddlers, 60.0% for 5 doses for children at school
entry and 51.4% for 6 doses for the teenagers.  Coverage levels for 1 dose of measles, mumps and
rubella are 82.3%, 81.1% and 80.8%, respectively, for toddlers and increase to 88.4%, 87.0% and
86.6% for those at school entry (Table 6.1, Annex F.4); they remain around 50% at 2 doses for all 3
vaccines for the adolescents. For children at school departure, HepB coverage estimates had a wide
range, from 7.5% to 88.3% (mean 46.3%) for 1 dose, 6.7% to 82.0% (mean 40.8%) for 2 doses
and 2.3% to 68.3% (mean 25.9%) for 3 doses. Here cantons AI, UR and SZ always have the lowest
coverage estimates for all 3 doses for HepB, whereas cantons NW and VD have the highest for the
1st and 2nd doses (Annex F.4).
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Table 6.1  Vaccination coverage (%) by number of doses, Switzerland 1999-2003
(cantonal range)
a) toddlers (24-35 months)
Vaccination Doses
0 ≥1 ≥2 ≥3 ≥4 ≥5 ≥6
Diphtheria 2.8
0 – 9.3
97.2
90.7 – 100.0
96.6
89.5 – 99.2
95.4
88.7 – 98.5
83.6
66.8 – 92.4
Tetanus 2.1
0 – 7.8
97.9
92.2 – 100.0
97.3
91.1 – 99.5
95.9
89.9 – 98.5
83.7
67.2 – 92.4
Pertussis 5.3
0.7 – 13.2
94.7
86.8 – 99.3
94.1
86.4 – 98.2
92.9
86.0 – 97.8
81.3
63.7 – 92.0
Poliomyelitis 2.8
0.3– 8.9
97.2
91.1 – 99.7
96.6
90.3 – 99.5
95.3
89.1 – 97.8
82.7
61.1 – 90.8
H. influenzae 5.9
1.1 – 12.4
94.1
87.6 – 98.9
92.8
87.6 – 97.0
91.1
86.0 – 96.0
79.3
60.8 – 87.1
Measles 17.7
6.3 – 31.4
82.3
68.6 – 93.7
7.8
0 – 48.2
Mumps 18.9
6.7 – 33.2
81.1
66.8 – 93.3
7.7
0 – 47.8
Rubella 19.2
6.7 – 48.7
80.8
51.3 – 93.3
7.7
47.8
b) school entry (Grades: Kindergarten, 1-3)
Vaccination Doses
0 ≥1 ≥2 ≥3 ≥4 ≥5 ≥6
Diphtheria 0.9
0 – 2.9
99.1
97.1 – 100.0
98.0
95.8 – 100.0
97.1
94.1 – 98.8
92.5
83.2 – 95.6
60.0
14.6 – 80.9
Tetanus 0.6
0 – 2.2
99.4
97.8 – 100.0
98.3
98.8 – 100.0
97.3
94.1 – 98.8
92.7
85.6 – 98.9
60.2
14.6 – 80.9
Pertussis 6.6
1.1 – 15.7
93.4
84.3 – 98.9
91.0
69.9 – 97.7
88.9
64.0 – 96.8
60.9
32.1 – 92.8
19.4
1.2 – 51.5
Poliomyelitis 0.9
0 – 2.4
99.1
97.6 – 100.0
98.0
96.0 – 100.0
97.0
93.5 – 98.8
92.0
73.6 – 95.9
59.6
9.2 – 78.8
H. influenzae 9.9
3.3 – 15.6
90.1
84.4 – 96.7
86.6
79.5 – 96.6
78.3
67.5 – 91.3
26.6
3.0 – 80.1
Measles 11.6
6.2 – 19.3
88.4
80.7 – 93.8
36.6
3.5 – 69.6
Mumps 13.0
6.3 – 23.6
87.0
76.4 – 93.7
36.0
3.0 – 69.4
Rubella 13.4
6.3 – 38.1
86.6
61.9 – 93.7
35.9
3.0 – 69.6
c) school exit (Grades: 6-9)
Vaccination Doses
0 ≥1 ≥2 ≥3 ≥4 ≥5 ≥6
Diphtheria 1.1
0 – 5.1
98.9
94.9 – 100.0
95.5
87.7 – 99.2
93.1
86.3 – 99.2
90.2
81.6 – 95.9
81.6
56.3 – 94.0
51.4
15.8 – 78.7
Tetanus 1.0
0 – 5.1
99.0
94.9 – 100.0
95.7
87.9 – 100.0
93.3
86.7 – 99.2
90.5
82.8 – 96.2
82.2
58.9 – 94.0
52.1
17.3 – 78.8
Pertussis 12.5
2.1 – 55.8
87.5
44.2 – 97.9
86.0
42.4 – 96.2
83.5
41.1 – 95.0
12.9
0.7 – 28.7
3.4
0.0 – 22.5
Poliomyelitis 1.1
0 – 6.8
98.9
93.2 – 100.0
95.7
89.2 – 100.0
93.0
86.0 – 98.4
90.0
84.1 – 96.2
80.7
64.0 – 91.7
Measles 6.2
0.9– 16.0
93.8
84.0 – 99.1
54.0
13.5 – 82.6
Mumps 6.9
0.9 – 18.2
93.1
81.8 – 99.1
52.7
12.3 – 82.6
Rubella 9.4
0 – 20.5
90.6
79.5 – 100.0
49.8
12.3 – 82.6
Hepatitis B 53.7
11.7 – 92.5
46.3
7.5 – 88.3
40.8
6.7 – 82.0
25.9
2.3 – 68.3
JU: not included for schoolchildren. BE: Per ≥4 doses and MMR ≥ 2 doses were not considered; Reference: A.-M. Maurer. Durchimpfung bei Kleinkindern, nach Schuleintritt und -austritt im Kanton Bern 2001. BAG Bulletin
2003. 26: 445-50. TI: Data collected by Ufficio del medico cantonale. Instead of 24-35 months of age, data was collected from the children in kindergarten.
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Using information extracted from the vaccination card, 219 (2.0%) children 24-35 months remain
completely unvaccinated, 39 (0.4%) for those at school entry, and 48 (0.5%) for those at school
departure (Table 7, Annex G). More specifically, the German-speaking region has the majority of
the kids who are unvaccinated living in their area. The total number of children who remain
unvaccinated is relatively small, with more toddlers remaining unvaccinated as compared to
schoolchildren.
Table 7.  Distribution of children who remain unvaccinated among toddlers 24-35 months of age
and children at school entry and departure in the German-, French- and Italian-speaking regions
of Switzerland, 1999-2003
  Unvaccinated children
Age groups Regions N n %
Toddlers German-speaking 5734 203 2.6
 French-speaking 2282 16 0.7
 Italian-speaking 679 0 0.0
 Switzerland 8715 219 2.0
   
School entry German-speaking 6275 38 0.6
 French-speaking 2018 0 0.0
 Italian-speaking 787 1 0.1
 Switzerland 9080 39 0.4
   
School departure German-speaking 6043 29 0.4
 French-speaking 2320 13 0.5
 Italian-speaking 681 6 0.9
 Switzerland 9044 48 0.5
"Not vaccinated status" is determined by vaccination card.  Because vaccination cards were not collected in canton JU, questionnaires
used to confirm vaccination status. Hence, the calculation for school children does not include JU.
3.4 Demographic influence on immunization coverage
Tables 8 display results from the logistic regression analysis for social and demographic factors
extracted from the questionnaire with immunization coverage. Sex does not play a significant role in
vaccination coverage; in contrast, the total number of siblings, both older and younger, are
significant factors in vaccination coverage, but only with selected vaccines. 95.0% of toddlers who
have 1 or more siblings are vaccinated with 3 doses for Di compared to 97.4% of those who do not
have any siblings (Table 8.1).
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The odds of being UTD at 3 doses of Di among toddlers who have 1 or more siblings is 0.52 (CI:
0.34, 0.79) times that of those who do not have any siblings. Furthermore, the odds of being UTD
for Di at 3 doses among toddlers with more than one younger sibling is 0.69 times (CI: 0.51, 0.93)
that of those with no younger siblings. In this case, only 94.4% of those with younger siblings are
UTD for 3 doses of Di, in comparison to 96.1% of those without younger siblings. Similar to Di at
3 doses, toddlers with siblings are significantly less vaccinated for measles than those with no
siblings, with 81.2% and 84.8%, respectively, and the odds ratio being 0.77 (CI: 0.62, 0.97).
Toddlers with older siblings have a significantly lower chance of being UTD for measles at 1 dose
than those without older siblings, with the odds being 0.83 (CI: 0.70, 0.97). Another significant
factor associated with being UTD for measles at one dose and series 33333111 is the nationality of
the child. 82.2% of children of foreign background are UTD at the series 33333111 compared to
only 76.4% of Swiss toddlers; for measles at one dose, they are 87.7% and 80.2%, respectively. The
odds of being UTD for measles at one dose among children of foreign ethnicity is 1.76 (CI: 1.40,
2.20) times that of the Swiss children; at series 33333111 the odds of being UTD among non-
Swiss children is 1.42 (CI: 1.19, 1.68) times that of Swiss children. Closer examination of the
nationality of the children revealed in Table 8.1.1 that only children from countries designated as
from southern Europe are significantly better vaccinated against Di and Hib and are more likely to
be UTD at the 333333111 series than Swiss children. The odds of being UTD for 3 doses of Di,
Hib and at the 333333111series among children from southern Europe is 2.85 (CI: 1.28, 6.34), 2.42
(1.24, 4.72) and 4.54 (CI: 2.91, 7.09), respectively, times that of Swiss children. For measles at one
dose, the odds is increased to 7.39 (CI: 4.40, 12.43) times; children of African background also
have a significantly higher chance of being vaccinated for measles than Swiss children (odds ratio:
4.28 (CI: 1.40, 13.07)).
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Table 8.1. Logistic regression of social and demographic factors and vaccination coverage for
DTPPolHibMMR for the number of doses at series 3333111, diphtheria at 3 doses, Haemophilus
influenzae  type B  (Hib) at 3 doses and measles at 1 dose for children 24-35
months of age living in Switzerland, 1999-2003
Coverage for Odds Ratio Coverage Odds Ratio
series 33333111 33333111 Di (3 doses) Di (3 doses)
variable  n % %(±95%CI) (±95%CI) %(±95%CI) (±95%CI)
sex of child female 4553 51.4 78.5 (76.4, 80.5) ref 95.5 (94.6, 96.4) ref
male 4176 48.6 77.6 (75.7, 79.5) 0.94 ( 0.81, 1.10) 95.3 (94.4, 96.2) 0.96 (0.73, 1.25)
sibling none 1820 25.2 80.6 (77.4, 83.8) ref 97.4 (96.3, 98.5) ref
≥1 6039 74.8 77.0 (75.3, 78.6) 0.80 (0.64, 1.00) 95.0 (94.3, 95.8) 0.52 (0.34, 0.79)
younger sibling none 5546 72.3 78.8 (76.9, 80.6) ref 96.1 (95,4, 96.8) ref
≥1 2313 27.7 75.6 (72.9, 78.3) 0.84 (0.69, 1.00) 94.4 (93.1, 95.8) 0.69 (0.51, 0.93)
older sibling none 3413 45.3 79.2 (77.0, 81.4) ref 96.3 (95.2, 97.4) ref
≥1 4446 54.7 76.8 (74.9, 78.7) 0.87 (0.74, 1.02) 95.1 (94.2, 95.9) 0.74 (0.52, 1.05)
nationality of Swiss 7144 72.4 76.4 (74.6, 78.1) ref 95.1 (94.4, 95.8) ref
child nonSwiss 1585 27.6 82.2 (79.7, 84.6) 1.42 (1.19, 1.68) 96.2 (94.9, 97.5) 1.31 (0.90, 1.90)
educational level low 965 15.5 83.9 (80.9, 87.0) ref 96.5 (94.8, 98.2) ref
of the mother middle 5563 63.4 78.4 (76.7, 80.1) 0.69 (0.55, 0.88) 96.0 (95.2, 96.7) 0.86 (0.51, 1.45)
high 1604 21.1 73.0 (69.5, 76.5) 0.52 (0.39, 0.68) 93.6 (92.0, 95.2) 0.53 (0.30, 0.91)
Coverage Odds Ratio Coverage Odds Ratio
Hib (3 doses) Hib  (3 doses) Measles (1 dose) Measles (1 dose)
variable  n % %(±95%CI) (±95%CI) %(±95%CI) (±95%CI)
sex of child female 4553 51.4 91.2 (90.0, 92.5) ref 82.4 (80.4, 84.3) ref
male 4176 48.6 91.0 (89.8, 92.3) 0.97 (0.80, 1.19) 82.2 (80.5, 83.8) 0.99 (0.84, 1.17)
sibling none 1820 25.2 92.6 (90.7, 94.5) ref 84.8 (82.1, 87.4) ref
≥1 6039 74.8 90.7 (89.6, 91.8) 0.78 (0.57, 1.07) 81.2 (79.7, 82.7) 0.77 (0.62, 0.97)
younger sibling none 5546 72.3 95.8 (95.0, 96.5) ref 82.9 (81.2, 84.5) ref
≥1 2313 27.7 94.8 (93.7, 95.9) 0.84 (0.64, 1.10) 80.1 (77.5, 82.8) 0.83 (0.68, 1.03)
older sibling none 3413 45.3 91.8 (90.4, 93.2) ref 83.6 (81.7, 85.6) ref
≥1 4446 54.7 90.7 (89.5, 91.9) 0.87 (0.69, 1.09) 80.8 (79.1, 82.5) 0.83 (0.70, 0.97)
nationality of Swiss 7144 72.4 90.6 (89.5, 91.7) ref 80.2 ( 78.7, 81.7) ref
child nonSwiss 1585 27.6 92.5 (90.6, 94.4) 1.28 (0.95, 1.71) 87.7( 85.4, 90.0) 1.76 (1.40, 2.20)
educational level low 965 15.5 93.2 (90.9, 95.6) ref 88.1 (85.1, 91.1) ref
of the mother middle 5563 63.4 91.8 (90.7, 92.9) 0.81 (0.55, 1.19) 82.8 (81.1, 84.5) 0.65 (0.48, 0.89)
high 1604 21.1 88.7 (86.5, 90.9) 0.57 (0.38, 0.86) 76.6 (73.0, 80.4) 0.44 (0.31, 0.63)
CI: confidence interval. ref: reference group. TI: not included in analysis for siblings
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Table 8.1.1 Logistic regression of nationality and vaccination coverage for DTPPolHibMMR
for the number of doses at series 3333111, diphtheria at 3 doses, Haemophilus influenzae type
B (Hib) at 3 doses and measles at 1 dose for children aged 24-35 months living in Switzerland,
1999-2003
Coverage for Odds Ratio Coverage Odds Ratio
series 33333111 33333111 Di (3 doses) Di (3 doses)
variable  n % %(±95%CI) (±95%CI) %(±95%CI) (±95%CI)
nationality of Swiss 7007 72.4 76.3 (74.7, 78.0) ref 95.1 (94.4, 95.8) ref
child Europe (EU + Norway) 929 15.6 83.7 (79.7, 87.8) 1.59 (1.19, 2.13) 96.8 (95.1, 98.6) 1.58 (0.87, 2.85)
Eastern Europe, incl.
Turkey 398 8.3 79.6 (74.0, 85.1) 1.21 (0.86, 1.69) 96.1 (93.3, 98.9) 1.26 (0.60, 2.65)
Asia 75 1.6 79.2 (67.5, 90.8) 1.78 (0.58, 2.38) 88.4 (78.0, 98.8) 0.39 (0.14, 1.08)
Others 123 2.1 82.7 (73.2, 92.2) 1.48 (0.74, 2.96) 97.8 (95.7, 99.9) 2.28 (0.84, 6.17)
nationality of Swiss 6158 71.2 76.1 (74.2, 78.0) ref 95.0 (94.2, 95.8) ref
child
Northern + Western
Europe 223 5.6 67.3 (57.1, 77.5) 0.65 (0.41, 1.02) 95.0 (91.0, 100.0) 1.02 (0.34, 3.01)
(in more detail- Southern Europe 464 11.2 93.5 (90.8, 96.3) 4.54 (2.91, 7.09) 98.2 (96.8, 99.6) 2.85 (1.28, 6.34)
does not include Eastern Europe 344 8.3 77.7 (71.2, 84.2) 1.09 (0.75, 1.60) 95.5 (92.0, 98.9) 1.11 (0.51, 2.44)
BE, TI, TG) Canada, US, Australia 25 0.5 70.0 (44.9, 93.0) 0.70 (0.22, 2.22) 97.3 (91.8, 102.8) 1.92 (0.23, 15.80)
Latin America, Caribbean 20 0.6 84.9 (67.2, 102.6) 1.77 (0.43, 7.22) 95.4 (88.6, 102.2) 1.10 (0.23, 5.23)
Asia 69 1.8 80.2 (68.2, 92.1) 1.27 (0.60, 2.69) 90.0 (79.4, 100.5) 0.47 (0.15, 1.51)
Africa 47 0.9 85.1 (74.7, 95.5) 1.80 (0.78, 4.13) 98.1 (94.3, 101.9) 2.71 (0.36, 20.34)
Coverage Odds Ratio Coverage Odds Ratio
Hib (3 doses) Hib (3 doses) Measles (1 dose) Measles (1 dose)
variable  n % %(±95%CI) (±95%CI) %(±95%CI)  (±95%CI)
nationality of Swiss 7007 72.4 90.6 (89.5, 91.7) ref 80.1 (78.6, 81.6) ref
child Europe (EU + Norway) 929 15.6 93.7 (91.0, 96.4) 1.54 (0.97, 2.44) 88.2 (84.9, 91.4) 1.85 (1.36, 2.52)
Eastern Europe, incl.
Turkey 398 8.3 91.0 (87.2, 94.7) 1.05 (0.65, 1.69) 86.1 (81.4, 90.8) 1.54 (1.03, 2.30)
Asia 75 1.6 86.7 (76.3, 97.0) 0.68 (0.27, 1.66) 92.3 (84.4, 100.2) 2.98 (0.98, 9.10)
Others 123 2.1 93.8 (90.0, 97.7) 1.58 (0.79, 3.16) 87.3 (79.6, 95.0) 1.70 (0.83, 3.50)
nationality of Swiss 6158 71.2 90.6 (89.3, 91.7) ref 80.1 (78.3, 81.8) ref
child
Northern + Western
Europe 223 5.6 89.6 (83.6, 95.6) 0.90 (0.47, 1.74) 75.3 (66.3, 84.3) 0.76 (0.47, 1.23)
(in more detail- Southern Europe 464 11.2 95.9 (93.2, 98.5) 2.42 (1.24, 4.72) 96.7 (95.1, 98.4) 7.39 (4.40, 12.43)
does not include Eastern Europe 344 8.3 90.3 (86.1, 94.6) 0.98 (0.58, 1.65) 85.4 (80.0, 90.8) 1.45 (0.93, 2.27)
BE, TI, TG) Canada, US, Australia 25 0.5 92.9 (85.3, 100.4) 1.36 (0.42, 4.42) 76.0 (57.0, 95.0) 0.79 (0.27, 2.29)
Latin America, Caribbean 20 0.6 95.4 (88.6, 102.2) 2.16 (0.45, 10.34) 84.9 (67.2, 102.6) 1.40 (0.34, 5.76)
Asia 69 1.8 88.3 (77.8, 98.8) 0.79 (0.29, 2.16) 91.9 (83.4, 100.4) 2.81 (0.90, 8.82)
Africa 47 0.9 89.1 (80.9, 97.3) 0.85 (0.36, 2.04) 94.5 (88.7, 100.3) 4.28 (1.40, 13.07)
CI: confidence interval;ref: reference group.
BE, TI, TG: detailed regrouping of nationality could not be done as further detail into nationality was not assessed.
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By the children at school entry, sex, the total number of siblings and the number of younger siblings
are not significantly associated with vaccination coverage (Table 8.2). More prominent than with the
toddlers, having an older sibling plays a significant role in influencing the chance that a child at
school entry will be vaccinated. Children with older siblings have a lower chance of being UTD for
the 44443111 series, for Di at 4 doses, for Hib at 3 doses and for measles at one dose. In contrast to
toddlers, children of foreign background at school entry are significantly less likely to be vaccinated
than their Swiss counterpart. The odds of being UTD at series 33333111among children of foreign
background is 0.85 (CI: 0.74, 0.99) times that of Swiss children; for Di at 4 doses, it is 0.36 (CI:
0.28, 0.46) times; and for Hib at 3 doses, it is 0.48 (CI: 0.42, 0.56). However, the odds of these
children being vaccinated for 1 dose of measles is 1.99 (CI: 1.53, 2.57) times that of Swiss children.
Further investigation into the influence of nationality reveals the same trend in Table 8.2.1, with
children, whose nationality is among one of the countries in the European Union or Norway, having
the same chances of being UTD at the 44443111 series and 4 doses of Di and 3 doses of Hib as the
Swiss children; children of Eastern European background, including Turkey, have a lower chance
with the odds being 0.61 (CI: 0.48, 0.79), 0.22 (CI: 0.16, 0.31) and 0.31 (CI: 0.25, 0.38),
respectively. In contrast, for measles at one dose, the pattern is reversed, where the former has a
significantly higher chance at being UTD with the odds being 2.51 (CI: 1.58, 3.99) times that of the
Swiss.
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Table 8.2. Logistic regression of social and demographic factors and vaccination coverage
for DTPPolHibMMR for the number of doses at series 4443111, diphtheria at 4 doses,
Haemophilus influenzae type B (Hib) at 3 doses and measles at 1 dose for children at school
entry living in Switzerland, 1999-2003
Coverage for series Odds Ratio Coverage Odds Ratio
44443111 44443111 Di (4 doses) Di (4 doses)
variable  n % %(±95%CI)  (±95%CI) %(±95%CI)  (±95%CI)
sex of child female 3906 49.4 46.2 (43.9, 48.6) ref 91.6 (90.4, 92.9) ref
male 3934 50.6 44.3 (42.1, 46.4) 0.92  (0.83, 1.03) 92.5 (91.3, 93.6) 1.12  (0.89, 1.40)
sibling none 703 10.5 50.6 (45.8, 55.4) ref 91.6 (89.6, 94.4) ref
≥1 5867 89.5 45.8 (43.8, 47.8) 0.82  (0.68, 1.00) 92.6 (91.7, 93.6) 1.10  (0.78, 1.53)
younger sibling none 3319 50.5 45.5 (43.0, 47.9) ref 92.0 (90.7, 93.3) ref
≥1 3251 49.5 47.1 (44.7, 49.5) 1.07  (0.95, 1.20) 93.1 (91.9, 94.4) 1.17  (0.90, 1.52)
older sibling none 2794 42.9 50.0 (47.5, 52.5) ref 94.2 (93.0, 95.3) ref
≥1 3776 57.1 43.5 (41.2, 45.8) 0.77  (0.69, 0.86) 91.3 (90.0, 92.6) 0.65  (0.50, 0.84)
nationality of Swiss 6474 77.2 48.7 (46.7, 50.6) ref 94.3 (93.6, 95.1) ref
child nonSwiss 1885 22.8 44.9 ( 41.5, 48.2) 0.85 (0.74, 0.99) 85.7 (83.3, 88.1) 0.36   (0.28, 0.46)
educat. level low 1135 17.4 45.5 (41.3, 49.8) ref 86.6 (83.7, 89.5) ref
of the mother middle 4223 67.7 47.0 (44.8, 49.3) 1.06  (0.88, 1.28) 94.4 (93.5, 95.3) 2.60  (1.94, 3.49)
high 945 14.9 44.5 (40.7, 48.4) 0.96  (0.77, 1.20) 91.8 (89.8, 93.9) 1.74  (1.20, 2.51)
Coverage Odds Ratio Coverage Odds Ratio
Hib (3 doses) Hib (3 doses) Measles (1 dose) Measles (1 dose)
variable  n  % %(±95%CI)  (±95%CI) %(±95%CI)  (±95%CI)
sex of child female 3906 49.4 77.8 (75.8, 79.8) ref 88.1 (86.7, 89.5) ref
male 3934 50.6 76.9 (75.2, 78.6) 0.95  (0.82, 1.10) 87.7 (86.2, 89.2) 0.96 (0.81, 1.14)
sibling none 703 10.5 77.0 (72.9, 81.2) ref 90.7 (87.9, 93.4) ref
≥1 5867 89.5 79.1 (77.5, 80.6) 1.13 (0.89, 1.42) 88.6 (87.5, 89.7) 0.80  (0.58, 1.11)
younger sibling none 3319 50.5 77.8 (75.8, 79.9) ref 88.6 (87.1, 90.1) ref
≥1 3251 49.5 79.9 (78.0, 81.8) 1.13  (0.97, 1.32) 89.0 (87.5, 90.5) 1.04 (0.85, 1.28)
older sibling none 2794 42.9 82.2 (80.3, 84.1) ref 90.3 (88.8, 91.8) ref
≥1 3776 57.1 76.3 (74.5, 78.2) 0.70  (0.60, 0.81) 87.7 (86.4, 89.1) 0.77  (0.64, 0.94)
nationality of Swiss 6474 77.2 80.9 (79.5, 82.3) ref 86.9 (85.7, 88.1) ref
child nonSwiss 1885 22.8 67.2 (64.4, 70.0) 0.48 (0.42, 0.56) 92.9 (91.3, 94.5) 1.99  (1.53, 2.57)
educat. level low 1135 17.4 75.1 (71.5, 78.8) ref 93.0 (90.9, 95.1) ref
of the mother middle 4223 67.7 81.1 (79.4, 82.7) 1.42  (1.14, 1.76) 88.7 (87.5, 89.9) 0.59  (0.42, 0.83)
high 945 14.9 74.4 (70.7, 78.2) 0.96  (0.74, 1.25) 84.8 (82.0, 87.6) 0.42  (0.29, 0.61)
CI: confidence interval. ref: reference group. BE, JU, TI: not included in analysis. VD: included only for nationality.
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Table 8.2.1 Logistic regression of nationality and vaccination coverage for DTPPolHibMMR
for the number of doses at series 4443111, diphtheria at 4 doses, Haemophilus influenzae
type B (Hib) at 3 doses and measles at 1 dose for children at school entry living in
Switzerland, 1999-2003
Coverage for series Odds Ratio Coverage Odds Ratio
44443111 44443111 Di (4 doses) Di (4 doses)
variable n % %(±95%CI) (±95%CI) %(±95%CI) (±95%CI)
nationality of Swiss 6047 78.0 45.9 (43.9, 47.9) ref 94.2 (93.4, 95.0) ref
child Europe (EU + Norway) 684 9.1 51.6 (46.6, 56.6) 1.26 (1.02, 1.55) 93.5 (90.8, 96.1) 0.88 (0.56, 1.38)
E. Europe, incl. Turkey 788 9.5 34.3 (29.0, 39.5) 0.61 (0.48, 0.79) 78.5 (73.8, 83.2) 0.22 (0.16, 0.31)
Asia 73 1.1 43.8 (27.1, 60.4) 0.92 (0.46, 1.81) 78.9 (67.2, 90.6) 0.23 (0.11, 0.47)
Others 166 2.3 31.1 (22.3, 39.8) 0.53 (0.35, 0.81) 78.9 (71.2, 86.6) 0.23 (0.14, 0.37)
Coverage Odds Ratio Coverage Odds Ratio
Hib (3 doses) Hib (3 doses) Measles (1 dose) Measles (1 dose)
variable n % %(±95%CI) (±95%CI) %(±95%CI) (±95%CI)
nationality of Swiss 6047 78.0 80.6 (79.1, 82.0) ref 86.5 (85.3, 87.8) ref
child Europe (EU + Norway) 684 9.1 80.3 (76.3, 84.3) 0.98 (0.76, 1.27) 94.2 (91.7, 96.6) 2.51 (1.58, 3.99)
E. Europe, incl. Turkey 788 9.5 56.1 (51.2, 61.1) 0.31 (0.25, 0.38) 91.5 (88.6, 94.4) 1.66 (1.13, 2.44)
Asia 73 1.1 69.2 (55.3, 83.1) 0.54 (0.28, 1.05) 94.0 (87.5, 100.5) 2.43 (0.77, 7.63)
Others 166 2.3 50.9 (40.6, 61.1) 0.25 (0.16, 0.38) 92.4 (87.9, 97.0) 1.90 (0.98, 3.66)
CI: confidence interval. ref: reference group. JU, TI, VD: not included in analysis
The demographic factors examined are also sporadically associated with vaccination coverage by the
children at school departure (Table 8.3). Here the number of younger siblings does not play a
significant role, but gender significantly influences coverage when examined at the DTPPolMMR
immunization series 5505111 and for Pol at 5 doses. Only 68.3% of boys are vaccinated at the
5505111 series and 78.3% for Pol, compared to 73.2% and 81.4%, respectively, of the girls. The
odds of being UTD at the 5505111 series and for 5 doses of Pol among boys is 0.79 (CI: 0.69,
0.91) and 0.83 (CI: 0.71, 0.97), respectively, times that of girls. This difference between boys and
girls are also found for rubella, at one dose and two doses, where girls have significantly higher
coverage estimates for rubella than boys at the national level (Annex H.1, H.2). The same trend can
be seen with the number of siblings and the number of older siblings, with the same chances of
being UTD for the 5505111 series and Pol significantly lower for those with siblings, particularly
older siblings. The odds of being UTD for the 5505111 series for those with siblings is
approximately 0.72 (CI: 0.53, 0.97) and older siblings is 0.77 (CI: 0.65, 0.90) times that of those
without siblings. Unlike the two younger age groups, coverage for measles at one dose is not
significantly associated with the number of siblings, regardless if they are older or younger. In
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addition to siblings, nationality also plays a highly significant role on vaccination coverage, with
children of foreign background being less likely to be UTD at the 5505111 series, and for 5 doses
of Di and Pol. More specifically, the odds of these children being UTD at the 5505111 series is
0.35 (CI: 0.29, 0.41) times that of the Swiss children. The chances of being UTD for 5 doses of Di
and Pol for those children of foreign background are even more reduced at 0.20 (CI: 0.17, 0.26) and
0.21 (CI: 0.17, 0.25), respectively. In contrast to the two younger groups, coverage for measles at
one dose is not significantly associated with the ethnic background of the oldest age group. Sex and
the number of siblings, regardless if they are older or younger, have no association with HepB
coverage; on the other hand, children of foreign background are significantly better vaccinated than
Swiss children for HepB (Table 8.3.1). The odds of being UTD for 1 dose of HepB for children of
foreign background is 1.46 (CI: 1.20, 1.77) times that of Swiss children; the odds of being UTD for
3 doses of HepB is 1.39 (CI: 1.15, 1.68). More detailed analysis into the effect of nationality
confirmed the aforedescribed phenomenon:  aside from the 5505111 series for children whose
nationality is part of the European Union or Norway, adolescents of foreign background have a
significantly lower chance of being UTD at the 5505111 series, for 5 doses of Di and Pol than
Swiss children; by HepB at 1 and 3 doses, the effect is in the opposite direction, where foreigners
have a higher chance of being UTD (Table 8.3.2).
The highest level of education attained by the mother plays a significant role in immunization
coverage (p<0.05). Toddlers of mothers with higher educational background (masters or university
degree) are less likely to be UTD with the recommended vaccination plan at series 33333111 than
those with middle (technical and teaching schools) and low educational backgrounds (completing 9
mandatory school years or lower), with vaccination coverage estimates at 73.0%, 78.4%, and 83.9%,
respectively (Table 8.1). The odds of being UTD at series 33333111 among those with a middle
degree of education is 0.69 (CI: 0.55, 0.88) times, and those with the highest educational
background is 0.52 (CI: 0.39, 0.68) times, that of lower educational background. For Di and Hib at
3 doses, there is a significant difference between vaccination coverage only between those children
whose mothers’ educational level is classified as low and high, with high educational background
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yielding significantly lower coverage. By measles for toddlers and children at school entry, this
trend is also observed (Tables 8.1 and 8.2). For children at school entry, the odds of being UTD
among children whose mothers‘ educational background lies in the middle is 2.60 (CI: 1.94, 3.49)
times, and those with the highest educational background is 1.74 times (CI: 1.20, 2.51), that of lower
educational background. For the children at school departure, teenagers whose mothers’ educational
level is rated as being in the middle have significantly the highest coverage estimates at the 5505111
series and for 5 doses of Di and Pol; adolescents of mothers with low educational background have
the lowest coverage (Table 8.3). By measles at one dose, the odds of being UTD among teenagers
whose mothers’ educational background is defined as high is 0.51 (CI: 0.33, 0.77) times that of
those whose mother’s educational background is rated as low. Similarly, teenagers whose mother’s
educational level is rated low has a higher chance of being UTD for HepB than those whose
mother’s educational background is rated medium or high, although there is little or no difference in
coverage estimates between the two latter groups (Table 8.3.1).
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Table 8.3.  Logistic regression of social and demographic factors and vaccination coverage for
DTPPolMMR for the number of doses at series 5505111, diphtheria at 5 doses, polio at 5
doses and measles at 1 dose for children at school departure living in Switzerland, 1999-2003
Coverage for Odds Ratio Coverage Odds Ratio
series 5505111 series 5505111 Diphtheria (5 doses) Diphtheria (5 doses)
variable  n % %(±95%CI) (±95%CI) %(±95%CI) (±95%CI)
sex of child female 3801 49.4 73.2 (71.1, 75.3) ref 81.5 (79.7, 83.4) ref
male 3829 50.6 68.3 (65.8, 70.8) 0.79  (0.69, 0.91) 79.7 (77.3, 82.0) 0.89  (0.76, 1.04)
sibling none 459 7.8 77.8 (73.3, 82.3) ref 84.7 (80.8, 88.6) ref
≥1 5414 92.2 71.5 (69.4, 73.6) 0.72  (0.53, 0.97) 79.9 (77.8, 81.9) 0.72  (0.51, 1.01)
younger sibling none 2535 43.2 73.2 (70.6, 75.8) ref 81.1 (78.9, 83.3) ref
≥1 3338 56.8 71.0 (68.5, 73.6) 0.90  (0.76, 1.06) 79.5 (77.2, 81.9) 0.90 (0.76, 1.07)
older sibling none 2485 42.2 75.1 (72.9, 77.2) ref 83.4 (81.4, 85,4) ref
≥1 3388 57.8 69.7 (67.0, 72.4) 0.77  (0.65, 0.90) 77.9 (75.5, 80.4) 0.70  (0.59, 0.83)
nationality of Swiss 6677 77.5 77.1 (75.6, 78.7) ref 87.9 (86.8, 89.0) ref
child nonSwiss 1718 22.5 53.8 (50.0, 57.7) 0.35  (0.29, 0.41) 59.6 (55.8, 63.3) 0.20 (0.17, 0.26)
educational level low 1399 25.2 61.4 (57.5, 65.3) ref 66.6 (62.6, 70.6) ref
of the mother middle 3499 62.1 76.6 (74.5, 78.8) 2.06 (1.70, 2.50) 85.7 (84.3, 87.2) 3.01  (2.46, 3.70)
high 691 12.7 70.5 (66.4, 74.6) 1.50 (1.17, 1.92) 81.9 (78.0, 85.8) 2.27 (1.67, 3.08)
Coverage Odds Ratio Coverage Odds Ratio
Polio 5 doses) Polio (5 doses) Measles (1 dose) Measles (1 dose)
variable  n % %(±95%CI) (±95%CI) %(±95%CI) (±95%CI)
sex of child female 3801 49.4 81.3 (79.4, 83.3) ref 94.6 (93.6, 95.5) ref
male 3829 50.6 78.3 (76.0, 80.6) 0.83  (0.71, 0.97) 93.3 (92.3, 94.4) 0.80  (0.62, 1.04)
sibling none 459 7.8 86.7 (82.9, 90.6) ref 94.5 (91.9, 97.2) ref
≥1 5414 92.2 78.7 (76.6, 80.8) 0.57 (0.39, 0.82) 94.5 (93.7, 95.2) 0.99  (0.59, 1.67)
younger sibling none 2535 43.2 80.2 (77.7, 82.8) ref 95.0 (94.0, 96.1) ref
≥1 3338 56.8 78.6 (76.3, 80.9) 0.90 (0.76, 1.08) 94.1 (93.1, 95.1) 0.83  (0.62, 1.11)
older sibling none 2485 42.2 82.9 (81.1, 84.7) ref 94.2 (93.1, 95.4) ref
≥1 3388 57.8 76.7 (74.0, 79.3) 0.68  (0.57, 0.80) 94.7 (93.8, 95.5) 1.09  (0.83, 1.42)
nationality of Swiss 7035 77.5 87.2 (85.9, 88.5) ref 94.0 (93.3, 94.7) ref
child nonSwiss 1758 22.5 58.3 (54.7, 62.0) 0.21 (0.17, 0.25) 93.4 (91.9, 94.9) 0.90  (0.69, 1.17)
educational level low 1399 25.2 66.6 (63.0, 70.7) ref 94.2 (92.5, 95.8) ref
of the mother middle 3499 62.1 84.6 (82.9, 86.4) 2.77  (2.29, 3.35) 95.4 (94.5, 96.3) 1.28  (0.90, 1.82)
high 691 12.7 79.2 (75.4, 83.1) 1.92  (1.46, 2.53) 89.1 (86.2, 92.1) 0.51  (0.33, 0.77)
CI: confidence interval; ref: reference group
BE: only included in analysis for nationality and sex. JU, TI: not included in the analysis. VD: only included in analysis for nationality.
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Table 8.3.1. Logistic regression of social and demographic factors and vaccination coverage
for Hepatitis B (HepB) at one dose and three doses for children at school departure
living in Switzerland, 1999-2003
Coverage for Odds Ratio Coverage for Odds Ratio
variable HepB (1 dose) HepB (1 dose) HepB (3 doses) HepB (3 doses)
  n % %(±95%CI) (±95%CI) %(±95%CI) (±95%CI)
sex of child female 3801 49.4 41.2 (37.8, 44.6) ref 25.2 (22.6, 27.9) ref
male 3829 50.6 41.9 (38.4, 45.5) 1.03 (0.91, 1.17) 24.7 (22.1, 27.4) 0.97 (0.85, 1.11)
sibling none 459 7.8 47.2 (39.9, 54.5) ref 28.2 (22.6, 33.8) ref
≥1 5414 92.2 41.5 (37.7, 45.3) 0.79 (0.61, 1.04) 23.8 (21.1, 26.5) 0.80 (0.61, 1.04)
younger sibling none 2535 43.2 41.1 (37.1, 45.1) ref 23.2 (20.5, 25.8) ref
≥1 3338 56.8 42.6 (38.4, 46.8) 1.06 (0.93, 1.22) 24.9 (21.7, 28.2) 1.10 (0.95, 1.28)
older sibling none 2485 42.2 44.0 (39.5, 48.5) ref 25.5 (22.0, 28.9) ref
≥1 3388 57.8 40.4 (36.5, 44.4) 0.86 (0.74, 1.00) 23.2 (20.5, 25.9) 0.89 (0.76, 1.03)
nationality of Swiss 6677 77.5 43.2 (40.1, 46.4) ref 23.0 (20.8, 25.3) ref
child nonSwiss 1718 22.5 52.6 (48.2, 57.0) 1.46  (1.20, 1.77) 29.4 (25.6, 33.2) 1.39  (1.15, 1.68)
educational level low 1399 25.2 47.6 (42.3, 52.8) ref 29.1 (24.3, 33.9) ref
of the mother middle 3499 62.1 39.4 (35.1, 43.7) 0.72 (0.57, 0.90) 21.6 (18.9, 24.2) 0.67 (0.53, 0.84)
high 691 12.7 39.4 (33.1, 45.7) 0.72 (0.52, 0.99) 23.5 (19.0, 28.1) 0.75 (0.54, 1.04)
CI: confidence interval. ref: reference group
BE: only included in analysis for nationality and sex. JU, TI: not included in the analysis. VD: only included in analysis for nationality.
Table 8.3.2 Logistic regression of nationality and vaccination coverages for DTPPolMMR for the
number of doses at series 5505111, diphtheria at 5 doses, Hepatitis B at 1 and 3 doses, polio at 5
doses and measles at 1 dose for children at school departure living in Switzerland, 1999-2003
Coverage for Odds Ratio Coverage Odds Ratio
variable series 5505111 series 5505111 Di (5 doses) Di (5 doses)
  n % %(±95%CI) (±95%CI) %(±95%CI) (±95%CI)
nationality of Swiss 6001 78.0 76.1 (74.4, 77.8) ref 87.2 (86.0, 88.4) ref
child Europe (EU + Norway) 599 9.7 73.0 (68.5, 77.4) 0.85 (0.66, 1.08) 82.6 (78.9, 86.4) 0.70 (0.52, 0.93)
E. Europe, incl. Turkey 681 9.6 32.6 (26.4, 38.9) 0.15 (0.11, 0.20) 35.2 (29.3, 41.3) 0.08 (0.06, 0.11)
Asia 57 1.0 44.2 (27.5, 60.9) 0.25 (0.13, 0.49) 44.2 (27.5, 60.9) 0.12 (0.06, 0.23)
Others 118 1.7 36.0 (24.9, 47.1) 0.18 (0.11, 0.29) 39.2 (28.0, 50.4) 0.09 (0.06, 0.15)
Coverage for Odds Ratio Coverage Odds Ratio
HepB (1 dose) HepB (1 dose)      HepB(3 doses) HepB (3 doses)
  %(±95%CI) (±95%CI) %(±95%CI) (±95%CI)
nationality of Swiss 6001 78.0 39.9 (36.5, 43.3) ref 24.0 (21.5, 26.4) ref
child Europe (EU + Norway) 599 9.7 46.8 (41.5, 52.2) 1.33 (1.06, 1.66) 27.8 (23.0, 32.6) 1.22 (0.96, 1.55)
E. Europe, incl. Turkey 681 9.6 45.0 (37.2, 52.8) 1.23 (0.89, 1.70) 28.3 (22.2, 34.4) 1.25 (0.93, 1.69)
Asia 57 1.0 56.3 (39.4, 73.3) 1.94 (0.96, 3.93) 45.7 (29.4, 61.9) 2.67 (1.37, 5.19)
Others 118 1.7 60.4 (49.5, 71.2) 2.29 (1.45, 3.62) 35.9 (25.2, 46.7) 1.78 (1.12, 2.84)
Coverage Odds Ratio Coverage Odds Ratio
Polio 5 doses) Polio (5 doses) Measles (1 dose) Measles (1 dose)
  %(±95%CI) (±95%CI) %(±95%CI) (±95%CI)
nationality of Swiss 6001 78.0 86.5 (85.0, 87.9) ref 94.2 (93.5, 95.0) ref
child Europe (EU + Norway) 599 9.7 79.9 (76.1, 83.8) 0.62 (0.48, 0.82) 92.3 (90.0, 94.6) 0.73 (0.51, 1.05)
E. Europe, incl. Turkey 681 9.6 35.3 (29.0, 41.5) 0.09 (0.06, 0.11) 93.6 (91.1, 96.0) 0.87 (0.59, 1.33)
Asia 57 1.0 44.2 (27.5, 60.9) 0.12 (0.06, 0.25) 92.1 (80.4, 103.7) 0.71 (0.14, 3.50)
Others 118 1.7 40.9 (29.5, 52.3) 0.11 (0.07, 0.18) 90.7 (84.2, 97.2) 0.60 (0.28, 1.29)
CI: confidence interval. ref: reference group. JU, TI, VD: not included in analysis.
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3.5 Vaccinating professionals
Question: By whom was your child vaccinated (More than one answer was possible.)
Table 9 displays the distribution of health professionals active in vaccinating children in the 3 age
groups. 79.2% of all toddlers were vaccinated by their pediatricians, whereas only 21.5% by general
practitioners (GPs). Combined, complementary / alternative medicine (CAM) practitioners and other
health professionals contributed to approximately 3%. Pediatricians remain by far as the most cited
health profesional to vaccinate children at school entry (71.3%), followed by GPs (40.6%) and
school health personnel (12.8%) while CAM practitioner and others making up the last category at
4.1%. By children at school departure, the distribution of vaccinators is more evenly dispersed:
58.4% were the GPs, 60.4% were pediatricians, 47.5% were school health officials; 4.1% were
vaccinated by other health professionals. When examining this distribution among the different
linguistic regions, the same trends are observed, with pediatricians playing an even more apparent
role by vaccination than the GPs in the French- and Italian-speaking regions compared to the
German-speaking region for the two younger age groups. By the older schoolchildren, the
differences are less apparent in the German-speaking region, but remains the same in the French-
speaking region. Upon examination of this distribution of health professionals by cantons, it is
noteworthy to see that in smaller cantons, such as in AR, GL, LU, OW and NW, the frequency of
the toddlers being vaccinated by the GP and pediatrician is the same (Annexes I.1, I.2, I.3). AI is an
exception where 85.9% of the vaccinators are GPs, and only 15.5% are pediatricians. By
schoolchildren, vaccination policy and additional help of school or LL nurses become apparent.
Parents living in cantons with additional help in the school health service or where the school
doctors are permitted to vaccinate in the schools cited that their children were vaccinated by school
officials much more often than those without these conditions.
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Table 9.  Distribution of health professionals who are active in vaccinating toddlers
24-35 months of age, and children at school entry and departure in Switzerland as
perceived by parents, 1999-2003
 Toddlers
 D-CH W-CH TI CH
n 5717 2150 532 8399
 n % n % n % n %
General practitioner 1785 25.9 230 10.7 16 3.3 2031 21.5
Pediatrician 3933 74.4 1931 91.1 508 95.3 6372 79.2
Complementary / alternative medicine practitioner 101 1.7 27 1.3 - - 128 1.6
Others 27 0.9 39 2.6 8 1.5 74 1.4
 School entry
 D-CH W-CH CH
n 5178 1706 6884
 n % n % n %
General practitioner 2289 44.6 433 26.2 2722 40.6
Pediatrician 3511 68.3 1440 82.2 4951 71.3
Complementary / alternative medicine practitioner 76 1.5 36 2.7 112 1.7
School health personnel 483 9.6 436 24.2 919 12.8
Others 66 2.0 54 4.0 120 2.4
 School departure
 D-CH W-CH CH
n 4500 1814 6314
 n % n % n %
General practitioner 2863 64.1 744 37.9 3607 58.4
Pediatrician 2481 55.7 1403 77.6 3884 60.4
Complementary / alternative medicine practitioner 51 1.1 21 1.1 72 1.1
School health personnel 2161 45.9 1033 53.3 3194 47.5
Others 102 4.0 78 4.4 180 4.1
Multiple answers were possible.
BE, TI, VD: no information available for schoolchildren as questionnaire was not used.
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3.6 Sources of information
Question: Have you received information regarding vaccination? If yes, are you happy with this
information? From whom have you received this information?  How would you like to be informed
about vaccination? (More than one answer was possible.)
Having possession of information regarding vaccination also significantly influence vaccination
coverage (Table 10). Of the 88.7% of the families of toddlers who claimed to have received
information regarding vaccination, 66.9% are satisfied with the existing information, 21.2% are not
satisfied, 4.8% did not know and 7.1% did not answer the question.
Table 10.  Information status regarding vaccination as perceived by parents of toddlers 24-35 months
of age and children at school entry and departure in the German-, French- and Italian-speaking
regions of Switzerland, 1999-2003
   received  If yes (%)........   
Age groups R e g i o n s n Info (%) n satisfied not satisfied do not know no answer
Toddlers German-speaking 5717 90.3 5274 67.5 19.9 4.7 7.8
 French-speaking 2150 84.1 1858 64.9 25.7 4.8 4.5
 Italian-speaking 532 89.2 477 67.6 15.6 5.9 10.9
 Switzerland 8399 88.7 7609 66.9 21.2 4.8 7.1
     
School entry German-speaking 5178 90.3 4657 66.9 18.1 7.0 7.9
 French-speaking 1698 86.2 1482 67.3 16.7 5.9 10.1
 Switzerland 6876 91.8 6139 67.0 17.8 6.8 8.4
     
School departure German-speaking 4499 86.3 3960 69.7 14.7 8.2 7.4
 French-speaking 1814 90.4 1649 68.7 14.5 8.1 8.7
 Switzerland 6313 87.2 5609 69.5 14.7 8.1 7.7
BE, TI, VD: no information available for schoolchildren as the questionnaire was not used.
When detailed into the different linguistic regions, parents of toddlers in the French-speaking region
appear to be slightly more unsatisfied with the current information than parents in the other two
regions; however when including those who did not answer, the difference between regions are no
longer apparent. However, closer examination by cantons confirms that dissatisfaction is highest
among parents in cantons VS, NE and FR. On the other hand, the canton of JU has the highest level
of satisfaction (Annex J.1). Toddlers whose parents claimed to have received information regarding
vaccination are significantly less likely to be vaccinated than those who have not received
information (Table 11.1). The odds of being UTD at series 333331111 and measles at one dose
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among toddlers whose parents have received information is 0.65 (CI: 0.51, 0.82) and 0.55 (CI: 0.40,
0.75), respectively, times that of those who have not received information. Among those who have
received information, and are satisfied, 72.0% fit into this category; the other 28.0% were not
satisfied or did not know how to respond. Among those who are satisfied with the information,
79.7% are UTD with the 33333111 immunization series and only 70.3% for those who are not
satisfied; the odds of being UTD among those satisfied is 1.65 (CI: 1.39, 1.96) times that of those
not satisfied or did not know. This pattern is also significantly observed with Di at 4 doses, Hib at 3
doses and measles at 1 dose.
The same pattern for information status is also observed by the schoolchildren, as shown in Table
10. 91.8% of the parents of children at school entry have received information regarding vaccination,
and 87.2% of those at school departure. Of these families, 67.0% of the former group are satisfied
with the current information, 17.8% are not satisfied, and 6.8% remained undecided and 8.4% did
not answer the question. By children at school departure, it is 69.5%, 14.7%, 8.1% and 7.7%,
respectively. The percentage of those not satisfied decreased as those who did not know or refrained
from answering increased. This distribution of satisfaction/ dissatisfaction is similar throughout the
different linguistic regions. Among the parents of children at school entry, those in canton OW
displayed the least amount of satisfaction. The highest proportion of parents of schoolchildren who
refrained from answering the question or who responded as did not know resided in canton AI
(Annexes J.2, J.3). Similar to the toddlers, children at school entry whose parents have received
information have lower coverage for measles at one dose than those where parents have not received
information (Table 11.2). The odds of these children being UTD for 1 dose of measles is 0.64 (CI:
0.44, 0.94) times that of those who have not received information. Unlike the toddlers, children at
school entry whose parents have received information are significantly better vaccinated for Di at 4
doses and Hib at 3 doses than those who have no information, with the odds being 1.88 (CI: 1.34,
2.64) and 1.47 (CI: 1.17, 1.85), respectively. Those who are satisfied with the information received
are significantly better vaccinated for the 44443111 immunization series, Di, Pol and measles than
those who are dissatisfied.
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In contrast to the other two age groups, coverage for measles at one dose for children at school
departure who have or have not received information regarding vaccination is not significantly
different. However, children in this age group whose parents have received information are
significantly better vaccinated than those with no information at the 5505111 series and for Di and
Pol at 5 doses (Table 11.3). The odds of being UTD at series 5505111, 5 doses of Di and Pol
among adolescents whose parents have information regarding vaccination are 1.88 (CI: 1.49, 2.37),
2.17 (CI: 1.72, 2.76), and 2.29 (CI: 1.78, 2.95), respectively, times that of those whose parents have
no information or who were not sure of the information they received. Like the other two age
groups, teenagers whose parents are satisfied with the information they have regarding vaccination
are significantly better vaccinated than those whose parents are dissatisfied, with the highest odds of
being UTD for measles at one dose. This trend is also seen with HepB, where having information
about vaccination and satisfaction with the information received increase the chances of the
adolescent being UTD for this vaccine, with the odds being 1.53 (CI: 1.25, 1.89) and 1.39 (CI: 1.08,
1.79), respectively, for HepB at one dose and 1.54 (CI: 1.30, 1.82) and 1.50 (CI: 1.25, 1.82),
respectively, for HepB at 3 doses (Table 11.3.1).
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Table 11.1.  Logistic regression of various factors and vaccination coverage for DTPPolHibMMR
for the number of doses at series 33333111, diphtheria at 3 doses, Haemophilus influenzae type B
(Hib) at 3 doses,  and measles at 1 dose for children  24-35 months of age living in Switzerland,
1999-2003
Coverage for Odds Ratio Coverage Odds Ratio
series 33333111 33333111 Di (3 doses) Di (3 doses)
variable  n % %(±95%CI) (±95%CI) %(±95%CI) (±95%CI)
have information no/don't know 790 11.3 83.9 (80.7, 87.0) ref 95.8 (93.3, 98.4) ref
about immunization yes 7609 88.7 77.2 (75.6, 78.8) 0.65 (0.51, 0.82) 95.5 (94.8, 96.2) 0.93 (0.46, 1.85)
if yes, are you happy no/don't know 1997 28.0 70.3 (67.3, 73.3) ref 78.1 (75.7, 80.6) ref
with the information yes 5189 72.0 79.7 (77.9, 81.4) 1.65 (1.39, 1.96) 85.8 (84.3. 87.3) 1.64 (1.20, 2.25)
alternative no 4341 58.3 84.7 (83.3, 86.2) ref 97.8 (97.1, 98.5) ref
medicine use yes 3510 41.7 68.0 (65.5, 70.5) 0.38 (0.33, 0.43) 92.3 (90.9, 93.6) 0.27 (0.18, 0.38)
yes, alternative German 2356 67.3 61.7 (58.8, 64.5) 90.3 (88.5, 92.0)
medicine use French 1144 32.7 81.0 (78.5, 83.5) 2.66 (2.17, 3.25) 96.3 (95.0, 97.7) 2.83 (1.84, 4.37)
language of region German 5755 70.8 74.6 (72.8, 76.3) ref 94.5 (93.7, 95.4) ref
French 2290 26.8 86.0 (84.4, 87.6) 2.10 (1.78, 2.47) 97.5 (96.7, 98.3) 2.24 (1.57, 3.19)
Italian 684 2.4 90.7 (88.6, 92.8) 3.33 (2.56, 4.34) 98.5 (97.3, 99.6) 3.72 (1.70, 8.14)
Coverage for Odds Ratio Coverage Odds Ratio
Hib (3 doses) Hib (3 doses) Measles (1 dose) Measles (1 dose)
variable  n % %(±95%CI) (±95%CI) %(±95%CI) (±95%CI)
have information no/don't know 790 11.3 93.7 (91.1, 96.3) ref 88.8 (85.9, 91.8) ref
about immunization yes 7609 88.7 90.9 (90.0, 91.9) 0.67 (0.43, 1.05) 81.4 (79.9, 82.8) 0.55 (0.40, 0.75)
if yes, are you happy no/don't know 1997 28.0 88.2 (86.2, 90.2) ref 74.3 (71.5, 77.2) ref
with the information yes 5189 72.0 91.8 (90.5, 93.1) 1.50 (1.14, 1.98) 83.8 (82.2, 85.4) 1.79 (1.50, 2.13)
alternative no 4341 58.3 95.0 (93.8, 96.2) ref 89.2 ( 87.8, 90.5) ref
medicine use yes 3510 41.7 85.8 (84.0, 87.7) 0.32 (0.24, 0.43) 72.0 ( 69.5, 74.5) 0.31 (0.26, 0.37)
yes, alternative German 2356 67.3 83.2 (80.8, 85.6) ref 65.9 (63.2, 68.7) ref
medicine use French 1144 32.7 91.2 (89.2, 93.2) 2.09 (1.54, 2.84) 84.6 (82.1, 87.0) 2.83 (2.26, 3.53)
speaking regions German 5755 70.8 90.1 (89.0, 91.2) ref 79.0 (77.4, 80.6) ref
French 2290 26.8 93.4 (92.1, 94.8) 1.57 (1.22, 2.01) 90.1 (88.6, 91.5) 2.41 (1.99, 2.92)
Italian 684 2.4 96.0 (94.5, 97.5) 2.62 (1.75, 3.92) 93.7 (92.0, 95.4) 3.96 (2.90, 5.40)
CI: confidence interval. ref: reference group. TI: not included in analysis for alternative medicine use.
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Table 11.2.  Logistic regression of various factors and vaccination coverage for DTPPolHibMMR
for the number of doses at series 44443111, diphtheria at 4 doses, Haemophilus influenzae type B
(Hib) at 3 doses and measles at 1 dose for children at school entry living in Switzerland,
1999-2003
Coverage for Odds Ratio Coverage Odds Ratio
series 44443111 44443111 Di (4 doses) Di (4 doses)
variable  n % %(±95%CI) (±95%CI) %(±95%CI) (±95%CI)
have information no/don't know 713 10.6 42.6 (38.2, 47.0) ref 87.8 (84.5, 91.0) ref
about immunization yes 5862 89.4 46.7 (44.7, 48.7) 1.18 (0.98, 1.42) 93.1 (92.1, 94.1) 1.88  (1.34, 2.64)
if yes, are you happy no/don't know 1507 26.9 44.9 (41.5, 48.3) ref 91.1 (89.4, 92.9) ref
with the information yes 3935 73.1 50.0 (47.6, 52.3) 1.22 (1.05, 1.43) 94.1 (93.1, 95.1) 1.55 (1.18, 2.03)
alternative no 4091 62.3 49.9 (47.5, 52.2) ref 93.3 (92.2, 94.5) ref
medicine use yes 2476 37.7 40.3 (37.6, 43.0) 0.67 (0.59, 0.77) 91.2 (89.6, 92.8) 0.74 (0.57, 0.95)
yes, alternative German 1787 73.6 39.5 (36.4, 42.5) ref 91.6 (89.7, 93.6) ref
medicine use French 689 26.4 42.6 (37.5, 47.8) 1.14 (0.89, 1.46) 89.8 (87.3, 92.4) 0.81 (0.55, 1.18)
language of region German 6337 72.2 44.8 (42.9, 46.7) ref 92.5 (91.6, 93.5) ref
French 2022 24.0 56.9 (53.2, 60.6) 1.62 (1.37, 1.92) 91.8 (90.3, 93.4) 0.91  (0.71, 1.16)
Italian 793 3.8 83.9 (80.5, 87.2) 6.40 (4.95, 8.28) 95.2 (93.6, 96.8) 1.60  (1.10, 2.34)
Coverage for Odds Ratio Coverage Odds Ratio
Hib (3 doses) Hib (3 doses) Measles (1 dose) Measles (1 dose)
variable  n % %(±95%CI) (±95%CI) %(±95%CI) (±95%CI)
have information no/don't know 737 10.6 72.6 (68.4, 76.7) ref 92.3 (89.7, 94.8) ref
about immunization yes 6139 89.4 79.5 (77.9, 81.1) 1.47  (1.17, 1.85) 88.4 (87.2, 89.6) 0.64 (0.44, 0.94)
if yes, are you happy no/don't know 1575 26.9 78.4 (75.5, 81.3) ref 81.6 (79.0, 84.2) ref
with the information yes 4143 73.1 81.5 (79.6, 83.3) 1.21   (0.98, 1.49) 91.0 (89.7, 92.3) 2.28  (1.81, 2.88)
alternative no 4223 62.3 80.3 (78.4, 82.1) ref 93.5 (92.5, 94.5) ref
medicine use yes 2653 37.7 76.3 (74.0, 78.7) 0.79  (0.67, 0.94) 81.0 (78.8, 83.1) 0.30  (0.24, 0.36)
yes, alternative German 1787 73.6 77.6 (74.9, 80.3) ref 79.5 (77.1, 82.0) ref
medicine use French 689 26.4 72.8 (68.4, 77.3) 0.77 (0.59, 1.02) 85.0 (80.3, 89.7) 1.46 (0.98, 2.16)
speaking regions German 6337 72.2 77.8 (76.3, 79.3) ref 87.4 (86.2, 88.7) ref
French 2323 24.0 77.7 (75.1, 80.2) 0.99 (0.83, 1.18) 90.6 (88.8, 92.4) 1.39  (1.09, 1.76)
Italian 793 3.8 91.0 (88.4, 93.6) 1.19  (1.05, 1.35) 93.8 (91.6, 96.0) 2.17  (1.46, 3.23)
CI: confidence interval. ref: reference group. BE, TI, VD: only included in analysis for school vaccination policy. JU: not included in analysis.
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Table 11.3.  Logistic regression of various factors and vaccination coverage for DTPPolMMR for
the number of doses at series 5505111, diphtheria at 5 doses, polio at 5 doses and measles at 1 dose
for children at school departure living in Switzerland, 1999-2003
Coverage for Odds Ratio Coverage Odds Ratio
series 5505111 5505111 Di (5 doses) Di (5 doses)
variable  n % %(±95%CI) (±95%CI) %(±95%CI) (±95%CI)
have information no/don't know 669 12.8 59.4 (53.9, 64.8) ref 67.3 (62.0, 72.7) ref
about immunization yes 5228 87.2 75.2 (71.3, 75.3) 1.88 (1.49, 2.37) 81.8 (80.0, 83.5) 2.17  (1.72, 2.76)
if yes, are you happy no/don't know 1238 24.6 69.2 (66.0, 72.5) ref 79.1 (76.3, 82.0) ref
with the information yes 3662 75.4 75.2 (73.1, 77.3) 1.35 (1.15, 1.58) 83.3 (81.4, 85.2) 1.31  (1.07, 1.61)
alternative no 4086 69.3 71.8 (69.4, 74.3) ref 78.8 (76.4, 81.3) ref
medicine use yes 1811 30.7 70.8 (67.9, 73.8) 0.95 (0.80, 1.13) 82.4 (80.2, 84.5) 1.26  (1.06, 1.56)
yes, alternative German 1203 71.8 72.7 (69.0, 76.5) ref 84.3 (81.7, 87.0) ref
medicine use French 608 28.2 66.0 (61.8, 70.2) 0.73 (0.56, 0.95) 77.4 (74.1, 80.7) 0.64 (0.48, 0.84)
language of region German 6072 70.1 72.0 (69.9, 74.0) ref 81.9 (79.9, 83.9) ref
French 2324 25.0 71.8 (69.5, 74 0) 0.99  (0.85, 1.15) 80.5 (78.6, 82.4) 0.91  (0.76, 1.09)
Italian 686 39.8 75.9 (72.6, 79.2) 1.23 (1.00, 1.51) 84.0 (81.5, 86.5) 1.16 (0.92, 1.46)
Coverage for Odds Ratio Coverage Odds Ratio
Pol  (5 doses) Pol  (5 doses) Measles (1 dose) Measles (1 dose)
variable   n % %(±95%CI) (±95%CI) %(±95%CI) (±95%CI)
have information no/don't know 669 12.8 64.9 (59.3, 70.6) ref 93.4 (91.0, 95.9) ref
about immunization yes 5228 87.2 80.9 (79.0, 82.8) 2.29  (1.78, 2.95) 94.5 (93.7, 95.3) 1.20  (0.79, 1.85)
if yes, are you happy no/don't know 1238 24.6 77.0 (74.2, 80.1) ref 91.2 (89.4, 93.0) ref
with the information yes 3662 75.4 82.2 (80.3, 84.2) 1.38  (1.15, 1.66) 95.5 (94.7, 96.3) 2.05 (1.54, 2.72)
alternative no 4086 69.3 77.6 (75.2, 80.0) ref 95.9 (95.1, 96.7) ref
medicine use yes 1811 30.7 81.7 (79.3, 84.1) 1.29 (1.06, 1.56) 90.8 (89.1, 92.5) 0.42 (0.31, 0.57)
yes, alternative German 1203 71.8 81.9 (78.9, 84.9) ref 92.0 (90.0, 93.9) ref
medicine use French 608 28.2 81.1 (77.4, 84.9) 0.95 (0.69, 1.31) 87.9 (84.7, 91.0) 0.63 (0.42, 0.94)
speaking regions German 6072 70.1 79.7 (77.7, 81.8) ref 94.7 (93.9, 95.4) ref
French 2324 25.0 83.4 (81.5, 85.3) 1.28  (1.06, 1.54) 91.7 (90.5, 92.9) 0.62  (0.50, 0.77)
Italian 686 39.8 81.8 (78.7, 84.9) 1.14  (0.90, 1.46) 91.2 (89.5, 93.0) 0.59  (0.45, 0.77)
CI: confidence interval. ref: reference group. BE, TI, VD: only included in analysis for school vaccination policy. JU: not included in analysis.
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Table 11.3.1   Logistic regression of various factors and vaccination coverage for Hepatitis B (HepB)
at one dose and three doses for children at school departure living in Switzerland, 1999-2003
Coverages for Odds Ratio Coverages for Odds Ratio
HepB (1 dose) HepB (1 dose) HepB (3 doses) HepB (3 doses)
variable  n % %(±95%CI) (±95%CI) %(±95%CI) (±95%CI)
have information no/don't know 669 12.8 32.6 (27.8, 37.5) ref 18.8 (14.7, 22.9) ref
about immunization yes 5228 87.2 42.6 (38.7, 46.5) 1.53 (1.25, 1.89) 24.3 (21.6, 27.1) 1.39  (1.08, 1.79)
if yes, are you happy no/don't know 1238 24.6 35.8 (31.2, 40.4) ref 19.5 (16.0, 23.0) ref
with the information yes 3662 75.4 46.2 (42.0, 50.3) 1.54 (1.30, 1.82) 26.7 (23.7, 29.8) 1.50 (1.25, 1.82)
alternative no 4086 69.3 44.7 (40.7, 48.6) ref 25.7 (22.6, 28.8) ref
medicine use yes 1811 30.7 33.9 (29.5, 38.2) 0.64 (0.54, 0.75) 19.0 (16.2, 21.9) 0.68 (0.56, 0.82)
yes, alternative German 1203 71.8 29.2 (23.8, 34.6) 13.1 (10.1, 16.1)
medicine use French 608 28.2 45.9 (40.2, 51.5) 2.06 (1.45, 2.91) 34.1 (28.7, 39.6) 3.44 (2.41, 4.93)
language of region German 6072 70.1 38.7 (35.0, 42.3) ref 21.7 (19.0, 24.4) ref
French 2324 25.0 64.3 (60.9, 67.7) 2.86 (2.31, 3.54) 32.2 (28.7, 35.7) 1.71  (1.37, 2.15)
Italian 686 39.8 70.4 (65.5, 75.3) 3.77 (2.85, 5.00) 60.9 (55.4, 66.4) 5.62 (4.25, 7.44)
CI: confidence interval. ref: reference group. BE, TI, VD: only included in analysis for school vaccination policy. JU: not
included in analysis.
Of the information available, the top 3 resources for information regarding vaccination for all 3 age
groups include information from the doctors upon request, followed by information brochures, and
obtaining the information from their physicians without it being requested. In the future, parents
would like to receive more information from the doctors, instead of having to ask the doctors
themselves (Table 12, Annex K). They would like less information from the media, but more from
the health insurance. Among the different language regions, the same trend is observed for the type
of information available and what they wish to receive in the future. The two major differences are
the information from public health facilities and the active seeking of information. More precisely,
parents in all regions for the 2 youngest age groups prefer information to be given to them freely by
the physicians; by the adolescents, the same trend is observed in the German-speaking region, but
the difference is not apparent, either by the French-speaking region or by the overall mean. Parents
in the German-speaking region significantly receive more information from the public health
facilities than those in the French- and Italian-speaking regions. Parents of toddlers generally would
like more information from public health services, whereas the trend is reversed for those in the
school age groups. Finally, more parents recognize the increase in information from school health
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official as their children are older; consequently, they would like this flow of information to also
increase in the future.
Table 12.   Sources for information regarding vaccination (%) for parents of children in
Switzerland, 1999-2003
 Toddlers
 D-CH W-CH TI CH
n 5717 2150 532 8399
 present future present future present future present future
Information broshures 47.8 65.4 36.4 60.4 38.3 55.5 44.6 63.9
Doctor upon request 50.8 41.0 44.4 42.1 56.2 39.6 49.2 41.3
Doctor without request 36.0 65.3 36.6 63.7 40.9 61.2 36.2 64.8
School doctor 1.7 11.1 2.0 15.1 - 23.6 1.8 12.4
The media 38.2 33.7 30.5 25.8 27.6 20.8 36.0 31.4
Public health services 26.0 32.0 10.4 17.2 8.5 3.4 21.6 27.6
Health insurance 2.3 17.1 2.2 14.8 1.8 12.9 2.3 16.4
Job / Education 9.8 2.7 9.3 2.4 11.6 9.6 9.7 2.7
Other resources 14.1 9.4 10.3 8.0 5.4 0.8 13.0 8.5
 School entry
 D-CH W-CH CH
n 5178 1695 6873
 present future present future present future
Information broshures 41.4 61.1 34.7 53.1 39.9 59.4
Doctor upon request 50.6 37.4 45.1 45.9 49.4 39.2
Doctor without request 34.9 58.1 41.4 54.8 36.3 57.4
School doctor 8.4 24.0 12.5 26.4 9.3 24.5
The media 37.9 29.6 30.5 23.0 36.3 28.2
Public health services 23.4 22.3 14.7 12.7 21.6 20.2
Health insurance 2.8 17.5 1.8 12.0 2.6 16.3
Job / Education 9.0 2.4 9.8 2.9 9.2 2.5
Other resources 10.9 5.8 11.3 6.4 11.0 5.9
 School departure
 D-CH W-CH CH
n 4499 1814 6313
 present future present future present future
Information broshures 37.1 56.4 44.3 54.3 38.6 56.0
Doctor upon request 42.4 38.5 45.7 48.5 43.1 40.7
Doctor without request 29.9 47.8 29.4 44.5 29.8 47.1
School doctor 23.8 31.6 25.8 33.9 24.2 32.1
The media 31.3 27.7 35.0 27.8 32.1 27.8
Public health services 20.7 16.5 11.3 9.3 18.7 14.9
Health insurance 3.3 18.0 2.4 12.9 3.1 16.9
Job / Education 9.4 4.5 8.0 3.4 9.1 4.3
Other resources 9.6 7.2 13.1 7.8 10.4 7.4
Multiple answers were possible. BE, TI, VD: questionnaires were not used with schoolchildren.
D-CH: German-speaking region. W-CH: French-speaking region.
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3.7 Use of complementary / alternative medicine (CAM)
Question: Have you ever used any form of alternative medicine for your child?
In Switzerland, 41.7% of families of toddlers use some form of CAM, with a steady decrease as the
children are older, down to 37.9% at school entry and to 30.9% at school departure (Table 13).
Table 13.  Distribution of use of CAM among  parents of toddlers 24-35 month of age and
children at school entry and departure in the German- and French- speaking regions of
Switzerland, 1999-2003
  Alternative medicine use
Age groups Regions n Yes (%) No (%) No Answer (%)
Toddlers German-speaking 5701 38.2 58.4 3.5
 French-speaking 2150 51.4 44.5 4.1
 Switzerland 7851 41.7 54.7 3.6
   
School entry German-speaking 5178 34.9 60.9 4.3
 French-speaking 1698 49.0 46.7 4.3
 Switzerland 6876 37.9 57.8 4.3
   
School departure German-speaking 4499 27.8 70.7 1.5
 French-speaking 1814 42.2 55.3 2.5
 Switzerland 6313 30.9 67.4 1.7
TI: by toddlers, no information since the theme of alternative medicine was not included in the
questionnaire. BE, TI, VD: no information for schoolchildren since questionnaire was not used.
More specifically, parents in the French-speaking region utilize CAM much more than their German
counterpart, although the pattern of decrease use of CAM with increasing age remains the same. In
all three age groups, the most frequently reported use of CAM are in the French-speaking cantons,
with the exception of canton OW, where 56.5% of parents of toddlers admitted to using some form
of CAM (Annex L). When examining the use of CAM against immunization coverage, it appears to
be consistently associated with vaccination rates. Toddlers of parents who use CAM have a lower
chance of being UTD. For the 33333111 series, the odds of being UTD among these toddlers is
0.38 (CI: 0.33, 0.43) times that of those where the parents do not use CAM. Further investigation
into the individual vaccines for both toddlers and children at school entry reveal the same pattern
(Tables 11.1, 11.2). This pattern is also found among the children at school departure for measles at
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one dose and HepB at one dose and at 3 doses, but for Di and Pol at 5 doses, the trend is reversed
(Tables 11.3, 11.3.1). Here, adolescents whose parents use CAM are better vaccinated than those
whose parents do not practice CAM.  The odds of being UTD for 5 doses of Di and Pol among
teenagers whose parents use CAM is 1.26 (CI: 1.06, 1.56) and 1.29 (CI: 1.06, 1.56), respectively,
times that of those whose parents do not use CAM.
For toddlers and children at school departure whose parents use CAM, a significant difference
could be found in coverage levels between those residing in the French- and German-speaking
regions (Tables 11.1, 11.3). The odds of being UTD for toddlers from the French-speaking region
at the 33333111 DTPPolHibMMR series, 3 doses of Di and Hib, and 1 dose of measles is 2.66
(CI: 2.17, 3.25), 2.83 (CI: 1.84, 4.37), 2.09 (CI: 1.54, 2.84) and 2.83 (CI: 2.26, 3.53), respectively,
times that of those from the German-speaking region. In contrast,  the odds that  adolescents from
the French-speaking region are UTD with the 5550111 DTPPolHibMMR series, 5 doses of Di and
1 dose of measles is 0.73 (CI: 0.56, 0.95), 0.64 (CI: 0.48, 0.84) and 0.63 (CI: 0.42, 0.94),
respectively, times that of those from the German-speaking region; for 1 dose and 3 doses of HepB,
the odds of being UTD are 2.06 (CI: 1.45, 2.91) and 3.44 (CI: 2.41, 4.93), respectively (Table
11.3.1). There was no significant difference in CAM use between the linguistic regions for the
children at school entry, as seen in Table 11.2.
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3.8      Linguistic region
Almost as pronounced as the use of alternative medicine is the influence of the different linguistic
regions on vaccination coverage.  The general trend for the two younger age groups shows that
those children from the German-speaking regions are significantly less vaccinated, followed by the
French-speaking region, and finally the Italian-speaking region has the highest immunization
coverage, with the trend being less distinct as the age of the children climbs (Tables 11.1, 11.2).
Only 74.6% of toddlers residing in the German-speaking region have completed the vaccination
series 33333111 in comparison to 86.0% of those residing in the French-speaking region and
90.7% in the Italian-speaking region. The odds of being UTD for the 33333111 series among those
toddlers in the French-and Italian-speaking regions are 2.10 (CI: 1.78, 2.47) and 3.33 (CI: 2.56,
4.34), respectively, times that of those in the German-speaking region. By Di and Hib at 3 doses,
this pattern is also significantly similar. For measles at one dose, the odds is even higher at 2.41 (CI:
1.99, 2.92) for the French-speaking region, and 3.96 (CI: 2.90, 5.40) for the Italian-speaking region
to be UTD, as compared to their German counterparts. This trend is also apparent for children at
school entry, with the odds of being UTD for series 44443111 and measles at 1 dose for the
French-speaking region are 1.62 (CI: 1.37, 1.92) and 1.39 (CI: 1.09, 1.76), respectively, and for the
Italian-speaking region are 6.40 (CI: 4.95, 8.28) and 2.17 (CI: 1.46, 3.23), respectively, times that of
those from the German-speaking region. By 4 doses of Di and 3 doses of Hib, the odds that
children from the Italian-speaking region are UTD are 1.60 (CI: 1.10, 2.34) and 1.19 (CI: 1.05,
1.35), respectively, times that of those residing in the German-speaking region.
This pattern is not so distinct in the oldest age group as displayed in Table 11.3. By the 5505111
series and Di at 5 doses, coverage levels for the children in the German- and French-speaking
regions are similar, but they are lower than those in the Italian-speaking region; by Pol, coverage  in
the German- and Italian-speaking regions are similar, but significantly lower than the French-
speaking region; for measles at one dose, children from the French- and Italian-speaking regions,
91.7% and 91.5%, respectively, are significantly less vaccinated than those from the German-
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speaking region (94.7%). The odds of being UTD for measles at one dose for among adolescents
living in the French- speaking region is 0.62 (CI: 0.50, 0.77) times that of those in the German-
speaking region; for the Italian-speaking region, the odds is 0.59 (CI: 0.45, 0.77) times. In contrast
to measles, adolescents in the French-and Italian-speaking regions have significantly higher chances
of being vaccinated for HepB than those children in the German-speaking region (Table 11.3.1).
The odds of being UTD for HepB at one dose among those living in the French-speaking region is
2.86 (CI: 2.31, 3.54) times that of those living in the German-speaking region; for the Italian
speaking region, the odds is 3.77 (CI: 2.85, 5.00) times.
3.9 School vaccination policy
Vaccination coverage in schoolchildren was also examined against school immunization policy.
Cantons with cantonal employed school or  LL nurses supplementing school health services (AG,
BL, BS, GE, NW, SZ, VD and VS) have overall significantly higher vaccination coverage by the
immunization series than those without these services for both age groups, with coverage estimates
for children at school entry being 59.3% and 44.0%, respectively, for the 44443111
DTPPolHibMMR series and for school departure, 75.7% and 70.0%, respectively,  for the 5505111
DTPPolMMR series (Tables 14.1, 14.2). The odds of being UTD for the 44443111 series for
children at school entry in cantons with these services is 1.86 (CI: 1.61, 2.14) times that of those in
cantons where there are no supplementary school health nurses; by the adolescents, the odds is 1.33
(CI: 1.14, 1.55) at the 5505111 immunization series. For measles at one dose, coverage is
significantly higher for children at school entry in cantons with these services, whereby they do not
influence coverage by the adolescents. However, by the children at school departure, the odds of
being UTD for Pol at 5 doses and HepB at 1 dose for children in cantons with additional school
health nurses is 1.46 (CI: 1.20, 1.76) and 1.66 (CI: 1.33, 2.08), respectively, times that of those
residing in cantons without the extra help (Tables 14.2, 14.2.1). Further analyses of the services
with the additional nurses against higher doses for the recommended vaccines (i.e. for school entry,
5 doses for Di and Pol, 4 doses for Hib; for school departure, DTPPolMMR immunization series at
6605111 and 5505222, 6 doses for Di and 2 doses for measles) as displayed in Tables 14.1 and
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14.2 show that children in cantons where the additional nurses are available have a significantly
better chance of being vaccinated than those living in cantons where they rely solely on the school
doctors for school health services.
In contrast to additional help from school / LL nurses, the policy in which immunization is permitted
in the schools is not significantly associated with vaccination coverage by the adolescents;  however,
when analyzed against higher doses, children where vaccination is permitted in the schools do have a
significantly higher chance of being vaccinated than those living in cantons where immunization is
done privately by the GPs (Table 14.2). At 5 doses of Di, 1 dose of measles and immunization
series 5505111, the differences in vaccination coverage levels are not significant, whereas at 6 doses
of Di, 2 doses of measles and the immunization series 6605111, the odds of being UTD among
adolescents living in cantons where vaccination is permitted in the schools are significantly higher at
1.32 (CI: 1.12, 1.56), 1.39 (CI: 1.16, 1.66), and 1.22 (CI: 1.04, 1.44), respectively, than those where
it is not possible to vaccinate in the schools. There is no significant difference in HepB coverage
among the cantons with and without HepB campaign in the schools. There is however a significant
association between the odds of being UTD for 3 doses of HepB and whether or not HepB
vaccination is permitted in the schools. Adolescents residing in cantons where HepB vaccination is
administered in the schools have an odds of being UTD at 3 doses of HepB of 0.58 (CI: 0.46, 0.71)
times that of adolescents living in cantons where HepB vaccination is not offered during school
hours (Table 14.2.1).
Association between vaccination status of children at school entry and the factor of residing in
cantons where vaccination is permitted in the schools depends  on the vaccine. At 5 doses of Di and
Pol, children living in cantons where vaccination is permitted in school have a significantly higher
chance of being vaccinated than children living in cantons where immunizations are done privately,
with the odds at 1.99 (CI: 1.73, 2.28) and 2.10 (CI: 1.83, 2.41), respectively (Table 14.1). In
contrast, by the 44443111 immunization series and Hib, at 3 and 4 doses, children at school entry
living in cantons where they can be vaccinated by school health officials have lower immunization
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coverage than compared to those living in cantons where vaccination is encouraged to be
administered by the family physicians. 47.8% of children in cantons belonging to the former group
is UTD for the 44443111 series as compared to 53.4% in the latter group; it is 76.9% and 82.3%,
respectively for Hib at 3 doses and 23.9% and 33.3%, respectively, at 4 doses (Table 14.1). The
odds of being UTD for the series 44443111 for children at school entry residing in cantons where
immunization is permitted in the schools is 0.80 (CI: 0.70, 0.91) times that of those where
immunization is not permitted; for Hib at 3 doses, the odds is 0.72 (CI: 0.61, 0.84) and at 4 doses it
is 0.63 (CI: 0.54, 0.74).
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Table 14.1.  Logistic regression of school vaccination policy and vaccination coverage for
DTPolHibMMR for the number of doses at series 44443111 and 33333111, diphtheria at 4
and 5 doses, Haemophilus influenzae type B (Hib)  at 3 and 4 doses, polio at 5 doses and
measles at one dose for children at school entry living in Switzerland, 1999-2003
Coverage for Odds Ratio Coverage Odds Ratio
series 44443111 44443111 Di (4 doses) Di (4 doses)
variable  n % %(±95%CI) (±95%CI) %(±95%CI) (±95%CI)
cantonally employed no 5710 65.8 44.0 (42.0, 46.0) ref 92.5 (91.4, 93.5) ref
school health nurses yes 3434 34.2 59.3 (56.5, 62.1) 1.86 (1.61, 2.14) 92.5 (91.4, 93.5) 1.00  (0.81, 1.24)
vaccination in school no 3145 25.2 53.4 (50.8, 56.0) ref 91.9 (90.6, 93.1) ref
yes 5999 74.8 47.8 (45.7, 49.9) 0.80 (0.70, 0.91) 92.7 (91.7, 93.6) 1.12  (0.90, 1.39)
Coverage for Odds Ratio Coverage Odds Ratio
series 33333111 series 3333111 Di (5 doses) Di (5 doses)
variable  n % %(±95%CI) (±95%CI) %(±95%CI) (±95%CI)
cantonally employed no 5710 65.8 67.5 (65.6, 69.4) ref 57.7 (55.2, 60.1) ref
school health nurses yes 3434 34.2 72.5 (70.4, 74.5) 1.27  (1.11, 1.45) 64.4, (62.1, 66.7) 1.33  (1.15, 1.53)
vaccination in school no 3145 25.2 71.2 (69.0, 73.4) ref 47.4 (44.9, 50.0) ref
yes 5999 74.8 68.5 (66.7, 70.3) 0.88  (0.77, 1.01) 64.2 (62.0, 66.4) 1.99  (1.73, 2.28)
Coverage for Odds Ratio Coverage Odds Ratio
Hib (3 doses) Hib (3 doses) Measles (1 dose) Measles (1 dose)
variable  n % %(±95%CI) (±95%CI) %(±95%CI) (±95%CI)
cantonally employed no 5710 65.8 77.6 (75.9, 79.3) ref 87.6 (86.2, 88.9) ref
school health nurses yes 3434 34.2 79.7 (77.9, 81.4) 1.13  (0.98, 1.31) 90.1 (88.8, 91.4) 1.30  (1.07, 1.57)
vaccination in school no 3145 25.2 82.3 (80.4, 84.2) ref 89.0 (87.6, 90.5) ref
yes 5999 74.8 76.9 (75.4, 78.5) 0.72  (0.61, 0.84) 88.2 (87.0, 89.5) 0.92 (0.76, 1.11)
Coverage Odds Ratio Coverage Odds Ratio
Hib (4 doses) Hib (4 doses) Pol (5 doses) Pol (5 doses)
variable  n % %(±95%CI) (±95%CI) %(±95%CI) (±95%CI)
cantonally employed no 5710 65.8 26.4 (24.4, 28.4) ref 56.5 (53.9, 59.0) ref
school health nurses yes 3434 34.2 26.9 (24.2, 29.6) 1.03  (0.87, 1.22) 65.7 (63.5, 67.8) 1.47  (1.28, 1.70)
vaccination in school no 3145 25.2 33.3 (30.7, 35.9) ref 46.0 (43.6, 48,5) ref
yes 5999 74.8 23.9 (21.9, 25.9) 0.63  (0.54, 0.74) 64.2 (61.9, 66.4) 2.10  (1.83, 2.41)
CI: confidence interval. ref: reference group. JU: not included in analysis
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Table 14.2.  Logistic regression of school vaccination policy and vaccination coverage for
DTPPolMMR for the number of doses at series 6605111, 5505222 and 5505111, diphtheria at 5
and 6 doses, polio at 5 doses and measles at 1 and 2 doses for children at school departure living
in Switzerland, 1999-2003
Coverage for Odds Ratio Coverage Odds Ratio
series 5505111 5505111 Di (5 doses) Di (5 doses)
variable  n % %(±95%CI) (±95%CI) %(±95%CI) (±95%CI)
cantonally employed no 5503 64.2 70.0 (67.8, 72.3) ref 80.7 (78.6, 82.8) ref
school health nurses yes 3579 35.8 75.7 (73.7, 77.7) 1.33  (1.14, 1.55) 83.2 (81.3, 85.1) 1.18  (0.98, 1.43)
vaccination in school no 2747 22.6 74.4 (71.7, 77.0) ref 82.2 (79.8, 84.7) ref
yes 6335 77.4 71.4 (69.5, 73.3) 0.86  (0.73, 1.02) 81.4 (79.6, 83.3) 0.95  (0.77, 1.16)
Coverage for Odds Ratio Coverage Odds Ratio
series 6605111 6605111 series 5505222 5505222
variable  n % %(±95%CI) (±95%CI) %(±95%CI) (±95%CI)
cantonally employed no 5503 64.2 42.0 (39.0, 45.0) ref 36.1 (33.2, 38.9) ref
school health nurses yes 3579 35.8 56.4 (53.9, 58.9) 1.79  (1.53, 2.10) 56.0 (53.8, 58.2) 2.26  (1.94, 2.62)
vaccination in school no 2747 22.6 43.3 (40.2, 46.3) ref 41.6 (38.5, 44.8) ref
yes 6335 77.4 48.3 (45.8, 50.8) 1.22  (1.04, 1.44) 43.7 (41.3, 46.1) 1.09 (0.92, 1.28)
Coverage for Odds Ratio Coverage Odds Ratio
Pol (5 doses) Pol (5 doses) Measles (1 dose) Measles (1 dose)
variable  n % %(±95%CI) (±95%CI) %(±95%CI) (±95%CI)
cantonally employed no 5503 64.2 78.7 (76.5, 80.9) ref 93.4 (92.5, 94.2) ref
school health nurses yes 3579 35.8 84.3 (82.5, 86.1) 1.46  (1.20, 1.76) 94.5 (93.7, 95.4) 1.23  (0.99, 1.53)
vaccination in school no 2747 22.6 79.7 (77.0, 82.3) ref 93.7 (92.5, 94.9) ref
yes 6335 77.4 81.1 (79.3, 82.9) 1.10  (0.89, 1.33) 93.8 (93.1, 94.5) 1.02  (0.80, 1.29)
Coverage for Odds Ratio Coverage Odds Ratio
Di (6 doses) Di (6 doses) Measles (2 doses) Measles (2 doses)
variable  n % %(±95%CI) (±95%CI) %(±95%CI) (±95%CI)
cantonally employed no 5503 64.2 46.7 (43.5, 50.0) ref 47.5 (44.4, 50.7) ref
school health nurses yes 3579 35.8 59.8 (57.4, 62.3) 1.70  (1.44, 2.01) 65.5 (63.2, 67.9) 2.10 (1.78, 2.47)
vaccination in school no 2747 22.6 46.1 (42.9, 49.2) ref 47.6 (44.1, 51.2) ref
yes 6335 77.4 53.0 (50.3, 55.7) 1.32  (1.12, 1.56) 55.8 (53.2, 58.5) 1.39  (1.16, 1.66)
CI: confidence interval. ref: reference group. JU: not included in analysis
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Table 14.2.1.   Logistic regression of Hepatitis B (HepB) vaccination policy in the schools and
vaccination coverage for HepB at one dose and three doses for children at school departure
living in Switzerland, 1999-2003
Coverage for Odds Ratio Coverage for Odds Ratio
HepB (1 dose) HepB (1 dose) HepB (3 doses) HepB (3 doses)
variable  n % %(±95%CI) (±95%CI) %(±95%CI) (±95%CI)
cantonally employed no 5503 64.2 41.8 (38.3, 45.4) ref 27.0 (24.2, 29.7) ref
school health nurses yes 3579 35.8 54.4 (50.2, 58.7) 1.66 (1.33, 2.08) 24.0 (20.8, 27.2) 0.86 (0.68, 1.07)
HepB campaign in no 2634 19.6 50.7 (43.7, 57.8) ref 21.9 (17.0, 26.7) ref
the schools yes 6448 80.4 45.3 (42.3, 48.3) 0.80 (0.59, 1.09) 26.9 (24.6, 29.2) 1.31 (0.97, 1.78)
HepB vaccination in no 2587 19.5 43.3 (39.3, 47.3) ref 35.1 (31.3, 38.8) ref
the schools yes 6495 80.5 47.1 (43.8. 50.4) 1.16 (0.95, 1.44) 23.7 (21.2, 26.2) 0.58 (0.46, 0.71)
CI: confidence interval. ref: reference group. JU: not included in analysis
3.10 Attitudes towards vaccination
Parents were asked if they strongly agreed, agreed, or disagree with these six statements
regarding vaccination in general:
1. I follow the doctor’s recommendations regarding vaccination.
2. There is too much social pressure to vaccinate children.
3. I believe that vaccination protects from certain diseases.
4. As many children as possible should be vaccinated so that all children will be protected from
complications associated with certain diseases.
5. Doctors provide enough information on childhood immunization.
6. I am concerned about possible side effects from vaccines.
Parental attitudes toward vaccination in general are also strongly associated with immunization
coverage, with the same trend revealed for all six statements described above (Tables 15). These six
statements posed on the questionnaire dealt with following the doctor’s recommendations, social
pressure to vaccinate, effectiveness of vaccination, importance of solidarity, explanation of doctors,
and concerns regarding possible side effects. By parents of toddlers, 89.9% parents agree or
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strongly agree that they follow the recommendations of the physicians, 58.0% disagree that there is
too much social pressure in society, 96.7% believe in the effectiveness of vaccination, 78.8% would
vaccinate their children for the benefit of all kids, 64.0% agree or strongly agree that doctors provide
enough information about vaccination, and 55.7% of the parents are concerned with possible side
effects (Table 15.1). In short, toddlers whose parents follow the recommendations of their doctors,
believe in the effectiveness of vaccination, concur with the advantage of herd immunity and agree
that doctors provide enough explanations about vaccination are better vaccinated than those whose
parents do not agree with these statements. In contrast, toddlers whose parents thought there were
too much social pressure to vaccinate their children and have concerns about possible side effects
from vaccines are less likely to be vaccinated as compared to those who disagree. Most pronounced
are the responses to following the doctor’s recommendations and the effectiveness of vaccination
where the odds of being UTD for measles at 1 dose among those who strongly agree with these
statements are  42.70 (CI: 31.88, 57.17) and 22.25 (CI: 13.74, 36.06) times, respectively, that of
those who disagree. In contrast, the odds of being UTD for measles at 1 dose among those who
strongly agree that there is too much pressure to vaccinate their children and are concerned about
side effects from vaccination are 0.08 (CI: 0.06, 0.10) and 0.09 (CI: 0.07, 0.12) times, respectively,
that of those who disagree. The odds of being UTD are higher for those who responded with
”strongly agree” than with ”agree” or ”do not know” when the reference group is ”do not
agree” for statements with positive consequences towards vaccination, whereas the odds of being
UTD for those who responded with ”strongly agree” than with ”agree” to statements that are
negative towards vaccination are lowest.
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Table 15.1.  Logistic regression of parental attitudes towards immunization and vaccination coverage
for DTPPolHibMMR for the number of doses at series 33333111, diphtheria and Haemophilus
influenzae  type B (Hib) at 3 doses and measles at 1 dose for children  24-35 months living in
Switzerland, 1999-2003
Coverage for Odds Ratio Coverage Odds Ratio
series 33333111 33333111 Di (3 doses) Di (3 doses)
variable  n % %(±95%CI) (±95%CI) %(±95%CI) (±95%CI)
follow recommendations do not know 82 1.1 52.2 (35.5, 68.9) 4.84 (3.00, 10.21) 84.1 (69.4, 98.8) 1.69 (0.51, 5.62)
of doctor disagree 851 9.0 18.4 (14.4, 22.4) ref 75.8 (71.1, 80.5) ref
agree 4409 56.2 81.5 (79.5, 83.4) 19.50 (14.61, 26.03) 97.5 (96.9, 98.2) 12.62 (8.87, 17.98)
strongly agree 2973 33.7 89.6 (88.0, 91.2) 38.34 (27.94, 52.60) 98.2 (97.4, 99.0) 17.46 (10.40, 29.32)
too much social pressure do not know 831 12.4 84.3 (81.0, 87.7) 0.80 (0.61, 1.10) 97.7 (96.3, 99.1) 0.61 (0.28, 1.33)
to vaccinate kids disagree 4465 58.0 86.9 (85.5, 88.4) ref 98.6 (98.0, 99.2) ref
agree 1812 22.8 62.5 (59.1, 65.9) 0.25 (0.21, 0.30) 92.9 (91.2, 94.6) 0.19 (0.11, 0.30)
strongly agree 617 6.9 39.2 (33.8, 44.5) 0.10 (0.08, 0.12) 74.9 (70.3, 79.6) 0.04 (0.03, 0.70)
vaccination protects from do not know 140 1.3 54.7 (43.6, 65.8) 4.31 (2.33, 8.00) 74.2 (62.6, 85.8) 2.77 (1.38, 5.57)
certain diseases disagree 191 2.1 21.9 (13.9, 29.9) ref 51.0 (39.6, 62.4) ref
agree 4805 61.0 76.9 (75.0, 78.8) 11.87 (7.36, 19.15) 96.0 (95.2, 96.8) 23.00 (13.94, 38.1)
strongly agree 3172 35.7 84.6 (82.7, 86.4) 19.58 (11.87, 32.30) 98.5 (97.8, 99.2) 64.63 (33.11, 126.16)
solidarity is important do not know 642 7.3 75.3 (70.2, 80.5) 5.14 (3.64, 7.26) 94.8 (91.9, 97.7) 4.39 (2.22, 8.68)
disagree 1151 13.9 37.3 (32.4, 42.1) ref 80.7 (77.3, 84.0) ref
agree 4030 50.0 83.2 (81.5, 85.0) 8.36 (6.55, 10.66) 98.0 (97.4, 98.6) 11.72 (8.10, 17.03)
strongly agree 2451 28.8 89.5 (87.7, 91.4) 14.36  (10.94, 18.86) 98.9 (98.2, 99.7) 22.52 (10.34, 49.04)
doctors provide enough do not know 489 6.2 69.6 (64.2, 75.0) 1.58 (1.18, 2.10) 94.8 (92.0, 97.5) 1.67 (0.91, 3.05)
information about disagree 2389 29.7 59.3 (56.3, 62.2) ref 91.6 (90.0, 93.1) ref
vaccination agree 4251 51.2 75.4 (73.5, 77.3) 2.11 (1.84, 2.41) 97.7 (97.1, 98.4) 4.00 (2.87, 5.56)
strongly agree 1179 12.8 77.5 (80.8, 1.73) 2.36 (1.90, 2.94) 97.2 (95.4, 99.0) 3.20 (1.58, 6.46)
concerns about possible do not know 508 7.4 87.7 (83.7, 91.8) 0.95     (0.63, 1.44) 96.6 (94.0, 99.1) 0.46 (0.18, 1.17)
side effects disagree 3063 36.8 88.2 (86.5, 90.0) ref 98.4 (97.7, 99.1) ref
agree 3444 43.2 76.2 (73.6, 78.8) 0.43     (0.35, 0.52) 96.5 (95.5, 97.5) 0.45 (0.26, 0.77)
strongly agree 1243 12.5 47.8 (43.8, 51.7) 0.12     (0.10, 0.15) 84.0 (81.3, 86.8) 0.09 (0.05, 0.14)
Coverage for Odds Ratio Coverage Odds Ratio
Hib (3 doses) Hib (3 doses) Measles (1 dose) Measles (1 dose)
variable  n % %(±95%CI) (±95%CI) %(±95%CI) (±95%CI)
follow recommendations do not know 82 1.1 75.8 (61.6, 90.1) 1.76 (0.75, 4.11) 60.3 (44.0, 76.6) 4.90 (2.40, 10.01)
of doctor disagree 851 9.0 64.1 (58.9, 69.4) ref 23.7 (19.6, 27.8) ref
agree 4409 56.2 93.1 (92.0, 94.1) 7.53 (5.71, 9.93) 85.9 (84.1, 87.7) 19.65 (14.99, 25.78)
strongly agree 2973 33.7 96.1 (95.1, 97.1) 13.68 (9.77, 19.14) 93.0 (91.8, 94.2) 42.70 (31.88, 57.17)
too much social pressure do not know 831 12.4 93.4 (91.3, 95.4) 0.59 (0.41, 0.85) 89.1 (85.6, 92.7) 0.85 (0.58, 1.25)
to vaccinate kids disagree 4465 58.0 96.0 (95.2, 96.8) ref 90.6 (89.4, 91.7) ref
agree 1812 22.8 85.6 (82.9, 88.2) 0.25 (0.19, 0.32) 67.7 (64.6, 70.9) 0.22 (0.18, 0.26)
strongly agree 617 6.9 64.6 (59.5, 69.7) 0.08 (0.06, 0.10) 43.6 (38.2, 48.9) 0.08 (0.06, 0.10)
vaccination protects from do not know 140 1.3 66.4 (55.0, 77.9) 2.83 (1.43, 5.60) 64.4 (54.2, 74.7) 5.16 (2.73, 9.74)
certain diseases disagree 191 2.1 41.2 (29.5, 52.9) ref 26.0 (17.4, 34.5) ref
agree 4805 61.0 91.2 (90.1, 92.3) 14.80 (9.20, 24.26) 81.0 (79.2, 82.8) 12.15 (7.61, 19.39)
strongly agree 3172 35.7 95.6 (94.5, 96.6) 31.00  (17.80, 53.96) 88.6 (87.0, 90.3) 22.25 (13.74, 36.03)
solidarity is important do not know 642 7.3 89.5 (86.1, 92.9) 3.88    (2.52, 5.96) 81.3 (77.4, 85.1) 6.26 (4.55, 8.62)
disagree 1151 13.9 68.8 (64.6, 72.9) ref 40.9 (36.1, 45.7) ref
agree 4030 50.0 95.0 (93.9, 96.0) 8.54 (6.31, 11.56) 87.3 (85.7, 89.0) 9.96 (7.79, 12.74)
strongly agree 2451 28.8 96.3 (95.3, 97.4) 11.97 (8.47, 16.90) 93.6 (92.3, 95.0) 21.30 (15.95, 28.44)
doctors provide enough do not know 489 6.2 87.1 (83.3, 90.9) 1.17 (0.82, 1.67) 83.2 (78.7, 87.8) 2.06 (1.47, 2.88)
information about disagree 2389 29.7 85.2 (83.2, 87.3) ref 70.7 (67.9, 73.5) ref
vaccination agree 4251 51.2 94.2 (93.2, 95.2) 2.81 (2.23, 3.55) 87.0 (85.6, 88.5) 2.79 (2.35, 3.30)
strongly agree 1179 12.8 95.4 (93.9, 96.9) 3.58 (2.44, 5.25) 88.9 (86.4, 91.4) 3.33 (2.50, 4.44)
concerns about possible do not know 508 7.4 96.6 (94.0, 99.2) 0.45 (0.18, 1.11) 92.1 (88.2, 96.0) 1.01 (0.57, 1.79)
side effects disagree 3063 36.8 98.4 (97.8, 99.0) ref 92.0 (90.6, 93.4) ref
agree 3444 43.2 96.5 (95.5, 97.5) 0.44 (0.27, 0.72) 80.7 (78.5, 83.0) 0.36 (0.29, 0.45)
strongly agree 1243 12.5 82.8 (79.9, 85.6) 0.08 (0.05, 0.12) 51.5 (47.5, 55.4) 0.09 (0.07, 0.12)
CI: confidence interval; ref: reference group
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For schoolchildren, the trend remains similar to those apparent by the toddlers, but the magnitude of
the odds of being UTD is smaller, with the magnitude decreasing with increasing age (Tables 15.2,
15.3). Of the 4 conditions examined for being UTD, the differences in the odds of being UTD for
measles at one dose are distinctly magnified among the 6 statements posed. For example, for
responses as to whether or not parents of children at school entry follow the recommendations of
their doctor, the odds of being UTD for the 44443111 series, 4 doses of Di and 3 doses of Hib for
those who strongly agree with this statement are 6.51 (CI: 4.81, 8.82), 3.26 (CI: 2.29, 4.62), and
3.86 (CI: 2.96, 5.04) times, respectively, that of those who disagree; for measles at one dose, the
odds of being UTD is 22.15 (CI: 15.80, 31.05). Although the same trend is prominent among the
adolescents, the the odds of being UTD for the 5505111 series, 5 doses of Di and 5 doses of Pol,
and 1 dose of measles vaccination for those who strongly agree with this statement are only 3.39
(CI: 2.55, 4.49), 2.10 (CI: 1.53, 2.86), 1.76 (CI: 1.29, 2.41), and 6.51 (CI: 4.10, 10.38) times,
respectively, that of those who disagree. Notable is also for those who responded with ”do not
know” to these questions. Teenagers whose parents are unsure of how to respond have a lower
chance of being UTD for the immunization series 5505111 and Di and Pol at 5 doses than those
who disagreed with the statements. As seen in Table 15.3.1, the same trend is revealed for HepB at
both 1 dose and 3 doses.
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Table 15.2.  Logistic regression of parental attitudes towards immunization and vaccination coverage
for DTPPolHibMMR for the number of doses at series 44443111, diphtheria at 4 doses and
Haemophilus influenzae type B (Hib) at 3 doses and measles at 1 dose for children at school entry
living in Switzerland, 1999-2003
Coverage for Odds Ratio Coverage Odds Ratio
series 44443111 series 44443111 Di (4 doses) Di (4 doses)
variable  n % %(±95%CI) (±95%CI) %(±95%CI) (±95%CI)
follow recommendations do not know 94 1.5 24.0 (12.8, 35.1) 1.48  (0.78, 2.78) 70.4 (56.2, 84.5) 0.55 (0.26, 1.14)
of doctor disagree 531 8.2 17.6 (13.4, 21.8) ref 81.3 (77.2, 85.4) ref
agree 3341 56.9 44.6 (42.1, 47.1) 3.77 (2.78, 5.11) 94.8 (93.8, 95.8) 4.21 (2.98, 5.96)
strongly agree 2481 33.5 58.2 (55.3, 61.0) 6.51 (4.81, 8.82) 93.4 (92.1, 94.7) 3.26 (2.29, 4.62)
too much social pressure do not know 796 13.1 44.0 (39.1, 48.8) 0.74 (0.61, 0.90) 89.6 (86.6, 92.5) 0.37 (0.25, 0.52)
to vaccinate kids disagree 3520 57.1 51.5 (49.1, 53.9) ref 95.9 (95.0, 96.8) ref
agree 1485 22.9 42.0 (38.8, 45.3) 0.68 (0.59, 0.79) 90.7 (88.7, 92.7) 0.42 (0.30, 0.58)
strongly agree 528 7.0 30.5 (25.1, 35.9) 0.41 (0.32, 0.54) 80.4 (76.0, 84.8) 0.17 (0.12, 0.25)
vaccination protects do not know 110 1.8 27.2 (16.4, 38.1) 0.96 (0.44, 2.13) 82.6 (74.2, 91.0) 2.11 (1.00, 4.43)
from certain diseases disagree 115 1.7 28.0 (16.7, 39.3) ref 69.2 (58.2, 80.3) ref
agree 3674 61.9 42.3 (40.0, 44.7) 1.89 (1.08, 3.29) 93.5 (92.3, 94.6) 6.34 (3.70, 10.88)
strongly agree 2567 34.6 56.4 (53.7, 59.1) 3.32 (1.89, 5.82) 93.4 (92.2, 94.7) 6.32 (3.67, 10.89)
solidarity is important do not know 440 6.8 44.4 (38.6, 50.2) 2.33 (1.69, 3.20) 94.2 (91.6, 96.8) 2.66 (1.53, 4.65)
disagree 916 16.0 25.5 (21.3, 29.8) ref 86.0 (83.0, 89.0) ref
agree 3040 49.7 47.9 (45.4, 50.4) 2.68 (2.12, 3.39) 94.9 (93.8, 96.0) 3.00 (2.20, 4.10)
strongly agree 2006 27.4 58.2 (55.1, 61.3) 4.06 (3.17, 5.19) 92.9 (91.3, 94.5) 2.12 (1.48, 3.02)
doctors provide enough do not know 405 6.6 43.4 (37.2, 49.6) 1.14 (0.86, 1.52) 89.8 (86.0, 93.5) 0.85 (0.53, 1.36)
information about disagree 1660 26.4 40.1 (37.1, 43.1) ref 91.2 (89.2, 93.1) ref
vaccination agree 3285 52.5 48.1 (45.6, 50.7) 1.39 (1.20, 1.60) 94.7 (93.7, 95.8) 1.74 (1.29, 2.35)
strongly agree 1090 14.6 55.5 (51.5, 59.4) 1.86 (1.54, 2.25) 91.2 (89.0, 93.3) 1.00 (0.71, 1.42)
concerns about possible do not know 497 8.1 41.9 (36.7, 47.1) 0.66 (0.52, 0.83) 87.9 (84.3, 91.6) 0.33 (0.21, 0.51)
side effects disagree 2249 35.5 52.3 (49.3, 55.4) ref 95.7 (94.5, 96.9) ref
agree 2590 42.0 44.9 (42.1, 47.8) 0.74 (0.63, 0.87) 94.0 (92.7, 95.2) 0.70 (0.51, 0.97)
strongly agree 1042 14.4 41.2 (37.2, 45.2) 0.64 (0.52, 0.78) 85.7 (82.8, 88.6) 0.27 (0.19, 0.39)
Coverage for Odds Ratio Coverage Odds Ratio
Hib (3 doses) Hib (3 doses) Measles (1 dose) Measles (1 dose)
variable  n % %(±95%CI) (±95%CI) %(±95%CI) (±95%CI)
follow recommendations do not know 94 1.5 59.7 (46.3, 73.2) 1.15 (0.64, 2.05) 68.0 (56.0, 80.1) 2.47 (1.36, 4.50)
of doctor disagree 531 8.2 56.4 (51.0, 61.8) ref 46.3 (40.7, 51.9) ref
agree 3341 56.9 80.8 (78.9, 82.7) 3.25 (2.54, 4.16) 92.1 (90.8, 93.4) 13.52 (10.11, 18.06)
strongly agree 2481 33.5 83.3 (81.1, 85.5) 3.86 (2.96, 5.04) 95.1 (93.9, 96.1) 22.15 (15.80, 31.05)
too much social pressure do not know 796 13.1 76.7 (72.9, 80.5) 0.65 (0.51, 0.83) 92.6 (90.3, 94.8) 0.64 (0.46, 0.89)
to vaccinate kids disagree 3520 57.1 83.6 (81.6, 85.5) ref 95.1 (94.2, 96.1) ref
agree 1485 22.9 74.9 (71.6, 78.2) 0.59 (0.47, 0.74) 79.1 (76.5, 81.8) 0.19 (0.15, 0.25)
strongly agree 528 7.0 65.4 (60.2, 70.6) 0.37 (0.29, 0.48) 60.8 (55.3, 66.3) 0.08 (0.06, 0.11)
vaccination protects from do not know 110 1.8 69.3 (59.3, 79.2) 1.90 (0.94, 3.85) 72.9 ( 63.0, 82.9) 1.83 (0.92, 3.63)
certain diseases disagree 115 1.7 54.2 (41.5, 67.0) ref 59.6 (47.9, 71.2) ref
agree 3674 61.9 77.8 (75.8, 79.7) 2.95 (1.76, 4.95) 87.5 (86.0, 89.0) 4.75 (2.90, 7.77)
strongly agree 2567 34.6 83.7 (81.6, 85.7) 4.32 (2.55, 7.31) 93.6 (92.8, 94.8) 9.88 (5.75, 16.96)
solidarity is important do not know 440 6.8 80.1 (75.3, 84.9) 2.12 (1.51, 2.98) 87.7 (84.1, 91.2) 3.91 (2.65, 5.76)
disagree 916 16.0 65.6 (61.6, 69.5) ref 64.5 (60.6, 68.4) ref
agree 3040 49.7 81.8 (79.7, 83.9) 2.36 (1.91, 2.92) 93.3 (92.0, 94.5) 7.61 (5.98, 9.69)
strongly agree 2006 27.4 82.9 (80.6, 85.3) 2.55 (2.02, 3.24) 95.4 (94.2, 96.6) 11.35 (8.18, 15.76)
doctors provide enough do not know 405 6.6 71.9 (66.3, 77.5) 0.76 (0.56, 1.04) 86.7 (82.4, 91.0) 1.66 (1.11, 2.47)
information about disagree 1660 26.4 77.0 (73.3, 79.7) ref 79.8 (77.2, 82.3) ref
vaccination agree 3285 52.5 81.5 (79.5, 83.5) 1.31 (1.09, 1.59) 93.0 (91.7, 94.2) 3.36 (2.67, 4.24)
strongly agree 1090 14.6 79.6 (76.2, 83.1) 1.17 (0.90, 1.51) 92.0 (90.1, 94.0) 2.94   (2.16, 4.01)
concerns about possible do not know 497 8.1 75.8 (71.5, 80.1) 0.66 (0.50, 0.86) 93.5 (91.0, 96.1) 0.72 (0.44, 1.18)
side effects disagree 2249 35.5 82.7 (80.2, 85.1) ref 95.3 (94.1, 96.4) ref
agree 2590 42.0 78.8 (76.5, 81.1) 0.78 (0.62, 0.97) 88.3 (86.6, 90.1) 0.38 (0.28, 0.50)
strongly agree 1042 14.4 75.4 (72.1, 78.7) 0.64 (0.51, 0.81) 71.3 (68.0, 74.7) 0.12 (0.09, 0.17)
CI: confidence interval. ref: reference group. BE, JU, TI, VD: not included in analysis.
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Table 15.3. Logistic regression of parental attitudes towards immunization and vaccination
coverage for DTPPolMMR for the number of doses at series 5505111, diphtheria at 5 doses,
polio at 5 doses and measles at 1 dose for children at school departure living in Switzerland,
1999-2003
Coverage for Odds Ratio Coverage for Odds Ratio
series 5505111 series 5505111 Di(5 doses) Di (5 doses)
variable  n % %(±95%CI) (±95%CI) %(±95%CI) (±95%CI)
follow recommendations do not know 127 2.5 47.5 (34.5, 60.5) 0.87 (0.51, 1.49) 52.8 (40.1, 65.5) 0.46 (0.27, 0.77)
of doctor disagree 421 7.6 51.0 (45.0, 57.0) ref 71.0 (65.6, 76.4) ref
agree 3297 61.6 72.7 (70.0, 75.3) 2.55 (2.01, 3.25) 80.9 (78.5, 83.3) 1.73 (1.31, 2.29)
strongly agree 1940 28.4 77.9 (75.3, 80.5) 3.39 (2.55, 4.49) 83.7 (81.2, 86.2) 2.10 (1.53, 2.86)
too much social pressure do not know 840 15.9 65.4 (60.5, 70.3) 0.57 (0.46, 0.72) 70.9 (66.0, 75.9) 0.44 (0.35, 0.57)
to vaccinate kids disagree 3217 57.3 76.7 (74.3, 79.0) ref 84.6 (82.6, 86.5) ref
agree 1241 21.1 68.4 (65.1, 71.7) 0.66 (0.55, 0.79) 79.3 (76.4, 82.2) 0.70 (0.56, 0.87)
strongly agree 395 5.7 58.5 (52.1, 64.8) 0.43 (0.32, 0.57) 72.5 (66.3, 78.7) 0.48 (0.34, 0.68)
vaccination protects from do not know 94 1.5 56.1 (43.2, 68.9) 0.85 (0.39, 1.84) 62.8 (49.4, 76.3) 0.55 (0.24, 1.24)
certain diseases disagree 72 1.2 60.1 (46.1, 74.1) ref 75.4 (64.0, 86.9) ref
agree 3232 62.7 70.2 (67.5, 72.9) 1.56 (0.89, 2.76) 80.1 77.6, 82.5() 1.31 (0.71, 2.41)
strongly agree 2565 34.7 75.4 (73.0, 77.9) 2.04 (1.12, 3.71) 81.2 (78.7, 83.7) 1.41 (0.75, 2.63)
solidarity is important do not know 384 7.0 68.6 (61.9, 75.3) 1.35 (0.95, 1.92) 79.9 (73.8, 86.0) 1.12 (0.72, 1.74)
disagree 650 12.5 61.8 (57.5, 66.0) ref 78.1( 74.5, 81.6) ref
agree 2959 52.0 73.4 (70.5, 76.2) 1.71 (1.39, 2.09) 80.9 (78.2, 83.7) 1.19 (0.93, 1.53)
strongly agree 1965 28.6 74.8 (71.9, 77.7) 1.84 (1.45, 2.33) 80.2 (77.3, 83.0) 1.13 (0.87, 1.49)
doctors provide enough do not know 436 8.3 60.3 (53.9, 66.8) 0.70 (0.54, 0.92) 72.0 (66.0, 77.9) 0.70 (0.51, 0.96)
information about disagree 1341 24.4 68.4 (65.3, 71.6) ref 78.6 (75.9, 81.4) ref
vaccination agree 3102 54.8 74.4 (72.1, 76.8) 1.34 (1.15, 1.57) 82.3 (79.9, 84.6) 1.26 (1.04, 1.53)
strongly agree 889 12.4 74.4 (70.5, 78.3) 1.34 (1.04, 1.72) 80.2 (76.4, 84.0) 1.10 (0.83, 1.46)
concerns about possible do not know 533 10.4 60.3 (54.5, 66.1) 0.46 (0.36, 0.60) 66.6 (60.7, 72.5) 0.41 (0.31, 0.52)
side effects disagree 2189 39.0 76.6 (73.9, 79.4) ref 83.3 (80.8, 85.7) ref
agree 2261 39.8 71.1 (68.4, 73.8) 0.75 (0.62, 0.90) 81.0 (78.8, 83.2) 0.86 (0.70, 1.05)
strongly agree 762 10.8 68.9 (65.0, 72.7) 0.67 (0.53, 0.85) 79.3 (75.5, 83.1) 0.77 (0.58, 1.02)
Coverage Odds Ratio Coverage Odds Ratio
Pol (5 doses) Pol (5 doses) Measles (1 dose) Measles (1 doses)
variable   n % %(±95%CI) (±95%CI) %(±95%CI) (±95%CI)
follow recommendations do not know 127 2.5 52.8 (40.1, 65.5) 0.44 (0.26, 0.75) 90.4 (84.0, 96.7) 1.96 (0.90, 4.30)
of doctor disagree 421 7.6 71.9 (66.4, 77.4) ref 82.7 (78.5, 86.9) ref
agree 3297 61.6 80.1 (77.7, 82.4) 1.57 (1.21, 2.04) 94.8 (93.9, 95.7) 3.79 (2.69, 5.35)
strongly agree 1940 28.4 81.8 (79.3, 84.4) 1.76 (1.29, 2.41) 96.9 (95.8, 98.0) 6.51 (4.10, 10.38)
too much social pressure do not know 840 15.9 70.8 (66.3, 75.4) 0.50 (0.39, 0.63) 95.8 (94.1, 97.4) 0.79 (0.51, 1.20)
to vaccinate kids disagree 3217 57.3 82.9 (80.8, 85.1) ref 96.6 (95.9, 97.4) ref
agree 1241 21.1 78.5 (75.5, 81.6) 0.75 (0.60, 0.95) 91.0 (89.1, 92.9) 0.35 (0.26, 0.49)
strongly agree 395 5.7 72.8 (66.4, 79.1) 0.55 (0.39, 0.78) 80.6 (75.4, 85.8) 0.14 (0.10, 0.22)
vaccination protects from do not know 94 1.5 63.9 (50.7, 77.1) 0.66 (0.29, 1.49) 81.9 (72.1, 91.8) 0.78 (0.29, 2.05)
certain diseases disagree 72 1.2 72.9 (60.3, 85.6) ref 85.4 (76.6, 94.1) ref
agree 3232 62.7 79.4 (76.9, 81.9) 1.43 (0.76, 2.68) 93.6 (92.6, 94.5) 2.48 (1.22, 5.07)
strongly agree 2565 34.7 79.4 (76.9, 81.9) 1.43 (0.75, 2.72) 96.7 (95.9, 97.6) 5.09 (2.36, 11.00)
solidarity is important do not know 384 7.0 76.6 (70.3, 82.9) 1.04 (0.70, 1.56) 90.8 (86.6, 95.0) 1.82 (1.03, 3.23)
disagree 650 12.5 75.9 (72.0, 79.7) ref 84.5 (81.2, 87.7) ref
agree 2959 52.0 80.8 (78.2, 83.4) 1.34 (1.08, 1.67) 96.0 (95.2, 96.9) 4.45 (3.11, 6.36)
strongly agree 1965 28.6 78.7 (75.8, 81.6) 1.17 (0.90, 1.53) 96.9 (95.9, 97.8) 5.69 (3.83, 8.45)
doctors provide enough do not know 436 8.3 68.8 (62.6, 75.0) 0.64 (0.48, 0.86) 90.3 (86.3, 94.3) 0.78 (0.46, 1.31)
information about disagree 1341 24.4 77.4 (74.6, 80.2) ref 92.3 (90.5, 94.1) ref
vaccination agree 3102 54.8 81.5 (79.3, 83.7) 1.29 (1.07, 1.54) 95.6 (94.8, 96.4) 1.81 (1.33, 2.48)
strongly agree 889 12.4 79.4 (75.4, 83.4) 1.13 (0.85,  1.49) 95.9 (94.1, 97.7) 1.96 (1.16, 3.30)
concerns about possible do not know 533 10.4 68.9  (63.3, 74.6) 0.47 (0.36, 0.62) 95.0 (92.8, 97.2) 0.64 (0.38, 1.07)
side effects disagree 2189 39.0 82.5 (80.0, 85.0) ref 96.8 (95.9, 97.6) ref
agree 2261 39.8 78.9 (76.5, 81.3) 0.79 (0.65, 0.96) 93.6 (92.4, 94.8) 0.49 (0.34, 0.70)
strongly agree 762 10.8 78.5 (74.7, 82.3) 0.77 (0.59, 1.10) 87.6 (84.6, 90.6) 0.24 (0.16, 0.35)
CI: confidence interval; ref: reference group. BE, JU, TI, VD: not included in the analysis
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Table 15.3.1. Logistic regression of parental attitudes towards immunization and vaccination
coverage for Hepatitis B (HepB) at one dose and three doses for children at school departure
living in Switzerland, 1999-2003
Coverage for Odds Ratio Coverage for Odds Ratio
variable HepB (1 dose) HepB (1 dose) HepB (3 doses) HepB (3 doses)
  n % %(±95%CI) (±95%CI) %(±95%CI) (±95%CI)
follow recommendations do not know 127 2.5 31.6 (18.6, 44.6) 1.98 (1.05, 3.74) 20.3 (7.5, 33.0) 2.90 (1.37, 6.14)
of doctor disagree 421 7.6 18.9 (14.1, 23.8) ref 8.1 (4.9, 11.2) ref
agree 3297 61.6 37.8 (33.6, 41.9) 2.60 (1.96, 3.44) 21.4 (18.5, 24.2) 3.10 (2.09, 4.62)
strongly agree 1940 28.4 56.6 (51.7, 61.4) 5.58 (3.97, 7.85) 33.1 (29.2, 37.0) 5.65 (3.62, 8.82)
too much social pressure do not know 840 15.9 45.3 (39.4, 51.1) 1.04 (0.82, 1.32) 28.9 (23.7, 34.2) 1.21 (0.96, 1.55)
to vaccinate kids disagree 3217 57.3 44.3 (40.1, 48.6) ref 25.0 (22.2, 27.9) ref
agree 1241 21.1 34.5 (29.9, 39.0) 0.66 (0.56, 0.78) 18.8 (15.5, 22.2) 0.69 (0.58, 0.83)
strongly agree 395 5.7 32.0 (25.4, 38.7) 0.59 (0.44, 0.80)  14.0 (9.9, 18.1) 0.49 (0.35, 0.68)
vaccination protects from do not know 94 1.5 28.4 (17.2, 39.6) 0.95 (0.40, 2.23) 15.8 (6.3, 25.3) 1.64 (0.55, 4.86)
certain diseases disagree 72 1.2 29.6 (16.1, 43.0) ref 10.3 (3.0, 17.6) ref
agree 3232 62.7 35.5 (31.5, 39.6) 1.31 (0.67, 2.59) 19.9 (16.9, 22.8) 2.16 (0.98, 4.75)
strongly agree 2565 34.7 53.0 (48.2, 57.9) 2.69 (1.43, 5.08) 31.3 (27.6, 35.0) 3.97 (1.83, 8.61)
solidarity is important do not know 384 7.0 35.8 (29.3, 42.3) 2.51 (1.81, 3.48) 18.3 (13.7, 22.9) 2.21 (1.52, 3.24)
disagree 650 12.5 18.2 (13.8, 22.6) ref 9.1 (6.5, 11.8) ref
agree 2959 52.0 40.1 (35.9, 44.2) 3.00 (2.33, 3.87) 22.6 (19.4, 25.8) 2.90 (2.18, 3.87)
strongly agree 1965 28.6 55.7 (50.9, 60.4) 5.65 (4.16, 7.67) 33.4 (29.5, 37.4) 5.00 (3.58, 6.96)
doctors provide enough do not know 436 8.3 36.9 (30.5, 43.3) 1.32  (1.01, 1.74) 20.4 (15.5, 25.2) 1.33 (0.96, 1.83)
information about disagree 1341 24.4 30.7 (26.5, 34.8) ref 16.1 (13.2, 19.1) ref
vaccination agree 3102 54.8 43.6 (39.5, 47.8) 1.75 (1.50, 2.04) 25.5 (22.4, 28.7) 1.78 (1.49, 2.13)
strongly agree 889 12.4 56.1 (50.8, 61.4) 2.89 (2.32, 3.59) 32.7 (27.8, 37.5) 2.52 (1.94, 3.27)
concerns about possible do not know 533 10.4 42.4 (35.4, 49.3) 0.84 (0.62, 1.12) 25.9 (19.5, 32.3) 0.95 (0.69, 1.30)
side effects disagree 2189 39.0 46.8 (42.3, 51.3) ref 26.9 (23.8, 30.0) ref
agree 2261 39.8 38.1 (34.0, 42.3) 0.70 (0.60, 0.82) 21.3 (18.4, 24.3) 0.74 (0.63, 0.87)
strongly agree 762 10.8 33.1 (27.7, 38.4) 0.56 (0.44, 0.71) 18.0 (13.8, 22.2) 0.60 (0.46, 0.77)
CI: confidence interval; ref: reference group
BE, JU, TI, VD: not included in the analysis
3. Results 70
3.11  Perception of the dangers of childhood vaccine preventable diseases
Question:  In your opinion, would the following illnesses be very dangerous, dangerous, or not
dangerous for your child if he / she has not been vaccinated?
Presented in Tables 16.1-16.3 is the logistic regression of parental perceptions of the dangers of
certain childhood vaccine preventable diseases with different immunization coverage estimates for all
three age groups. For toddlers, Pol, Hib and Te are perceived as extremely dangerous by 72.8%,
80.0% and 56.5% respectively, of parents, with Di at 44.7% and Per at 23.1%; in contrast, almost
50% of parents do not view measles, mumps and rubella as dangerous (Table 16.1). Consequently,
this perception greatly influences the chances of the child being vaccinated, with the likelihood that a
toddler is vaccinated for a disease perceived as dangerous is significantly higher than when the
disease is not perceived as dangerous; the odds ratios range between 1.57- 11.50, with the largest
difference observed with Hib. Moreover, even toddlers of parents who answer ”do not know” to
this question are better vaccinated than those responding ”not dangerous”; the percentages of those
UTD increase as the responses proceed towards the positive spectrum, with ”very dangerous”
yielding the highest immunization coverage.
As in the comparison for attitudes towards vaccination between children at school entry and
toddlers, the same pattern can be found with the perception of the dangers of childhood preventable
diseases. Children at school entry whose parents believed that a disease is very dangerous have the
greatest chance of being UTD (range 1.25-3.06), with the magnitude of the odds of being UTD
higher by the toddlers (Table 16.2).
Teenagers whose parents perceived that a vaccine preventable disease is dangerous have a
significantly higher chance of being UTD than those whose parents find it not dangerous. There is
no distinction between those who responded with “dangerous” and “very dangerous”. Only by
measles are the odds of being UTD for those who found it very dangerous not significantly
different from those who do not find it dangerous. In contrast, adolescents whose parents are unsure
3. Results 71
of how to rate the dangerousness of measles, mumps and rubella are less likely to be UTD at the
6605111 and 5505111 immunization series than those whose parents perceived these diseases as
being not dangerous; the odds of being UTD for the 5505111 series being 0.56 (CI: 0.41, 0.76),
0.63 (CI: 0.45, 0.87) and 0.68 (CI: 0.52, 0.90), respectively (Table 16.3).
Table 16.1.  Logistic regression of parental perceptions of the dangers of certain childhood
vaccine preventable diseases and immunization coverage for DTPPolHibMMR for the number
of doses at series 44443111 and 3333111 for children  24-35 months of age living in
Switzerland, 1999-2003
Coverage for Odds Ratio Coverage for Odds Ratio
Vaccine preventable series 44443111 44443111 series 33333111 33333111
illnesses  n % %(±95%CI) (±95%CI) %(±95%CI) (±95%CI)
Diphtheria do not know 1075 15.0 72.5 (68.8, 76.1) 2.88 (2.03, 4.10) 80.2 (77.0, 83.3) 3.05 (2.04, 4.57)
not dangerous 315 3.4 47.7 (40.0, 55.4) ref 57.0 (48.5, 65.4) ref
dangerous 3068 37.2 68.8 (66.3, 71.4) 2.42 (1.72, 3.40) 76.3 (73.9, 78.8) 2.44 (1.63, 3.63)
very dangerous 3611 44.4 73.2 (70.9, 75.6) 3.00 (2.14, 4.19) 80.3 (78.2, 82.3) 3.08      (2.14, 4.43)
Tetanus do not know 440 6.0 68.6 (62.1, 75.2) 1.59 (0.97, 2.58) 77.2 (71.3, 83.1) 1.75 (1.07, 2.84)
not dangerous 274 3.0 58.0 (49.4, 66.6) ref 66.0 (57.3, 74.8) ref
dangerous 2882 34.5 69.3 (66.7, 72.0) 1.64 (1.12, 2.40) 77.2 (74.6, 79.7) 1.74 (1.11, 2.72)
very dangerous 4533 56.5 72.0 (69.9, 74.2) 1.86 (1.28, 2.72) 79.0 (77.1, 80.8) 1.93 (1.28, 2.90)
Pertussis do not know 830 12.0 75.7 (71.5, 79.9) 2.83 (2.17, 3.70) 83.5 (79.7, 87.3) 3.58 (2.60, 4.93)
not dangerous 1404 16.1 52.3 (48.6, 56.0) ref 58.6 (54.7, 62.5) ref
dangerous 3928 48.7 73.4 (70.9, 75.9) 2.51 (2.07, 3.05) 80.9 (78.7, 83.1) 3.00 (2.40, 3.74)
very dangerous 1899 23.1 74.9 (71.8, 77.9) 2.72       (2.20, 3.35) 82.6 (79.9, 85.4) 3.36 (2.71, 4.17)
Polio do not know 344 5.3 74.8 (68.5, 81.0) 3.44 (1.92, 6.18) 82.3 (76.9, 87.7) 4.35 (2.31, 8.18)
not dangerous 142 1.8 46.3 (33.7, 58.8) ref 51.6 (39.4, 63.8) ref
dangerous 1686 20.1 60.3 (56.7, 63.9) 1.76 (1.03, 3.03) 66.8 (63.2, 70.4) 1.88 (1.11, 3.21)
very dangerous 5904 72.8 73.9 (72.1, 75.7) 3.29 (1.97, 5.50) 81.5 (80.0, 83.0) 4.13 (2.51, 6.79)
Coverage for Odds Ratio Coverage for Odds Ratio
Vaccine preventable series 44443111 44443111 series 33333111 33333111
illnesses  n % %(±95%CI) (±95%CI) %(±95%CI) (±95%CI)
Haemophilus do not know 247 3.6 64.7 (57.3, 72.0) 6.49 (3.52, 11.95) 69.8 (61.8, 77.9) 5.64 (2.66, 11.96)
 Influenzae not dangerous 160 2.0 22.0 (13.5, 30.5) ref 29.1 (17.5, 40.8) ref
type B (Hib) dangerous 1166 14.4 55.0 (50.6, 59.3) 4.33 (2.60, 7.20) 61.4 (57.2, 65.6) 3.87 (2.17, 6.91)
very dangerous 6557 80.0 74.9 (73.1, 76.7) 10.56 (6.34, 17.59) 82.5 (81.1, 84.0) 11.50 (6.39, 20.69)
Measles do not know 473 6.6 73.3 (67.4, 79.1) 1.57 (1.52, 2.14) 81.5 (76.6, 86.5) 1.88 (1.32, 2.68)
not dangerous 4190 49.3 63.6 (61.4, 65.8) ref 70.1 (68.0, 72.3) ref
dangerous 2804 35.9 77.9 (75.2, 80.6) 2.02 (1.70, 2.39) 85.8 (83.8, 87.8) 2.57 (2.15, 3.08)
very dangerous 641 8.2 77.2 (72.4, 81.9) 1.94 (1.48, 2.53) 86.6 (83.0, 90.1) 2.74 (2.00, 3.77)
Mumps do not know 445 6.9 72.7 (65.9, 79.5) 1.79 (1.24, 2.60) 80.3 (74.9, 85.7) 2.06 (1.44, 2.96)
not dangerous 3932 46.2 59,7 (57.3, 62.1) ref 66.4 (64.1, 68.6) ref
dangerous 3041 38.4 81.2 (78.9, 83.5) 2.92 (2.49, 3.41) 89.0 (87.3, 90.7) 4.09 (3.42, 4.89)
very dangerous 669 8.5 79.6 (74.9, 84.4) 2.64 (1.94, 3.59) 88.9 (85.1, 92.7) 4.05 (2.73, 6.01)
Rubella do not know 498 6.9 74.1 (68.9, 79.4) 1.83 (1.37, 2.45) 81.6 (77.1, 86.6) 2.17 (1.55, 3.04)
not dangerous 4067 48.4 61.0 (58.7, 63.3) ref 67.5 (65.3, 69.7) ref
dangerous 2697 34.1 79.0 (76.4, 81.6) 2.40 (2.04, 2.83) 87.1 (85.0, 89.2) 3.25 (2.68, 3.94)
very dangerous 822 10.7 83.0 (79.0, 87.0) 3.13 (2.32, 4.22) 91.5 (88.9, 94.1) 5.17 (3.65, 7.34)
CI: confidence interval; ref: reference group
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Table 16.2.  Logistic regression of parental perceptions of the dangers of certain childhood
coverage for DTPPolHibMMR for the number of doses at series vaccine preventable
diseases and immunization 44443111 and 3333111 for children at school entry living in
Switzerland, 1999-2003
Coverage for Odds Ratio Coverage for Odds Ratio
Vaccine preventable series 44443111 44443111 series 33333111 33333111
illnesses  n % %(±95%CI) (±95%CI) %(±95%CI) (±95%CI)
Diphtheria do not know 722 11.8 43.8 (39.0, 48.6) 1.55 (1.07, 2.25) 67.3 (62.4, 72.3) 1.76 (1.23, 2.53)
not dangerous 245 40.0 33.4 (26.6, 40.2) ref 53.9 (46.8, 61.0) ref
dangerous 2430 39.7 46.2 (43.5, 48.9) 1.71 (1.24, 2.35) 70.1 (67.8, 72.4) 2.01 (1.46, 2.77)
very dangerous 2759 44.5 48.8 (46.2, 51.4) 1.90 (1.39, 2.60) 72.5 (70.2, 74.8) 2.26 (1.67, 3.06)
Tetanus do not know 295 5.0 39.2 (32.0, 46.4) 1.30 (0.83, 2.02) 63.2 (55.2, 71.2) 1.40 (0.90, 2.20)
not dangerous 172 3.2 33.2 (25.2, 41.3) ref 55.0 (46.9, 63.2) ref
dangerous 2111 34.0 48.0 (45.3, 50.6) 1.85 (1.28, 2.69) 72.0 (69.7, 74.3) 2.10 (1.48, 2.99)
very dangerous 3694 57.9 46.8 (44.4, 49.1) 1.77 (1.22, 2.55) 70.4 (68.4, 72.4) 1.94 (1.37, 2.74)
Pertussis do not know 590 9.5 44.6 (39.0, 50.2) 1.51 (1.17, 1.94) 69.8 (64.9, 74.8) 1.87 (1.46, 2.41)
not dangerous 1179 19.8 34.8 (31.6, 38.0) ref 55.3 (52.0, 58.6) ref
dangerous 3177 51.7 48.5 (46.0, 51.0) 1.77 (1.50, 2.09) 73.7 (71.8, 75.7) 2.27 (1.93, 2.68)
very dangerous 1221 18.9 54.5 (51.0, 58.1) 2.25 (1.85, 2.73) 75.9 (73.0, 78.7) 2.54 (2.08, 3.12)
Polio do not know 215 3.5 37.0 (29.0, 44.9) 1.21 (0.67, 2.20) 59.9 (51.7, 68.1) 1.37 (0.80, 2.33)
not dangerous 98 2.0 32.6 (22.1, 43.2) ref 52.2 (41.9, 62.5) ref
dangerous 1309 20.8 40.9 (37.7, 44.1) 1.43 (0.89, 2.30) 64.4 (61.2, 67.6) 1.66 (1.06, 2.59)
very dangerous 4605 73.7 48.8 (46.6, 51.0) 1.97 (1.22, 3.18) 72.8 (70.9, 74.6) 2.45 (1.59, 3.76)
Coverage for Odds Ratio Coverage for Odds Ratio
Vaccine preventable series 44443111 44443111 series 33333111 33333111
illnesses  n % %(±95%CI) (±95%CI) %(±95%CI) (±95%CI)
Haemophilus
Influenzae do not know 181 11.8 31.9 (23.3, 40.4) 0.97 (0.50, 1.85) 56.2 (47.5, 64.9) 1.35 (0.79, 2.32)
type B (Hib) not dangerous 119 40.0 32.6 (21.1, 44.2) ref 48.7 (37.8, 59.5) ref
dangerous 927 39.7 35.3 (31.4, 39.3) 1.13 (0.66, 1.93) 55.4 (51.2, 59.5) 1.31 (0.82, 2.09)
very dangerous 4672 44.5 50.5 (48.3, 52.7) 2.11 (1.25, 3.55) 74.4 (72.6, 76.1) 3.06 (1.98, 4.75)
Measles do not know 382 5.0 38.9 (32.0, 45.8) 0.81 (0.60, 1.09) 63.7 (57.8, 69.7) 0.86 (0.66, 1.11)
not dangerous 3120 3.2 44.1 (41.7, 46.5) ref 67.2 (65.2, 69.2) ref
dangerous 2202 34.0 49.7 (46.8, 52.7) 1.25 (1.09, 1.45) 74.0 (71.6, 76.4) 1.39 (1.20, 1.61)
very dangerous 484 57.9 54.1 (48.8, 59.3) 1.49 (1.19, 1.87) 75.0 (70.3, 79.7) 1.46 (1.13, 1.90)
Mumps do not know 366 9.5 39.4 (32.5, 46.3) 0.95 (0.71, 1.28) 65.9 (59.5, 72.3) 1.11 (0.83, 1.47)
not dangerous 2848 19.8 40.5 (38.1, 43.0) ref 63.4 (61.2, 65.9) ref
dangerous 2395 51.7 54.0 (51.3, 56.7) 1.72 (1.51, 1.96) 77.1 (74.9, 79.4) 1.93 (1.66, 2.25)
very dangerous 577 18.9 50.7 (45.7, 55.7) 1.51 (1.22, 1.87) 75.5 (71.2, 79.9) 1.77 (1.37, 2.28)
Rubella do not know 389 3.5 39.4 (33.3, 45.5) 0.88 (0.68, 1.14) 66.8 (61.1, 72.6) 1.10   (0.85, 1.44)
not dangerous 2804 2.0 42.4 (40.0, 44.8) ref 64.6 (62.3, 66.9) ref
dangerous 2245 20.8 51.3 (48.5, 54.1) 1.43 (1.25, 1.63) 75.3 (72.9, 77.7) 1.67 (1.42, 1.96)
very dangerous 738 73.7 52.3 (47.7, 56.9) 1.49 (1.22, 1.81) 76.7 (72.7, 80.6) 1.80 (1.43, 2.27)
CI: confidence interval. ref: reference group. BE, JU, TI, VD: not included in analysis.
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Table 16.3.  Logistic regression of parental perceptions of the dangers of certain childhood
vaccine preventable diseases and immunization coverage for DTPPolMMR for the number
of doses at series 6605111 and 5505111 for children at school departure living in
Switzerland, 1999-2003
Coverage for Odds Ratio Coverage for Odds Ratio
Vaccine preventable series 6605111 series 6605111 series 5505111 series 5505111
illnesses  n % %(±95%CI) (±95%CI) %(±95%CI) (±95%CI)
Diphtheria do not know 753 14.4 35.2 (30.3, 40.2) 1.17 (0.84, 1.62) 60.6 (54.9, 66.2) 0.88 (0.63, 1.24)
not dangerous 298 5.9 31.8 (25.9, 37.6) ref 63.5 (57.0, 70.0) ref
dangerous 2305 40.7 47.2 (43.8, 50.7) 1.92 (1.43, 2.58) 74.3 (71.8, 76.7) 1.66 (1.23, 2.24)
very dangerous 2225 39.0 46.9 (43.3, 50.6) 1.90 (1.39, 2.58) 75.8 (73.4, 78.2) 1.80 (1.35, 2.41)
Tetanus do not know 272 5.4 27.1 (19.5, 34.8) 0.69 (0.38, 1.25) 45.8 (36.6, 55.1) 0.51 (0.30, 0.87)
not dangerous 186 4.1 35.1 (26.1, 44.1) ref 62.4 (52.4, 72.4) ref
dangerous 2015 35.4 42.8 (39.2, 46.4) 1.38 (0.91, 2.10) 70.8 (67.9, 73.6) 1.46 (0.94, 2.26)
very dangerous 3223 55.1 47.3 (44.2, 50.4) 1.66 (1.11, 2.47) 75.7 (73.8, 77.6) 1.88 (1.22, 2.88)
Pertussis do not know 594 11.3 37.6 (32.1, 43.0) 0.97 (0.75, 1.26) 60.4 (54.4, 66.3) 0.80 (0.62,1.04)
not dangerous 1245 22.4 38.2 (34.4, 42.0) ref 65.5 (62.2, 68.8) ref
dangerous 2913 52.1 47.9 (44.6, 51.1) 1.49 (1.24, 1.78) 76.9 (74.7, 79.1) 1.75 (1.46, 2.11)
very dangerous 829 14.2 47.2 (42.1, 52.3) 1.45 (1.13, 1.84) 76.0 (72.2, 79.8) 1.66 (1.32, 2.10)
Polio do not know 228 4.2 28.6 (21.9, 35.2) 1.02 (0.59, 1.76) 46.6 (39.2, 54.0) 0.65 (0.39, 1.07)
not dangerous 149 3.6 28.1 (18.9, 37.4) ref 57.4 (47.3, 67.5) ref
dangerous 1362 24.8 45.9 (42.0, 49.7) 2.16 (1.33, 3.53) 72.9 (69.7, 76.0) 1.99 (1.28, 3.10)
very dangerous 3895 67.5 45.9 (43.1, 48.7) 2.16 (1.36, 3.44) 74.5 (72.4, 76.6) 2.17 (1.42, 3.31)
Coverage for Odds Ratio Coverage for Odds Ratio
Vaccine preventable series 6605111 series 6605111 series 5505111 series 5505111
illnesses  n % %(±95%CI) (±95%CI) %(±95%CI) (±95%CI)
Measles do not know 391 7.2 33.6 (27.4, 39.8) 0.70 (0.52, 0.93) 58.0 (50.8, 65.3) 0.56 (0.41, 0.76)
not dangerous 2489 44.4 42.0 (38.9, 45.1) ref 71.3 (68.8, 73.8) ref
dangerous 2251 40.7 48.9 (45.2, 52.6) 1.32 (1.13, 1.53) 76.3 (73.8, 78.7) 1.29 (1.10, 1.52)
very dangerous 475 7.8 45.1 (39.4, 50.8) 1.13 (0.88, 1.46) 70.1 (64.9, 75.4) 0.95 (0.73, 1.23)
Mumps do not know 340 6.7 31.5 (24.9, 38.1) 0.69 (0.50, 0.95) 58.1 (50.2, 66.0) 0.63 (0.45, 0.87)
not dangerous 2043 36.6 40.0 (36.7, 43.5) ref 68.8 (65.9, 71.7) ref
dangerous 2513 44.6 48.6 (45.2, 51.9) 1.41 (1.22, 1.63) 76.0 (73.7, 78.2) 1.43 (1.22, 1.68)
very dangerous 711 12.1 48.9 (43.6, 54.3) 1.43 (1.12, 1.83) 77.8 (73.9, 81.8) 1.59 ( 1.24, 2.04)
Rubella do not know 372 7.1 35.0 (28.5, 41.5) 0.82 (0.61, 1.02) 58.2 (51.2, 65.1) 0.68 (0.52, 0.90)
not dangerous 1988 36.2 39.7 (36.5, 43.0) ref 67.1 (64.4, 69.9) ref
dangerous 2261 40.7 49.5 (45.9, 53.0) 1.48 (1.29, 1.71) 77.3 (75.0, 79.6) 1.66 (1.43, 1.94)
very dangerous 939 16.0 46.6 (41.6, 51.5) 1.32 (1.05, 1.67) 77.7 (74.2, 81.2) 1.70 (1.36, 2.15)
Hepatitis B do not know 359 6.5 34.1 (27.7, 40.4) 1.03 (0.67, 1.57) 58.9 (51.7, 66.2) 0.96 (0.62, 1.46)
not dangerous 348 6.7 33.4 (26.6, 40.2) ref 60.0 (53.4, 66.7) ref
dangerous 2077 37.1 45.6 (41.8, 49.3) 1.67 (1.20, 2.32) 73.5 (70.8, 76.2) 1.85 (1.37, 2.49)
very dangerous 2842 49.7 46.5 (43.5, 49.6) 1.73 (1.26, 2.39) 74.7 (72.0, 77.4) 1.96 (1.44, 2.68)
CI: confidence interval. ref: reference group
BE, JU, TI, VD: not included in the analysis
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3.12  Valais 1999 vs. 2003
3.12.1 Participation
Participation by parents of the toddlers improved from 58.4% in 1999 to 74.6% in 2003, with the
increase due to the 27.7% of the contacts made per telephone (Table 17.1). Participation acquired
via the first letter remained unchanged, but those acquired via the second recall letter decreased from
30.3% in 1999 to 19.5% in 2003. For children at school entry, the number of participating classes
increased, but the overall percentage slightly decreased from 93.3% in 1999 to 92.0% in 2003.
However, the number of submitted vaccination cards increased from 309 (55.2%) to 472 (76.6%).
Despite the 100% participation from the selected classes and the increase in the number of
submitted vaccination cards by the adolescents at school departure from 371 in 1999 to 590 in 2003,
the overall participation decreased from 86.5% to 79.2%. Because HepB vaccination was recorded
on a separate sheet of paper in 1999, and in some cases only these were submitted without the
vaccination cards sheets (from 16 students), the n for HepB was 387 in 1999.
Tables 17.2.1-.2 display reasons for nonparticipation in the survey only in 2003, as this information
was not collected for 1999. As seen in Table 17.2.1, the most prominent reason for nonparticipation
by parents of toddlers is the failure to make personal contact with the selected family, where
telephone numbers were not found for 55 (37.9%) households, no contact was made despite having
the telephone number for 29 (20.0%) households and letters were not delivered to the family as they
could not be found for 24 (16.6%) households. By the schoolchildren, 144  (23.4%) children at
school entry and 155 (20.8%) at school departure did not submit their vaccination cards to the
nurses. Many provided no reasons; for those who did, the most prominent reason is refusal to
participate.
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Table 17.1.  Participation in the study by toddlers 24-35 months of age,
and children at school entry and departure in canton VS in 1999 and 2003
Toddlers 1999 2003
n % n %
Total children selected 604 100 570 100
Response:
First letter 174 28.8 156 27.4
Reminder 183 30.3 111 19.5
Telephone contact 2 0.3 158 27.7
Total Responders 353 58.4 425 74.6
Nonresponders 251 41.6 145 25.4
School entry 1999 2003
1st grade 2nd grade
n % n %
Number of classes 45 50
Number of students 560 616
Number of participating classes 42 93.3 46 92.0
Total number of vaccination cards 309 55.2 472 76.6
Total nonresponse 251 44.8 144 23.4
School departure 1999 2003
8th grade 8th grade
n % n %
Number of classes 31 36
Number of students 429 745
Number of participating classes 29 93.5 36 100.0
Total number of vaccination cards 371 86.5 590 79.2
Total nonresponse 58 13.5 155 20.8
Table 17.2.1.   Reasons for nonparticipaton from parents of toddlers
selected for the survey in canton VS, 2003
Reasons for nonparticipation n %
No telephone number available 55 37.9
No telephone contact 29 20.0
Unknown, not found, moved away 24 16.6
No vaccination card available 9 6.2
Fundamentally against surveys 6 4.1
No time 6 4.1
Promised to send the requested information 5 3.5
No interest 4 2.8
Language barrier 3 2.1
Against monitoring by the government 1 0.7
No child in household 1 0.7
Other reasons 2 1.4
Total 145 100
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Table 17.2.2.  Status of vaccination card and reasons for card
not being submitted, VS 2003
2  nd grade  8  th grade  
n % n %
Status of vaccination card (VC)
Submitted and checked 467 75.8 560 75.2
New card (vaccinated only 1-2 times, as indicated on VC) 1 0.2 10 1.3
Incomplete(missing info on some vaccinations)* 4 0.6 20 2.7
Not submitted 144 23.4 155 20.8
Total 616 100.0 745 100.0
Reasons for VC not being submitted
Refusal of vaccination 0 0.0 5 3.2
Already vaccinated 1 0.7 2 1.3
Sick child 6 4.2 3 1.9
VC lost 9 6.3 4 2.6
Child not vaccinated at all 0 0.0 0 0.0
Parental refusal 10 6.9 21 13.5
Refusal to participate in the survey 27 18.8 23 14.8
Unknown 49 34.0 55 35.5
Other reasons 9 6.3 1 0.6
Child absent during examination 33 22.9 41 26.5
Total 144 100.0 155 100.0
2nd gr: n=472; 8th gr: n=590 (includes VC that were indicated as new or incomplete on the vaccination summaryforms as completed  by the nurses)
* vaccination doses were intentionally left empty by the nurses, when compared to the information completed for the other students in the class.
3.12.2  Immunization coverage
Immunization coverage by the toddlers for Di, Te, Per, Hib, Pol and MMR decreased from 1999 to
2003, with significance for Di, Te, Per and Pol at 3 doses and for MMR at both 1 and 2 doses; at 4
doses, although not significant, the decrease is also evident for Di, Te and Pol, while there is an
increase for Per and Hib (Table 17.3).
After removing the responses made through telephone contacts, differences in coverage levels
remained significant only by MMR and Hib (Fig 1). In contrast to the toddlers, coverage estimates
for all vaccines increased from 1999 to 2003 for the schoolchildren, as seen in Table 17.3. By
children at school entry, the difference in Per coverage between the two years is significant at all
doses, whereas Di and Te are significant only at 5 doses, Hib at 4 doses and MMR at 2 doses. For
adolescents at school departure, the differences in Di, Te and Per coverage estimates between the
two years are significant at all doses. For Pol at 6 doses, the coverage of 60.7% in 1999 decreased
to 10.6% in 2003, whereas at 4 doses of Pol, coverage increased from 89.5% to 94.1%. MMR has
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also significantly increased from approximately 30% in 1999 to 85% for 2 doses. This also applies
to HepB  for the 1st and 2nd doses, where it rose from 54% to 84%.
Table 17.3.  Vaccination coverage of toddlers 24-35 months of age,
children at school entry and departure in canton VS in 1999 and 2003
Toddlers : 24-35 months of age
n: 1999=353;   2003=425
≥ 3 doses ≥ 4 doses
1999 2003 1999 2003
Diphtheria 9 6 . 2 9 1 . 1 88.2 83.3
Tetanus 9 8 . 0 9 4 . 2 88.9 84.3
Pertussis 9 5 . 6 9 0 . 9 82.7 83.5
Hib 93.6 90.5 78.7 83.6
Polio 9 7 . 8 9 3 . 0 87.0 83.3
≥ 1 dose ≥ 2 doses
Measles 9 2 . 9 8 4 . 1 0 . 2 3 3 . 3
Mumps 9 2 . 6 8 4 . 1 0 . 2 3 3 . 3
Rubella 9 2 . 6 8 4 . 1 0 . 2 3 3 . 3
School entry 1999: 1st grade (n= 309) 2003: 2nd grade (n= 472)
≥ 3 doses ≥ 4 doses ≥ 5 doses
1999 2003 1999 2003 1999 2003
Diphtheria 95.5 96.1 89.9 92.2 5 1 . 3 7 8 . 5
Tetanus 97.7 98.3 91.2 93.9 5 1 . 7 7 9 . 3
Pertussis 8 8 . 4 9 4 . 3 3 9 . 2 8 8 . 0 4 . 5 6 7 . 0
Hib 75.2 77.3 8 . 1 3 4 . 1 - -
Polio 96.3 97.8 94.3 90.9 72.5 69.0
≥ 1 dose ≥ 2 doses
Measles 92.4 94.5 1 7 . 7 8 3 . 8
Mumps 92.0 94.5 1 6 . 7 8 3 . 5
Rubella 92.7 94.7 1 7 . 4 8 3 . 7
School departure  8th grade n: 1999= 371; 2003= 590
≥ 3 doses ≥ 4 doses ≥ 5 doses ≥ 6 doses
1999 2003 1999 2003 1999 2003 1999 2003
Diphtheria 8 9 . 5 9 4 . 5 8 1 . 6 9 3 . 1 5 6 . 3 8 6 . 0 1 5 . 8 5 6 . 3
Tetanus 8 9 . 7 9 6 . 9 8 2 . 8 9 5 . 0 5 8 . 9 8 8 . 0 1 7 . 3 5 7 . 1
Pertussis 8 2 . 8 9 1 . 8 6 . 9 6 5 . 3 0 . 9 3 5 . 3 - -
Hib 2.4 1.0 - - - - - -
Polio 91.8 96.1 8 9 . 5 9 4 . 1 83.3 82.6 6 0 . 7 1 0 . 6
≥ 1 dose ≥ 2 doses
Measles 94.8 96.9 3 4 . 2 8 4 . 3
Mumps 9 3 . 5 9 6 . 3 3 0 . 4 8 4 . 5
Rubella 8 9 . 1 9 6 . 6 2 9 . 0 8 4 . 5
School departure: 8th grade
Hepatitis B
1999 2003 Note: HepB 1999: n=387 includes
n 387 590 16 children who submitted info only on HepB
≥ 1 dose 5 4 . 5 8 4 . 2 Bold: significant p< 0.05
≥ 2 doses 5 3 . 8 8 4 . 1
≥ 3 doses 52.2 51.8
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Fig. 1 Vaccination coverage (%) of toddlers in canton 
VS 1999 and 2003 for families who responded to 
the first letter and reminder
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When examining the coverage by different immunization series, the trend described above by the
individual vaccines was also observed, as seen in Table 17.4. For toddlers, coverage for the
33333111 immunization series significantly decreased from 89.6% in 1999 to 83.0% in 2003. In
contrast, coverage increased significantly by the schoolchildren between 1999 and 2003, at all the
immunization series examined for both age groups, except for the 33333111 DTPPolHibMMR
series by the children at school entry, despite the increase from 68.7% in 1999 to 75.7% in 2003.
Table 17.4.  Vaccination coverage at different DTPPolHibMMR series among toddlers 24-35
months of age and children at school entry and DTPPolMMR for children at school departure
in canton VS in 1999 and 2003
% coverage at different DTPPolHibMMR series
Age groups Year n 33333111 44443111 55050111 55553222 66050111 66050222
Toddlers 1999 346 8 9 . 6 77.5 - - - -
2003 422 8 3 . 0 77.0 - - - -
School entry 1999 309 68.7 3 2 . 3 - 0 . 6 - -
2003 468 75.7 7 1 . 0 - 4 7 . 5 - -
% coverage at different DTPPolMMR series
3303111 4404111 5505111 5505222 6605111 6605222
School departure 1999 371 7 8 . 3 7 2 . 1 4 9 . 1 1 4 . 3 1 4 . 2 3 . 8
(without pertussis) 2003 568 9 1 . 8 9 0 . 2 7 7 . 0 7 0 . 7 5 3 . 0 5 1 . 1
3333111 4434111 5535111 5535222 6635111 6635222
School departure 1999 371 7 3 . 3 6 9 . 3 4 7 . 6 1 3 . 6 1 3 . 9 3 . 5
(with pertussis) 2003 568 8 9 . 3 8 7 . 9 7 5 . 6 6 9 . 5 5 2 . 1 5 0 . 2
Bold: significant at p< 0.05
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4. Discussion
During the 5 years of implementing this survey, much effort was expended to understand the
existing infrastructures and compile the necessary information before the methodology could
be adapted. Because one of the major goals of the study is to build a surveillance system to
determine vaccination coverage in each canton by utilizing this study as a foundation, we
attempted to use the existing infrastructure where possible to increase acceptance, ease the
workload and maintain an acceptable budget. While this was achieved, data quality was
compromised, particularly for the schoolchildren.
The methodology employed for the toddlers is an adaptation of the WHO recommended EPI
cluster sampling method to determine vaccination coverage for children between 24-35
months of age, and has been conducted in the past years by many cantons independently
[Henderson and Sundaresan, 1982; Schorr et al, 1993; Mütsch-Eckner and Schüpfer, 1995;
Vranjes et al, 1996; Bachmann, personal communication, 2000; Maurer, 1997, 2001, 2003].
Changes in our survey from the established protocol to increase precision from ±10% to ±7%
included sampling more clusters in each canton, selecting the number of samples proportional
to the size of the selected cluster and increasing sample size. Because of the inclusion of a
questionnaire and the larger sample size, effort to increase response rate, despite enormous
attempts, was not as successful as what was achieved by the cantons in the previous years.
Participation ranged from a low of 42% to a high of 83%. Comparison of responders and
nonresponders revealed differences by urbanicity and nationality. Although urbanicity does
not seem to be correlated with vaccination coverages, nationality is an important factor.
Nonresponse adjustment and post-stratification of responders were made to account for this
difference, but further research into characterization of nonresponders is warranted in order to
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make the necessary statistical adjustments more effective. Finally, our results also showed
that response rates correlate with vaccination coverage levels where children residing in
cantons with participation of more than 70% having a significantly higher chance of being
UTD than those residing in cantons where participation was below 60%. This clearly
indicates that more efforts should be expended to decrease bias resulting from participation
level in the study.
For the schoolchildren, the data collected have been compromised, such that comparison
among the cantons and among the age groups within the canton is difficult. Because
collaboration was sought with various organizations, potential variations in data collection
method were high among the cantons. This is due to diverse organizational structures within
the school health services and school authorities, different methods of data collection, the
wide grade range for health exams, and the different vaccination policy, such as grade levels
at which the routine health exams are mandated, vaccines that are offered in the school,
whether or not school doctors are allowed to vaccinate at all, and whether or not HepB
campaign is actively conducted in the school (Annex M.1, M.2). Our results showed that
coverage levels are affected by participation in the study and the data collection methodology
employed, with the latter being more influential. Additionally, the period during data
collection and school vaccination may not have coincided, which consequently could yield
inaccurate estimates. Catch-up shots administered by the family physicians would be missed
in some cases. Moreover, problems encountered within the individual cantons also exacerbate
the comparability problem, such as incompleteness of the vaccination summary form by some
of the school doctors and nurses. Finally, by using the schools, the nature of the non-
responders is not known. There could be many reasons, ranging from being recently
vaccinated by their family physician, to downright refusal of any vaccines.
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Moreover, coverage estimates obtained for all age groups could be an over-estimation of the
actual coverages in the population, due to the high nonresponse rate and not taking into
account valid vaccination doses. While some health studies show that there are not much
differences between responders and nonresponders, other studies have contradicted this
[Forthofer, 1983; Siemiatycki, 1984; Brambilla and McKinlay, 1987; Lasek et al, 1997;
Fowler et al, 2002]. A recent hypothetical cohort study revealed that studies with low
response proportions may actually be less biased than studies with high response proportions;
however, vaccination coverage was not the target health variable in this simulation [Stang and
Jöckel, 2004]. Confirming this, our survey did demonstrate that participation rates for the
toddlers and children at school departure are directly related to immunization coverage levels
where those living in cantons in which higher participation in the study was attained have a
higher chance of being UTD. Contrary to this, two studies in Switzerland have shown data
revealing differences in vaccination status of children with timeliness of response where those
responding later or not at all are less likely to be up to date with the recommended vaccination
scheme [Schorr et al, 1993; Golay, personal communication, 2003]. Although basic
adjustment has been made to address nonresponse bias by redistributing the weights of
nonresponders to responders and poststratification, more precise matching of the samples by
nationality would better address this problem. Subsequently, by assuming that nonresponders
behave similarly to responders, this naive nonresponse adjustment could also over-estimate
vaccination coverage. Further over-estimation of immunization coverage could stem from the
fact that the validity of vaccination doses was not evaluated before determining coverage
levels due to lack of resources. A study in the United States where the required interval
between doses were evaluated showed that 10.5% of children received at least one invalid
dose of vaccine and that coverage estimates were decreased by 0.7% for 3 doses of polio,
6.5% for 3 doses of Hepatitis B and 3.4% for the 4443111 DTPPolMMR series for those
between 19-35 months of age [Stokely et al, 2004]. Additionally, a large study in Sweden also
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demonstrated that when dates of actual vaccination were recorded, postponed MMR
vaccinations up to 1.5 years beyond the recommended 18 months accounted for about half the
reported drop in coverage in 2001 [Dannetun et al, 2004]. Over-estimation of vaccination
coverage could lead to missing kids and adding them to the pool of unvaccinated children,
which could eventually lead to future outbreaks. Moreover, kids who have an invalid dose
must be re-vaccinated, increasing not only health care cost, but also the risk of adverse
reactions and injection discomfort.
However, coverage estimates obtained could also be an under-estimation. Although new
vaccination cards were also accepted, no considerations were made for doses that were already
completed but recorded elsewhere. Additionally, many foreigners participating in the study
have missing information on vaccination completed outside of Switzerland. Hence, when
lacking written confirmation for abroad or in Switzerland, assumptions that no other
vaccinations were administered were made. This could lead to conservative immunization
coverage estimates.
Despite these methodological limitations, the results can be interpreted with some confidence,
as they corroborate coverage and significant associations obtained in the many studies already
conducted in and outside of Switzerland [Minder and Steffen, 1991; Schorr et al, 1993;
Bouvier, 1994; Mütsch-Eckner and Schüpfer, 1995; Vranjes et al, 1996; Masserey, 1997;
Roth-Kleiner and Gnehm, 1997; BAG, 1999; Bachmann, personal communication, 2001;
Golay and Sudre, 2002; Maurer, 1997, 2001, 2003; WHO: global summaries, 2003]. Despite
their overall higher response rate, national coverage estimates remain similar between 1991-
2003 in Switzerland (Table 18).
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Table 18.  Vaccination coverage of toddlers aged 24-35 months in Switzerland  in 1991,
1998 and 1999-2003, with and without adjustments.
Vaccination Year
1991 1998 1999-2003
n 402 403 8729 [a] 8730 [b] 9347 [c] 9639 [d]
Diptheria
       ≥3 doses 95.0 94.3 95.4 94.9 95.7 95.3
       ≥4 doses 71.1 71.7 83.6 83.7 81.6 84.9
Tetanus
       ≥3 doses 93.3 93.3 95.9 95.4 96.1 95.8
       ≥4 doses 70.9 71.5 83.7 83.8 84.7 85.0
Pertussis
       ≥3 doses 88.8 88.1 92.9 92.6 93.3 93.1
       ≥4 doses - 68.2 81.3 81.2 82.3 82.7
Polio
       ≥3 doses 94.8 92.1 95.3 94.7 95.6 95.0
       ≥4 doses 70.4 76.2 82.7 81.9 83.7 83.3
Hib
       ≥3 doses - 76.9 91.1 90.8 91.7 91.5
       ≥4 doses - 47.4 79.3 79.2 80.4 80.8
Measles
       ≥1 dose 83.1 81.4 82.3 81.4 83.1 82.3
Mumps
       ≥1 dose 80.1 78.9 81.1 79.8 82.0 80.7
Rubella
       ≥1 dose 79.6 78.7 80.8 79.0 81.7 80.0
1991: Minder C, Steffen R. BAG Bulletin 1992; Nr. 32: 504-507. 1998:  BAG. BAG Bulletin 1999; Nr. 20: 356-361.
a: estimates after weighting, nonresponse adjustment, poststratification.  Includes only information from the vaccination cards.
b: data at face value, i.e. not weighted, no nonresponse adjustment, and no poststratification. Includes onlyinformation from the vaccination cards.
c: same as a, but includes vaccination information based on parental recall.
d: vaccination information from parental recall and vaccination cards, but does not include any adjustments or weights.
Moreover, the method used with the toddlers is an established method by the WHO and has
been implemented in many countries worldwide to determine vaccination coverage. Although
the validity of the administered vaccine doses was not investigated in our survey, the study by
Stokely et al [2004] described earlier found that excluding invalid doses from vaccination
coverage estimates had litle effect on the national coverage levels for the United States,
except for HepB series; however, state coverage levels were affected. Furthermore, as data
was collected via mixed modes (mail and telephone), nonresponse bias due to single mode, as
shown by Fowler et al [2002] and Brambilla and McKinlay [1987], can be reduced while also
increasing the response rate. Finally, although comparability may be compromised in our
data, this is the first survey to examine vaccination coverage in every single canton.
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Examination of immunization coverage at different series of DTPPolHibMMR for toddlers
and children at school entry and of DTPPolHibMMR series for children at school departure
reveals that children in these age groups are far below the immunization coverage, as
recommended by the SFOPH and the WHO [Swiss National Immunization Survey, 2000].
When comparing coverage estimates attained and those needed to block transmission of the
infectious agent at the individual level [Anderson and May, 1990], toddlers have achieved this
critical coverage for Di and Pol, but are 12% below the minimum necessary coverage level
required for Per, 10% for measles, 9% for mumps, and 4% for rubella. Except for Pol at 5
doses for the adolescents, schoolchildren appear to be drastically under-vaccinated,
particularly those at school entry. Because of methodological difficulty encountered with the
completeness of the vaccination summary form, the DTPPolHibMMR series for toddlers and
children at school entry and DTPPolMMR for children at school departure were re-evaluated
without including Per and Hib for comparative purposes. From this re-evaluation, it can be
seen that catch-up shots are administered between the years examined, as coverage estimates
at the 33030111 and 44040111 series are lowest for the toddlers, then increased, although still
sub-optimal, by school entry and remains at this level at school departure; coverage levels
then increase at the 5505111 and 5505222 series by the adolescents compared to the children
at school entry. Coverage estimates are then drastically reduced when looking at 2 doses of
MMR and the recommended 5 doses of Di and Te for children at school entry and 6 for
school departure. This decrease in the already low immunization coverage indicates that more
efforts are needed to be expended in order to reach the optimal goal for vaccination coverage
set by the WHO to establish herd immunity and prevent circulation of the wild type virus
[Anderson and May, 1990]. Herd immunity is especially important for those vulnerable in the
population, such as infants, the elderly, and immuno-compromised individuals whose immune
system is underdeveloped or weakened [Vitek et al, 2003]. Recent increase in outbreaks due
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to importation of the infectious agent through faster and easier global mobility mandates high
immunization coverage levels [Wilson, 2003; Gushulak and MacPherson, 2004].
As demonstrated in the numerous measles outbreak throughout Europe as described in the
Introduction, containment of the various outbreaks in communities with low immunization
coverage had been probably due to high coverage in the neighboring communities that have
achieved herd immunity [van den Hof et al, 2002; de Melker, 2003; Yip et al, 2004]. In the
case where parents continue to decline vaccination to avoid the potential vaccine associated
risks, then a major epidemic outbreak could occur as the number of susceptible individuals
will increase [Jansen et al, 2003; Wallinga et al, 2005]. This predicament had already
happened in England with Per in the mid 1970’s when coverage dropped from 80-90% to a
30% low [Ulmer and Liu, 2002; Baker, 2003]. Consequently, two severe outbreaks of
whooping cough occurred, which resulted in more than 120,000 reported cases, with hundreds
of serious complications and 28 deaths.  Furthermore, Van der Wielen et al [2003] showed
that a pertussis booster vaccination is needed as the antibody level declined after the age of 20
years.
Comparison of the Swiss national coverage for children between 24-35 months to the WHO
global estimates and estimates from the WHO designated regions reveals, as displayed in
Table 19, that coverage levels for toddlers for 3 doses of DTP and Pol residing in Switzerland
between 1999-2003 are similar to those children in the European, American and developed
regions, and are far higher than the global estimates and in the remaining regions. For measles
at one dose, children in Switzerland are 6-8 percentage points below the European and the
developed regional estimates [WHO: Global summaries, 2003]. Measles coverage for
children in Switzerland is among the lowest of the selected European and industrialized
countries in Table 19. Compared to its immediate neighbors France, Italy, Germany and
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Austria, coverage for children in Switzerland is only higher than those from Austria for all
vaccines (DTP at 3 doses, Pol at 3 doses and MMR at one dose) and from Italy at one dose of
MMR.
Table 19.  Vaccination coverage (%) of toddlers 24-35 months of age in Switzerland (CH) in
comparison with coverage from the World Health Organization, globally and for the WHO
designated regions, and selected countries
WHO-designated regions
CH CH Global EUR AMR EMR AFR WPR SEAR Developed
1999-2003 2002* 2002* 2002* 2002* 2002* 2002* 2002* 2002* 2002*
n 77.6 (±95% CI) 72'091 6'206'429 877'091 852'551 503'620 672'238 1'710'096 1'590'833 864'730
DTP3 92.8 (91.9, 93.7) 95 75 93 90 74 56 79 73 95
Measles 82.3 (80.9, 83.9) 79 73 89 91 73 59 71 70 90
Pol3 95.3 (94.6, 95.9) 94 75 93 90 74 56 79 73 91
CH CH France Italy Germany Austria Greece Portugal Spain U.Kingdom Finland Norway USA
1999-2003 2002* 2002* 2002* 2002* 2002* 2002* 2002* 2002* 2002* 2002* 2002* 2002*
DTP3 92.8 (91.9, 93.7) 95 98 95 97 83 88 96 96 91 99 91 94
Measles 82.3 (80.9, 83.9) 79 85 70 89 78 88 87 97 83 96 88 91
Pol3 95.3 (94.6, 95.9) 94 98 96 95 82 87 96 96 91 95 91 90
n: in thousands; for CH, n: target population; for WHO, n: total population.    CI: confidence interval.
* Source: WHO vaccines-preventable diseases: monitoring system.  2003 Global summary. WHO: Vaccine and Biologicals. Regions: EUR: European;
AMR: Americas; EMR: Eastern Mediterranean; AFR: African; WPR: Western Pacific; SEAR: South-East Asia. All vaccination coverages are WHO/UNICEF
national estimates, derived from country reports.
Except for Greece and Italy at one dose of MMR, the results obtained from our survey,
indicating that toddlers from countries designated as from southern Europe (France, Portugal,
Greece, Spain and Italy) have higher immunization coverage estimates for DTP, Pol, and
measles than Swiss children, correlate with coverage as reported by these countries
individually (Table 19) and the study conducted in 1992 by Bouvier et al [1994]. Because
there were very few children in our samples originating from Greece, their impact on
vaccination coverage was minimal. Furthermore, immigrants seeking asylum in Switzerland
so far must have a mandatory health exam conducted by the “grenzsanitarische
Untersuchungen” (GSU). This includes checking immunization status and vaccination when
necessary. Every year about 2,200 foreign children aged 13 and under are vaccinated by the
GSU, of which 0.3% are infants [Neyens, 2003]. In total about one quarter of the applicants
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are permitted to remain in Switzerland. This could be one factor to help explain why foreign
kids are better vaccinated for measles at one dose than Swiss kids; by the other vaccines, as
more than one dose is necessary, the impact of the GSU on coverage could not be observed.
As presented in Table 18, comparison of coverage for toddlers for MMR at one dose and Di,
Te, and Pol at 3 doses with those from 1991 and 1998 revealed that coverage has remained
relatively unchanged; however, for Per and Hib at 3 and 4 doses and 4 doses of Di, Te, and
Pol, coverage has increased, with the uptake of Hib being most apparent, climbing from 77%
in 1998 to 91% in our survey at 3 doses and from 47% to 98% at 4 doses. The increased
coverage for Per and Hib could be a result of more frequent use of combined vaccines. For
Hib, as it is only included in the recommended vaccination plan since 1991, the large increase
in coverage could be due to greater understanding of the dangers of the disease, reinforced by
the inclusion of Hib in the combined vaccines. Since 1991, MMR remained a controversial
vaccination, with coverage fluctuating at the low 80’s.
Because coverage by the DTPPolHibMMR series are affected by the individual vaccines, any
level of rejection or promotion of one vaccine will affect the overall estimate. By toddlers in
the canton of SH, discussion with the CMO revealed that one pediatrician in this relatively
small canton prefer not to immunize toddlers against rubella; catch-up shots for rubella are
then administered during their attendance in kindergarten [Häggi, personal communication,
2003]. This position by the pediatrician, consequently renders the canton of SH with the
lowest coverage for both DTPPolHibMMR immunization series examined, at 49.4% for the
33333111 series and 30.9% for the 44443111 series. On the other hand, cantons GE and TI
have the highest vaccination coverages for both the 44443111 and 33333111 series. Because
Di is mandatory in these cantons, it could account for the higher vaccination coverage for Di,
and consequently Te, Per, Hib and Pol due to more frequent use of combined vaccines.
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Although only Di vaccination is mandatory, many parents may forget that MMR is not; this
uncertainty may prompt them to have their children immunized for MMR. A study in Italy
demonstrated that mandatory vaccines have much higher coverage than those that are
facultative, with many parents often mistakening the vaccines in these two categories
[Bonannni and Berganini, 2002]. As mandatory vaccinations are found only in the French-
speaking cantons (GE, FR, NE) and TI, coverage differs significantly by regions, with
toddlers in the Italian- and French-speaking cantons being better vaccinated than their
German counterpart. This difference is also observed in Germany where measles coverage in
former western Germany, with its decentralized health care services, is lower than that in the
former eastern side who had a centralized health care system and mandatory immunizations
[Hellenbrand et al, 2003]. This phenomenon for TI must be cautiously interpreted as children
in the first year of kindergarten, i.e. children between 3-4 years of age, were selected instead
of those between 24-35 months of age as in the other cantons.
Furthermore, based on the results from the survey conducted in VS in 1999 and 2003,
coverage for toddlers at the 33333111 DTPPolHibMMR immunization series have
significantly decreased from 89.6% in 1999 to 83.0% in 2003. More precisely, vaccination
coverage estimates for Di,Te, Per and Pol appear to be significantly higher for toddlers in
1999 than in 2003. However, after removing the responses from the telephone contacts,
differences in coverage remained significant only by MMR and Hib. Acceptance for MMR
appears to be slowly decreasing for VS, perhaps due to greater influence and popular use of
alternative medicine, which selectively promotes vaccination, if at all. Diseases that are
considered rare but often fatal, such as Di, Te, and Pol are recommended by some licensed
homeopathic physicians, whereas those that are recognized as rather benign childhood
diseases (MMR), or are considered to be indicated only for certain risk groups (Hib and
HepB) are not recommended; by factions of homeopathic practitioners, all vaccinations are
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discouraged [Lehrke, 2001]. In contrast to what has been recommended by some homeopathic
practitioners, the President of the Swiss Homeopathy Society has confirmed that homeopathy
is purely therapeutic, and that they do not oppose vaccination [Steffen, personal
communication, 2004].
The gradual decline in MMR acceptance in VS could also be caused by the perception that
measles, mumps and rubella are not particularly dangerous diseases, which naturally results in
lower vaccination coverage. In our survey, only 50% of parents perceive measles, mumps and
rubella as dangerous diseases. Furthermore, CAM practitioners recommend that children
experience these childhood diseases (measles, mumps and rubella) to strengthen the immune
system, although a newly published cohort study contradicted this by showing that children
who were exposed to childhood infectious diseases before 18 months of age are more likely to
develop atopic dermatitis [Ernst, 2002; Benn et al, 2004]. Compounding these perceptions of
MMR are unsubstantiated claims that MMR is connected to autism, despite the many studies
that have disproved this link [Wakefield et al, 1998; Taylor et al, 1999; Kaye et al, 2001;
Madsen et al, 2002; Mäkelä et al, 2002; Owens, 2002; Ramsey et al, 2002; Wilson et al.,
2003; DeStefano et al, 2004; Geier and Geier, 2004; Smeeth et al, 2004; Demicheli et al,
2005; Elliman and Sengupta, 2005; Afzal et al, 2006].
Regional difference in immunization coverage as revealed by the toddlers is still prevalent at
the school level. Children at school entry level residing in TI have the highest coverage,
followed by the French-speaking region and lastly, the German-speaking region. Perhaps as
children have not received their catch-up shots for rubella, the estimates for the 33333111 and
444431111 series for the canton of SH remain low. Although TI only works with school
doctors and do not vaccinate in the schools, according to the CMO the local pediatricians are
young and very active; their enthusiasm ensures active participation in school health
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promotion, and hence high vaccination coverage. While it was conducted in an adult
population in Switzerland, Bovier et al [2001] confirmed that physicians play an important
role in attaining adequate immunization coverage where lack of recommendation from the GP
accounted for most missed vaccination opportunities. For VS, because students in the 2nd
grade were recruited for the study in 2003 instead of the 1st grade as in 1999, this could most
likely be the reason for the increase in vaccination coverage; this particularly applies to MMR
as catch-up shots could be accounted for, along with cases where children prefer to be
vaccinated by their private doctors than the school doctors.
By the adolescents, the regional difference is still apparent, but the magnitude has diminished.
Examination at the cantonal level reveals that the canton of SZ has the highest vaccination
coverage, regardless if it included examining the series with or without Per. This is most
probably due to the fact that school nurses in canton SZ travel to every schoolhouse in the
canton offering DiTe, DiTe-Pol, MMR vaccinations to students in the 1st or 8th grade.
Furthermore school vaccination policy appears to play a more important role in coverage
estimates. Because the school nurses in cantons VD, AG and SZ are permitted to vaccinate
the children on their scheduled visits during the routine health examinations, the children in
these cantons have the highest coverage estimates when examining the various DTPPolMMR
series with 6 doses of Di and Te. On the other hand, at lower doses for Di and Te, cantons
working only with school doctors have higher coverage. It appears that catch-up shots are
administered effectively to teenagers by the school nurses in the schools; this phenomenon is
also apparent for children at school entry for Di and Pol. However, for Hib for children at
school entry, the reverse is applied because it is not offered in the schools as part of school
vaccination, but are administered by the GPs / pediatricians, and offered only during the first
5 years.
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Coverage for 3 doses of HepB range from a low of 7.5% in canton AI and 8.6% in SZ to a
high of 88.3% in NW and 81.2% in VD. This large range indicate that HepB coverage varies,
depending on whether or not a canton has already implemented a HepB vaccination
campaign, the extent of the campaign, the HepB vaccine used [i.e. whether 2 or 3 applications
are needed] and the school vaccination policy. In cantons AI and SZ, HepB vaccination is not
offered in the schools during the routine health examinations whereby in cantons NW and
VD, the school nurses vaccinate against HepB in the schoolhouses. Furthermore, there is a
large HepB campaign in canton VD in the 7th grade; data for the survey was collected in the
8th grade. By the 1st and 2nd HepB dose is NW high while it is one of the lowest at the 3rd dose.
The vaccination nurse in NW examines adolescents in February, and does not administer the
3rd dose until the beginning of the next school year. Since we collected the vaccination cards
at the end of the school year, doses number 1 and 2 were quite high, whereby number three
was not yet administered. Thus, this could also be a reason why one of our results showed that
the odds of being UTD at 3 doses of HepB for adolescents in cantons where vaccination is
permitted in the schools is lower (0.58 (CI: 0.46, 0.71)) than that of those living in cantons
where vaccination is not permitted; the time of data collection differed for each canton and
was not necessarily coordinated with the application of the final dose of the Hepatitis B
vaccine, whether it be a 2 or 3 application scheme.
When interpreting the estimates for schoolchildren, caution must be taken since 3 or 4
different school grades were evaluated depending on the canton, i.e. by school entry is
kindergarten, 1st, 2nd or 3rd accepted and by school exit, 6th-9th, the grades depending on when
the cantons allow their school doctors to perform the school health exams. Hence, coverage
by the 6th graders in AI is much lower than that from the older classes, especially with HepB.
However, although the 3rd graders were recruited in BS, students in this canton do not have
the highest overall coverage in this age group. Furthermore, there are many cantons that
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remain either at the top as being best vaccinated or vice-versa; however, reasons for this are
not superficially apparent, such as the low rubella coverage for SH. Especially important
would be further discussions with the CMOs and school doctors to explore plausible
explanations regarding differences in coverage due to the wide diversity in mentality and
vaccination policies among the cantons. Only then can theories as to cantonal vaccination
behaviors be more confidently hypothesized.
As also described in many other studies, vaccination coverage is affected by various factors,
such as social and demographic factors, use of CAM, information availability, attitudes
towards vaccination and the perceptions of the dangers of the disease [Masserey, 1997; BAG,
1999; Gellin et al, 2000; Impicciatore et al, 2000; Taylor et al, 2002; Luman et al, 2003; Chu
et al, 2004; Cassell et al, 2006]. Our results confirm that having siblings, educational level of
the mother, and the nationality of the child are all significant predictors of vaccination
coverage. Having siblings, more specifically, toddlers with older siblings have a lower chance
of being vaccinated for measles as compared to those who have no siblings. Single children
have the full attention of the parents, whereas those who are the youngest, are more likely to
be neglected as parents are pre-occupied with increased household responsibilities and family
commitments. As mentioned also in earlier reports [Masserey, 1997; BAG, 1999], nationality
of the child and highest level of education attained by the mother is a significant predictor of
being UTD, particularly for measles. Toddlers of Swiss background have a less likely chance
of being UTD for measles than those children from a foreign country and toddlers whose
mother has attained a higher level of education are less likely to be vaccinated than those with
a lower educational level.
In contrast, schoolchildren of Swiss background have a significantly higher chance of being
vaccinated than their non-Swiss counterpart. By the measles vaccine is the odds reversed,
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with the non-Swiss children at school entry having a significantly better chance of being
vaccinated than the Swiss children. Like the toddlers, the odds of schoolchildren whose
parents have a middle or high level of education being UTD with 1 dose of measles is lower
than those whose parents educational level is rated low. However, by the immunization series
and Di, Pol and Hib, the opposite is seen where the latter has a much higher chance of being
vaccinated. Because coverage levels of Di, Pol and Hib are higher for Swiss children and
children whose mothers have a higher educational degree, access to health care may have a
strong influence on vaccination status. A study showed that refugees in southern Italy has a
much lower immunity to diphtheria than native Italians [Chironna, 2003]. A recent study of
newly arrived adult immigrants and refugees in Canada also revealed that 36% of the target
population was susceptible to measles, mumps or rubella [Greenaway et al, 2007].
Additionally, an examination of more than 57 000 children between ages 5 and 12 years in
Amsterdam showed that foreign born children who had been born abroad were most likely not
to be fully vaccinated [van der Wal et al, 2005]. Furthermore, this phenomenon could also be
influenced by the use of CAM. As CAM is only recently popular, parents whose education is
rated as being in the middle and are parents of children at school departure still follow the
vaccination plan as recommended by their physicians; hence, the odds of these adolescents to
be UTD with the examined immunization series and Di, Pol and Hib are higher than those
whose mothers’ educational level is rated low and children at school entry.
For HepB, the reverse is true, where children of foreign background have a higher chance of
being vaccinated than Swiss children; moreover, children whose mother’s educational
background is rated low has a higher chance of being vaccinated for HepB than those whose
mother’s educational level is rated medium or high. Since many foreigners in Switzerland
originate from countries where HepB is more endemic, many families welcome the chance to
be vaccinated for this disease. Swiss parents, on the other hand, do not believe that their
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children fall into the HepB risk group. Furthermore, because asylum seekers must go for their
check-up at the GSU, vaccination is made during these examinations, when necessary.
Finally, many foreigners from the eastern European countries have very limited education
opportunity, as compared to the Swiss where the majority of the educational background is at
the middle level [SFSO, SAKE, 2004].
Highly influential on the level of vaccination coverage are 3 factors also observed in our
findings: the use of CAM, attitudes towards vaccination, and perceptions of the dangers of
childhood vaccine-preventable diseases. As seen in other studies [Masserey 1997; BAG,
1999; Robert Koch Institute, 2003; Cassell et al, 2006], parental use of CAM was strongly
and significantly associated with vaccination status regardless of differences in the cantons or
type of vaccines while the other factors varied randomly among the cantons. Approximately
41.7% of the parents of toddlers have used some type of alternative medicine, with a steady
decrease to 37.9% for students at school entry and to 30.9% by school departure. The odds of
being UTD at the 33333111 series among toddlers where CAM is used in the home is 0.38
(CI: 0.33, 0.43) times that of those toddlers in homes where only classical medicine is
followed. This is especially true for infectious diseases perceived as less dangerous, such as
MMR. Although no follow-up of one cohort was possible in this cross-sectional survey, it
appears that as children are older, the influence of CAM on vaccination coverage declines, as
its use is also reduced. For those who practice homeopathy more rigorously, there is an
alternative vaccination scheme recommended by their homeopathic practitioner, where the
number of doses and vaccines are reduced and the administration of the vaccines are
postponed until the infant is older [Klein and Albonico, 2003]. With the rise in popularity of
CAM [Eisenberg et al, 1998; Kessler et al, 2001; Marstedt and Moebus, 2002], the use of
CAM is a crucial factor that must be addressed in order to deter the possibility of
immunization coverage further declining in this population. A Canadian study showed that
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only 12.8% of the students enrolled in a naturopathic university would recommend the full
vaccination scheme to their patients, and 74.4% only partially [Wilson et al, 2004], due to
concerns of unknown side effects and doubtful efficacy. Similar to those attending a
chiropractic university, students attending these schools longer have significantly more
critical view of vaccination [Busse et al, 2002]. Collaboration with the educational boards is
vital to ensure that immunization is fairly and accurately represented in the curriculum.
With strongly significant association is the finding that the predominant language spoken in
the region plays a crucial role in the immunization status of children residing in Switzerland.
Toddlers and children at school entry residing in the French- and Italian- speaking regions are
better vaccinated than those residing in the German-speaking region, despite more use of
CAM in the former regions. In fact, toddlers residing in the French- and Italian-speaking
regions whose parents use CAM have a significantly higher chance of being vaccinated than
those in the German-speaking region. As mentioned earlier, perhaps the different childhood
vaccination recommendation guidelines in each canton can confound these results. For
example, 4 out of 7 of the cantons in the French- and Italian-speaking regions require that
children be vaccinated for Di, but none of those in the German-speaking region has made that
mandatory. Consequently, as cited earlier, because parents often mistaken the vaccinations
that are categorized as mandatory or facultative, and will bring their children to be vaccinated
since some will believe that all vaccinations are obligatory, toddlers residing in these cantons
will be better vaccinated than those where no vaccinations are mandatory [Bonanni and
Beganini, 2002]. This political factor, as well as other factors, must be controlled in a
multivariate logistic regression to determine if there is really a significant difference between
the different language speaking regions. Furthermore, the higher immunization coverage
levels of toddlers in TI compared to those in the German-speaking region was also influenced
by the fact that children 3-4 years of age, instead of the standard 24-35 months of age were
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recruited for the study. By the children at school entry, this significant difference between
linguistic regions could be affected by the school immunization policy, along with the efforts
of the school doctors.
Contrary to this pattern, adolescents in the French- and Italian- speaking regions have a lower
chance of being vaccinated for measles at one dose than those children in the German-
speaking region. This could be due to the fact that, parents in the French- and Italian-speaking
regions utilize more alternative medicine, than their German counterparts, where the use of
alternative medicine is negatively correlated with measles uptake. As confirmed in this
survey, adolescents from families where alternative medicine is practiced and reside in the
French-speaking region have an odds of 0.63 times of being UTD for measles at one dose
than those in the German-speaking region. For HepB, as vaccination campaigns are more
organized and well publicized in the schools in the French- and Italian-speaking regions (5
from 7 cantons), adolescents in these regions have a significantly higher chance of being UTD
for HepB than those in the German-speaking region (8 from 19 cantons), despite higher use of
alternative medicine. Furthermore this significance could also be exacerbated by the use of
cantonal employed school / LL nurses, in which cantons supplementing their health services
with school nurses have an odds of 1.66 times of being UTD for 1 dose of HepB than the
cantons without this supplementation.
Naturally, parents with negative attitude towards vaccination will less likely have their
children fully vaccinated, as seen by Cassell et al [2006]. In our survey, the most significant
predictors of a child being UTD with the recommended vaccination plan is if parents agree
that they follow the doctor’s recommendation, believe in the effectiveness of vaccination, and
think that as many children as possible should be vaccinated for the benefit of the community.
This pattern applies to children in all 3 age groups, with the magnitude of the association
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decreasing with increasing age. Because schoolchildren, particularly those at school
departure, have had already received many of the recommended vaccinations, and vaccination
is now only a very controversial topic, attitudes of the parents of these children are not as
strong predictors of vaccination behaviors as those from parents of toddlers. Parents of
toddlers must make a decision regarding immunization for their children with contradictory
opinions and information being constantly expressed. The ”Arbeitsgruppe für differenzierte
Impfungen” encourages parents to delay recommended childhood vaccination, where the
delay time varies with the vaccine [Klein and Albonico, 2003]. Measles, mumps and rubella
vaccinations are only recommended for teenagers between 12-14 years of age when the
respective diseases have not yet been contracted. It is hypothesized that suppression of acute
diseases in childhood may induce chronic diseases in the future (Teixeira, 2002). The delay in
immunization of these children could result in an epidemic, especially when there is a
clustering of children who remain unvaccinated [Van den Hof, 2002; May and Silverman,
2003; de Melker, 2003]. Furthermore, Siedler et al. [2002] showed that more than 50% of
measles cases in infants in Germany could be prevented if the 85% coverage for toddlers
could be reached by the second, instead of third year of life.
With the success of vaccination, many of the childhood diseases prevalent before the advent
of vaccination are no longer experienced, with small pox being eradicated globally
[CDC/MMWR, 1999(b)]. This lack of experience with certain diseases and advancement in
medical knowledge and technology support the illusion that certain diseases are no longer
dangerous. Additionally, a study by Smailbegovic et al [2003] showed that parents perceived
that having their child immunized with a particular vaccine was more risky than non-
immunization. This particularly applies to measles and rubella as more than 50% of parents
do not find these two diseases to be dangerous. In contrast, many parents perceive Hib as very
dangerous; hence, these parents of toddlers are 8 times and parents of children at school entry
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are two times more likely to have their children comply with the recommended vaccination
scheme than those who perceive Hib as not dangerous, although Hib coverage is still sub-
optimal. Children at school departure have the highest odds of being vaccinated for Pol as
parents perceive it as more dangerous than any of the other diseases. Pol is also perceived as
very dangerous by parents of the 2 younger groups. Extremely noteworthy is also the high
odds of being UTD for those who responded that they do not know how to perceive the
dangers of the certain childhood vaccine preventable diseases. This particular group could be
parents who are less critical of immunization, and vaccinate their children simply because it is
part of the routine.
Although we see that the magnitude of the perceptions of the dangers of certain diseases vary
by age groups, when comparing the perceptions of parents of toddlers from this survey to that
of those from the national survey conducted in 1998 by the SFOPH, perceptions of the
diseases, as well as immunization coverage, have not changed much (see Fig. 2). There are,
however, two exceptions. While coverage for Hib has drastically increased, the perception of
the dangers of this disease remained the same. This increase in coverage is probably a result
of the more popular use of combined vaccines, as is the case with Per, although the perception
of the danger of Per has increased by 8%.
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Good information is an important aspect of obtaining high vaccination compliance [Gellin et
al, 2000; Swennen et al, 2002]. Surprisingly, approximately 90% of parents of children in all
3 age groups did acknowledge the receipt of information regarding vaccination. Of these, on
average, 67% are happy with the information they have, 18% are not, 7% did not know, and
8% refrained from answering. Our results also surprisingly reveal that parents of toddlers who
have information about vaccination available to them are not as well vaccinated as those who
have no access to this information. This also applies to children at school entry for measles.
Perhaps this could be due to the fact that parents seeking information are more critical and
concern about the type of information available, particularly about vaccination than those who
do not seek any information. This phenomenon has been confirmed by Cassell et al [2006],
Fig. 2  Vaccination coverage (%) and perception 
of disease severity (%) of parents of toddlers 24-
35 months of age in 1998 and 1999- 2003
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where mothers actively seeking information on MMR are more likely to be vaccination non-
compliers than those who are more passive regarding this theme. In contrast, for children at
school departure, receipt of information is a strong consistent predictor of being vaccinated.
This could be accounted to the influence of the information from the school health officials.
Additionally, approximately 20% of parents are not satisfied with the information available.
Finally, toddlers whose parents are not satisfied with the available information are not so well
vaccinated as toddlers whose parents are satisfied with the information obtained. This
confirms that vaccination campaigns need to improve the type of information available to
parents to restore the public’s trust in vaccines and hence increase acceptance and
immunization coverage. To ensure not only compliance, but also concordance, they should
disseminate information in such a way that parents are actively involved and their views and
concerns are respected [Vernon, 2003].
Our results also indicate that doctors are the primary resource for parents about information
regarding vaccination, regardless if the parents need to request this information, as in many
other studies [Masserey, 1997; BAG, 1999; Gellin et al, 2000; Swennen et al, 2002]. Because
doctors are often highly regarded by their patients, many follow their doctor’s advice despite
their own hesitations [Kolasa et al, 2001; Leask et al, 2006]. Additionally, parents distinguish
between their doctors and doctors in general, where they have more trust in their doctors than
doctors in general [Casiday et al, 2006]. Zucs et al [2004] showed that among all the factors
examined, the main independent predictors of non-immunization of preschool children from
Bavaria, Germany were doctors advising against vaccination and those abstaining from giving
advice.
Moreover, parents of schoolchildren desire more information from school health officials.
Although many parents may wish that information from the media is reduced and that from
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the health insurance is increased, scientists should strive to build a long-term relationship with
these two groups. An analysis of the media coverage of the MMR controversy in Great
Britain between January and September 2002 showed that the media misled the public over
the MMR vaccine by focusing their reports on the possible link between MMR vaccine and
autism and giving the same coverage for those supporting and contradicting the link; only
23% of the public were aware that the bulk of the evidence favored supporters of the vaccine
[Hargraves et al, 2003].  Moreover, in addition to MMR, the negative impact of the media
was clearly evident also during the controversy surrounding Per and smallpox vaccination in
Great Britain [Fitzpatrick, 2004; Baker, 2003]. By working closely with the media and health
insurance, we can ensure that accurate information are disseminated, particularly in times of
disease outbreaks [Cookson, 2002].
4.1 Limitations
Because one of the major goals of the study is to build a surveillance system in each canton
concerning vaccination coverage by using this study as a foundation, we attempted to use the
existing infrastructure as much as possible in each canton to increase acceptance and ease the
workload, while maintaining an acceptable budget. While all cantons do employ some method
of checking the vaccination cards, information is recorded only enough to suffice for vaccine
reimbursement. Unfortunately, this does not provide enough information for in-depth
statistical analysis into vaccination coverage levels. This required that new procedures were
created and adapted to the needs and resources of each canton. Our collaboration with various
health organizations and school health officials in each canton have reduced the workload for
ISPMZ substantially, but unfortunately, has also compromised the comparability of the results
among the cantons. As described earlier, this variability is due to the different vaccination
policy in each canton, such as the grade levels at which the routine health examines are
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mandated, vaccines that are offered in the school, whether or not school doctors are allowed
to vaccinate at all, and whether or not HepB campaign is actively conducted in the school
(Annex M.1, M.2). For example, in many cantons school doctors can perform the routine
health examination and vaccination card control anytime during the entire school year. Some
cantons allow the school doctors the choices to examine the students either at kindergarten or
1st grade or at grades 7th, 8th or 9th. Because the study was coordinated with the routine school
health examination so as not to overburden the school doctors, teachers and parents,
comparability among the cantons was compromised. Moreover, in many cantons vaccination
policies require that students be referred to their GPs for catch-up shots; this vaccination
could not be assessed through the school health exams. In contrary, although some cantons
allow the physicians to vaccinate in the schools, some physicians may prefer referring the
schoolchildren to their GPs for catch-up shots. Comparisons of the immunization coverage for
schoolchildren where vaccinations are permitted in the schools and where they are not should
be done with caution, despite significant associations. HepB coverage is especially influenced
by such policies as some cantons expend much resource to educate their students about HepB
while other cantons spend very little or nothing at all. Additionally the period during data
collection and school vaccination may not have coincided, which consequently could yield
inaccurate estimates.  Catch-up shots administered by the family physicians would be missed
in some cases. Completion of the vaccination summary form by the school doctors and nurses
also added to the problem as some health officials also checked for Per and Hib during their
examination of the vaccination cards while others ignored these two vaccines. After
correcting for this error, data for Per and Hib were incomplete for 2 classes from canton AI
for children at school entry and Per for 5 (3 from AI and 2 from GR) for those at school
departure. In BS information for these two vaccines was missing for 24 children at school
entry and 57 at school departure, in addition to single cases in cantons SG, SH, TI, ZG and
ZH where this information could not be assessed from the vaccination cards. As evident in
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our results, coverage estimates for teenagers were also associated with mode of data
collection; adolescents where nurses collected the data have a higher chance of being
vaccinated than those in cantons where doctors aided in data collection. Perhaps higher
coverage could be accounted to better data collection by the cantonal employed school / LL
nurses as they have more time than the school doctors for the evaluation. Furthermore, by
using the schools, the nature of the non-responders is not known. There could be many
reasons, ranging from being recently vaccinated by their family physician, to downright
refusal of any vaccines since those kids who do not want to be vaccinated will normally not
submit their vaccination booklets to the school health officials.
Moreover, clear communication between ISPMZ and the school health officials must be
improved to avoid any misunderstandings. Although collaboration with the LL nurse in the
canton of JU was very simple and efficient with telephone inquiries from ISPMZ throughout
the school period to inquire about the process of data collection, the vaccination information
delivered at the end of the school year was not adequate to determine vaccination coverage by
vaccination per dose due to misunderstandings. Consequently, despite utilizing all the
available information, ISPMZ was not able to reconstruct the necessary information; hence,
vaccination coverage from JU for schoolchildren was missing.
Finally, the use of the vaccination summary form has simplified data entry, but other work
arose due to unforeseen problems. According to the wish of the CMOs to increase compliance
among the school doctors by reducing their work, school doctors should be allowed to check
one box if the child is UTD for all vaccines;  hence, it would not be necessary to complete the
individual boxes for each vaccine if the child is UTD. Although the SFOPH recommended
vaccination plan was attached to the summary form, it was nevertheless not defined enough
for the school doctors. Some doctors defined UTD as having 4 doses for Di, Te, Per, Pol and
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Per and one for MMR for school entry and for the children at school departure, UTD was
defined as 5 doses for Di, Te, Pol, 0 for Per and two for MMR. We contacted all the school
doctors to confirm the nature of UTD if the UTD boxes were checked. Moreover, because Per
and Hib do not apply to the children at school departure and are not vaccinated in the schools,
some school doctors did not even control for the number of doses for these two vaccines in
the vaccination booklet.
Some of these uncertainties along with the unknown nature of nonresponders have been
addressed in the study repeated in VS. The pilot study conducted in 1999 in VS served as a
good platform on which to change data collection methods to improve data quality, ensure
comparability and improve the chances for sustainability. The collaborators in 1999 were
eager to join efforts once more, with many ideas to overcome some of the problems
encountered in the pilot study. For VS, the nurses from the LL were requested to make sure
that all kids are represented on the vaccination summary form, and reasons for not vaccinating
a child or checking the vaccination card should be clearly indicated. The nurses were also
requested to complete the form fully, regardless if the child is vaccinated according to the
recommended SFOPH childhood vaccination plan.
In the case of the toddlers, difficulties encountered originated from other areas. For example,
in the canton of NE as all three age groups were sent the same letter at the same time, chaos
broke for the first letter since placing the returned answers in the correct age group was
sometimes impossible. In the canton of VD, where the “Bureau Vaudois d’Adresses”
performed the sampling and sent the first letter, the mistakes were not realized until too late.
The first set of letters was sent to the wrong families as children of all ages were sampled,
instead of those between 24-35 months of age. After this error was noticed, a second sampling
was done. It was not until the completion of the survey was it realized that the sampled
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population was not representative of the general population in VD. The sampled population
consisted of 60% foreigners, whereas the general population had only 30%. After inquiry into
the sampling method of the BVA, it was discovered that simple random sampling was not
used, but the method employed was similar to proportional to the size of the different
ethnicity, based on the judgement of the person in charge. To exacerbate this error, the
selection of parents within the different ethnicity were not random, but were more systematic
where those first on the list were always selected. The last convenience utilized by BVA for
selection of samples could unknowingly select the same families for various different studies,
with negative consequence for those depending on their participation. Hence, despite the huge
efforts expended by ISPMZ to increase the response rates, participation from parents of
toddlers in canton VD remained at a modest 68%.
Among the 3 different methods used to collect data for the schoolchildren, coordination with
the school health services supplemented with cantonal employed or LL nurses was most
efficient and clear. For data entry, the vaccination summary form was easy to interpret and
clearly more completed. Furthermore, participation rate was distinctly higher. Although many
school doctors agreed to help out with the study, one refusal could lower the response rate
dramatically, particularly in the smaller cantons. Sustainability by cantons would be most
feasible by collaborating with cantonal employed school or LL nurses supplementing school
health services. Since many cantons do not offer such services, collaboration with school
doctors would be sought next where feasible. However, the vaccination form would have to
be drastically simplified to reduce the amount of work for these doctors in order to ensure
compliance and acceptance.
By the toddlers, not many methods exist by which to reach the toddlers. The method used for
the majority of the cantons, in which help from municipal halls were sought, was feasible,
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although quite labor intensive. In three cantons where there is a single registry for all residents
in the canton, sampling by simple random sampling was done, and direct contact with the
family was taken. With help from Dr. Philip Smith from the National Immunization Program,
Centers for Disease Control and Prevention, we employed a self-weighting sampling design
for data collection of toddlers in 2002, which eased the sampling procedure, simplified weight
calculations and produce accurate estimates and confidence intervals [Smith, personal
communication, 2001]. In short, using this sampling design each child will have the same
weights regardless of the cluster to which the child belongs [Levy and Lemeshow, 1999]. A
comparison study between telephone and written surveys to assess adolescent immunization
coverage rates showed that combining both methods would maximize the data collected,
increase response rate while maintaining cost and attaining accurate vaccination coverage
rates [Peddecord et al, 2004]. An additional improvement that would ease data collection
methods for toddlers would include a procedural change in cantons where Di or Te
vaccination is mandatory. Because a method must exist to check that all toddlers are
vaccinated for either Di or Te, the vaccination card can be simultaneously copied or a
vaccination form completed for the district, as in canton GE. No additional surveys would
then be needed for the toddlers in these cantons; adaptations or modifications to an existing
infrastructure are ideal if comparable data can be collected, and should be seriously
considered as a step towards establishing a sustainable and comparable vaccination
surveillance system.
Nonresponse continues to be a major obstacle in this study for both schoolchildren and
toddlers. As aforementioned, this could be addressed adequately for the schoolchildren with
the help of the school nurses in VS, but the problem remained difficult to resolve with the
toddlers. Personal communication with Dr. Sudre from GE indicate that the addition of a
questionnaire to the routine letter decreased the usual response rate of 70% down to about
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50% after the first letter, when comparing the participation in the survey with the routine data
collection by the Health Department in GE to monitor vaccination coverage [Sudre, personal
communication, 2003]. This effect is also confirmed when one compares the usual 80-90 %
response rate conducted in other cantons in previous years [Schorr, 1993; Vranjes, 1996;
Maurer, 1997, 2001, 2003]. In our current survey, we also showed that toddlers residing in
cantons where participation of more than 70% could be achieved had a higher chance of being
UTD with the recommended immunizations.  Perhaps more parents who are willing to
participate in the study have a more positive attitude towards immunization.  Furthermore,
accessibility to copiers could also hurt compliance with the study. We have experienced from
many parents, particularly those living in the rural regions, that the process of going out and
making a copy of the vaccination card had also hindered them from immediately returning the
completed questionnaire. By repeating the study in VS in 2003 and collecting only
vaccination cards, it has been confirmed that participation from the parents can be greatly
increased by: dropping the questionnaire, hiring telephone assistants to contact parents of
foreign background, contacting GPs when parents do not have the vaccination cards available,
increasing the number of telephone attempts, and using more resources to find missing
telephone numbers.
As most school doctors, nurses, CMOs, and teachers are willing to assist in the study, more
strategies are needed to utilize their assistance effectively, perhaps even paying for their
assistance, if need must be to enhance data quality. For example, in canton NW, the
vaccination nurse was willing to collect all available vaccination cards and bring them home
and complete the vaccination summary form, if we could have paid her for this extra effort.
The time and effort spent to contact the schools and to get compliance from teachers,
directors, and parents could have been saved, while increasing our meager response rate of
20% in canton NW considerably if we were to use this strategy. Moreover, some school
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doctors have directly contacted ISPMZ to complain that participating in the study required
much time and that they should be monetarily reimbursed for their efforts.
Strategies to combat nonresponse should be investigated and carefully implemented. By this
study, the high nonresponse rate, especially by schoolchildren in cantons ZG, OW and NW,
and for vaccines where coverage levels were much lower than the assumed 80% prevalence,
had compromised the results considerably. Some confidence intervals were much wider than
the desired ±7% precision that was used to calculate the sample size, particularly by
schoolchildren in the aforementioned cantons where participation was meager at 11.8%,
20.2%, 29.2% at school entry and 8.6%, 13.0%, 20.5% at school exit, respectively.
Nonresponse bias can also be handled statistically by using nonresponder adjustment,
imputation and poststratification. Use of these methods should yield estimates closer to the
true population estimate and more accurate confidence intervals. Basically, by nonresponder
adjustment, it is assumed that the sample is representative of the general population and that
behavior of those who do not respond will be similar to those who do respond. Hence, it is
possible to distribute the results among the population to get appropriate population estimates
[Korn and Graubard, 1999; Levy and Lemeshow, 1999]. Imputation involves using data
obtained from the survey to fill in missing information and poststratification entails adjusting
the weights of each individual child so that the overall proportion will be equal to that
obtained in an independent authoratative resource, i.e. the census figure [Brick, 1996; Smith,
personal communication, 2001]. Before the analysis of the results with the toddlers, these
statistical procedures were used, with conservative imputations for gender and nationality
based on names of the children selected for the study. Many parents claimed not to have
refused or missed any opportunities to have their children vaccinated. Further inquiries, when
possible, requested that the parents clearly state the number of shots for the recommended
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number of doses for each vaccine. By the toddlers, parents who are too busy to participate in
the study or have no interest in the topic also confirmed that their children never missed a
doctor’s appointment for vaccination. Moreover, those who were clearly against or sceptical
about vaccination were very open about their opinions on the phone. For comparative
purposes, Table 18 presents coverage estimates resulting from different statistical
manipulations. As can be seen, there is at most a 2.0% difference between these different
procedures, with data using weights and adjustments, along with parental recall yielding
slightly higher figures than when taken at face value, i.e. without weights, imputation or
adjustments. Based on many statistical analysis, those using nonresponse adjustment and
poststratification will yield estimates that are closer to the true population estimates with
appropriate standard errors [Korn and Graubard, 1999].
4.2 Conclusions
Vaccination coverage of children in Switzerland has not reached the optimal level to establish
solid herd immunity, but it has reached a threshold where major outbreaks are avoided, but
not small minor ones (Wallinga et al, 2005). When infection is re-introduced, an outbreak can
occur in the communities with low coverage. This can be clearly seen with the numerous local
measles outbreaks throughout Europe, as described in the Introduction. These outbreaks
usually affect unvaccinated, or not fully vaccinated children who due to common
philosophical, religious and / or social bonds are clustered geographically [Smith et al, 2004].
Future vaccination campaigns need to more clearly define their target population as there are
many factors associated with immunization coverage. They include socio-demographic
variables (such as nationality, number of older siblings and maternal level of education),
parental attitudes and perceptions of disease and healthcare, type of information available, use
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of complementary / alternative medicine, relationship with healthcare providers, all
influenced by regional differences in local and national immunization policies. The interplay
of these factors results in varying degrees of impact on coverage level.
Campaigns directed towards parents should include strategies that are informative, personal
and compelling, and yet transparent, explaining also the differences between coincidental and
causal relationships while communicating risks and addressing vaccine safety concerns more
effectively [Bellaby, 2003; Offit and Coffin, 2003]; moreover, strategies should treat parents
as active partners, rather than passive recipients of information, respecting their intentions to
protect their children’s health [McMurray et al, 2004]. A working relationship between the
media, health care professionals and scientists would benefit everyone immensely with the
correct information being produced and used. Furthermore, campaign strategies should also
include educating / re-educating doctors or healthcare providers about the benefits of
immunization and the basic principles behind vaccinology, immunology and herd immunity.
Furthermore, many healthcare providers would like more information and resources to be
easily available to them to help refute the anti-vaccination claims and alleviate parental
concerns especially regarding vaccine safety without compromising their credibility, as many
parents re-instate their trust in their GPs [Petousis-Harris et al, 2004; Casiday et al. 2006;
Petousis-Harris et al, 2005]. In one study, many health professionals in Wales were not aware
of or do not use the good written resources available about the second dose of MMR [Petrovic
et al, 2001]; 3 other studies showed that healthcare providers lacked substantial knowledge
about the recommended immunization schedules and vaccine contraindications [Cohen et al,
2003; Petousis-Harris et al, 2004; Petousis-Harris et al, 2005]. With greater understanding,
health care providers can easily promote vaccination and persuade their sceptical patients
toward this goal. Moreover, as the use of CAM increases, collaboration with educational
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institutions is important to ensure that immunization is accurately represented in the
curriculum [Busse et al, 2002; Wilson et al, 2004].
Utilizing the findings from this study, a new vaccination campaign in Switzerland must
prepare new information directed especially towards Swiss parents and who reside in the
German-speaking region. This new information should address the increasing negative
attitudes toward vaccination, concerns about possible adverse effects, perception that
childhood vaccine-preventable diseases are not so dangerous, and contradictory information
provided by CAM practitioners. Additionally, vaccination policy should be carefully
constructed as it significantly affects vaccination coverage. Since more parents consistently
would like more health information from school officials, health authorities should use this
invaluable opportunity to distribute information during the school years.
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5. Future research 
 
As the controversy over vaccination will only grow, more research into this topic should be 
invested. Areas that deem further investigation include: 
 
1. Knowledge, attitudes and perceptions of physicians towards vaccination, especially in 
light of the increase influence of complementary / alternative medicine. As physicians 
are the most important resource for parents concerning vaccination, and they are 
responsible for immunization in their practices, hospitals and health clinics, it is 
especially important to understand their views, knowledge, attitudes and opinions not 
only about current vaccination policies, but also vaccination in general [Petrovic et al, 
2001; Seid et al, 2001; Milledge et al, 2003]. A recent study showed that many 
physicians’ knowledge regarding catch-up regimes and contraindications are minimal, 
with more errors occurring when the children are older and immunization 
recommendation plans are more complex [Cohen et al, 2003]. Studies of health 
professionals in Germany and New Zealand confirmed that physician’s uncertainty in 
assessing contraindications correctly and lack of knowledge were important reasons 
for insufficient vaccination rates [Schupfner et al, 2002; Petousis-Harris et al, 2004; 
Petousis-Harris et al, 2005]. Furthermore, Bovier et al [2001] also demonstrated that 
lack of physician’s encouragement accounted for most missed vaccinations in the adult 
population in Switzerland.  A survey of school nurses and personnel in the US showed 
that vaccination exemptions were more likely to be given to children attending schools 
where nonmedical personnels were responders, and those who hold disease 
susceptibility and severity and vaccine efficacy and safety as low, have less confidence 
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in local and state department, have consulted with an alternative medicine practitioner, 
or use few professional organizations or government resources for vaccine information 
[Salmon et al, 2004]. A current study in Switzerland examined vaccination behaviours 
of physicians in Switzerland [Posfay-Barbe et al, 2005]. The authors showed that 
pediatricians and physicians who were not pediatrications (nonpediatricians) vaccinate 
differently, with a significant proportion of nonpediatricians twice unlikely to follow 
the recommended Swiss vaccination plan for their own children. These groups of 
nonpediatricians would also more likely to postpone DTP and MMR vaccinations and 
refrain from using combined vaccines, despite their scientific training and education. 
 
Qualitative questionnaires and/ or personal interviews with general practitioners and 
pediatricians would provide more in-depth understanding of the knowledge, attitudes 
and perceptions of this critical group. If necessary, further education into vaccinology 
and immunology with focus on contraindications and vaccines, along with current 
popular perceptions of immunizations and reasons for anti-vaccination should be 
integrated during the medical training year or as a refresher course for practicing 
physicians. The information ascertained from the interviews with the physicians will 
help plan vaccination campaigns to increase immunization coverage. 
 
2. Knowledge, attitudes and perceptions of parents in Switzerland towards vaccination. 
Although this was also examined in the current survey, a closed structured 
questionnaire was used. Focus groups or in-depth open-ended questionnaires of 
parents with opposing views about immunizations (supporting, waivering, postponing 
and declining) could provide more essential information towards planning vaccination 
campaigns [Ramsey et al, 2002; Swennen et al, 2002; Taylor et al, 2002; Smailbegovic 
et al, 2003; Cassell et al, 2006; Tickner et al, 2006].  A recent telephone survey in 
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Sweden found that parents postponing MMR are different from those who abstain 
from vaccinating their child [Dannetun et al, 2005] while another study in Scotland 
[Friederichs et al, 2006] demonstrated that levels of economical deprivation affect 
vaccination coverage and time at vaccination where those most affluent either 
vaccinate their children promptly or not at all; hence different strategies would be 
needed to target these parents successfully. Equally important would also be to 
determine the extent of parental refusal towards immunization, i.e. if this negative 
perception pertains only to certain immunizations, combination vaccinations or all 
immunizations in general. Primary barriers to vaccination for parents are concerns of 
vaccine safety, distrust in the government, growing distrust in the medical authority 
and prior experience with vaccine adverse effects [Allred et al, 2004; Gust et al, 2004; 
McMurray et al, 2004]. Because of the multi-cultural and language diversity 
embedded in Switzerland, it would be critical to differentiate parental views and 
perceptions among the different regions. Our study also confirmed this phenomenon, 
as toddlers and children at school entry residing in the French- and Italian-speaking 
regions in Switzerland, are better vaccinated than their German-speaking counterparts; 
adolescents residing in the former regions, on the other hand, have higher coverage. 
Additionally, a recent publication showed that acceptance of immunization among 
Swiss mothers living in Geneva depends on their level of education, use of CAM and 
perception of individual control over the health of their family [Burton-Jeangros et al, 
2005]. Furthermore, more effective communication of immunization implies that new 
and existing information must reworked so that it can be integrated into parent’s 
context of their individual situation and level of understanding [McMurray et al, 
2004]. Limited resources and funding could be more adequately allocated to achieve 
effective results. 
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3. Patterns of complementary / alternative medicine (CAM) use and its influence on 
vaccination in Switzerland. Because the use of CAM has become increasingly popular 
among consumers [Eisenberg et al, 1998; Kessler et al, 2001; Marstedt and Moebus, 
2002] and GPs [White et al, 1997; Marstedt and Moebus, 2002], with often opposing 
views as those supporting vaccination [Busse et al, 2002; Robert Koch Institute, 2003; 
Wilson et al, 2004], it is important to understand the level of its impact on 
immunization. In-depth investigations from other countries have also shown the 
difference in perceptions of immunization by different groups of CAM practitioners 
[Ernst, 1997, 2002; Lehrke et al, 2001]. Moreover, about one third of the visits to 
homeopathic practitioners or naturopathic doctors are children and adolescents; 
however only half of those CAM practitioners participating in the study have any 
formal pediatric training, with most not actively recommending immunizations [Lee 
and Kemper, 2000].  Furthermore, a current survey in canton VD, Switzerland, 
confirmed that children whose main healthcare providers are homeopaths are less 
likely to be vaccinated against MMR than those whose providers are certified doctors 
or pediatricians [Masserey et al, 2006]. 
 
Further research into CAM, its prevalence, and especially influence on vaccination in 
Switzerland needs be done. Qualitative questionnaires and/ or personal interviews 
targeting this group would be critical for evaluating their attitudes and influence on 
vaccination. As seen in our study, the influence of CAM practitioners varies, 
depending on the linguistic region and field of specialization. A comprehensive list 
outlining the geographical location of CAM practitioners and their specialization 
would aid in differentiating and understanding this difference. 
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4. Analysis of coverage by validity of vaccination doses and / or age-appropriate 
vaccination since coverage estimates could be an over-estimation and timely 
vaccinations can protect children as early as possible and prevent disease outbreaks. 
As mentioned earlier, the study by Stokely et al. [2004] has shown that coverage 
estimates decline between 0.7% to 6.5% when the validity of the doses are taken into 
account. Furthermore, another study has revealed that by the age of 24 months, 9 out 
of 10 children will have received at least one dose of vaccine outside the 
recommended age ranges [Luman et al, 2002]. Hence over-estimation of coverage will 
leave many of these kids unprotected.  A study in Germany calculated that if the 
current measles coverage of 85% can be achieved in the second instead of third year of 
life, then more than 50% of measles cases in 1 year old children could be prevented 
[Siedler et al, 2002]. A recent publication from the canton of Basel, Switzerland, also 
confirmed that when examined by doses, coverage level was high, while when 
examined if vaccinations were timely made, coverage level dropped significantly 
[Heininger and Zuberbühler, 2005]. This information should and could be easily 
assessed in the next cycle to determine vaccination coverage of children in each 
canton.  Date of birth and dates of all vaccine administration for each child must be 
recorded at time of data collection. 
 
5. Greater understanding of the level of population immunity in Switzerland. A recent 
publication showed that a minimum vaccine coverage of 80% at the second birthday in 
the United States may be sufficient to prevent measles transmission among preschool-
aged children if population immunity is ≥ 93% among persons ≥ 6 years of age 
[Hutchins et al, 2004]. This coverage level varies by the age group and depends on the 
immunity of the target population, vaccination requirements and contact rates among 
children during preschool-aged years, along with contact rates with schoolchildren and 
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adults, their population immunity and the risk of introduction of measles from sources 
outside the preschool-aged population. A household contact study, as conducted by 
Arbenz et al [2005] would be useful to calculate vaccine effectiveness. Knowledge of 
the minimum vaccine coverage will aid in achieving and maintaining disease 
elimination while assessment of the population immunity will also help in evaluating 
epidemiological effects of the existing vaccines and new vaccines [de Melker, 2003]. 
This information should also be assessed for Switzerland. 
 
6. More in-depth investigation into the impact of nonresponder bias, timeliness of 
response to survey, and mode of data collection on vaccination coverage in 
Switzerland. Although there has been research documenting the influence of these 
factors on immunization coverage in the USA [Smith et al, 2005; Salmon et al, 2006], 
there is not enough information in this domain for Switzerland. While time at and 
mode of participation in the survey will be important in determining effective methods 
of data collection, recording reasons for nonresponse, and vaccination status of these 
children, will be imperative to investigate its effect on vaccination coverage obtained 
from participants; more detailed nonresponder adjustments could be made in future 
surveys. Additionally, the prevalence of mobile telecommunication in the Swiss 
population also needs to be calculated, since more families, particularly foreigners, 
rely on them as the sole source of contact. Greater understanding of the 
aforementioned factors will aid in more applicable statistical adjustment and improved 
data quality, such as those implemented in the National Immunization Survey [Smith 
et al, 2005]. 
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6. Practical Recommendations 
 
 
6.1 To increase vaccination coverage 
 
 
Based on these preliminary results, a few recommendations to increase vaccination coverage 
and for immunization campaigns could now be drawn: 
 
1. The easiness to obtain vaccination does affect immunization coverage, particularly at 
school departure and for vaccines Per and MMR, with possibly higher coverage estimates 
for the cantons where immunization is offered in the schools and those with cantonal 
employed school or LL nurses to supplement the school health services. School health 
services could be a direct source of information to the parents, since more parents rely on 
schools for information as their children get older. An emphasis on the importance of 
prevention to the adolescents in the school would also help in raising awareness. 
Additionally, a uniform method of vaccine reimbursement and distribution would 
decrease confusion [Schmitt, 2002]. Immunization policy and school health guidelines 
need to be adapted to the present conditions to achieve higher vaccination coverage.  A 
recent study in the United States revealed that school vaccination requirements can 
substantially increase vaccination coverage among students subject to the law (Averhoff et 
al, 2004). Furthermore, many of the well, organized school health services in Switzerland 
have coverage information detailed by local schoolhouses and zip codes; areas with low 
coverage could be easily identified and efforts to increase immunization acceptance 
focused. 
 
2. Clear, but yet compelling information is very critical to immunization acceptance in the 
current society. Vaccination campaigns should directly address parental concerns while 
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discreetly responding to false allegations purported by the anti-vaccinators, whether it be 
through publications or in the Internet [Spier, 2002; Wolfe et al, 2002]. Strategies need to 
be implemented to convert the 44% comprising of those who have not received 
information regarding vaccination, are dissatisfied with the information received, or have 
no interest in the topic. Because parents are weary of the types of information shared by 
the media, this form of information is less desired. However, as a strategic maneuver the 
scientific community should also begin to build long-term relationship with the media so 
that accurate information is disseminated, especially in times of an outbreak. Such steps 
can prevent the tragedy that was seen with the rotavirus vaccine in the US, as a balanced 
portrayal of vaccines with its risks and benefits may avoid the sudden shifts in the media 
and public reaction and lend credit to the information distributed [Danovaro-Holliday et 
al, 2002]. Moreover, as more parents assess the Internet for information regarding 
vaccination, accurate and compelling information in support of vaccination while 
addressing parental attitudes and perceptions, in particular vaccine safety and efficacy 
should be easily accessible.  After utilizing the MMR web based decision aid which 
provided numerical and graphical evidence of the risks associated with the diseases 
alongside with potential risks associated with the vaccines, many parental attitudes 
towards MMR vaccination had improved significantly [Wallace et al, 2005]. 
 
3. Healthcare providers also need to be targets of vaccination campaigns as many parents 
rely on these providers, and still prefer them to other resources, for information regarding 
vaccination. Despite their concerns regarding vaccine safety, a recent study by Leask et al  
[2006] demonstrated that mothers whose children are fully vaccinated reasserted their 
support for immunizations by deferring to authority figures, particularly their GPs. 
Reviews and revised medical education need to clearly emphasize basic immunology, 
vaccinology and herd immunity principles, especially in light of increased acceptance and 
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use of CAM. More resources, such as INFOVAC-PED, should be more available to 
provide support for the growing demands placed on health care providers as increasingly 
more new vaccines are being produced and more questions pertaining to adverse events 
and long term effects are being asked [Siegrist et al, 2002]. Rigorous surveillance of 
adverse effects in Switzerland by Swissmedic and at the global level by the Global 
Advisory Committee on Vaccine Safety should be continually monitored and updates 
published for more information on the safety of vaccines [Folb et al, 2004]. With a strong 
background, healthcare providers can confidently respond to the criticisms and scepticism 
frequently expressed. 
 
4. Vaccination coverage could be improved through simply reminding patients of an 
upcoming / overdue vaccination shot. An updated Cochrane Database Review recently 
confirmed that simple procedures such as patient reminders via telephone, postcards or 
letters could increase immunization rates by 1 to 20 percentage points, with a pooled 
random effect of OR 1.45 (CI: 1.28, 1.66) for increased likelihood for routine childhood 
vaccinations, and the effectiveness increasing with several reminders [Jacobson Vann and 
Szilagyi, 2005]. Reminder and recall were effective for both adults and children, all 
medical settings and all vaccinations.  
 
6.2  To improve survey methodology 
 
In order to develop a surveillance system that is feasible, comparable and sustainable, a 
consensus must be found between the cantons and SFOPH to set priorities and goals. Areas 
that must be discussed include: 
 
 6. Recommendations 122 
 
1. Grade levels for the schoolchildren. As seen from the data, due to the diversity among 
the cantons, comparability had been compromised, particularly for HepB, by 
attempting to use the existing infrastructure. To ensure strong and comparable data, a 
decision must be taken on the grade levels to be examined. Three options are 
available: 1) regardless of the grade level of the current routine school examination, all 
cantons must agree on the grade level and period of data collection. The advantages 
and disadvantages must be thoroughly discussed.  2) the cantons would have to amend 
school health policy and synchronize the age at which vaccination cards are examined 
in order to coordinate the survey with existing infrastructures while maintaining 
comparability among the cantons. 3) to adapt the method [via municipalities] 
implemented for the toddlers for data collection. This method would not utilize the 
existing infrastructure for the schoolchildren, but comparability among the cantons 
will be increased substantially. 
 
2. Mode of data collection for the schoolchildren should be thoroughly discussed, in 
terms of feasibility, comparability and sustainability. Should we continue to work with 
school health services and school doctors and nurses? Or is it better to go through the 
municipalities, like in NE and BE? 
 
3. Continued collaboration with the school doctors and a standard vaccination summary 
form require clear guidelines as to what is defined as being up to date. 
 
4. More detailed information are needed regarding the responsibilities of the school 
doctors: the district for which the school doctor is responsible, name of the 
schoolhouse, number of classes, number of students. This information is crucial for 
 6. Recommendations 123 
 
accurate sampling design and would reduce the amount of work for ISPMZ incredibly 
since much energy was expended to ascertain this information ourselves. 
 
5. Cantons where Di or Te vaccination is mandatory could already begin collecting data 
on vaccination coverage very easily. Because a method must exist to check that all 
toddlers are vaccinated for either Di or Te, the vaccination card can be easily copied or 
a vaccination form completed at this time for the district, as in canton GE. This small 
effort could be easily incorporated into the existing infrastructure, and would 
subsequently reduce additional work and cost tremendously. 
 
6. Serious consideration should also be given to creating a computer database where 
vaccination coverage can be directly entered. This can be started for the younger 
children and would eventually render the need to collect vaccination coverage at 
school age obsolete, if data are recorded longitudinally. This would entail careful 
planning as to how to coordinate data entry so that there is a single continually updated 
registry. This database could overcome many current obstacles, such as nonresponder 
bias, low participation from foreigners, incomplete information due to record 
scattering, resulting from numerous vaccination cards and doctors. With this system, 
many purposes can be met: to determine vaccination coverage very easily and at all 
levels [local, cantonal and national], to examine demographic factors influencing 
coverage very quickly, to manage vaccine distribution, to maintain health care cost, to 
provide insight into patterns of immunization delivery, and especially to monitor the 
different types of vaccines for short and long term adverse effects [Navarro et al, 
2002]. Moreover, Kempe et al [2004] has also shown that a common registry can 
increase vaccination coverage up to 50% for children aged 24 months of age by 
reducing record scattering. Finally, a recent study in the USA showed that parental 
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support of immunization registries, particularly among parents of vaccinated children 
was relatively high; support was also given from parents whose child has been 
exempted for at least one vaccination, if registries offered choice for participation 
(Linkins et al, 2006). It could be expressed to the Office of Data Protection that such a 
vaccination registration would meet the criteria under the Epidemiology Law (Federal 
Law 818.101) as a method to prevent disease outbreaks, and naturally, that the data 
would be treated with the utmost confidentiality.  
 
6.3     To ensure data comparability 
 
Before implementation of the conducted survey as a proposed methodology in a surveillance 
system, some areas of improvements should be considered, such as  
 
1. Adopting a self-weighting sampling design to obtain accurate estimates and 
confidence intervals. 
 
2. Reducing respondent burden and maintaining cost, such as decreasing sample size. 
Because the goal is to utilize this survey as an annual surveillance system, reducing 
burden should be one of the priorities to ensure compliance and acceptance from all 
parties involved: parents, teachers, school doctors, municipal halls. There needs to be 
an acceptable balance between sample size, precision, available resources and cost. 
 
3. Measures to decrease nonresponse below 20%: stronger engagement of the cantons, 
intensifying telephone attempts, employing telephone assistants to contact foreigners 
in their native language, locating more telephone numbers, and contacting physicians 
when vaccination cards are not available from the parents, with permission granted. 
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4. Fine tuning of the nonresponse adjustments to account for difference in behaviors and 
attitudes toward vaccination between the Swiss and those of foreign backgrounds.  
 
5. Children must be of the same age to allow comparability, especially those in the 
school years. 
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7.  Swiss National Vaccination Coverage Survey (SNVCS) 2005-07 
With support of the “Schweizerischen Konferenz der kantonalen Gesundheitsdirektorinnen 
und –direktoren“, the second cycle to determine vaccination coverage of children in 
Switzerland is currently being executed between 2005-07. In this cycle most of the practical 
recommendations that were listed in sections 6.2 and 6.3 to improve data quality and ease data 
collection have been implemented, with adaptations mandated by the existing infrastructures 
and available resources in each canton.  The current methodology includes: 
 
1. Data collection for all 26 cantons will be a 3-year rolling cycle. Cantons are 
encouraged, and not obligated to participate. 
 
2. The same methodology, which was used for toddlers in 1999-2003 should be used 
for all 3 age groups.  Sampling depended on the available sampling frame, which 
can be summarized into 2 sampling methods:  
- cluster sampling: used in 11 cantons where no central registry of residents 
exist.  The sampling frame is a list of children born in each municipality in 
each canton. First the municipalities are selected, then the children. To 
decrease the complexities of the sampling method for the municipalities, the 
same sampling procedure will be implemented for all 3 age groups. 
- simple random sampling: used in cantons where either a central registry of 
residents exists, or in cantons with less than 35 municipalities. Since a central 
registry exists in 7 cantons the central office of registry in these cantons are 
requested to randomly selected the children for the study. In the remaining 8 
cantons, all municipalities are asked to provide a list of all children in the 
targeted age groups.  Once this list is compiled for each canton, then the 
children are selected via simple random sampling. 
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3. The target population includes: toddlers 24-35 months, 8-yr olds and 16-yr olds.  
The exact birth cohort will depend on the time of participation. 
 
4. Funding is provided by both the cantons (2/3) and the SFOPH (1/3). Final financial 
contribution depends on the amount of work the cantons can assume. 
 
All families of selected children are then invited to participate per mail, which included an 
introductory letter and a pre-paid return envelope. Families are asked to send a copy or the 
original vaccination card. Four to five weeks later a reminder is sent to all those who still have 
not responded, followed by a final telephone attempt, which included 5-6 calls at different 
hours during the week.  
 
Only vaccination information is evaluated, along with certain demographic factors as supplied 
by the municipalities or the central registries. Questionnaires are not used.  Dates of all 
administration of selected vaccinations are registered, along with the time of response. Only 
the names of Hepatitis B vaccines have been recorded due to the numerous HepB 
vaccinations and schemes available in Switzerland. For those who do not want to participate 
in the survey, reasons for nonresponse are also noted, and if possible a general vaccination 
status of the selected child (fully vaccinated, partially vaccinated). 
 
Many of the limitations from the survey 1999-2003, particularly comparability among the 3 
age groups and 26 cantons, have been eliminated in the cycle 2005-07 due to methodological 
improvements as described above. By the end of the 3-year data collection period, 25 cantons 
will have participated. Only one canton has not joined this national effort. In 2005 data were 
collected in 10 cantons (AI, AG, BL, BS, NE, SH, SO, SZ, ZH), in 2006 in 8 cantons (FR, JU, 
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LU, OW, UR, SG, TI, ZG) and in 2007 in 7 cantons (AR, GE, GL, GR, TG, VD, VS).  
Cantons BE, GE, TI and VD conducted the survey independently of ISPMZ and will share 
their database at a later time point; while the municipalities and children were sampled by 
ISPMZ, cantons BL and LU collected the data independently and have already given the data 
for analysis. The national coverage will be released in 2008.  
 
Collaboration with the cantons has been simple and easy, and most cantons have opted to 
utilize the same data collection method for all 3 age groups. Due to logistic and financial 
restrictions, 3 cantons (BS, JU, VD) will continue to collect the data for the school children 
with the aid of school / LL nurses employed through their highly organized school health 
services. Despite their organized school health infrastructure, VS has opted to adopt one 
method for all 3 age groups as recommended for comparative purposes. Data quality and 
operational cost will be calculated to compare the cost / benefits of the different 
methodologies utilized. 
 
Annexed is an article providing coverage obtained in the first year of survey cycle 2005-2007 
for 9 participating cantons [Lang et al, 2007]. In short, while comparison with data from 
1999-2003 revealed that coverage for toddlers has remained relatively unchanged at the 
national level for Di, Te, and Pol, the rise in coverage for MMR at 1 and 2 doses, Hib and Per 
at 4 doses at the national level is significant. This could be impacted by the use of combined 
vaccinations, the change from whole-cell Per to acellular Per [Kuno-Sakai and Kimura, 2004; 
Bundesamt für Gesundheit, 1996], numerous local measles outbreaks in 2003 [Bundesamt für 
Gesundheit, 2006], improved vaccination campaign by the SFOPH and increase acceptance of 
new recommendations due to a general lag time needed to allow for implementation by health 
care professionals and acceptance by the community.  
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Of the 9 cantons participating in 2005, there is a general rise in coverage in 8 cantons while in 
canton SZ there is a clear reduction. There is also a significant rise in coverage for the 
schoolchildren for all vaccinations; it could however, be a result of the different age recruited 
for the study. HepB coverage jumped to 65.3% for 1 dose, 60.8% for 2 doses and 36.8% for 3 
doses. Similar to Hib and Per, greater acceptance of HepB vaccination since its introduction 
in 1998, together with heightened knowledge of the disease and improved immunization 
campaigns in the school could be reasons for the rise in HepB coverage. Furthermore, the 
change from a 3-dose to a 2-dose scheme for HepB could have also increased acceptance 
among the adolescents, parents and healthcare professionals. 
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Questionnaire (in German, French, Italian and English) 
 
Vaccination summary forms and instructions (old and revised in 2003 for VS) 
 
A. Sampling frames for toddlers 
 
B. Sampling and data collection procedure 
 
C. Cantonal participation and distribution of responsibility 
C.1   Toddlers 
C.2   Schoolchildren 
 
D. Participation by the schoolchildren during school years 1999-2003 
D.1 In collaboration with cantonally employed school / “Lungenliga” nurses in the   
school health services 
D.2  In collaboration with school doctors in the school health services 
D.3  In collaboration with school officials and teachers 
D.4  In cantons BE, JU, NE and TI 
 
E. Demographic comparison (%) of children participating in the survey, with and without 
weights, nonresponse adjustments and poststratification 
E.1  Toddlers 
E.2  Children at school entry 
E.3  Children at school departure 
 
F. Vaccination coverage (%) of children at different DTPPolHibMMR series, with and 
without including pertussis and Hib, by canton 
F.1  For toddlers at series 33333111, 44443111, 33030111, 44040111 
F.2  For children at school entry at series 33333111, 44443111, 55553111, 55553222 
   F.2.1   Includes pertussis and Hib  
   F.2.2   Does not include pertussis and Hib 
F.3  For children at school departure at series 3333111, 4434111, 5535111, 5535222, 
        635111, 635222 DTPPolMMR 
 F.3.1   Includes pertussis 
 F.3.2   Does not include pertussis 
F.4  Vaccination coverage of children in Switzerland 24-35 months of age, at school 
    entry and school departure (by vaccine, doses and canton) 
 
G. Distribution of the number of children living in Switzerland who remain unvaccinated, 
by canton 
 
H. Vaccination coverage, with and without imputation for rubella at 1 and 2 doses, by 
canton  
H.1 For girls at school departure 
H.2 For boys at school departure 
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Instruktionen zum Ausfüllen des Impf-Statistikblattes
Impfinformationen
Bitte pro Klasse ein Blatt ausfüllen; alle Schüler sollten darauf vermerkt sein, auch wenn der Impfausweis
nicht kontrolliert wurde.
1. Nationalität:  Bitte verwenden Sie den Code unten auf dem Impfblatt:
 0: Schweiz
 1: Europa, EU-Länder, Norwegen, USA, Kanada
 2: Ost-Europa, inkl. Türkei und Ex-Yugoslawien
 3: Asien, Afrika
 4: Andere
 
2. Status des Impfausweises (IA):  Bitte den entsprechenden Code einfügen:
 1: kontrolliert: IA geprüft
 2: neuer IA: keine alten Impfdaten vorhanden
 3: IA fehlt: nicht vorhanden, siehe unten
 
3. Fehlender Impfausweis (IA): Bitte den entsprechenden Code einfügen:
 1: Impfung abgelehnt
 2: schon geimpft (z. B. beim Haus-Kinderarzt, im Spital, usw.)
 3: Kind krank
 4: IA verloren
 5: gar nicht geimpft (bei Anzahl Dosen ”0” eintragen)
 6: andere Gründe, bitte vermerken
 
4. Impfungen: Anzahl bisherige Dosen / genügend geimpft
Bitte tragen Sie die Anzahl Dosen ins linke Kästchen ein.  Falls das Kind genügend geimpft ist, das
rechte Kästchen ankreuzen.  Siehe Ausnahmen auf dem Impfstatistikblatt und Erläuterungen auf dem
Impfplan nach Richtlinien des BAG und der Schweizerische Kommission für Impffragen.  Bitte
Angaben über Hepatitis B auch bei Zweitklässlern erfassen.
Zum Beispiel: Ein Zweitklässler erhielt bisher gemäss Impfbüchlein 4 Dosen für Di/Te/Per, 5 für
Polio, 1 für Hib (nach 15 Monaten) und 1 für MMR. Dann sollten bei Di/Te/Per die Zahl “4“, bei
Polio “5“, bei Hib “1“ und bei MMR “1“ ins linke Kästchen eingetragen werden.  Rechts wird nur
Hib und Polio angekreuzt “X“.
                     Pol
       
        5     X
Ich hoffe, dass diese Erklärungen verständlich sind und Ihnen das Ausfüllen des Impfblattes erleichtern.
Bitte kontaktieren Sie ISPMZ, falls Sie Fragen haben.  Besten Dank für Ihre Mitarbeit.
Phung Lang oder Ursula Piller      email:   plang@ifspm.unizh.ch   Tel: 01 634 46 72/13
Institut für Sozial- und Präventivmedizin der Universität Zürich, Sumatrastr. 30, 8006 Zürich
¨X¨wenn das Kind genügend
geimpft ist
 Anzahl Dosen (gemäss
Impfbüchlein)
* Nationalität: 0: Schweiz; 1: Europa, EU-Länder, Norwegen, USA, Kanada; 2: Ost-Europa, inkl. Türkei, Ex-Yugoslawien; 3: Asien, Afrika; 4: Andere.
Durchimpfungsstudie - Schulen VS 2003
Impf-Statistikblatt (Wir bitten Sie, für jede Klasse ein eigenes Formular zu verwenden.)
Periode: ❏  Nov. – Dez. 02 ❏  Jan. – März 03 ❏  Apr. - Juni 03
Krankenschwester __________________________________________________
Schulhaus _________________________________ Postleitzahl _____________
Klasse: ❏  2. P ❏  2. OS
Durchschnittsalter der Schüler Total Schülerzahl in der Klasse
Anzahl kontrollierter Impfausweise (IA)
Status IA:    1. kontrolliert;     2. neuer IA;     3. IA fehlt
Fehlende (fehl.) IA:   1. Impfung abgelehnt       2. schon geimpft    3. Kind krank
4.  IA  verloren     5. gar nicht geimpft     6. Andere Gründe:  bitte angeben.
Impfungen:  Bitte Anzahl Dosen in das linke Kästchen eintragen und ein “X“ in das
rechte Kästchen schreiben, falls das Kind genügend geimpft ist.  Siehe Impfplan
unten.
Di° Te° Per/Pa Pol Hib° Mas Mum Röt HepB°
2.P 5 5 5 5 4 2 2 2 Twinrix: 2 oder 3
2.OS 6 6 5 5 - 2 2 2 Gen-H-B-Vax : 2
Engerix : 3
°Ausnahmen:
Di Te :    2.OS : 6 Dosen falls vor dem 1.Geburtstag geimpft; 5 Dosen nach dem 1.
Geburtstag ;  2.P :  5 Dosen, falls vor dem 1. Geburtstag geimpft oder 4 Dosen nach dem
1. Geburtstag (3 Dosen +1 Rappel)
Hib: 1 Dosis, falls nach 15 Monaten geimpft wurde
HepB: bei allen Kindern : 3 Dosen (oder 2 Dosen mitTwinrix für Erwachsene) ;
Jugendl. (11-18 Jährige) : 2 Dosen mit GenHb für Erwachsene od. 3 Dosen  mit Engerix
Nation- männl. Status bei fehl. Andere Gründe, IMPFUNGEN:  ANZAHL BISHERIGE DOSEN / GENÜGEND GEIMPFT
alität * weibl. IA IA bitte angeben: Di Te Per / Pa Pol Hib Mas Mum Rot HepB
1.
2.
3.
4.
5.
6.
7.
8.
9.
* Nationalität: 0: Schweiz; 1: Europa, EU-Länder, Norwegen, USA, Kanada; 2: Ost-Europa, inkl. Türkei, Ex-Yugoslawien; 3: Asien, Afrika; 4: Andere.
Ort/Datum _____________________Unterschrift und Stempel der Krankenschwester __________________________________________________
Nation- männl. Status bei fehl. Andere Gründe, IMPFUNGEN:  ANZAHL BISHERIGE DOSEN / GENüGEND GEIMPFT
alität * weibl. IA IA bitte angeben: Di Te Per / Pa Pol Hib Mas Mum Rot HepB
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
Instructions pour remplir la feuille de statistique pour les vaccinations
Informations sur les vaccinations
S.v.p. utiliser pour chaque classe une feuille. Marquer tous les enfants, même si le carnet de
vaccinations n’est pas contrôlé.
1. Nationalité:  Noter le code correspondant, s.v.p:
 0: Suisse
 1: Europe, pays EU, Norvège, USA, Canada
 2: Europe de l´Est, incl. Turquie et Ex-Yougoslavie
 3: Asie, Afrique
 4: Autres
 
2. Statut du carnet de vaccinations (CV): Noter le code correspondant, s.v.p:
 1: contrôlé: CV examiné
 2: nouveau CV: pas d’anciennes données de vaccination
 3: CV manque: pas de CV, voir en bas
 
3. Carnet de vaccinations (CV) manque: Noter le code qui correspond, s.v.p:
1 : refusé la vaccination
2 : déjà vacciné (p.ex: hôpital, médecin de famille, etc.)
3 : enfant malade
4 : CV perdu
5 : pas vacciné (inscrire le chiffre "0" sous nombre des doses)
6 : autres raisons: marquer s.v.p.
4.  Vaccinations :  Nombre de doses reçues / suffisamment vacciné
Mettre la quantité exacte dans la case de gauche.  Au cas où l’enfant est suffisamment vacciné
mettre une croix dans la case de droite. Voir exceptions sur la feuille de statistique pour les
vaccinations et les explications sur la liste de OFSP et de la Commission suisse pour les
vaccinations selon leur directive.  Mettre aussi les doses de l’ Hépatite B pour les enfants de    
2ème, s.v.p.
Exemple: pour une élève de 2ème années qui a reçu selon CV 4 doses de DTP, 5 de Polio 1 Hib
(après 15 mois) et 1 ROR, il faut inscrire le chiffre "4" dans la case de gauche Di/ Te/ Per, "5"
pour Polio, "1" pour Hib et le chiffre "1" pour Rougole, Oreillons et Rubéole. Mettre seulement
une croix "X" pour Hib et Polio dans la case de droite.
       Pol
     5      X
Nous espérons que ces explications sont claires et vous permettent de remplir la feuille de statistique
pour les vaccinations. En cas de questions, nous vous prions de contacter l'ISPMZ.  Nous vous
remercions cordialement de votre collaboration.
Phung Lang oder Ursula Piller    email: plang@ifspm.unizh.ch               Tel: 01 634 46 72/13
Institut für Sozial- und Präventivmedizin der Universität Zürich, Sumatrastr. 30, 8006 Zürich
Nombre des doses (selon
carnet de vaccination
“X” si l´enfant est vacciné
suffisamment
* Nationalité: 0: Suisse; 1: Europe, pays EU, Norvège, USA, Canada; 2: Europe de l´Est, y c. Turquie, ex-Yougoslavie; 3:  Asie, Afrique; 4: Autres.
Etude sur la couverture vaccinale - écoles VS 2003
Feuille de relevé de vaccinations (Merci de prendre pour chaque classe une nouvelle feuille)
Période: ❏  nov. – déc. 02 ❏  jan. - mars 03 ❏  avr. - juin 03
Infirmière scolaire    __________________________________________________
Ecole   ____________________________________    Code postal _____________
Classe: ❏  2P ❏  2 PCO
Age moyen en classe Nombre d‘élèves en classe
Nombre de carnets de vaccinations (CV) contrôlés
Statut CV:   1. contrôlé    2. nouveau CV      3. CV manque
CV manque: 1. refusé la vaccination     2. déjà vacciné     3. enfant malade
4. CV perdu     5. pas vacciné    6.  autres raisons, marquer s.v.p.
Vaccinations:  Mettre la quantité exacte dans la case de gauche et un “X“ dans la case de
droite, si l’élève est vacciné suffisamment, s.v.p. Voir le plan de vaccinations en-bas.
Di° Te° aPer Pol Hib° Roug Oreill Rub HépB°
2P 5 5 5 5 4 2 2 2 Twinrix: 2 ou 3
2 PCO 6 6 5 5 - 2 2 2 Gen-H-B-Vax : 2
Engerix : 3
°Exceptions:
Di Te :    2 PCO: 6 doses si la vaccination a débuté avant 1 an ou 5 doses après 1 an ;
2P:  5 doses si la vaccination a débuté avant 1 an ou 4 doses après 1 an  (3 dos. +1 rappel)
Hib: 1 dose après 15 mois
HépB: à tout âge : 3 doses (ou 2 doses de Twinrix adulte) ;
adolescent (11-18 ans) : 2 doses de GenHbvax adulte ou 3 doses de Engerix
Natio- Sexe Statut si le CV autres raisons VACCINATIONS:  NOMBRE DE DOSES REÇUES / SUFFISAMMENT VACCINE
nalité * CV manque marquer, s.v.p.: Di Te Per/ aPer Pol Hib Roug Oreill Rub HépB
1.
2.
3.
4.
5.
6.
7.
8.
9.
* Nationalité: 0: Suisse; 1: Europe, pays EU, Norvège, USA, Canada; 2: Europe de l´Est, y c. Turquie, ex-Yougoslavie; 3:  Asie, Afrique; 4: Autres.
Lieu/Date ___________________________Timbre et signature de l’ infimière ________________________________________________________
Natio- Sexe Statut si le CV autres raisons VACCINATIONS:  NOMBRE DE DOSES REÇUES / SUFFISAMMENT VACCINE
nalité * CV manque marquer s.v.p.: Di Te Per/ aPer Pol Hib Roug Oreill Rub HépB
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
Annex A. SAMPLING FRAMES FOR TODDLERS
Canton AVAILABLE SAMPLING FRAME
AG Standard list
AI Single central registry 
AR Standard list
BE Standard list
BL Standard list
BS Single central registry 
FR Standard list
GE A monthly list of all children at 28 months
GL Standard list
GR Standard list
JU Standard list
LU Standard list
NE Single central registry 
NW Standard list
OW Standard list
SG Standard list
SH Standard list
SO Standard list
SZ Standard list
TG Standard list
TI Standard list
UR Standard list
VD Single central registry 
VS Standard list
ZG Standard list
ZH Standard list
Standard list:  a list of the number of children born in a certain year in each town. 
This list can be obtained from the statistical office in every canton. A self-weighing 
sampling design has been developed for cantons with this standard list.  It has  
been used in 6 cantons in 2002 and and it is recommended to be used in the future.
For cantons with a a single central registry, random sampling was used.  
For small Cantons (AI, NW, GL, UR, OW), all children were recruited.
GE: all children who have reached 28 months of age are required to submit the 
vaccination cards to the office of the cantonal physician.  Letters are sent out
monthly,which includes about 500 children.
   
Annex B.  Sampling and Data Collection Procedure 
 
 
I. TODDLERS (24-35 months of age) 
 
1. Obtain approval from the office of data protection. 
2. Obtain a list of children born in a specific year per municipality. 
3. Select municipalities. 
4. Select children in the municipalities. 
5. Send letters to the municipalities requesting information on these children. 
6. Send letters to the parents of the selected children. 
7. One month later, send a reminder. 
8. After another month, telephone. 
9.  Return the vaccination card to the parents after information has been extracted. 
 
 
II. SCHOOLCHILDREN (School entry and departure) 
 
1. Obtain a list of all public schools and the number of classes in the one grade,  
    and if possible, the number of children in each class. 
 
2. Randomly select the classes.  
 
3. Request schooldoctors and teachers (or school nurses or school officials)  
    of these selected classes for their cooperation and supply them with the  
    questionnaires.  
  
4. Request the teachers to send the vaccination cards and completed  
    questionnaires directly to ISPMZ, or to the schooldoctors who should 
    send the information back to ISPMZ. 
 
5. Return the vaccination cards directly to the teachers or doctors once  
    copies have been made, unless otherwise specified. 
Annex C: Cantonal Participation and Distribution of Responsibility 
C.1. Toddlers
Sampling Selection Telephone Data 
KT Participation  List of Samples Mailing Reminders Entry Evaluation
AG 2000 ISPMZ ISPMZ ISPMZ ISPMZ ISPMZ ISPMZ
AI 2000 None None ISPMZ ISPMZ ISPMZ ISPMZ
AR 2002 ISPMZ ISPMZ ISPMZ ISPMZ ISPMZ ISPMZ
BE 2001 Canton Canton Canton none Canton Canton
BL 2000 ISPMZ ISPMZ ISPMZ ISPMZ ISPMZ ISPMZ
BS 2000 ISPMZ ISPMZ ISPMZ ISPMZ ISPMZ ISPMZ
FR 2001 ISPMZ ISPMZ ISPMZ ISPMZ ISPMZ ISPMZ
GE 2002 Canton Canton Canton none Canton /ISPMZ Canton /ISPMZ
GL 2001 None None ISPMZ ISPMZ ISPMZ ISPMZ
GR 2002 ISPMZ ISPMZ ISPMZ ISPMZ ISPMZ ISPMZ
JU 2002 ISPMZ ISPMZ ISPMZ ISPMZ ISPMZ ISPMZ
LU 2001 ISPMZ ISPMZ ISPMZ ISPMZ ISPMZ ISPMZ
NE 2000 ISPMZ ISPMZ ISPMZ ISPMZ ISPMZ ISPMZ
NW 2001 None None ISPMZ ISPMZ ISPMZ ISPMZ
OW 2002 None None ISPMZ ISPMZ ISPMZ ISPMZ
SG 2002 ISPMZ ISPMZ ISPMZ ISPMZ ISPMZ ISPMZ
SH 2001 ISPMZ ISPMZ ISPMZ ISPMZ ISPMZ ISPMZ
SO 2000 ISPMZ ISPMZ Canton none ISPMZ ISPMZ
SZ 2001 ISPMZ ISPMZ ISPMZ ISPMZ ISPMZ ISPMZ
TG 2000 ISPMZ ISPMZ Canton none ISPMZ ISPMZ
TI 2002 Canton Canton Canton Canton Canton ISPMZ
UR 2001 None None ISPMZ ISPMZ ISPMZ ISPMZ
VD 2003 ISPMZ ISPMZ ISPMZ ISPMZ ISPMZ ISPMZ
VS 1999 ISPMZ ISPMZ ISPMZ ISPMZ ISPMZ ISPMZ
ZG 2002 ISPMZ ISPMZ ISPMZ ISPMZ ISPMZ ISPMZ
ZH 1999 ISPMZ ISPMZ ISPMZ ISPMZ ISPMZ ISPMZ
BE, TI: conducted survey independent of ISPMZ.  
GE: Birth cohort of children 28 months of age were selected  TI: children in Kindergarten were sampled. All other cantons: 24-35 months of age.
AD.kt.workdistrib2.xls   20.2.2007  
C.2. Schoolchildren
School year Sampling Selection Data vax card or Data 
KT Participation  List of Samples Collection vax.sum.form Entry Evaluation
AG 2000-02 Canton ISPMZ Canton vax card ISPMZ ISPMZ
AI 2000-01 None None Canton vax.sum.form ISPMZ ISPMZ
AR 2001-02 ISPMZ ISPMZ Canton vax.sum.form ISPMZ ISPMZ
BE 2001-02 Canton Canton Canton Canton Canton Canton
BL 2000-01 ISPMZ ISPMZ Canton vax.sum.form ISPMZ ISPMZ
BS 2001-02 Canton ISPMZ Canton Canton Canton ISPMZ
FR 2000-01 ISPMZ ISPMZ Canton/ISPMZ vax card ISPMZ ISPMZ
GE 2001-02 Canton ISPMZ Canton vax.sum.form ISPMZ ISPMZ
GL 2000-01 None None Canton/ISPMZ vax.sum.form ISPMZ ISPMZ
GR 2001-02 Canton ISPMZ Canton/ISPMZ vax.sum.form ISPMZ ISPMZ
JU 2001-02 Canton ISPMZ Canton Canton ISPMZ ISPMZ
LU 2000-01 ISPMZ ISPMZ ISPMZ vax card ISPMZ ISPMZ
NE 2000-01 ISPMZ ISPMZ ISPMZ vax card ISPMZ ISPMZ
NW 2001-02 None None ISPMZ vax card ISPMZ ISPMZ
OW 2001-02 None None ISPMZ vax card ISPMZ ISPMZ
SG 2001-02 Canton ISPMZ Canton/ISPMZ vax card ISPMZ ISPMZ
SH 2000-01 Canton ISPMZ Canton/ISPMZ vax.sum.form ISPMZ ISPMZ
SO 2000-01 ISPMZ ISPMZ Canton vax card ISPMZ ISPMZ
SZ 2000-01 Canton ISPMZ Canton vax.sum.form ISPMZ ISPMZ
TG 2000-01 ISPMZ ISPMZ Canton vax card ISPMZ ISPMZ
TI 2002-03 Canton Canton Canton Canton Canton ISPMZ
UR 2001-02 None None Canton/ISPMZ vax.sum.form ISPMZ ISPMZ
VD 2001-03 Canton Canton Canton vax.sum.form ISPMZ Canton/ISPMZ
VS 1998-99 ISPMZ ISPMZ ISPMZ vax card ISPMZ ISPMZ
ZG 2001-02 ISPMZ ISPMZ ISPMZ vax card ISPMZ ISPMZ
ZH 1998-99 ISPMZ ISPMZ ISPMZ vax card ISPMZ ISPMZ
vax: vaccination;  vax.sum.form: vaccination summary form.  In some cantons, many school doctors used the vax.sum.form, however, we still 
needed to collect a few vax cards for the study to be completed.  
BE, TI, VD: no questionnaires were used. JU: vax. coverage not possible to be determined. AD.kt.workdistrib2.xls   20.2.2007  
Annex D.1. Participation by the schoolchildren during school years 1999-2003, in collaboration 
with cantonally employed school / "Lungenliga" nurses in the school health services
School entry AG BL BS GE SZ VD VS           Total
1.Kl 1.Kl 3.Kl 1.Kl 1.Kl 1.Kl 1.Kl School entry
n % n % n % n % n % n % n % n %
Number of classes 38 40 39 45 40 36 45 283
Number of students 600 562 617 582 714 538 560 4173
Number of participating classes 32 84.2 40 100.0 38 97.4 45 100.0 35 87.5 36 100.0 42 93.3 268 94.7
Number of vaccination cards 470 78.3 412 73.3 566 91.7 510 87.6 518 72.5 518 96.3 309 55.2 3303 79.2
Number of questionnaires 464 77.3 429 76.3 444 72.0 457 78.5 376 52.7 0 0.0 377 67.3 2547 61.0
Total response (VC or Q): 503 83.8 434 77.2 591 95.8 535 91.9 564 79.0 518 96.3 395 70.5 3540 84.8
Total nonresponse: 97 16.2 128 22.8 26 4.2 47 8.1 150 21.0 20 3.7 165 29.5 633 15.2
School departure 8.Kl 9.Kl 9.Kl 8.Kl 8.Kl 8.Kl 8.Kl School departure
n % n % n % n % n % n % n % n %
Number of classes 32 35 43 31 27 44 31 243
Number of students 580 604 746 593 675 849 429 4476
Number of participating classes 31 96.9 35 100.0 43 100.0 31 100.0 24 88.9 41 93.2 29 93.5 234 96.3
Number of vaccination cards 532 91.7 347 57.5 499 66.9 534 90.1 441 65.3 765 90.1 371 86.5 3489 77.9
Number of questionnaires 514 88.6 364 60.3 474 63.5 446 75.2 255 37.8 0 0.0 372 86.7 2425 54.2
Total response (VC or Q): 555 95.7 370 61.3 660 88.5 548 92.4 459 68.0 765 90.1 422 98.4 3779 84.4
Total nonresponse: 25 4.3 234 38.7 86 11.5 45 7.6 216 32.0 84 9.9 7 1.6 697 15.6
VC: vaccination card       Q: questionnaire
VD: questionnaire was not used.
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Annex D.2. Participation by the schoolchildren during school years 1999-2003, in 
collaboration with school doctors in the school health services
School entry AI AR GL GR SG SH UR ZH           Total
1.Kl Kg. Kg./ 1.Kl 1.Kl 1.Kl Kg. 1.Kl 1.Kl School entry
n % n % n % n % n % n % n % n % n %
Number of classes 17 34 29 40 36 33 32 39 260
Number of students 253 523 470 644 603 602 508 677 4280
Number of participating classes 15 88.2 30 100.0 24 82.8 23 57.5 28 77.8 27 81.8 19 59.4 38 97.4 204 78.5
Number of vaccination cards 204 80.6 308 58.9 254 54.0 258 40.1 260 43.1 340 56.5 261 51.4 538 79.5 2423 56.6
Number of questionnaires 171 67.6 234 44.7 263 56.0 248 38.5 267 44.3 374 62.1 225 44.3 584 86.3 2366 55.3
Total response (VC or Q): 209 82.6 324 62.0 276 58.7 273 42.4 279 46.3 379 63.0 275 54.1 592 87.4 2607 60.9
Total nonresponse: 44 17.4 199 38.0 194 41.3 371 57.6 324 53.7 223 37.0 233 45.9 85 12.6 1673 39.1
School departure 6.Kl 8.Kl 8./ 9.Kl 9.Kl 8.Kl 8.Kl 8.Kl 8.Kl School departure
n % n % n % n % n % n % n % n % n %
Number of classes 14 35 25 35 34 40 32 37 252
Number of students 192 488 381 604 599 768 464 560 4056
Number of participating classes 10 71.4 23 65.7 19 76.0 26 74.3 24 70.6 34 85.0 20 62.5 33 89.2 189 75.0
Number of vaccination cards 128 66.7 317 65.0 264 69.3 340 56.3 306 51.1 457 59.5 302 65.1 444 79.3 2558 63.1
Number of questionnaires 111 57.8 132 27.0 147 38.6 304 50.3 342 57.1 297 38.7 267 57.5 484 86.4 2084 51.4
Total response (VC or Q): 137 71.4 322 66.0 275 72.2 351 58.1 350 58.4 480 62.5 310 66.8 499 89.1 2724 67.2
Total nonresponse: 55 28.6 166 34.0 106 27.8 253 41.9 249 41.6 288 37.5 154 33.2 61 10.9 1332 32.8
VC: vaccination card       Q: questionnaire
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Annex D.3. Participation by schoolchildren during school years 1999-2003, in 
collaboration with school officials and teachers
School entry FR LU NW OW SO TG ZG           Total
1.Kl 1.Kl 2.Kl 1.Kl 1.Kl Kg. 2.Kl School entry
n % n % n % n % n % n % n % n %
Number of classes 34 40 30 27 45 40 49 265
Number of students 467 800 473 445 712 678 1150 4725
Number of participating classes 23 67.6 33 82.5 12 40.0 7 25.9 40 88.9 29 72.5 9 18.4 153 57.7
Number of vaccination cards 313 67.0 399 49.9 130 27.5 82 18.4 374 52.5 334 49.3 122 10.6 1754 37.1
Number of questionnaires 349 74.7 426 53.3 138 29.2 88 19.8 411 57.7 359 52.9 134 11.7 1905 40.3
Total response (VC or Q): 354 75.8 427 53.4 138 29.2 90 20.2 411 57.7 359 52.9 136 11.8 1915 40.5
Total nonresponse: 113 24.2 373 46.6 335 70.8 355 79.8 301 42.3 319 47.1 1014 88.2 2810 59.5
School departure 8.Kl 9.Kl 9.Kl 8.Kl 8.Kl 8.Kl 9.Kl School departure
n % n % n % n % n % n % n % n %
Number of classes 30 25 27 27 34 54 51 248
Number of students 632 500 459 491 725 1025 882 4714
Number of participating classes 23 76.7 18 72.0 8 29.6 5 18.5 27 79.4 22 40.7 8 15.7 111 44.8
Number of vaccination cards 372 58.9 254 50.8 89 19.4 61 12.4 376 51.9 365 35.6 59 6.7 1576 33.4
Number of questionnaires 390 61.7 270 54.0 93 20.3 63 12.8 414 57.1 388 37.9 76 8.6 1694 35.9
Total response (VC or Q): 394 62.3 273 54.6 94 20.5 64 13.0 415 57.2 389 38.0 76 8.6 1705 36.2
Total nonresponse: 238 37.7 227 45.4 365 79.5 427 87.0 310 42.8 636 62.0 806 91.4 3009 63.8
VC: vaccination card       Q: questionnaire
NE: same sampling procedure was used as with toddlers: simple random sampling of schoolchildren, who were directly contacted.
Total: does not include NE
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Annex D.4. Participation by schoolchildren during school years 1999-2003 in 
cantons BE, JU, NE and TI.
School entry BE JU NE TI
KG 1.Kl 1.Kl 1.Kl
n % n % n % n %
Number of classes - 45 - 45
Number of students 572 471 605 900
Number of participating classes - 35 77.8 - 42 93.3
Number of vaccination cards 512 89.5 0 0.0 371 61.3 758 84.2
Number of questionnaires 0 0.0 301 63.9 419 69.3 0 0.0
Total response (VC or Q): 512 89.5 301 63.9 421 69.6 758 84.2
Total nonresponse: 60 10.5 170 36.1 184 30.4 142 15.8
School departure 8.Kl 8.Kl 8.Kl 9.Kl
n % n % n % n %
Number of classes - 25 - 41
Number of students 543 454 600 820
Number of participating classes - 24 96.0 - 34 82.9
Number of vaccination cards 492 90.6 0 0.0 281 46.8 686 83.7
Number of questionnaires 0 0.0 416 91.6 376 62.7 0 0.0
Total response (VC or Q): 492 90.6 416 91.6 381 63.5 686 83.7
Total nonresponse: 51 9.4 38 8.4 219 36.5 134 16.3
VC: vaccination card       Q: questionnaire
BE: A.-M. Maurer. Durchimpfung bei Kleinkindern, nach Schuleintritt und -austritt im Kanton Bern 2001. BAG Bulletin 2003; 26:445-50.
JU: Vaccination coverage cannot be determined due to a misunderstanding; data collection per "Lungenliga" nurse.
BE, NE: same sampling procedure was used as with toddlers: simple random sampling of schoolchildren, who were directly contacted.
TI: Data collected by "Ufficio del medico cantonale" per school doctors in November 2002. 
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Annex E.1.  Demographic comparison (%) of toddlers participating in the survey, with and without
weights, nonresponse adjustments and poststratification, 1999-2003
Survey Swiss Federal Survey Swiss Federal Survey Swiss Federal 
w/o adjust. w/adjust. Stats.Office w/o adjust. w/adjust. Stats.Office w/o adjust. w/adjust. Stats.Office
KT Canton n Swiss Foreign. Swiss Foreign. Swiss Foreign. Male Female Male Female Male Female City Land City Land City Land
1 AG 321 90.0 10.0 72.4 27.6 72.4 27.6 47.7 52.3 51.3 48.7 51.3 48.7 63.6 36.4 57.9 42.1 57.9 42.1
2 AI 185 92.4 7.6 88.3 11.7 88.3 11.7 60.0 40.0 61.7 38.3 61.7 38.3 0.0 100.0 0.0 100.0 0.0 100.0
3 AR 270 92.6 7.4 81.0 19.0 81.0 19.0 54.1 45.9 52.0 48.0 48.0 52.0 55.9 44.1 46.9 53.1 46.9 53.1
4 BE 460 85.2 14.8 79.5 20.5 79.5 20.5 51.7 48.3 51.1 48.9 51.1 48.9 - - - - - -
5 BL 337 87.5 12.5 75.2 24.8 75.1 24.9 48.7 51.3 52.3 47.7 52.3 47.7 73.3 26.7 77.5 22.5 77.5 22.5
6 BS 291 68.4 31.6 58.4 41.6 58.4 41.6 48.1 51.9 51.5 48.5 51.5 48.5 100.0 0.0 100.0 0.0 100.0 0
7 FR 281 94.3 5.7 80.0 20.0 80.0 20.0 52.3 47.7 50.4 49.6 50.4 49.6 34.5 65.5 35.0 65.0 35.0 65.0
8 GE 702 66.5 33.5 59.0 41.0 59.0 41.0 50.3 49.7 51.2 48.8 51.2 48.8 - - - - - -
9 GL 272 86.0 14.0 76.4 23.6 76.4 23.6 51.8 48.2 53.4 46.6 53.4 46.6 0.0 100.0 0.0 100.0 0.0 100.0
10 GR 278 88.5 11.5 80.6 19.4 80.6 19.4 51.8 48.2 51.0 49.0 51.0 49.0 44.2 55.8 38.4 61.6 38.4 61.6
11 JU 237 94.1 5.9 85.2 14.8 85.2 14.8 51.5 48.5 50.2 49.8 50.2 49.8 20.3 79.7 14.9 85.1 14.8 85.2
12 LU 356 86.5 13.5 77.1 22.9 77.1 22.9 47.5 52.5 49.7 50.3 49.7 50.3 42.7 57.3 47.1 52.9 47.1 52.9
13 NE 335 85.1 14.9 71.9 28.1 71.9 28.1 55.8 44.2 50.8 49.2 50.8 49.2 60.0 40.0 71.3 28.7 71.3 28.7
14 NW 296 92.9 7.1 89.2 10.8 89.2 10.8 55.1 44.9 55.2 44.8 55.2 44.8 78.0 22.0 81.7 18.3 81.7 18.3
15 OW 240 92.1 7.9 86.2 13.8 86.2 13.8 55.8 44.2 55.3 44.7 55.2 44.8 0.0 100.0 0.0 100.0 0.0 100.0
16 SG 278 85.6 14.4 71.6 28.4 71.6 28.4 51.1 48.9 51.1 48.9 51.1 48.9 50.0 50.0 47.7 52.3 47.7 52.3
17 SH 365 81.1 18.9 69.6 30.4 69.6 30.4 55.3 44.7 53.3 46.7 46.7 53.3 64.9 35.1 71.5 28.5 71.5 28.5
18 SO 295 86.8 13.2 74.7 25.3 74.7 25.3 54.2 45.8 52.5 47.5 47.5 52.5 56.3 43.7 70.1 29.9 70.1 29.9
19 SZ 387 91.2 8.8 78.4 21.6 78.4 21.6 48.8 51.2 51.0 49.0 51.0 49.0 56.8 43.2 57.7 42.3 57.7 42.3
20 TG 235 80.0 20.0 75.1 24.9 75.1 24.9 54.5 45.5 51.6 48.4 51.6 48.4 32.3 67.7 37.7 62.3 37.7 62.3
21 TI 684 59.4 40.6 72.5 27.5 72.5 27.5 52.3 47.7 51.7 48.3 51.8 48.2 - - - - - -
22 UR 289 95.2 4.8 90.8 9.2 90.8 9.2 51.9 48.1 51.8 48.2 51.7 48.3 0.0 100.0 0.0 100.0 0.0 100.0
23 VD 382 51.6 48.4 59.3 40.7 59.3 40.7 53.9 46.1 50.7 49.3 50.7 49.3 79.8 20.2 72.8 27.2 72.8 27.2
24 VS 353 90.7 9.3 75.3 24.7 75.3 24.7 53.0 47.0 51.7 48.4 51.7 48.3 44.8 55.2 51.2 48.8 51.2 48.8
25 ZG 255 87.8 12.2 74.9 25.1 74.9 25.1 54.9 45.1 50.2 49.7 50.2 49.8 81.6 18.4 83.4 16.6 83.4 16.6
26 ZH 345 78.6 21.4 70.6 29.3 70.6 29.4 51.9 48.1 52.1 47.8 52.1 47.9 85.5 14.5 89.7 10.3 89.7 10.3
27 CH 8729 81.8 18.2 72.4 27.6 72.4 27.6 52.2 47.8 51.4 48.6 51.1 48.9 40.3 38.6 63.5 36.5 63.5 36.5
Swiss Federal Statistical Office (SFSO): Data collected for the SFSO, but shared with ISPMZ by the Statistical Office in ZH. Total compiled between 1999-2003.
BE, GE, TI: data not collected for city / land. AI, BS, GL, 0W, UR: not poststratified by city /land. CH: n for city/land: 61518.
adj.: adjustments, includes weights, nonresponse adj., poststratification. 
Annex E.2.  Demographic comparison (%) of children at school entry participating in the survey,
with and without weights, nonresponse adjustments and poststratification, 1999-2003
Survey Swiss Federal Survey Swiss Federal 
w/o adjust. w/adjust. Stats.Office w/o adjust. w/adjust. Stats.Office
KT Canton n Swiss Foreigners Swiss Foreigners Swiss Foreigners Male Female Male Female Male Female
1 AG 470 81.1 18.9 77.0 23.0 77.0 23.0 49.6 50.4 51.0 49.0 51.0 49.0
2 AI 204 91.2 8.8 90.0 10.0 90.1 9.9 49.0 51.0 50.7 49.3 51.0 49.0
3 AR 308 78.2 21.8 86.4 13.6 86.4 13.6 52.9 47.1 51.0 49.0 51.0 49.0
4 BE 512 84.4 15.6 85.8 14.2 85.8 14.2 48.0 52.0 50.6 49.4 50.6 49.4
5 BL 412 72.6 27.4 79.4 20.6 79.4 20.6 50.2 49.8 51.0 49.0 51.0 49.0
6 BS 566 52.8 47.2 59.2 40.8 59.2 40.8 52.5 47.5 49.0 51.0 49.0 51.0
7 FR 313 93.3 6.7 82.0 18.0 82.0 18.0 46.3 53.7 51.0 49.0 51.0 49.0
8 GE 511 60.9 39.1 57.0 43.0 57.0 43.0 50.5 49.3 50.9 49.1 51.0 49.0
9 GL 254 72.8 27.2 74.7 25.3 74.7 25.3 51.6 48.4 52.8 47.2 52.8 47.2
10 GR 258 87.2 12.8 88.7 11.3 88.7 11.3 49.2 50.8 50.4 49.6 50.4 49.6
11 JU 301 91.0 9.0 87.1 12.9 87.1 12.9 49.5 50.5 48.0 52.0 48.0 52.0
12 LU 399 85.0 15.0 81.5 18.5 81.5 18.5 49.9 50.1 51.2 48.8 51.2 48.8
13 NE 371 84.1 15.9 74.1 25.9 74.1 25.9 52.3 47.7 51.0 49.0 51.0 49.0
14 NW 130 86.2 13.8 90.0 10.0 90.1 9.9 55.4 44.6 51.0 49.0 51.0 49.0
15 OW 82 91.5 8.5 89.0 11.0 89.0 11.0 53.7 46.3 51.0 49.0 51.0 49.0
16 SG 260 75.8 24.2 75.0 25.0 75.0 25.0 53.5 46.5 51.4 48.6 53.1 49.0
17 SH 340 79.1 20.9 76.0 24.0 76.0 24.0 50.6 49.4 50.5 49.5 50.5 49.5
18 SO 374 81.0 19.0 76.2 23.8 76.2 23.8 46.5 53.5 50.7 49.3 50.7 49.3
19 SZ 518 78.4 21.6 79.0 21.0 79.0 21.0 50.6 49.4 49.9 50.1 49.9 50.1
20 TG 342 76.0 24.0 79.7 20.3 79.7 20.3 45.0 55.0 51.0 49.0 51.0 49.0
21 TI 793 - - - - - - - - - - - -
22 UR 248 82.7 17.3 87.4 12.6 87.4 12.6 51.2 48.8 51.0 49.0 51.0 49.0
23 VD 518 71.0 29.0 70.3 29.7 70.3 29.7 - - - - - -
24 VS 309 83.2 16.8 80.6 19.4 80.6 19.4 49.5 50.5 51.0 49.0 51.0 49.0
25 ZG 122 83.6 16.4 78.0 22.0 78.0 22.0 49.2 50.8 51.8 48.2 51.0 49.0
26 ZH 538 77.7 22.3 74.6 25.4 74.6 25.4 51.5 48.5 49.3 50.7 49.3 50.7
27 CH 8660 77.9 22.1 77.3 22.7 77.1 22.9 50.2 49.8 50.6 49.4 50.5 49.5
Swiss Federal Statistical Office (SFSO): Figures provided by SFSO and cantonal offices of statistics. Total compiled for period between 1999-2003.
TI: poststratification not done, only nonresponse adjustment made; not included in totals. VD: not poststratified by sex. Hence, CH: n for sex: 8141
adj.: adjustments, includes weights, nonresponse adj., poststratification. 
Annex E.3.  Demographic comparison (%) of children at school departure participating in the survey,
with and without weights, nonresponse adjustments and poststratification, 1999-2003
Survey Swiss Federal Survey Swiss Federal 
w/o adjust. w/adjust. Stats.Office w/o adjust. w/adjust. Stats.Office
KT Canton n Swiss Foreigners Swiss Foreigners Swiss Foreigners Male Female Male Female Male Female
1 AG 532 79.9 20.1 77.0 23.0 77.0 23.0 50.8 49.2 51.0 49.0 51.0 49.0
2 AI 128 95.3 4.7 90.1 9.9 90.1 9.9 53.9 46.1 51.1 48.9 51.0 49.0
3 AR 317 89.3 10.7 86.4 13.6 86.4 13.6 48.3 51.7 51.0 49.0 51.0 49.0
4 BE 492 88.4 11.6 85.8 14.2 85.8 14.2 53.5 46.5 49.6 50.4 49.6 50.4
5 BL 347 81.3 18.7 79.4 20.6 79.4 20.6 47.0 53.0 51.0 49.0 51.0 49.0
6 BS 499 62.3 37.7 64.0 36.0 64.0 36.0 51.1 48.9 49.0 51.0 49.0 51.0
7 FR 372 84.9 15.1 82.0 18.0 82.0 18.0 52.4 47.6 51.0 49.0 51.0 49.0
8 GE 534 63.9 36.1 57.9 42.1 58.0 42.0 48.9 51.1 51.1 48.9 51.0 49.0
9 GL 264 69.7 30.3 74.0 26.0 74.0 26.0 50.8 49.2 51.2 48.8 51.2 48.8
10 GR 340 86.8 13.2 91.2 8.8 91.3 8.8 45.9 54.1 50.6 49.4 50.6 49.4
11 JU 416 90.4 9.6 87.1 12.9 87.1 12.9 46.9 53.1 48.1 51.9 48.1 51.9
12 LU 254 86.6 13.4 80.5 19.5 80.5 19.5 51.2 48.8 51.2 48.8 51.2 48.8
13 NE 281 86.1 13.9 77.7 22.3 77.7 22.3 49.1 50.9 51.0 49.0 51.0 49.0
14 NW 89 87.6 12.4 90.6 9.4 90.6 9.4 39.3 60.7 48.8 51.2 48.8 51.2
15 OW 61 96.7 3.3 88.9 11.1 88.8 11.2 55.7 44.3 50.5 49.5 50.9 49.1
16 SG 306 71.2 28.8 75.0 25.0 75.0 25.0 52.6 47.4 51.0 49.0 51.0 49.0
17 SH 457 73.3 26.7 77.5 22.5 77.5 22.5 48.1 51.9 50.9 49.1 50.9 49.1
18 SO 375 88.3 11.7 77.8 22.2 77.8 22.2 49.9 50.1 51.2 48.8 51.0 49.0
19 SZ 441 85.5 14.5 85.9 14.1 85.9 14.1 53.3 46.7 50.5 49.5 50.5 49.5
20 TG 365 82.5 17.5 79.7 20.3 79.7 20.3 52.3 47.7 51.0 49.0 51.0 49.0
21 TI 686 - - - - - - - - - - - -
22 UR 302 88.1 11.9 89.9 10.1 89.9 10.1 51.0 49.0 51.1 48.9 51.1 48.9
23 VD 765 74.1 25.9 73.4 26.6 73.4 26.6 - - - - - -
24 VS 371 82.2 17.8 80.6 19.4 80.6 19.4 45.0 55.0 51.0 49.0 51.0 49.0
25 ZG 59 91.5 8.5 78.0 22.0 78.0 22.0 50.8 49.2 51.0 49.0 51.0 49.0
26 ZH 444 74.3 25.7 74.6 25.4 74.6 25.4 51.4 48.6 50.2 49.8 50.2 49.8
27 CH 8277 80.0 20.0 77.6 22.4 77.4 22.6 50.0 50.0 50.6 49.4 50.6 49.4
Swiss Federal Statistical Office (SFSO): Figures provided by SFSO and cantonal offices of statistics. Total compiled for period between 1999-2003.
TI: poststratification not done, only nonresponse adjustment made; not included in totals. VD: not poststratified by sex. Hence, CH: n for sex: 8046
adj.: adjustments, includes weights, nonresponse adj., poststratification. 
Annex F.1.  Vaccination coverage of children 24-35 months at different DTPPolHibMMR  
series with and without including pertussis and Hib, 1999-2003 
33333111 44443111 33030111 44040111
KT Canton n % 95% CI % 95% CI n % 95% CI % 95% CI
1 AG 321 74.8 69.5, 80.1 66.6 60.4, 72.7 321 77.8 72.6, 83.1 69.3 63.2, 75.4
2 AI 185 66.7 62.6, 70.9 52.8 46.5, 59.2 185 69.8 65.7, 73.9 56.4 49.9, 62.8
3 AR 270 66.4 60.1, 72.8 61.6 54.9, 68.2 270 66.4 60.1, 72.8 61.6 54.9, 68.2
4 BE 460 76.8 72.8, 80.9 71.3 67.0, 75.5 460 77.4 73.4, 81.5 72.7 68.3, 77.1
5 BL 337 68.6 63.2, 74.0 58.7 53.6, 63.8 337 73.0 68.8, 77.2 63.1 58.3, 67.9
6 BS 291 68.1 62.4, 73.9 59.7 58.0, 61.4 291 71.6 65.6, 77.7 62.1 60.1, 64.1
7 FR 281 82.8 77.5, 88.2 75.2 69.6, 80.8 281 84.3 79.3, 82.3 75.5 69.8, 81.1
8 GE 702 87.4 85.3, 89.5 82.7 80.2, 85.2 702 89.2 87.1, 91.3 85.0 82.6, 87.4
9 GL 272 76.3 70.6, 81.9 71.5 65.9, 77.0 272 77.2 71.8, 82.7 73.1 67.9, 78.3
10 GR 278 74.2 69.6, 78.9 69.2 64.2, 74.1 278 75.6 70.9, 80.2 69.8 64.9, 74.8
11 JU 237 81.7 75.4, 88.1 77.0 71.4, 82.6 237 82.5 75.3, 89.6 77.7 71.7, 83,7
12 LU 356 67.0 60.4, 73.7 59.9 53.9, 66.0 356 68.5 62.3, 74.7 62.4 56.4, 68.4
13 NE 335 82.4 77.4, 87.4 76.1 70.3, 82.0 334 86.6 82.3, 90.9 80.3 75.5, 85.2
14 NW 296 75.0 67.7, 82.4 68.1 60.5, 75.7 296 75.3 68.0, 82.6 68.1 60.5, 75.6
15 OW 240 71.7 67.4, 76.0 66.0 61.2, 70.7 240 73.3 69.2, 77.3 67.5 62.2, 72.8
16 SG 278 73.8 67.7, 79.8 69.2 62.7, 75.7 278 75.0 69.2, 80.7 71.1 65.0, 77.3
17 SH 365 49.4 45.1, 53.7 30.9 22.9, 39.4 365 51.0 46.9, 55.1 41.4 37.4, 45.4
18 SO 295 77.8 71.6, 84.0 69.2 62.1, 76.3 295 79.0 72.8, 85.1 70.3 63.2, 77.4
19 SZ 387 78.4 73.4, 83.4 68.4 62.4, 74.4 387 78.6 73.6, 83.6 69.3 63.5, 75.1
20 TG 235 77.4 70.5, 84.2 65.6 57.4, 73.7 235 79.8 73.3, 86.2 68.5 61.0, 76.0
21 TI 683 90.7 88.6, 92.8 84.9 81.8, 88.1 684 92.4 90.5, 94.3 87.1 84.1, 90.1
22 UR 289 79.5 74.5, 84.6 74.6 70.5, 78.7 289 81.2 76.6, 85.8 75.6 71.6, 79.5
23 VD 382 86.3 83.1, 89.5 78.9   74.9, 82.9 382 87.4 84.4, 90.4 79.6 75.8, 83.4
24 VS 353 89.6 86.4, 92.7 77.5 71.9, 83.1 346 91.6 88.6, 94.6 82.3 77.5, 87.1
25 ZG 255 76.9 72.2, 81.6 72.7 68.7, 76.6 255 76.9 72.2, 81.6 72.7 68.7, 76.6
26 ZH 345 77.5 73.4, 81.6 69.1 63.3, 74.9 345 79.7 75.4, 84.0 73.6 67.5, 79.7
27 CH 8716 78.0 76.5, 79.5 70.6  68.8, 72.4 8721 79.8 78.3, 81.2 73.0 71.3, 74.8
CI: confidence interval
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Annex F.2.1.    Vaccination coverage of children at school entry at different 
DTPPolHibMMR series, including pertussis and Hib, 1999-2003
33333111 44443111  55553111  55553222
KT Canton Kl. n % 95% CI % 95% CI % 95% CI % 95% CI
1 AG 1 469 69.4 64.8, 74.1 64.1 58.9, 69.3 21.0 14.1, 27.9 19.6 13.0, 26.1
2 AI 1 191 69.6 61.2, 78.0 53.2 36.0, 70.6 48.6 29.2, 68.0 0.5 -0.5, 1.5
3 AR KG/ 1 308 78.1 70.5, 85.7 72.3 63.7, 80.9 47.0 32.3, 61.8 42.2  27.2, 57.1
4 BE KG 512 58.8 54.5, 63.1 38.0 33.9, 42.0 3.2 1.6, 4.8 2.3 1.0, 3.5
5 BL 1 412 67.6 62.4, 72.8 35.5 31.1, 39.9 6.2 3.9, 8.6 2.0  0.3, 3.8
6 BS 3 531 61.9 56.6, 67.2 29.2 25.0, 33.4 3.9 2.2, 5.5 2.8 1.6, 4.1
7 FR 1 313 62.8 52.8, 72.8 25.9 17.7, 34.2 2.5 1.1, 3.8 1.4 0.3, 2.5
8 GE 1 508 76.6 71.6, 81.6 70.5 65.2, 75.8 16.2 11.9, 20.6 12.7 8.5, 16.9
9 GL KG/ 1 250 76.8 70.0, 83.6 53.6 41.9, 65.3 20.3 7.5, 33.0 18.7  6.4, 30.9
10 GR 1 258 84.9 77.0, 92.7 70.6 54.8, 86.5 47.6 32.9, 62.3 31.1 16.2, 46.0
11 JU 1 - - - - - - - - -
12 LU 1 399 64.3 59.5, 69,0 46.0 39.8, 52.3 10.9 7.8, 14.0 7.2 5.0, 9.3
13 NE 1 371 65.2 61.1, 69.3 56.9 52.0, 61.9 15.4 12.1, 18.7 11.0 7.3, 14.6
14 NW 2 130 76.3 70.3, 82.3 57.5 44.0, 71.1 19.2 8.0, 30.4 16.8 5.6, 28.1
15 OW 1 82 57.3 32.6, 82.0 27.1 16.2, 38.0 13.6 4.1, 23.0 9.8 1.3, 18.4
16 SG KG 260 81.4   76.2, 86.6 76.8 70.8, 84.7 26.8 14.2, 39.3 21.1 10.1, 32.2
17 SH KG 340 56.7 49.7, 63.7 25.1 16.4, 33.7 5.1 -0.8, 11.0 3.1 -1.0, 7.2
18 SO 1 374 66.6 62.3, 70.9 31.8 26.8, 36.8 5.6 3.3, 7.8 4.0 2.1, 5.8
19 SZ 1 518 71.6 66.9, 76.3 61.7 56.9, 66.6 27.5 21.6, 33.4 25.0 19.8, 30.1
20 TG KG 334 78.3 74,0, 82.5 28.4 22.6, 34.1 0.9 -0.6, 1.8 0.6 -0.2, 1.3
21 TI 1 787 86.5 83.4, 89.7 83.9 80.5, 87.2 42.1 36.6, 47.5 30.9 24.9, 36.9
22 UR KG 248 76.9 70.6, 83,1 69.6 62.7, 76.6 19.3 6.5, 32.1 12.7 2.4, 22.9
23 VD 1 517 79.0 74.4, 83.6 75.0 68.5, 81.4 51.8 43.3, 60.2 13.7 9.6, 17.9
24 VS 1 309 68.7 64.1, 73.3 32.3 22.9, 41.7 2.5 0.3, 4.8 0.6 -0.2, 1.5
25 ZG 2 121 67.7 57.3, 78.0 39.1 28.4, 49.9 5.7 0.6, 10.8 3.3 -1.6, 8.3
26 ZH 1 538 61.4 56.0, 66.7 27.0 22.4, 31.6 3.6 1.7, 5.5 2.1  0.8, 3.4
27 CH 9080 69.2 67.7, 70.6 49.2 47.5, 50.9 16.0 14.4, 17.5 9.9 8.7, 11.1
CI: confidence interval
JU: not included since vaccination cards were not collected
T6/AG.vaxcov.series.xls   G.2.1 school entry w Per Hib  20.2.2007
Annex F.2.2.    Vaccination coverage of children at school entry at different 
DTPPolHibMMR series, without including pertussis and Hib, 1999-2003
33030111 44040111  55050111  55050222
KT Canton Kl. n % 95% CI % 95% CI % 95% CI % 95% CI
1 AG 1 469 83.4 79.4, 87.4 82.0 77.9, 86.1 68.8 63.4, 74.1 59.5 53.8, 65.4
2 AI 1 204 80.8 74.4, 87.2 74.5 66.2, 82.8 57.3 43.5, 71.2 3.0 0.3, 5.8
3 AR KG/ 1 308 86.9 81.4, 92.4 83.8 77.6, 89.9 53.1 38.7, 67.6 44.3 29.0, 59.6
4 BE KG 512 77.1 72.9, 81.3 74.9 70.4, 79.3 59.6 54.8, 64.4 22.6 19.0, 26.2
5 BL 1 412 81.8 76.9, 86.7 77.3 71.8, 82.9 50.4 45.3, 55.4 33.0 26.9, 39.1
6 BS 3 555 85.0 80.9, 89.1 78.0 73.7, 82.2 58.1 53.6, 62.7 46.4 40.9, 51.9
7 FR 1 313 77.6 69.6, 85.7 74.0 65.4, 82.6 52.2 43.3, 61.1 7.3 3.2, 11.4
8 GE 1 508 88.1 84.4, 91.8 81.2 76.5, 85.9 17.7 13.0, 22.4 13.7 9.2, 18.3
9 GL KG/ 1 250 86.4 81.8, 91.0 84.1 79.0, 89.1 60.4 50.0, 70.8 54.2 45.1, 63.4
10 GR 1 258 89.8 83.9, 95.7 87.2 80.5, 93.9 66.9 57.2, 76.6 40.7 26.5, 54.8
11 JU 1 - - - - - - - - -
12 LU 1 399 84.9 81.1, 88.8 81.7 77.1, 86.2 50.0 44.2, 55.9 36.8 31.5, 42.2
13 NE 1 371 89.7 87.6, 91.9 87.9  85.2, 90.5 67.7 61.8, 73.7 48.4 39.7, 57.1
14 NW 2 130 89.6 87.5, 91.7 87.2 84.1, 90.2 68.9 59.5, 78.2 53.5 45.8, 61.1
15 OW 1 82 88.6 81.3, 95.9 87.5 80.0, 94.9 62.7 55.4, 69.9 42.2 27.9, 56.6
16 SG KG 260 86.1 82.2, 89.9 81.4 76.0, 86.8 29.5 15.9, 43.1 23.5 11.5, 35.4
17 SH KG 340 61.6 54.7, 68.5 54.0 46.9, 61.2 8.6 2.8, 14.4 3.1 -1.0, 7.2
18 SO 1 374 84.0 80.3, 87.7 81.3 77.3, 85.2 33.5 26.7, 40.3 24.4 18.3, 30.4
19 SZ 1 518 87.7 85.0, 90.4 86.1 83.0, 89.3 66.9 61.5, 72.6 60.3 54.2, 66.4
20 TG KG 334 86.1 81.8, 90.4 81.8 76.3, 87.2 16.4 10.3, 22.5 10.8 6.5, 15.2
21 TI 1 789 92.4 89.9, 94.9 90.0 87.3, 92.7 45.4 39.8, 50.9 32.7 26.5, 38.9
22 UR KG 248 85.0 79.2, 90.9 80.4 74.4, 86.3 23.0 8.6, 37.3 14.3 3.3, 25.3
23 VD 1 518 91.1 88.8, 93.5 90.0 87.6, 92.4 74.3 70.1, 78.5 19.5 13.8, 25.2
24 VS 1 309 89.0 85.7, 92.3 85.1 81.3, 88.9 47.2 38.8, 55.7 11.7 7.6,  15.7
25 ZG 2 122 80.9 72.8, 89.1 75.2 65.2, 85.1 57.4 48.6, 66.1 48.0 36.6, 59.4
26 ZH 1 538 85.6 81.8, 89.3 83.3 79.6, 87.1 60.6 54.3, 66.8 29.8 23.7, 35.8
27 CH 9121 84.8 83.6, 85.9 81.7 80.5, 83.0 52.6 50.8, 54.5 29.6 27.8, 31.4
CI: confidence interval
JU: not included since vaccination cards were not collected
T6/AG.vaxcov.series.xls  G.2.2 school entry wo Per.Hib   20.2.2007 
Annex F.3.1.   Vaccination coverage of children at school departure at different DTPPolMMR  
series including pertussis, 1999-2003 
3333111 4434111 5535111 5535222 6635111 6635222
KT Canton Kl. n % 95% CI % 95% CI % 95% CI % 95% CI % 95% CI % 95% CI
1 AG 8 530 77.4 72.7, 82.0 77.0 72.4, 81.6 74.9 70.5, 79.3 61.8 57.3, 66.3 62.7 57.9, 67.5 54.9 50.0, 59.8
2 AI 6 128 90.0 83.8, 96.2 82.4 73.0, 91.8 50.8 36.3, 65.2 24.1 1.4, 46.7 12.9  -10.3, 36.1 11.9  -11.6, 35.3
3 AR 8 317 81.8 76.7, 86.9 79.9 74.3, 85.4 66.5 57.0, 76.0 48.1 38.4, 57.8 45.6 36.9, 54.3 36.9 28.9, 45.0
4 BE 8 492 70.3 64.9, 75.7 70.1 64.6, 75.5 66.7      61.1, 72.4   35.0 30.7, 39.4 51.4 45.3, 57.5 29.8 25.4, 34.3
5 BL 9 347 77.7 71.4, 83.9 75.5 69.3, 81.8 65.8 59.3, 72.2 29.3 24.5, 34.0 42.3 37.0, 48.7 22.9 18.6, 27.1
6 BS 9 487 75.6 69.7, 81.6 75.2 69.1, 81.3 69.4 63.4, 75.4 57.2 51.4, 63.1 55.4 49.3, 61.4 48.1 42.3, 54.0
7 FR 8 371 71.2 66.8, 75.6 69.8 65.5, 74.2 61.3 55.4, 67.3 43.3 36.0, 50.7 38.1 30.2, 46.0 27.9 20.6, 35.2
8 GE 8 534 81.8 77.5, 86.0 81.0 76.8, 85.1 73.0 67.7, 78.3 49.9 44.8, 54.9 48.4 43.5, 53.3 39.8 35.3, 44.3
9 GL 8 / 9 263 85.8 81.4, 90.3 84.8 80.1, 89.5 76.7 69.4, 83.9 64.8 54.8, 78.9 50.3 33.2, 67.4 46.0 29.6, 62.4
10 GR 9 340 88.3 84.2, 92.4 87.3 82.5, 92.0 74.7 65.6, 83.8 42.3 31.4, 53.1 41.1 29.9, 52.3 29.1 19.8, 38.3
11 JU 8 - - - - - - - - - - - - -
12 LU 9 254 66.4 57.6, 75.3 65.5 57.0, 74.0 57.8 47.3, 68.2 33.9 22.6, 45.2 38.5 28.4, 48.6 24.9 15.2, 34.6
13 NE 8 279 77.8 73.6, 81.9 76.2 72.3, 80.1 68.8 63.8, 73.9 32.1 25.3, 38.9 27.9 23.3, 32.5 17.2 12.6, 21.8
14 NW 9 89 86.4 79.5, 93.3 85.4 79.0, 91.8 59.1 50.0, 68.2 48.9 42.7, 55.1 53.8 43.2, 64.3 45.5 37.4, 53.6
15 OW 8 61 37.5 20.7, 54.2 37.5 20.7, 54.2 30.7 16.8, 44.6 6.1 2.5, 9.8 17.2 8.4, 26.0 6.1 2.5, 9.8
16 SG 8 296 80.5 74.2, 86.7 79.8 73.5, 86.0 72.2 65.9, 78.5 38.7 26.3, 51.1 38.5 26.8, 50.2 24.3 13.7, 34.9
17 SH 8 456 70.1 61.7, 78.4 68.7 60.5, 76.9 57.8 50.2, 65.3 34.9 27.0, 42.8 20.5 13.6, 27.3 13.8 7.6, 19.9
18 SO 8 374 81.3 74.9, 87.7 80.4 74.3, 86.5 69.5 63.0, 76.0 19.7 14.4, 25.1 19.2 13.5, 24.9 10.7 6.4, 15.0
19 SZ 8 441 93.1 89.8, 96.3 92.8 89.7, 96.0 89.6 85.9, 93.3 77.8 73.2, 82.5 76.9 72.1, 81.8 72.6 67.5, 77.7
20 TG 8 365 71.6 64.9, 78.2 70.4 63.5, 77.3 60.5 53.8, 67.3 22.8 17.2, 28.4 35.2 26.8, 43.5 14.8 9.7, 19.9
21 TI 9 681 78.2 74.6, 81.7 78.0 74.5, 81.6 70.1 65.9, 74.2 45.7 41.6, 49.8 45.7 41.9, 49.5 36.4 32.7, 40.2
22 UR 8 302 91.0 87.0, 95.1 89.5 85.1, 93.8 83.4 77.6, 89.2 69.8 64.8, 74.9 20.2 6.7, 33.7 16.8 6.7, 26.9
23 VD 8 765 82.0 78.6, 85.4 81.2 77.8, 84.6 78.7 75.2, 82.1 65.7 61.6, 69.7 64.4 60.1, 68.8 56.8 52.4, 61.2
24 VS 8 371 73.3 68.3, 78.3 69.3 64.1, 74.5 47.6 40.3, 54.9 13.6 8.6, 18.6 13.9 8.0, 19.9 3.5 0.8, 6.3
25 ZG 9 59 89.5 82.3, 96.8 89.5 82.3, 96.8 86.5 76.4, 96.7 66.6 54.6, 78.5 66.6 48.5, 84.6 53.6 37.4, 69.8
26 ZH 8 442 74.0 67.7, 80.3 73.4 67.1, 79.7 63.0 56.5, 69.4 25.8 18.9, 32.7 39.2 31.8, 46.5 20.3 13.9, 26.8
CH 9044 76.5 74.9, 78.0 75.6 74.0, 77.1 68.0 66.3, 69.6 40.9 39.0, 42.8 44.9 42.9, 47.0 31.9 30.1, 33.7
CI: confidence interval
JU: not included since vaccination cards were not collected
T6/AG.vaxcov.series.xls     G.3.1 school exit w Per   20.2.2007
Annex F.3.2.   Vaccination coverage of children at school departure at different DTPPolMMR  
series without including pertussis, 1999-2003 
3303111 4404111 5505111 5505222 6605111 6605222
KT Canton Kl. n % 95% CI % 95% CI % 95% CI % 95% CI % 95% CI % 95% CI
1 AG 8 530 85.5 81.3, 89.7 83.9 79.4, 88.4 81.0 76.7, 85.4 66.5 61.9, 71.1 67.9 62.7, 73.0 59.0 53.8, 64.2
2 AI 6 128 95.3 91.7, 98.8 88.7 81.9, 95.4 63.9 48.5, 79.3 18.8 0.7, 37.0 17.4  -2.9, 37.7 9.3 - 8.9, 27.4
3 AR 8 317 85.5 81.1, 89.9 82.0 76.9, 87.1 67.4 58.0, 76.8 48.4 38.7, 58.1 46.2 37.5, 54.8 36.9 28.8, 45.0
4 BE 8 492 74.1 69.5, 78.7 73.2 68.2, 78.2 67.9 62.5, 73.3 35.2 30.9, 39.6 51.8 45.5, 58.1 29.8 25.4, 34.3
5 BL 9 347 84.8 78.5, 91.2 81.4 75.2, 87.6 70.4 63.9, 76.9 30.6 25.8, 35.5 45.2 39.5, 50.9 24.0 19.8, 28.1
6 BS 9 487 84.4 80.7, 88.1 77.8 73.3, 82.4 68.4 63.5, 73.3 56.8 51.8, 61.9 52.8 46.8, 58.7 45.5 40.0, 51.0
7 FR 8 371 81.4 76.9, 85.8 78.9 74.7, 83.2 67.6 62.8, 72.5 48.3 40.7, 55.9 40.7 33.3, 48.2 30.0 22.6, 37.4
8 GE 8 534 85.7 81.4, 90.0 83.8 79.5, 88.1 75.0 69.8, 80.2 51.0 45.9, 56.1 49.1 44.2, 54.0 40.3 35.9, 44.8
9 GL 8 / 9 263 90.9 87.6, 94.2 88.8 85.6, 92.1 78.6 72.0, 85.2 66.5 56.5, 76.5 51.5 35.2, 67.8 47.3 31.6, 63.0
10 GR 9 340 89.7 85.8, 93.5 88.4 83.9, 92.8 75.4 66.8, 84.0 41.1 30.3, 52.0 43.4 32.6, 54.3 28.3 19.4, 37.2
11 JU 8 - - - - - - - - - - - - -
12 LU 9 254 86.0 78.4, 93.6 83.2 75.7, 90.7 73.8 65.4, 82.2 42.4 31.8, 53.0 49.1 39.0, 59.2 31.5 22.1, 41.0
13 NE 8 279 79.6 75.7, 83.6 77.4 73.5, 81.4 68.8 63.8, 73.9 32.1 25.3, 38.9 27.9 23.3, 32.5 17.2 12.6, 21.8
14 NW 9 89 91.8 86.7, 96.9 90.8 85.8, 95.8 63.1 52.0, 74.1 52.8 44.8, 60.9 56.7 43.8, 69.6 48.4 38.0, 58.8
15 OW 8 61 84.7 69.4, 99.9 81.6 66.0, 97.2 55.2 47.0, 63.5 9.2 3.3, 15.1 21.5 14.0, 29.0 9.2 3.3, 15.1
16 SG 8 296 86.0 81.2, 90.9 84.2 78.9, 89.4 74.5 68.6, 80.3 40.8 28.3, 53.3 39.6 28.4, 50.8 25.5 15.2, 35.8
17 SH 8 456 74.1 66.4, 81.8 70.7 63.3, 78.2 59.0 52.1, 66.0 35.9 28.1, 43.6 20.6 13.6, 27.5 13.9 7.6, 20.2
18 SO 8 374 87.4 82.2, 92.5 85.9 80,9, 91.0 73.4 67.2, 79.5 20.2 15.0, 25.5 19.9 14.1, 25.7 10.7   6.4, 15.0
19 SZ 8 441 95.1 92.5, 97.6 94.2 91.6, 96.8 90.5 87.2, 93.9 78.5 73.9, 83.1 77.4 72.6, 82.1 73.1 68.0, 78.1
20 TG 8 365 81.4 76.0, 86.9 77.9 71.7, 84.0 65.6 58.6, 72.7 25.4 19,1, 31.7 37.8 29.0, 46.5 16.6 11.4, 21.9
21 TI 9 681 87.2 85.0, 89.4 86.3 84.0, 88.7 75.9 72.6, 79.2 48.2 44.3, 52.1 48.5 44.7, 52.2 38.5 34.7, 42.2
22 UR 8 302 94.7 91.3, 98.1 92.4 88.8, 96.1 84.1 78.7, 89.4 70.5 65.5, 75.5 20.5 7.0, 34.1 17.1 6.9, 27.3
23 VD 8 765 90.6 88.5, 92.6 88.4 86.2, 90.7 83.2 80.0, 86.3 69.0 65.1, 72.8 66.9 62.5, 71.4 58.9 54.4, 63.3
24 VS 8 371 78.3 73.5, 83.0 72.1 66.5, 77.7 49.1 41.3, 56.9 14.3 9.3, 19,3 14.2 8.1, 20.2 3.8 0.7, 6.8
25 ZG 9 59 91.0 83.7, 98.3 91.0 83.7, 98.3 88.0 78.3, 97.7 68.1 55.3, 80.8 66.6 48.5, 84.6 53.6 37.4, 69.9
26 ZH 8 442 83.8 78.9, 88.8 80.0 74.6, 85.4 66.8 60.0, 73.6 27.9 20,4, 35.5 41.3 33.7, 48.9 21.4 14.6, 28.1
27 CH 9044 84.2 82.9, 85.4 81.7 80.4, 83.1 72.1 70.5, 73.7 43.2 41.2, 45.2 47.2 45.1, 49.2 33.3 31.5, 35.2
CI: confidence interval
JU: not included since vaccination cards were not collected
T6/AG.vaxcov.series.xls     G.3.2school exit wo Per     21.2.2007   
Annex F.4  Vaccination coverage of children in Switzerland  24-35 
months of age, at school entry and school departure, 1999-2003 
Diphtheria
24-35 months School entry School departure
n ≥3 D. ≥4 D. Kl. n ≥3 D. ≥4 D. ≥5 D. Kl. n ≥4 D. ≥5 D. ≥6 D.
AG 321 95.0 83.1 1 470 96.7 94.3 78.7 8 531 89.1 87.4 71.8
AI 185 90.9 66.8 1 204 98.0 83.2 59.2 6 128 93.3 68.9 17.4
AR 270 91.1 78.7 KG/ 1 308 98.4 93.7 58.9 8 317 90.3 77.2 51.5
BE 460 95.2 84.2 KG 512 96.4 92.4 71.6 8 492 94.3 87.4 64.5
BL 337 95.4 78.2 1 412 95.8 90.9 62.7 9 347 88.5 78.6 47.7
BS 291 94.7 78.7 3 564 96.8 87.5 71.2 9 490 85.1 78.3 56.6
FR 281 98.2 83.5 1 313 94.1 87.4 64.4 8 372 91.0 79.5 45.3
GE 702 97.9 89.8 1 508 97.0 88.7 19.2 8 534 91.3 83.8 53.1
GL 272 95.1 86.2 KG/ 1 254 96.1 92.3 68.9 8 / 9 263 91.1 82.9 52.6
GR 278 94.7 82.5 1 258 98.4 95.4 73.2 9 340 95.9 84.7 46.9
JU 237 95.8 90.4 1 301 - - - 8 416 - - -
LU 356 90.4 76.2 1 399 97.6 92.4 57.5 9 254 89.8 82.8 53.1
NE 335 96.7 87.9 1 371 97.5 95.6 74.9 8 279 92.3 80.3 29.2
NW 296 92.2 82.2 2 130 97.9 95.0 80.9 9 89 93.5 87.9 72.8
OW 240 88.7 78.8 1 82 97.6 94.7 74.1 8 61 88.3 65.1 27.0
SG 278 93.6 83.8 KG 260 97.7 90.2 33.4 8 300 88.5 79.8 42.9
SH 365 95.4 79.0 KG 340 98.3 86.9 14.6 8 456 83.2 73.1 24.6
SO 295 97.1 82.4 1 374 98.1 92.9 39.2 8 374 88.5 80.8 21.2
SZ 387 93.0 79.4 1 518 94.7 92.1 72.5 8 441 95.4 94.0 78.8
TG 235 95.7 84.1 KG 334 98.0 92.3 19.8 8 365 87.1 76.5 40.3
TI 684 98.5 92.4 1 793 98.2 95.2 50.2 9 682 94.3 84.0 50.6
UR 289 96.4 87.1 KG 248 97.3 93.6 25.8 8 302 95.7 89.4 21.9
VD 382 97.8 84.9 1 518 98.8 95.5 78.4 8 765 94.8 90.6 70.2
VS 353 96.2 88.2 1 309 95.5 89.9 51.3 8 371 81.6 56.3 15.8
ZG 255 92.9 82.2 2 122 95.9 91.3 73.5 9 59 92.5 88.0 66.6
ZH 345 95.1 82.7 1 538 97.2 93.7 66.9 8 444 87.3 77.0 44.5
CH 8729 95.4 83.6 9139 97.1 92.5 60.0 9056 90.2 81.6 51.4
CH 98 403 94.3 71.7 BAG. BAG Bulletin 1999; Nr. 20: 356-361.
CH 91 402 95.0 71.1 Minder C, Steffen R. BAG Bulletin 1992; Nr. 32: 504-507.
BE: A.-M. Maurer. Durchimpfung bei Kleinkindern, nach Schuleintritt und -austritt im Kanton Bern 2001. BAG Bulletin 2003; 26:445-50.
BE, NE: for all 3 age groups, data were collected via municipals and then directly from the parents.
JU: due to misunderstandings, coverage by doses cannot be determined for schoolchildren.
TI: Data collected by Ufficio del medico cantonale. Instead of 24-35 months of age, data was collected from the children in 
kindergarten.
Because information on some vaccination cards are incomplete, the sample size may vary by vaccines for some cantons.
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Annex F.4 Vaccination coverage of children in Switzerland 24-35 
months of age, at school entry and school departure, 1999-2003 
Tetanus
24-35 months School entry School departure
n ≥3 D. ≥4 D. Kl. n ≥3 D. ≥4 D. ≥5 D. Kl. n ≥4 D. ≥5 D. ≥6 D.
AG 321 95.5 82.9 1 470 96.7 94.3 78.7 8 531 89.1 87.4 72.0
AI 185 92.4 67.2 1 204 98.5 85.6 59.7 6 128 96.2 69.6 17.4
AR 270 91.1 78.7 1 308 98.0 93.0 58.6 8 317 90.6 77.2 51.5
BE 460 95.4 84.8 KG 512 96.7 92.4 71.7 8 492 94.9 88.4 64.7
BL 337 96.4 78.2 1 412 96.3 91.2 63.2 9 347 88.8 79.2 49.4
BS 291 95.0 79.3 3 564 96.8 87.9 71.5 9 490 85.5 78.9 56.7
FR 281 98.2 83.5 1 313 94.1 87.4 64.4 8 372 90.8 80.5 47.2
GE 702 98.2 89.5 1 508 97.3 89.5 19.4 8 534 91.6 84.0 54.5
GL 272 95.8 86.6 1 254 96.1 92.3 68.5 8 / 9 263 90.7 83.7 53.0
GR 278 95.0 82.5 1 258 98.8 95.4 73.2 9 340 96.2 85.7 46.9
JU 237 95.8 90.0 1 301 - - - 8 416 - - -
LU 356 90.6 76.7 1 399 97.6 92.6 58.6 9 254 89.8 83.1 52.8
NE 335 97.9 87.7 1 371 98.4 95.9 75.1 8 279 92.3 81.0 29.5
NW 296 92.2 82.2 2 130 97.9 95.0 80.9 9 89 93.5 87.9 73.7
OW 240 89.9 79.1 1 82 97.6 94.7 74.1 8 61 93.9 65.1 27.0
SG 278 93.8 84.3 KG 260 97.7 90.2 33.4 8 300 88.8 79.9 42.5
SH 365 96.3 79.0 KG 340 98.3 86.6 14.6 8 456 83.4 73.0 24.4
SO 295 97.5 82.4 1 374 98.1 92.9 39.2 8 374 89.3 81.0 22.4
SZ 387 93.4 79.8 1 518 94.7 92.0 71.9 8 441 95.4 94.0 78.8
TG 235 95.7 84.1 KG 334 98.0 92.6 20.4 8 365 86.8 76.2 41.1
TI 684 98.5 92.4 792 98.2 95.2 50.3 9 682 94.3 84.0 51.2
UR 289 96.4 87.1 KG 248 97.7 93.6 25.8 8 302 96.0 89.4 21.5
VD 382 98.5 84.9 1 518 98.8 95.7 78.2 8 765 94.7 90.1 69.9
VS 353 98.1 88.9 1 309 97.7 91.2 51.7 8 371 82.8 58.9 17.3
ZG 255 93.2 82.2 2 122 95.9 91.3 73.5 9 59 92.5 88.0 66.6
ZH 345 95.6 82.7 1 538 97.4 94.0 67.1 8 444 88.0 78.6 46.5
CH 8729 95.9 83.7 9138 97.3 92.7 60.2 9056 90.5 82.2 52.1
CH 98 403 93.3 71.5 BAG. BAG Bulletin 1999; Nr. 20: 356-361.
CH 91 402 93.3 70.9 Minder C, Steffen R. BAG Bulletin 1992; Nr. 32: 504-507.
BE: A.-M. Maurer. Durchimpfung bei Kleinkindern, nach Schuleintritt und -austritt im Kanton Bern 2001. BAG Bulletin 2003;
26: 445-50.
BE, NE: for all 3 age groups, data were collected via municipals and then directly from the parents.
JU: due to misunderstandings, coverage by doses cannot be determined for schoolchildren.
TI: Data collected by Ufficio del medico cantonale. Instead of 24-35 months of age, data was collected from the children in 
kindergarten.
Because information on some vaccination cards are incomplete, the sample size may vary by vaccines for some cantons.
G4.tet.ass.xls  21.2.2007
Annex F.4 Vaccination coverage of children in Switzerland 24-35 
months of age, at school entry and school departure, 1999-2003 
Pertussis
24-35 months School entry School departure
n ≥3 D. ≥4 D. Kl. n ≥3 D. ≥4 D. ≥5 D. Kl. n ≥3 D. ≥4 D. ≥5 D.
AG 321 91.9 81.0 1 470 89.9 81.3 27.6 8 531 80.3 7.8 1.2
AI 185 89.8 63.7 1 191 94.3 58.9 49.1 6 100 95.0 12.2 -
AR 270 88.7 77.6 1 308 96.0 86.1 54.6 8 317 90.1 4.8 1.1
BE 460 92.8 82.4 KG 512 81.4 53.5 4.7 8 492 90.0 - -
BL 337 89.8 75.1 1 412 82.1 40.4 7.8 9 347 81.9 8.6 1.4
BS 291 90.4 76.8 3 546 82.1 39.9 7.8 9 431 80.8 8.5 1.6
FR 281 95.9 82.9 1 313 82.7 35.0 3.5 8 372 78.0 10.5 1.9
GE 702 96.9 89.2 1 508 96.6 86.6 19.0 8 534 88.7 23.1 8.2
GL 272 94.8 86.2 1 254 93.4 60.3 20.7 8 / 9 263 87.7 9.4 5.6
GR 278 92.4 81.9 1 258 94.1 77.7 51.5 9 319 94.9 18.0 9.7
JU 237 94.5 89.1 1 301 - - - 8 416 - - -
LU 356 86.2 72.8 1 399 79.2 52.5 12.9 9 254 70.8 7.4 0.9
NE 335 94.9 85.9 1 371 94.7 78.0 21.0 8 279 90.4 28.7 14.0
NW 296 90.3 79.6 2 130 87.8 63.0 22.4 9 89 87.4 11.8 3.1
OW 240 86.0 76.8 1 82 64.0 32.1 19.6 8 61 41.1 4.3 3.1
SG 278 91.9 82.6 KG 260 95.4 86.8 29.9 8 295 83.7 7.5 2.3
SH 365 93.1 64.5 KG 340 94.6 37.9 6.6 8 454 81.4 7.8 3.6
SO 295 94.9 80.2 1 374 90.8 40.0 6.5 8 374 83.0 9.6 0.2
SZ 387 90.8 77.9 1 518 91.4 76.7 34.8 8 441 93.5 0.7 -
TG 235 92.9 80.5 KG 334 95.1 36.2 1.2 8 365 78.9 6.9 0.8
TI 684 97.8 92.0 1 792 96.8 92.8 48.4 9 682 83.3 22.1 7.2
UR 289 93.4 84.8 KG 248 94.0 84.8 22.5 8 302 93.7 25.6 22.5
VD 382 95.5 84.3 1 518 94.0 88.4 61.9 8 765 86.8 26.3 5.7
VS 353 95.6 82.7 1 309 88.4 39.2 4.5 8 371 82.8 6.9 1.0
ZG 255 91.0 81.7 2 122 89.1 53.6 8.7 9 59 92.4 14.5 8.9
ZH 345 91.9 78.6 1 538 88.5 37.5 5.2 8 442 81.4 11.9 2.0
CH 8729 92.9 81.3 9107 88.9 60.9 19.4 8939 83.5 12.9 3.4
CH 98 403 88.1 68.2 BAG. BAG Bulletin 1999; Nr. 20: 356-361.
CH 91 402 88.8 - Minder C, Steffen R. BAG Bulletin 1992; Nr. 32: 504-507.
BE: A.-M. Maurer. Durchimpfung bei Kleinkindern, nach Schuleintritt und -austritt im Kanton Bern 2001. BAG Bulletin 2003;
26: 445-50.
BE, NE: for all 3 age groups, data were collected via municipals and then directly from the parents.
JU: due to misunderstandings, coverage by doses cannot be determined for schoolchildren.
TI: Data collected by Ufficio del medico cantonale. Instead of 24-35 months of age, data was collected from the children in 
kindergarten.
Because information on some vaccination cards are incomplete, the sample size may vary by vaccines for some cantons.
G4.per.ass.xls  21.2.2007
Annex F.4 Vaccination coverage of children in Switzerland 24-35 
months of age, at school entry and school departure, 1999-2003 
Polio
24-35 months School entry School departure
n >3 D. >4 D. Kl. n >3 D. >4 D. >5 D. Kl. n >3 D. >4 D. >5 D.
AG 321 96.6 83.5 1 470 96.6 94.1 78.8 8 531 90.4 88.9 85.7
AI 185 92.4 70.7 1 204 97.0 84.7 58.8 6 128 98.4 94.7 68.3
AR 270 90.8 77.8 KG/1 308 98.2 92.7 57.8 8 317 93.4 90.2 76.0
BE 460 94.6 86.1 KG 512 96.5 92.2 71.3 8 492 95.7 93.5 87.8
BL 337 94.6 75.3 1 412 95.3 87.9 55.9 9 347 90.4 86.7 74.1
BS 291 94.6 77.3 3 562 96.7 87.5 64.7 9 490 93.5 86.3 75.1
FR 281 97.6 81.9 1 313 93.5 88.0 59.9 8 371 91.3 86.4 74.7
GE 702 96.7 89.5 1 508 96.0 87.1 19.5 8 534 94.3 91.1 81.9
GL 272 95.5 84.9 KG/1 254 95.8 91.9 66.5 8 / 9 263 93.9 92.2 82.5
GR 278 93.4 82.2 1 258 98.0 95.3 70.8 9 340 98.4 96.2 82.9
JU 237 95.0 88.1 1 301 - - - 8 416 - - -
LU 356 90.6 75.3 1 399 97.1 92.8 59.3 9 254 92.1 88.5 78.5
NE 335 96.7 86.8 1 371 98.6 95.6 73.8 8 281 94.9 92.6 78.9
NW 296 91.9 80.2 2 130 97.4 95.0 73.3 9 89 92.8 91.8 64.0
OW 240 89.1 78.0 1 82 96.1 91.0 68.6 8 61 87.7 84.1 67.5
SG 278 93.7 83.8 KG 260 98.1 86.8 31.4 8 298 91.0 89.1 79.7
SH 365 94.3 61.1 KG 340 96.8 73.6 9.2 8 457 86.0 84.2 73.8
SO 295 96.8 80.1 1 374 98.1 92.1 37.0 8 374 91.5 89.3 77.5
SZ 387 93.0 78.9 1 518 95.6 92.5 70.9 8 441 95.5 94.6 91.7
TG 235 95.8 79.1 KG 334 98.4 91.7 18.1 8 365 89.8 85.3 75.0
TI 684 97.8 90.8 1 791 98.4 94.9 47.7 9 682 94.6 93.0 81.8
UR 289 96.4 85.2 KG 248 97.7 90.2 25.5 8 302 98.3 96.0 87.1
VD 382 96.9 82.7 1 518 98.8 95.9 77.6 8 765 97.3 94.2 89.3
VS 353 97.8 87.0 1 309 96.3 94.3 72.5 8 371 91.8 89.5 83.3
ZG 255 91.6 81.2 2 122 95.9 87.8 66.6 9 59 97.1 92.5 91.0
ZH 345 95.3 82.0 1 538 96.9 93.2 66.0 8 442 91.7 87.0 72.8
CH 8729 95.3 82.7 9135 97.0 92.0 59.6 9054 93.0 90.0 80.7
CH 98 403 92.1 76.2 BAG. BAG Bulletin 1999; Nr. 20: 356-361.
CH 91 402 94.8 70.4 Minder C, Steffen R. BAG Bulletin 1992; Nr. 32: 504-507.
BE: A.-M. Maurer. Durchimpfung bei Kleinkindern, nach Schuleintritt und -austritt im Kanton Bern 2001. BAG Bulletin 2003;
26: 445-50.
BE, NE: for all 3 age groups, data were collected via municipals and then directly from the parents.
JU: due to misunderstandings, coverage by doses cannot be determined for schoolchildren.
TI: Data collected by Ufficio del medico cantonale. Instead of 24-35 months of age, data was collected from the children in 
kindergarten.
Because information on some vaccination cards are incomplete, the sample size may vary by vaccines for some cantons.
G4.pol.ass.xls  21.2.2007  
Annex F.4  Vaccination coverage of children in Switzerland 24-35 
months of age and at school entry, 1999-2003 
Haemophilus influenzae type B
24-35 months School entry
n ≥3 D. ≥4 D. Kl. n ≥3 D. ≥4 D.
AG 321 89.9 80.7 1 469 78.8 28.7
AI 185 87.3 60.8 1 191 73.7 48.6
AR 270 88.5 76.2 KG/ 1 308 85.7 57.3
BE 460 90.7 80.0 KG 512 72.1 -
BL 337 86.3 68.3 1 412 81.4 11.0
BS 291 87.8 71.8 3 532 74.2 7.2
FR 281 92.5 83.6 1 313 69.4 9.4
GE 702 93.8 86.2 1 509 81.7 47.9
GL 272 93.8 81.1 KG/ 1 250 83.4 46.2
GR 278 91.0 82.0 1 258 91.2 51.5
JU 237 92.5 85.7 1 301 - -
LU 356 86.1 73.9 1 399 79.8 18.4
NE 335 90.8 75.5 1 371 70.3 6.1
NW 296 88.7 74.8 2 130 84.8 32.1
OW 240 86.0 76.4 1 82 91.3 40.3
SG 278 89.7 79.2 KG 260 89.9 64.0
SH 364 91.1 78.6 KG 340 83.8 37.4
SO 295 93.5 76.1 1 374 80.7 15.3
SZ 387 91.3 77.3 1 518 76.2 33.5
TG 235 90.9 77.8 KG 334 89.2 21.7
TI 679 96.0 87.1 1 790 91.0 80.1
UR 289 91.4 84.8 KG 248 84.1 46.7
VD 382 94.4 81.1 1 517 82.5 29.5
VS 353 93.6 78.7 1 309 75.2 8.1
ZG 255 90.5 79.8 2 121 76.8 7.4
ZH 345 91.1 78.8 1 538 67.5 3.0
CH 8723 91.1 79.3 9085 78.3 26.6
CH 98 403 76.9 47.4 BAG. BAG Bulletin 1999; Nr. 20: 356-361.
CH 91 402 - - Minder C, Steffen R. BAG Bulletin 1992; Nr. 32: 504-507.
BE: A.-M. Maurer. Durchimpfung bei Kleinkindern, nach Schuleintritt und -austritt im Kanton Bern 2001. BAG Bulletin 2003; 
26: 445-50.
BE, NE: for all 3 age groups, data were collected via municipals and then directly from the parents.
JU: due to misunderstandings, coverage by doses cannot be determined for schoolchildren.
TI: Data collected by Ufficio del medico cantonale. Instead of 24-35 months of age, data was collected from the children in 
kindergarten.
Because information on some vaccination cards are incomplete, the sample size may vary by vaccines for some cantons.
G4.hae.ass.xls  21.2.2007
Annex F.4 Vaccination coverage of children in Switzerland 24-35
months of age, at school entry and school departure, 1999-2003 
Measles
24-35 months School entry School departure
n ≥1 D. Kl. n ≥1 D. ≥2 D. Kl. n ≥1 D. ≥2 D.
AG 321 82.5 1 469 88.3 68.4 8 532 96.2 75.8
AI 185 71.3 1 204 81.8 3.5 6 128 95.3 19.6
AR 270 68.6 KG/1 308 88.2 48.4 8 317 92.0 57.5
BE 460 77.6 KG 512 82.7 25.4 8 492 92.3 52.2
BL 337 75.6 1 412 85.2 42.0 9 347 92.2 33.5
BS 291 78.5 3 559 88.9 62.5 9 489 95.0 75.5
FR 281 86.0 1 313 84.0 10.7 8 372 89.3 59.8
GE 702 92.7 1 509 91.2 29.4 8 534 91.7 57.2
GL 272 77.9 KG/1 250 89.5 63.1 8 / 9 264 96.6 77.3
GR 278 78.7 1 258 91.0 45.7 9 340 93.4 46.4
JU 237 83.5 1 301 - - 8 416 - -
LU 356 71.4 1 399 89.2 45.1 9 254 97.2 50.6
NE 334 89.4 1 371 92.2 58.6 8 281 84.0 36.4
NW 296 80.2 2 130 92.0 63.1 9 89 99.0 78.1
OW 240 73.7 1 82 91.3 51.1 8 61 87.7 13.5
SG 278 76.1 KG 260 88.1 32.0 8 303 96.0 51.1
SH 365 75.0 KG 340 80.7 4.3 8 457 91.9 54.1
SO 295 81.0 1 374 86.8 26.9 8 374 96.8 27.1
SZ 387 80.0 1 518 91.9 69.6 8 441 99.1 82.6
TG 235 84.1 KG 334 88.6 16.0 8 365 93.7 39.9
TI 684 93.7 1 791 93.8 46.5 9 685 91.2 54.3
UR 289 83.2 KG 248 87.0 17.2 8 302 95.8 77.9
VD 382 89.7 1 518 91.9 23.8 8 765 93.4 76.0
VS 346 92.9 1 309 92.4 17.7 8 371 94.8 34.2
ZG 255 77.1 2 122 82.8 59.1 9 59 92.4 69.4
ZH 345 81.4 1 538 89.9 35.6 8 444 94.2 41.7
CH 8721 82.3 9128 88.4 36.6 9066 93.8 54.0
CH 98 403 81.4 BAG. BAG Bulletin 1999; Nr. 20: 356-361.
CH 91 401 83.1 Minder C, Steffen R. BAG Bulletin 1992; Nr. 32: 504-507.
BE: A.-M. Maurer. Durchimpfung bei Kleinkindern, nach Schuleintritt und -austritt im Kanton Bern 2001. BAG Bulletin 2003; 
26: 445-50.
BE, NE: for all 3 age groups, data were collected via municipals and then directly from the parents.
JU: due to misunderstandings, coverage by doses cannot be determined for schoolchildren.
TI: Data collected by Ufficio del medico cantonale. Instead of 24-35 months of age, data was collected from the children in 
kindergarten.
Because information on some vaccination cards are incomplete, the sample size may vary by vaccines for some cantons.
G4.mas.ass.xls  21.2.2007  
Annex F.4 Vaccination coverage of children in Switzerland 24-35
months of age, at school entry and school departure, 1999-2003 
Mumps
24-35 months School entry School departure
n ≥1 D. Kl. n ≥1 D. ≥2 D. Kl. n ≥1 D. ≥2 D.
AG 321 79.7 1 469 86.4 66.8 8 532 95.9 75.8
AI 185 71.3 1 204 81.8 3.0 6 128 95.3 19.6
AR 270 66.8 KG/ 1 308 88.2 48.1 8 317 93.0 57.5
BE 460 77.6 512 79.1 25.4 492 90.9 49.0
BL 337 73.7 1 412 84.1 42.0 9 347 92.0 33.3
BS 291 74.3 3 559 87.3 60.6 9 489 93.6 74.1
FR 281 84.6 1 313 82.0 10.1 8 372 88.0 58.0
GE 702 90.3 1 509 89.9 29.2 8 534 89.8 55.0
GL 272 77.6 KG/ 1 250 89.1 63.5 8 / 9 264 96.6 76.6
GR 278 76.6 1 258 90.2 45.3 9 340 91.5 46.1
JU 237 83.3 1 301 - - 8 416 - -
LU 356 69.6 1 399 86.3 44.3 9 254 96.9 50.6
NE 334 89.0 1 371 91.3 57.4 8 281 81.8 35.3
NW 296 75.6 2 130 91.2 63.1 9 89 99.0 78.1
OW 240 73.3 1 82 91.3 51.1 8 61 86.5 12.3
SG 278 75.8 KG 260 87.7 31.3 8 303 95.7 50.8
SH 365 69.2 KG 340 76.4 4.1 8 457 90.8 53.7
SO 295 79.9 1 374 84.6 26.9 8 374 96.6 25.6
SZ 387 79.1 1 518 91.7 69.4 8 441 99.1 82.6
TG 235 82.2 KG 334 87.3 15.7 8 365 93.4 39.9
TI 684 93.3 1 790 93.7 45.8 9 685 90.1 54.2
UR 289 81.5 KG 248 85.3 17.2 8 302 95.8 77.9
VD 382 88.7 1 518 91.7 23.6 8 765 93.4 75.9
VS 346 92.6 1 309 92.0 16.7 8 371 93.5 30.4
ZG 255 77.1 2 122 82.1 59.1 9 59 92.4 69.4
ZH 345 81.1 1 538 88.9 34.8 8 444 94.0 39.4
CH 8721 81.1 9127 87.0 36.0 9066 93.1 52.7
CH 98 403 78.9 BAG. BAG Bulletin 1999; Nr. 20: 356-361.
CH 91 401 80.1 Minder C, Steffen R. BAG Bulletin 1992; Nr. 32: 504-507.
BE: A.-M. Maurer. Durchimpfung bei Kleinkindern, nach Schuleintritt und -austritt im Kanton Bern 2001. BAG Bulletin 2003;
26: 445-50.
BE, NE: for all 3 age groups, data were collected via municipals and then directly from the parents.
JU: due to misunderstandings, coverage by doses cannot be determined for schoolchildren.
TI: Data collected by Ufficio del medico cantonale. Instead of 24-35 months of age, data was collected from the children 
in kindergarten.
Because information on some vaccination cards are incomplete, the sample size may vary by vaccines for some cantons.
Annex F.4 Vaccination coverage of children in Switzerland 24-35 
months of age, at school entry and school departure, 1999-2003 
Rubella
24-35 months School entry School departure
n ≥1 D. Kl. n ≥1 D. ≥2 D. Kl. n ≥1 D. ≥2 D.
AG 321 78.4 1 469 86.0 66.8 8 532 95.0 74.1
AI 185 71.3 1 204 81.8 3.0 6 128 95.3 19.6
AR 270 66.8 KG/1 308 88.2 48.3 8 317 92.0 57.2
BE 460 77.6 KG 512 78.7 25.4 8 492 79.5 38.2
BL 337 73.6 1 412 83.9 41.6 9 347 92.2 32.7
BS 291 74.1 3 559 87.5 60.5 9 489 93.2 73.1
FR 281 84.6 1 313 81.3 10.1 8 372 88.0 59.4
GE 702 90.4 1 509 89.5 29.0 8 534 89.0 55.0
GL 272 77.6 KG/1 250 89.5 63.5 8 / 9 264 96.6 76.6
GR 278 76.1 1 258 90.2 45.3 9 340 90.8 45.7
JU 237 83.3 1 301 - - 8 416 - -
LU 356 68.8 1 399 85.8 44.3 9 254 95.2 51.3
NE 334 89.4 1 371 91.1 57.2 8 281 82.4 35.3
NW 296 76.2 2 130 90.5 63.1 9 89 100.0 80.1
OW 240 73.3 1 82 89.8 49.6 8 61 86.5 12.3
SG 278 75.8 KG 260 87.7 31.3 8 303 95.3 50.8
SH 365 51.3 KG 340 61.9 4.1 8 457 87.2 48.0
SO 295 79.9 1 374 84.6 26.9 8 374 95.9 24.4
SZ 387 79.3 1 518 91.7 69.6 8 441 99.1 82.6
TG 235 81.7 KG 334 87.3 15.7 8 365 90.8 30.2
TI 684 93.3 791 93.7 45.8 9 685 89.8 53.9
UR 289 81.8 KG 248 85.3 17.2 8 302 95.8 77.9
VD 382 88.7 1 518 91.7 23.6 8 765 93.1 75.3
VS 346 92.6 1 309 92.7 17.4 8 371 89.1 29.0
ZG 255 76.9 2 122 82.1 58.4 9 59 92.4 68.1
ZH 345 81.1 1 538 88.3 34.3 8 444 90.2 33.0
CH 8721 80.8 9128 86.6 35.9 9066 90.6 49.8
CH 98 403 78.7 BAG. BAG Bulletin 1999; Nr. 20: 356-361.
CH 91 401 79.6 Minder C, Steffen R. BAG Bulletin 1992; Nr. 32: 504-507.
BE: A.-M. Maurer. Durchimpfung bei Kleinkindern, nach Schuleintritt und -austritt im Kanton Bern 2001. BAG Bulletin 2003;
26: 445-50.
BE, NE: for all 3 age groups, data were collected via municipals and then directly from the parents.
JU: due to misunderstandings, coverage by doses cannot be determined for schoolchildren.
TI: Data collected by Ufficio del medico cantonale. Instead of 24-35 months of age, data was collected from the children in 
kindergarten.
Because information on some vaccination cards are incomplete, the sample size may vary by vaccines for some cantons.
G4.rot.ass.xls   21.2.2007
Annex F.4 Vaccination coverage of children in Switzerland
at school departure, 1999-2003 
Hepatitis B
School departure
Kl. n ≥1 D. ≥2 D. ≥3 D.
AG 8 532 31.3 26.7 12.6
AI 6 128 7.5 6.7 2.3
AR 8 317 23.2 15.5 12.8
BE 8 492 44.7 41.3 35.0
BL 9 347 62.5 59.8 31.9
BS 9 479 72.5 71.0 67.9
FR 8 372 69.3 69.3 68.3
GE 8 534 57.6 54.7 21.2
GL 8 / 9 264 54.7 49.0 43.0
GR 9 340 32.5 27.1 23.5
JU 8 416 - - -
LU 9 254 49.3 47.1 39.7
NE 8 281 28.0 22.3 13.0
NW 9 89 88.3 82.0 9.0
OW 8 61 32.5 32.5 29.5
SG 8 304 55.4 27.2 17.1
SH 8 457 81.2 50.3 18.4
SO 8 374 39.2 38.7 34.0
SZ 8 441 8.6 7.3 6.1
TG 8 365 32.8 22.6 13.3
TI 9 686 70.4 68.2 60.9
UR 8 302 13.9 9.2 6.5
VD 8 765 81.2 79.5 19.3
VS 8 371 52.6 51.8 50.2
ZG 9 59 62.1 59.1 54.8
ZH 8 443 21.0 16.2 6.9
CH 9057 46.3 40.8 25.9
BE: A.-M. Maurer. Durchimpfung bei Kleinkindern, nach Schuleintritt und -austritt im Kanton Bern 2001. BAG Bulletin 2003; 
26: 445-50.
BE, NE: for all 3 age groups, data were collected via municipals and then directly from the parents.
JU: due to misunderstandings, coverage by doses cannot be determined for schoolchildren.
TI: Data collected by Ufficio del medico cantonale. 
Because information on some vaccination cards are incomplete, the sample size may vary by vaccines for some cantons.
Annex G.   Distribution of the number of children living 
in Switzerland who remain unvaccinated, 1999-2003
Toddlers School entry School exit
KT Canton N n % N n % N n %
1 AG 321 7 1.9 469 0 0.0 530 0 0
2 AI 185 6 3.5 191 3 1.6 100 0 0
3 AR 270 15 5.0 308 2 0.7 317 1 0.3
4 BE 460 10 2.1 512 5 1.0 492 3 0.7
5 BL 335 13 3.1 412 9 1.8 347 6 1.9
6 BS 291 2 0.5 531 0 0.0 430 0 0
7 FR 281 3 0.9 313 0 0.0 371 0 0
8 GE 702 4 0.7 508 0 0.0 534 5 0.9
9 GL 272 9 2.9 250 1 0.4 250 1 0.4
10 GR 278 10 3.5 258 3 1.1 319 2 0.4
11 JU 237 3 1.3 301 3 1.0 416 6 1.6
12 LU 356 23 6.1 399 4 1.0 254 2 0.7
13 NE 333 1 0.3 371 0 0.0 279 6 2.4
14 NW 296 17 5.5 130 0 0.0 89 0 0
15 OW 240 19 7.7 82 0 0.0 61 0 0
16 SG 278 9 3.1 260 1 0.4 294 0 0
17 SH 364 10 1.8 340 1 0.3 454 5 0.1
18 SO 295 3 0.6 374 0 0.0 374 2 1
19 SZ 377 18 4.5 518 3 0.6 441 0 0
20 TG 235 0 0 334 0 0.0 365 3 0.9
21 TI 679 0 0 787 1 0.1 678 6 0.9
22 UR 289 9 3 248 1 0.4 302 2 0.6
23 VD 382 4 0.9 517 0 0.0 765 2 0.3
24 VS 346 1 0.3 309 0 0.0 321 0 0
25 ZG 255 15 4.8 121 3 2.2 59 0 0
26 ZH 345 8 2.1 538 2 0.4 430 0 0
27 CH 8715 219 2.0 9080 39 0.4 9044 48 0.5
"Not vaccinated status" is determined by vaccination card.  Because vaccination cards were not
collected in canton JU, questionnaires used to confirm vaccination status. Hence, the national 
average for school children does not include JU.
T7/AH.notvax.xls   21.2.2007
Annex H.1.  Vaccination coverage, with and without imputation for 
rubella for girls at school departure, 1999-2003 
RUBELLA- 1 dose
with imputation    with imputation
KT Canton Kl. N n % 95% CI N n % 95% CI
1 AG 8 532 262 96.6 94.0, 99.1 486 238 96.7 94.0, 99.4
2 AI 6 128 59 91.7 83.7, 99.7 105 46 91.3 80.0, 102.6
3 AR 8 317 164 89.8 85.5, 94.1 126 68 90.6 83.9, 97.3
4 BE 8 492 229 84.7 * 79.5, 90.0 492 229 84.7 * 79.5, 90.0
5 BL 9 347 184 91.2 86.8, 95.6 338 179 91.5 87.2, 95.8
6 BS 9 489 238 94.8 92.0, 97.6 305 157 94.8 91.8, 97.8
7 FR 8 372 177 89.7 84.7, 94.6 367 176 89.6 84.6, 94.6
8 GE 8 534 273 92.3 * 89.4, 95.2 428 220 92.0 88.6, 95.5
9 GL 8 / 9 264 130 97.7 94.9, 100.6 135 65 98.4 94.3, 1.02
10 GR 9 340 184 91.5 86.7, 96.3 289 159 91.5 86.3, 96.6
11 JU 8 416 - - - 416 - - -
12 LU 9 254 124 95.5 91.4, 99.7 251 122 96.2 92.8, 99.6
13 NE 8 281 143 84.5 77.4, 91.6 269 133 87.1 80.7, 93.6
14 NW 9 89 54 100.0 100.0, 100.0 88 54 100.0 100.0, 100.0
15 OW 8 61 27 88.9 61.4, 116.4 60 26 92.3 * 74.6, 110.0
16 SG 8 303 144 96.0 92.5, 99.5 293 140 95.9 92.3, 99.4
17 SH 8 457 237 88.5 82.9, 94.1 270 143 92.8 86.9, 98.8
18 SO 8 374 187 96.6 93.1, 100.0 373 186 96.5 93.1, 100.0
19 SZ 8 441 206 99.5 98.5, 100.5 229 110 99.1 97.3, 100.9
20 TG 8 365 174 91.6 86.6, 96.6 361 171 91.4 86.4, 96.4
21 TI 9 685 - - - 685 - - -
22 UR 8 302 148 95.4 90.4,  100.4 250 125 94.6 88.6, 100.6
23 VD 8 765 - - - 765 - - -
24 VS 8 371 204 92.0 88.3, 95.8 371 204 92.0 88.3, 95.8
25 ZG 9 59 29 100.0 100.0, 100.0 59 29 100.0 100.0, 100.0
26 ZH 8 444 216 93.5 * 90.2, 96.8 444 216 93.5 * 90.2, 96.8
27 CH 7616 3793 92.6 * 91.4, 93.8 6389 3196 92.6 * 91.3, 93.9
CI: confidence interval
* p < 0.05: comparison between girls and boys for rubella
JU: no vaccination information; hence not included in total
TI, VD: no information on sex; hence not included in total
without imputation: implies sex is only evaluated through questionnaire  
with imputation: implies imputing sex for missing gender
without imputation
Annex H.1.  Vaccination coverage, with and without imputation for 
rubella for girls at school departure, 1999-2003 
RUBELLA - 2 doses
with imputation   without imputation
KT Canton Kl. N n % 95% CI N n % 95% CI
1 AG 8 532 262 78.9 73.1, 84.6 486 238 80.6 74.7, 86.5
2 AI 6 128 59 11.6 -1.8, 25.0 105 46 10.9 -0.3, 22.1
3 AR 8 317 164 55.3 43.2, 67.3 126 68 64.2 50.7, 77.7
4 BE 8 492 229 42.7 36.8, 48.5 492 229 34.2 27.5, 40.8
5 BL 9 347 184 39.4 * 31.4, 47.4 338 179 40.0 * 31.8, 48.1
6 BS 9 489 238 77.2 72.3, 82.2 305 157 80.3 74.9, 85.7
7 FR 8 372 177 66.1 * 56.1, 76.2 367 176 65.9 55.7, 76.1
8 GE 8 534 273 58.5 52.3, 64.7 428 220 60.5 53.5, 67.5
9 GL 8 / 9 264 130 76.5 65.0, 88.1 135 65 83.2 70.7, 95.6
10 GR 9 340 184 44.6 33.3, 55.9 289 159 43.2 32,7, 53.6
11 JU 8 416 - - - 416 - - -
12 LU 9 254 124 55.7 44.8, 66.7 251 122 55.6 44.7, 66.6
13 NE 8 281 143 36.8 28.6, 45.1 269 133 36.7 27.3, 46.1
14 NW 9 89 54 77.3 62.3, 92.4 88 54 77.3 62.3, 92.4
15 OW 8 61 27 13.8 -12.7,40.3 60 26 15.4 -12.3, 43.1
16 SG 8 303 144 45.9 28.8, 63.0 293 140 45.0 27.9, 62.1
17 SH 8 457 237 52.8 * 42.4, 63.1 270 143 57.8 * 44.3, 71.4
18 SO 8 374 187 25.5 18.4, 32.5 373 186 25.6 18.5, 32.6
19 SZ 8 441 206 83.5 77.8, 89.2 229 110 84.6 76.6, 92.6
20 TG 8 365 174 31.8 23.3, 40.3 361 171 31.8 23.4, 40.2
21 TI 9 685 - - - 685 - - -
22 UR 8 302 148 76.7 68.9, 84.5 250 125 75.6 68.8, 82.5
23 VD 8 765 - - - 765 - - -
24 VS 8 371 204 31.5 19.3, 43.7 371 204 31.5 19.3, 43.7
25 ZG 9 59 29 68.6 37.1, 100.0 59 29 68.6 37.1, 100.0
26 ZH 8 444 216 36.1 25.8, 46.3 444 216 36.1 25.8, 46.3
27 CH 7616 3793 49.5 * 46.5, 52.4 6389 3196 48.7 * 45.6, 51.8
CI: confidence interval
* p < 0.05: comparison between girls and boys for rubella
JU: no vaccination information; hence not included in total
TI, VD: no information on sex; hence not included in total
without imputation: implies sex is only evaluated through questionnaire 
with imputation: implies imputing sex for missing gender
Annex H.2  Vaccination coverage, with and without imputation for 
rubella for boys at school departure, 1999-2003 
RUBELLA- 1 dose
with imputation    without imputation with imputation
KT Canton Kl. N n % 95% CI N n % 95% CI
1 AG 8 532 270 93.4 90.0, 96.8 486 248 93.2 89.9, 96.5
2 AI 6 128 69 98.7 95.9, 101.5 105 59 98.5 95.3, 101.7
3 AR 8 317 153 94.1 89.8, 98.4 126 58 94.5 88.0, 101.0
4 BE 8 492 263 75.2 * 68.6, 81.8 492 263 75.2 * 68.6, 81.8
5 BL 9 347 163 93.1 87.4, 98.8 338 159 93.0 87.1, 98.8
6 BS 9 489 251 91.5 86.6, 96.4 305 148 91.0 84.2, 97.8
7 FR 8 372 195 86.4 80.3, 92.6 367 191 87.1 81.2, 93.2
8 GE 8 534 261 85.7 * 79.8, 91.7 428 208 88.6 83.3, 94.0
9 GL 8 / 9 264 134 95.5 91.6, 99.4 135 70 98.5 94.9,102.0
10 GR 9 340 156 90.2 84.3, 96.0 289 130 89.0 82.3, 95.7
11 JU 8 416 - - - 416 - - -
12 LU 9 254 130 95.0 91.4, 98.5 251 129 94.9 91.3, 98.6
13 NE 8 281 138 80.4 74.2, 86.7 269 136 80.8 74.3, 87.3
14 NW 9 89 35 100.0 100.0, 100.0 88 34 100.0  100.0, 100.0
15 OW 8 61 34 84.1 62.4, 105.9 60 34 79.0 * 53.9, 104.0
16 SG 8 303 159 94.7 90.8, 98.6 293 153 94.5 90.4, 98.6
17 SH 8 457 220 85.9 80.3, 91.5 270 127 85.0 78.3, 91.7
18 SO 8 374 187 95.2 91.7, 98.7 373 187 95.2 91.7, 98.7
19 SZ 8 441 235 98.7 97.3, 100.2 229 119 98.3 95.9, 100.8
20 TG 8 365 191 90.1 84.8, 95.4 361 190 90.0 84.7, 95.4
21 TI 9 685 - - - 685 - - -
22 UR 8 302 154 96.2 93.1, 99.4 250 125 95.4 91.3, 99.4
23 VD 8 765 - - - 765 - - -
24 VS 8 371 167 86.2 78.9, 93.6 371 167 86.2 78.9, 93.6
25 ZG 9 59 30 85.1 67.0, 103.3 59 30 85.1 67.0, 103.3
26 ZH 8 444 228 86.8 * 81.2, 92.5 444 228 86.8 * 81.2, 92.5
27 CH 7616 3823 88.3 * 86.8. 89.9 6389 3193 88.1 * 86.5, 89.8
CI: confidence interval
* p < 0.05: comparison between boys and girls for rubella
JU: no vaccination information; hence not included in total
TI, VD: no information on sex; hence not included in total
without imputation: implies sex is only evaluated through questionnaire  
with imputation: implies imputing sex for missing gender
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Annex H.2  Vaccination coverage, with and without imputation for 
rubella for boys at school departure, 1999-2003 
RUBELLA - 2 doses
with imputation    without imputation
KT Canton Kl. N n % 95% CI N n % 95% CI
1 AG 8 532 270 69.6 63.5, 75.6 486 248 68.6 61.9,  75.2
2 AI 6 128 69 27.3 -2.2, 56.9 105 59 22.4 -9.2, 54.0
3 AR 8 317 153 59.0 47.9, 70.1 126 58 64.9 42.3, 81.5
4 BE 8 492 263 34.2 27.5, 40.8 492 263 34.2 27.5, 40.8
5 BL 9 347 163 26.2 * 19.4, 33.0 338 159 25.6 * 18.9, 32.4
6 BS 9 489 251 68.8 62.6, 75.1 305 148 72.3 64.8, 79.7
7 FR 8 372 195 52.9 * 41.0, 64.9 367 191 53.6 41.4, 65.7
8 GE 8 534 261 51.7 43.9, 59.5 428 208 58.3 50.2, 66.5
9 GL 8 / 9 264 134 76.7 66.4, 87.0 135 70 87.6 79.6, 95.7
10 GR 9 340 156 46.8 32.2, 61.4 289 130 43.3 26.7, 59.8
11 JU 8 416 - - - 416 - - -
12 LU 9 254 130 47.1 31.9, 62.4 251 129 47.7 32.9, 62.5
13 NE 8 281 138 33.8 25.2, 42.4 269 136 33.6 24.8, 42.4
14 NW 9 89 35 83.0 72.8, 93.1 88 34 82.5 71.7, 93.2
15 OW 8 61 34 9.8 -4.9, 24.4 60 34 10.5  -4.2, 25.3
16 SG 8 303 159 55.5 40.5, 70.6 293 153 55.1  39.9, 70.2
17 SH 8 457 220 43.3 * 32.0, 56.7 270 127 42.9 * 28.0, 57.9
18 SO 8 374 187 23.4 14.0, 32.8 373 187 23.4 14.0, 32.8
19 SZ 8 441 235 81.7 75.4, 88.0 229 119 83.2 77.3, 89.0
20 TG 8 365 191 28.6 19.5, 37.7 361 190 28.8 19.7, 37.8
21 TI 9 685 - - - 685 - - -
22 UR 8 302 154 79.1 72.4, 86.0 250 125 77.4 69.6, 85.2
23 VD 8 765 - - - 765 - - -
24 VS 8 371 167 26.5 13.7, 39.3 371 167 26.5 13.7, 39.3
25 ZG 9 59 30 67.6 47.1, 88.1 59 30 67.6 47.1, 88.1
26 ZH 8 444 228 29.8 20.2, 39.4 444 228 29.8 20.2, 39.4
27 CH 7616 3823 44.5 * 41.6. 47.3 6389 3193 43.4 * 40.3, 46.4
CI: confidence interval
* p < 0.05: comparison between boys and girls for rubella
JU: no vaccination information; hence not included in total
TI, VD: no information on sex; hence not included in total
without imputation: implies sex is only evaluated through questionnaire  
with imputation: implies imputing sex for missing gender
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Annex I.1.  Distribution of health professionals who are active in 
vaccinating toddlers between 24-35 months of age in 
Switzerland as perceived by parents, 1999-2003
Toddlers
General CAM
Pediatrician Practitioner Others
KT Canton n n % n % n % n %
1 AG 321 73 22.1 252 80.0 7 1.7 2 0.4
2 AI 183 158 85.9 27 15.5 1 0.5 0 0
3 AR 268 111 40.3 167 63.8 5 1.8 1 0.3
4 BE 460 77 17.0 362 78.4 8 1.6 2 0.4
5 BL 337 49 14.5 290 86.1 8 2.5 1 0.2
6 BS 287 25 9.5 267 92.9 15 5.2 3 1.2
7 FR 280 42 14.4 246 89.9 5 1.5 3 2.1
8 GE 568 23 4.3 563 95.4 2 0.3 6 1.0
9 GL 268 114 42.5 163 60.8 1 0.3 0 0
10 GR 276 86 34.0 171 59.8 5 1.7 1 0.4
11 JU 234 42 17.9 168 72.0 1 0.4 0 0
12 LU 352 150 41.6 195 56.9 10 3.0 0 0
13 NE 333 33 8.7 307 93.2 4 1.1 2 1.3
14 NW 294 145 47.8 148 52.3 1 0.3 2 0.7
15 OW 236 117 50.4 99 42.3 2 0.1 1 0.7
16 SG 274 78 29.9 203 71.5 6 1.4 0 0
17 SH 363 91 23.1 281 80.3 4 1.1 0 0
18 SO 293 88 27.9 220 76.4 8 2.3 2 1.1
19 SZ 384 102 28.5 280 70.7 7 2.1 0 0
20 TG 234 89 36.6 152 66.6 3 1.3 0 0
21 TI 532 16 3.3 508 95.3 - - 8 1.5
22 UR 289 91 30.4 197 69.3 1 0.3 3 1.3
23 VD 363 33 9.6 334 91.8 3 0.9 5 1.3
24 VS 352 57 16.1 313 89.1 12 3.5 23 8.8
25 ZG 253 52 20.3 193 78.4 6 2.0 0 0
26 ZH 345 89 25.1 266 73.8 3 0.8 9 4.0
27 CH 8399 2031 21.5 6372 79.2 128 1.6 74 1.4
Multiple answers were possible.
TI: Complementary / alternative medicine (CAM) practitioner was not included as a choice.
 Practitioner
T9/AI.vaxperson.xls   2j  21.2.2007
Annex I.2.  Distribution of health professionals who are active in 
vaccinating children at school entry in Switzerland as perceived by 
parents, 1999-2003 
School entry
General School health CAM
Pediatrician official Practitioner Others
KT Canton schoolvax n n % n % n % n % n %
1 AG yes 431 157 35.9 314 73.0 46 10.7 8 1.8 4 0.9
2 AI no 166 149 89.9 16 9.8 10 5.8 2 1.2 1 0.6
3 AR yes 218 109 51.4 144 65.0 22 10.4 3 1.1 1 0.5
4 BE yes - - - - - - - - - - -
5 BL no 407 102 24.7 350 86.6 15 3.4 5 1.3 7 1.6
6 BS yes 418 86 19.9 343 83.0 25 5.3 8 1.9 6 1.4
7 FR yes 308 115 39.8 230 70.0 149 48.4 19 6.3 1 1.0
8 GE no 427 35 8.3 400 93.0 5 1.2 6 1.4 10 2.4
9 GL yes 212 139 6.6 100 46.9 32 15.0 1 0.5 1 0.5
10 GR yes 233 94 40.5 181 77.9 17 7.3 3 1.3 0 0.0
11 JU yes 301 94 31.1 246 80.8 179 59.6 1 0.3 7 2.3
12 LU no 398 214 53.7 258 64.7 24 6.1 6 1.4 4 1.0
13 NE yes 372 93 25.7 327 87.8 16 4.4 2 0.5 4 1.4
14 NW yes 211 82 62.3 65 50.1 64 49.6 0 0.0 3 2.4
15 OW no 80 52 65.3 36 45.2 6 7.4 0 0.0 0 0.0
16 SG yes 248 120 48.3 158 63.5 38 15.3 5 2.1 0 0.0
17 SH yes 335 127 37.6 247 74.2 15 4.6 8 2.4 1 0.3
18 SO no 374 151 40.8 280 74.2 13 3.3 5 1.3 3 0.9
19 SZ yes 325 128 39.6 222 68.8 69 21.4 8 2.5 2 0.6
20 TG yes 344 152 44.3 239 70.5 10 2.5 4 0.9 3 0.8
21 TI no - - - - - - - - - - -
22 UR no 130 89 43.0 144 67.3 7 3.5 1 0.5 0 0.0
23 VD yes - - - - - - - - - - -
24 VS yes 299 95 31.6 237 79.1 87 29.1 8 2.7 32 10.8
25 ZG no 120 84 68.0 73 61.4 8 6.5 2 1.6 0 0.0
26 ZH yes 530 254 47.4 341 64.1 62 11.9 7 1.3 30 5.8
27 CH 6884 2722 40.6 4951 71.3 919 12.8 112 1.7 120 2.4
Multiple answers were possible.
BE, TI, VD: no information available since questionnaires were not used with school children. 
schoolvax: vaccination is permitted in school
CAM: Complementary / alternative medicine 
 Practitioner
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Annex I.3.  Distribution of health professionals who are active in 
vaccinating children at school departure in Switzerland as perceived by 
parents, 1999-2003 
School departure
General School health CAM
Pediatrician official Practitioner Others
KT Canton schoolvax n n % n % n % n % n %
1 AG yes 492 232 47.0 311 62.7 359 72.9 8 1.6 6 1.3
2 AI no 107 94 87.9 15 17.2 18 17.9 0 0.0 0 0
3 AR yes 127 82 63.3 57 44.7 65 51.9 3 2.6 1 0.9
4 BE yes - - - - - - - - - - -
5 BL no 341 205 59.6 239 69.9 119 35.1 4 1.3 9 2.5
6 BS yes 313 93 29.4 230 73.9 173 55.3 8 2.5 10 3.2
7 FR yes 368 168 45.8 240 64.7 272 73.7 5 1.3 3 0.8
8 GE no 433 64 14.7 394 90.7 96 22.1 4 0.9 14 3.2
9 GL yes 136 108 79.3 29 21.7 98 72.6 0 0.0 0 0.0
10 GR yes 293 174 60.5 207 69.6 58 20.2 1 0.2 2 0.6
11 JU yes 416 240 57.9 290 69.0 343 82.4 5 1.3 18 4.2
12 LU no 252 198 77.3 113 45.5 72 28.9 3 1.1 4 1.7
13 NE yes 276 133 48.0 249 90.1 85 29.9 3 1.0 6 2.2
14 NW yes 88 69 78.9 38 44.8 59 67.2 1 1.0 1 0.7
15 OW no 60 43 74.0 38 64.9 8 11.7 0 0.0 1 1.3
16 SG yes 299 187 62.8 147 50.2 163 54.6 7 2.4 6 1.9
17 SH yes 285 179 65.8 143 52.4 193 70.3 2 0.8 2 0.6
18 SO no 374 291 77.7 189 48.5 180 46.4 4 1.0 2 0.5
19 SZ yes 231 115 49.8 118 51.2 169 73.1 1 0.4 7 3.0
20 TG yes 364 261 71.5 199 54.1 153 41.7 6 1.8 4 1.2
21 TI no - - - - - - - - - - -
22 UR no 259 191 74.4 136 52.4 110 42.9 0 0.0 2 0.7
23 VD yes - - - - - - - - - - -
24 VS yes 321 139 43.1 230 71.2 237 73.5 4 1.3 37 11.2
25 ZG no 59 53 91.3 28 40.0 11 16.0 3 4.5 2 6.2
26 ZH yes 430 288 67.1 244 56.8 153 35.5 0 0.0 43 10.0
27 CH 6314 3607 58.4 3884 60.4 3194 47.5 72 1.1 180 4.1
Multiple answers were possible.
BE, TI, VD: no information available since questionnaires were not used with school children. 
schoolvax: vaccination is permitted in school
CAM: Complementary / alternative medicine 
 Practitioner
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Annex J.1.  Information status regarding vaccination as perceived 
by parents of toddlers in each canton, 1999-2003
received If yes........
KT n Info (%) n satisfied (%) not satisfied (%) do not know(%) no answer(%)
AG 321 95.5 308 65.6 26.3 6.8 1.3
AI 183 96.0 176 67.8 19.8 6.9 5.5
AR 268 94.7 255 71.3 17.5 5.3 5.9
BE 460 90.7 422 76.5 14.5 5.1 3.8
BL 337 83.9 287 64.7 22.3 12.4 0.6
BS 287 88.7 260 70.5 20.6 5.3 3.7
FR 280 82.9 240 61.7 27.6 4.0 6.7
GE 588 84.0 498 68.9 16.3 8.0 6.8
GL 268 89.0 241 68.8 20.6 4.7 5.9
GR 276 94.1 261 73.5 18.4 4.5 3.6
JU 234 96.6 225 78.6 15.4 2.4 3.7
LU 362 90.9 323 63.9 22.7 4.4 9.0
NE 335 89.2 295 65.3 26.7 6.4 1.6
NW 294 96.7 285 69.8 22.9 3.3 4.0
OW 236 94.5 223 68.3 21.7 6.2 3.8
SG 274 91.7 251 67.6 20.2 6.8 5.4
SH 363 90.3 333 74.1 15.6 2.9 7.4
SO 293 88.7 266 67.0 18.0 6.8 8.2
SZ 384 89.6 351 68.0 20.4 4.3 7.4
TG 234 93.7 219 63.5 22.0 7.6 7.0
TI 532 89.3 477 67.6 15.6 5.9 10.9
UR 289 94.1 273 71.9 14.7 9.5 3.9
VD 363 80.0 288 63.4 25.1 5.8 5.7
VS 352 87.6 312 62.3 37.7 0.0 0.0
ZG 253 92.5 236 68.1 18.2 5.8 8.0
ZH 345 86.6 304 61.7 19.8 0.0 18.4
CH 8399 88.7 7609 66.9 21.2 4.8 7.1
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Annex J.2. Information status regarding vaccination as perceived
by parents of children at school entry in each canton
1999-2003
received If yes........
KT n Info (%) n satisfied (%) not satisfied (%) do not know%) no answer(%)
AG 431 91.8 397 71.9 16.7 6.8 4.7
AI 166 88.0 147 63.9 13.3 10.9 11.9
AR 218 93.5 202 75.6 14.7 9.4 0.3
BE - - - - - - -
BL 407 88.1 358 68.8 19.5 5.1 6.5
BS 719 83.8 348 69.3 16.6 5.6 8.5
FR 268 89.7 280 69.4 17.2 6.3 7.2
GE 429 81.0 349 64.8 18.1 11.5 5.6
GL 213 87.4 186 63.8 19.0 10.1 7.1
GR 233 95.8 223 68.3 20.2 10.5 1.0
JU 301 91.5 277 75.0 15.1 9.5 0.3
LU 398 89.8 358 63.7 21.5 13.4 1.4
NE 369 85.8 321 68.8 23.9 3.7 3.6
NW 130 94.5 122 68.1 22.5 8.0 1.4
OW 80 90.2 72 57.4 27.6 12.3 2.7
SG 248 92.3 229 68.5 17.8 11.4 2.2
SH 335 89.6 301 62.2 22.0 5.4 10.3
SO 374 89.7 337 66.1 19.7 7.8 6.4
SZ 323 90.7 293 68.3 16.5 13.3 2.0
TG 342 90.9 306 65.3 20.8 7.9 6.0
TI - - - - - - -
UR 211 93.6 197 69.2 16.2 12.0 2.7
VD - - - - - - -
VS 291 87.1 255 64.5 10.8 - 24.7
ZG 120 86.5 106 58.6 23.1 9.4 9.0
ZH 530 89.2 475 65.5 14.7 - 19.7
CH 6876 91.8 6139 67.0 17.8 6.8 8.4
BE, TI, VD: no information available for schoolchildren as the questionnaire was not used.
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Annex J.3. Information status regarding vaccination as perceived
by parents of children at school departure in each canton 
1999-2003
received If yes........
KT n Info (%) n satisfied (%) not satisfied (%) do not know(%) no answer(%)
AG 492 92.4 456 73.9 14.5 6.8 4.8
AI 107 89.5 95 68.3 6.2 12.1 13.4
AR 127 92.4 117 71.5 12.4 13.6 2.5
BE - - - - - -
BL 341 90.3 308 68.9 18.3 8.7 4.1
BS 313 84.0 262 69.2 16.8 7.0 6.9
FR 368 91.8 339 71.9 15.2 8.9 4.0
GE 433 85.3 372 68.1 12.1 13.6 6.1
GL 136 82.3 110 69.3 12.8 10.0 7.9
GR 293 87.5 254 66.2 15.7 17.6 0.5
JU 416 91.2 381 68.3 18.8 11.9 1.0
LU 252 89.7 227 76.6 11.6 11.4 0.4
NE 276 93.7 260 67.8 22.1 8.7 1.3
NW 88 91.0 80 65.7 18.1 15.2 1.1
OW 60 91.5 57 72.3 14.2 10.6 2.8
SG 299 90.6 270 72.1 11.0 15.6 1.3
SH 275 89.6 245 69.5 15.0 8.6 7.0
SO 374 86.6 333 71.9 13.7 8.1 6.3
SZ 231 90.9 210 73.7 12.9 12.4 1.0
TG 364 87.7 322 71.5 13.7 8.1 6.6
TI - - - - - - -
UR 259 88.1 227 74.3 11.2 13.2 1.3
VD - - - - - -
VS 321 92.3 297 66.6 10.0 - 23.4
ZG 59 84.0 54 53.6 17.3 24.0 5.1
ZH 429 77.7 333 63.4 17.6 - 18.9
CH 6313 87.2 5609 69.5 14.7 8.1 7.2
BE, TI, VD: no information available for schoolchildren as the questionnaire was not used.
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Annex K.1.   Sources for information regarding vaccination for parents
of children between 24-35 months of age in Switzerland, 1999-2003
AG AI AR BE BL BS
n 321 183 268 460 337 287
present future present future present future present future present future present future
Information broshures 61.7 78.2 39.3 55.8 47.3 62.6 46.2 64.7 44.7 71.1 38.2 68.1
Doctor upon request 56.2 55.3 54.2 32.2 59.4 50.1 51.8 39.1 60.4 47.1 58.5 48.9
Doctor without request 26.2 65.2 27.4 61.8 29.1 62.7 42.1 65.0 28.3 73.5 38.2 73.4
School doctor 1.2 10.9 1.1 8.9 0.4 8.3 3.0 8.7 0.6 11.3 3.6 15.1
The media 44.2 42.2 42.4 22.1 40.3 38.3 34.9 30.5 46.6 44.8 31.1 34.2
Public health services 27.8 32.4 37.7 36.0 25.0 29.5 28.7 30.8 14.7 24.1 13.5 19.7
Health insurance 1.4 14.6 3.6 16.0 0.6 14.0 2.2 18.0 2.7 19.1 2.6 21.9
Job / Education 13.0 2.0 16.2 3.8 14.0 4.0 11.2 3.3 13.3 6.2 13.0 5.3
Other resources 10.4 5.5 10.4 3.2 8.7 5.3 7.0 2.6 8.0 5.4 8.3 2.8
FR GE GL GR JU LU
n 280 588 268 276 234 352
present future present future present future present future present future present future
Information broshures 35.2 64.1 29.7 54.8 49.0 62.1 54.3 58.2 44.7 57.7 49.6 66.5
Doctor upon request 48.5 43.2 41.9 41.5 50.6 37.2 52.8 42.6 46.5 55.5 53.2 39.1
Doctor without request 29.0 62.9 40.0 61.8 27.2 62.8 31.8 60.5 41.8 51.5 25.5 57.3
School doctor 0.6 11.5 2.4 17.1 1.3 11.4 0.7 5.6 3.8 14.3 0.5 10.5
The media 39.1 31.0 26.3 19.6 31.5 28.2 38.9 27.2 20.1 18.6 45.0 38.5
Public health services 11.4 19.9 5.2 12.1 36.0 31.2 32.9 34.1 17.1 24.5 30.4 37.2
Health insurance 3.3 16.2 1.7 11.3 2.9 14.7 1.0 11.4 0.0 49.0 3.0 19.4
Job / Education 15.8 4.7 8.5 2.0 12.5 3.6 12.3 2.4 12.6 2.5 1.3 4.5
Other resources 6.3 3.0 4.8 1.8 7.5 2.6 13.8 5.6 7.8 4.1 10.9 3.4
NE NW OW SG SH SO
n 333 294 236 274 363 293
present future present future present future present future present future present future
Information broshures 30.3 69.1 56.2 71.2 58.6 61.8 50.8 64.5 37.7 66.1 45.2 62.1
Doctor upon request 58.6 61.6 58.5 43.2 54.2 40.8 54.0 40.1 61.9 39.4 48.6 36.9
Doctor without request 51.2 72.2 39.8 67.3 26.5 52.9 31.9 57.0 34.2 62.7 39.8 64.9
School doctor 1.1 8.3 0.8 6.9 1.6 7.0 1.8 8.8 2.1 11.0 2.7 14.0
The media 21.6 31.5 42.8 33.3 42.2 30.3 35.7 36.1 39.8 35.4 46.6 30.0
Public health services 10.2 9.1 24.7 32.1 21.8 27.8 28.5 27.2 23.5 26.8 32.0 37.2
Health insurance 1.8 13.5 1.1 17.4 1.1 11.8 3.8 13.7 2.0 17.8 4.1 20.1
Job / Education 12.5 3.6 10.9 3.2 10.7 2.4 11.5 4.0 13.6 2.7 12.2 2.9
Other resources 5.2 2.8 14.0 4.2 14.3 4.0 8.0 5.4 9.0 2.9 8.1 1.7
SZ TG TI UR VD VS
n 384 234 532 289 363 352
present future present future present future present future present future present future
Information broshures 41.3 61.0 48.5 64.0 38.3 55.5 59.1 63.1 37.3 59.0 44.6 62.0
Doctor upon request 55.1 40.8 50.8 35.6 56.2 39.6 49.8 38.9 38.6 34.7 46.7 42.4
Doctor without request 29.9 62.1 31.3 65.0 40.9 61.2 38.3 62.4 31.4 62.1 40.4 68.0
School doctor 2.5 11.3 1.4 8.7 - 23.6 1.7 9.9 1.7 13.3 4.0 23.6
The media 43.3 29.0 40.6 29.7 27.6 20.8 40.6 36.3 32.2 25.8 31.5 26.9
Public health services 22.2 29.4 28.4 37.4 8.5 3.4 20.5 25.1 8.7 17.6 17.5 22.5
Health insurance 2.1 19.7 1.3 18.4 1.8 12.9 2.0 19.1 2.7 17.3 1.3 15.4
Job / Education 12.4 5.0 12.4 1.8 11.6 9.6 9.0 2.0 9.3 2.4 2.2 0.0
Other resources 15.7 2.8 9.7 3.0 5.4 0.8 10.2 4.6 6.8 4.4 30.4 22.0
ZG ZH
n 253 345 Multiple answers were possible.
present future present future TI: School doctors were not included as a choice.
Information broshures 55.8 68.5 41.8 61.3
Doctor upon request 54.4 46.6 40.4 35.8
Doctor without request 30.4 64.7 44.8 70.8
School doctor 1.1 9.3 1.5 14.8
The media 44.5 41.6 31.9 30.0
Public health services 22.0 29.1 22.9 35.2
Health insurance 1.6 14.9 2.1 17.2
Job / Education 11.1 3.5 2.1 0.3
Other resources 10.2 8.9 29.6 26.8
Annex K.2.   Sources for information regarding vaccination for parents
of children at school entry in Switzerland, 1999-2003
AG AI AR BE BL BS
n 431 183 268 0 337 287
present future present future present future present future present future present future
Information broshures 52.6 62.1 26.7 39.8 47.6 51.2 39.1 62.8 31.3 57.5
Doctor upon request 45.4 30.6 52.6 31.7 49.8 43.2 53.7 38.5 55.0 40.0
Doctor without request 26.4 50.4 24.9 43.0 38.4 51.6 36.4 62.5 34.3 54.9
School doctor 10.5 23.0 3.5 17.3 5.0 20.0 5.0 16.9 7.4 22.4
The media 38.6 26.4 34.2 15.5 33.5 25.2 41.7 32.1 35.2 29.4
Public health services 27.6 22.5 35.7 27.7 31.3 24.7 13.9 18.7 9.0 12.0
Health insurance 3.3 19.3 1.7 15.9 3.7 14.0 2.4 17.9 2.6 15.6
Job / Education 12.6 4.0 10.8 3.8 13.3 2.7 16.3 5.8 14.3 4.5
Other resources 6.3 2.2 4.1 1.8 8.1 2.9 7.0 3.4 4.8 1.3
FR GE GL GR JU LU
n 280 588 268 276 234 352
present future present future present future present future present future present future
Information broshures 35.3 59.6 25.4 47.1 31.0 53.6 44.1 57.4 50.2 53.2 37.3 63.4
Doctor upon request 48.7 46.0 39.8 37.7 42.3 30.1 51.9 40.3 41.1 47.1 53.8 41.4
Doctor without request 36.9 53.2 39.8 50.7 34.4 55.4 37.5 59.0 37.0 43.7 33.5 53.9
School doctor 9.8 23.3 7.1 27.3 11.3 24.9 3.0 16.4 21.7 42.7 6.6 21.1
The media 38.7 26.4 26.5 20.6 32.0 23.1 41.0 31.9 26.9 17.0 44.3 36.8
Public health services 18.5 15.6 7.3 7.6 30.0 18.6 28.8 21.6 20.1 16.6 26.9 28.6
Health insurance 1.3 13.9 2.2 8.3 1.8 16.1 1.3 15.4 0.8 9.1 4.4 20.3
Job / Education 14.8 3.2 11.2 4.7 11.4 3.3 8.0 2.6 10.8 1.6 9.9 2.3
Other resources 3.5 1.5 8.1 2.7 4.8 1.9 4.8 2.6 5.5 2.6 9.3 1.4
NE NW OW SG SH SO
n 333 130 236 274 363 293
present future present future present future present future present future present future
Information broshures 30.7 56.3 61.6 65.9 36.3 61.0 39.0 59.9 33.8 61.9 38.4 61.8
Doctor upon request 48.4 53.6 56.6 32.2 56.3 30.9 46.1 28.7 55.5 42.4 55.8 36.3
Doctor without request 48.5 63.8 37.6 58.6 32.4 62.0 30.5 61.2 32.3 60.0 31.4 62.8
School doctor 7.6 16.1 12.9 25.9 9.8 26.7 11.6 27.3 6.9 26.0 6.2 24.0
The media 24.4 27.7 47.5 33.7 42.2 40.3 37.7 26.6 39.1 25.8 36.9 29.3
Public health services 10.4 10.2 28.2 28.7 20.7 24.2 25.5 22.0 21.7 20.2 26.6 25.1
Health insurance 2.5 14.1 2.1 18.2 4.9 26.2 4.0 16.9 3.4 17.3 2.5 20.3
Job / Education 12.1 4.5 13.2 6.1 11.3 3.5 7.7 1.6 14.3 3.5 10.5 3.5
Other resources 6.8 2.5 6.7 4.7 3.6 2.5 7.2 2.0 6.9 2.8 6.5 2.2
SZ TG TI UR VD VS
n 384 234 0 211 0 291
present future present future present future present future present future present future
Information broshures 38.2 62.0 47.0 64.5 56.1 65.6 42.7 51.2
Doctor upon request 51.4 31.5 50.3 41.2 47.6 39.7 46.5 49.3
Doctor without request 32.2 56.4 36.1 55.3 41.2 60.9 43.9 58.1
School doctor 8.3 20.7 4.2 23.0 9.0 20.2 21.7 30.9
The media 40.7 27.6 47.6 33.8 55.9 34.7 31.9 21.1
Public health services 24.6 21.1 29.6 25.1 20.0 23.7 20.5 15.9
Health insurance 4.9 18.0 2.0 16.9 3.4 20.2 1.7 13.5
Job / Education 10.2 3.1 13.7 2.9 8.7 3.5 1.6 0.0
Other resources 8.3 4.0 4.9 2.8 4.9 1.8 2.7 18.7
ZG ZH
n 253 530 Multiple answers were possible.
present future present future BE, TI, VD: questionnaires were not used.
Information broshures 41.0 63.4 37.9 59.8
Doctor upon request 49.6 34.7 51.2 42.5
Doctor without request 32.2 60.2 43.0 62.6
School doctor 9.2 15.9 10.1 28.9
The media 48.8 30.0 28.4 27.3
Public health services 35.5 25.7 16.4 18.9
Health insurance 3.1 17.7 1.2 14.8
Job / Education 9.5 3.2 2.1 0.0
Other resources 7.1 3.2 23.4 16.4
Annex K.3.   Sources for information regarding vaccination for parents
of children at school departure in Switzerland, 1999-2003
AG AI AR BE BL BS
n 492 107 127 0 341 313
present future present future present future present future present future present future
Information broshures 51.7 61.3 29.3 36.6 34.1 52.9 43.7 60.2 32.6 60.0
Doctor upon request 39.5 30.7 35.9 25.5 32.4 40.3 48.0 39.3 48.8 37.3
Doctor without request 20.7 38.2 32.0 48.6 29.4 39.2 37.3 56.3 30.8 51.7
School doctor 21.4 29.4 7.1 19.3 37.5 30.9 26.6 32.4 22.4 31.3
The media 34.0 28.6 26.0 11.5 29.0 27.9 36.0 36.1 29.0 26.7
Public health services 25.0 17.5 35.0 15.2 20.3 15.5 17.0 15.6 6.8 11.8
Health insurance 3.8 19.2 8.1 12.4 2.5 17.6 5.1 22.7 4.0 20.4
Job / Education 15.6 5.4 2.6 1.6 9.4 7.7 14.1 9.4 14.2 7.7
Other resources 9.1 2.7 5.5 2.6 8.6 3.9 4.5 1.7 6.6 1.9
FR GE GL GR JU LU
n 368 433 136 293 416 252
present future present future present future present future present future present future
Information broshures 44.8 57.8 30.2 49.5 29.9 49.0 32.2 54.7 58.9 56.0 37.1 55.2
Doctor upon request 44.3 40.4 46.5 46.3 32.5 31.5 45.0 37.4 36.5 44.2 44.6 47.7
Doctor without request 25.8 44.6 35.8 47.8 26.5 52.1 36.0 50.0 20.1 32.5 30.5 43.3
School doctor 25.5 28.1 15.0 30.2 32.7 38.4 15.4 21.0 36.5 47.7 32.1 33.6
The media 36.3 25.6 34.0 24.0 26.6 21.5 26.1 23.9 28.3 21.4 31.3 28.6
Public health services 9.0 5.2 5.1 5.2 28.2 20.7 23.9 19.6 15.5 14.0 21.8 19.6
Health insurance 2.7 12.7 1.7 90.3 2.3 16.3 2.5 20.0 4.3 10.6 3.2 20.0
Job / Education 9.6 3.0 10.5 4.2 11.6 6.0 13.2 6.7 8.5 6.4 7.0 6.5
Other resources 6.4 1.4 5.2 2.9 4.3 3.4 6.3 3.4 7.4 4.9 7.0 1.5
NE NW OW SG SH SO
n 276 88 60 299 275 374
present future present future present future present future present future present future
Information broshures 35.8 54.6 37.6 59.7 45.4 63.0 33.7 52.8 34.2 56.4 37.7 55.8
Doctor upon request 55.9 58.6 47.3 37.1 42.8 39.5 41.3 36.7 43.8 36.1 41.6 38.5
Doctor without request 34.7 47.8 31.4 52.4 33.8 52.6 26.3 38.5 28.6 41.7 29.9 47.2
School doctor 24.9 32.7 33.1 35.6 13.6 27.3 31.9 32.3 31.6 41.2 21.0 33.6
The media 31.3 34.6 39.6 37.5 48.0 37.7 35.1 27.5 35.3 30.8 37.6 26.0
Public health services 9.2 8.0 28.0 31.5 14.9 16.2 21.5 16.0 22.3 17.0 20.1 14.4
Health insurance 1.6 20.4 6.8 17.9 6.5 30.5 5.5 15.9 3.3 17.4 1.4 18.8
Job / Education 12.8 6.0 12.6 2.2 13.6 13.0 8.0 4.3 12.3 8.1 12.0 6.9
Other resources 5.5 2.9 6.0 0.1 5.9 1.3 6.2 3.1 5.4 1.7 5.3 3.0
SZ TG TI UR VD VS
n 231 364 0 259 0 321
present future present future present future present future present future present future
Information broshures 36.0 55.9 39.3 52.7 35.6 55.7 61.0 55.4
Doctor upon request 41.2 33.7 43.2 39.7 43.0 35.1 42.2 54.1
Doctor without request 24.6 42.0 30.6 46.3 29.5 45.0 25.0 42.1
School doctor 35.5 35.5 22.0 28.8 24.1 33.2 35.9 41.3
The media 29.0 22.1 40.6 29.5 34.8 31.5 38.6 31.7
Public health services 22.6 18.7 24.3 19.7 22.8 13.4 20.6 18.1
Health insurance 3.0 16.1 4.7 21.1 3.3 11.9 28.3 13.2
Job / Education 10.0 3.0 11.5 6.6 9.1 7.8 0.5 0.3
Other resources 3.5 2.6 6.1 2.4 6.3 3.1 35.3 24.1
ZG ZH
n 59 429 Multiple answers were possible.
present future present future
Information broshures 36.4 73.9 29.3 54.8 BE, TI, VD: questionnaires were not used.
Doctor upon request 34.8 29.2 42.9 42.4
Doctor without request 30.0 52.1 34.9 58.1
School doctor 32.3 29.6 18.2 32.7
The media 33.5 42.1 23.4 24.8
Public health services 27.5 23.2 17.0 13.8
Health insurance 1.5 14.4 1.6 15.8
Job / Education 17.3 13.0 3.5 0
Other resources 5.8 4.4 1.7 19.3
ANNEX  L.  Percentage of parents of toddlers 24-35 months of age and children at 
school entry and departure who use alternative medicine, 1999-2003
Toddlers School entry School departure
KT Canton n Yes No No Answer n Yes No No Answer n Yes No No Answer
1 AG 321 37.1 57.8 5.1 421 32.5 64.5 3.0 492 26.5 72.0 1.5
2 AI 183 31.9 61.2 7.0 164 34.5 62.4 3.1 107 30.1 69.9 0.0
3 AR 268 46.0 50.0 4.0 218 35.6 59.7 4.6 127 30.7 69.3 0.0
4 BE 460 35.0 59.2 5.8 - - - - - - - -
5 BL 337 45.6 54.2 0.3 407 33.9 58.9 7.2 343 22.9 69.4 7.8
6 BS 287 37.3 61.1 1.5 376 28.3 61.4 10.3 313 20.4 79.6 0.0
7 FR 280 54.7 39.2 6.1 306 55.3 42.9 1.9 368 43.6 56.4 0.0
8 GE 588 38.5 53.3 8.3 427 42.4 49.7 7.8 433 39.3 56.0 4.7
9 GL 268 33.1 62.3 4.6 209 27.9 70.7 1.3 232 21.9 76.8 1.3
10 GR 276 41.0 57.5 1.5 233 30.8 65.3 3.9 293 29.4 70.6 0.0
11 JU 234 58.4 39.3 2.3 301 56.6 41.1 2.2 416 43.4 53.1 3.5
12 LU 352 40.4 52.4 7.3 393 37.3 60.8 1.9 252 29.0 71.0 0.0
13 NE 333 57.4 41.6 1.0 368 41.9 55.7 2.3 276 46.5 53.5 0.0
14 NW 296 39.3 54.8 5.9 130 46.4 47.0 6.7 88 38.8 61.2 0.0
15 OW 236 56.6 39.6 3.8 80 36.7 55.9 7.5 60 30.5 69.5 0.0
16 SG 274 38.6 59.7 1.8 248 31.2 65.6 3.1 299 29.7 70.3 0.0
17 SH 347 36.4 63.1 4.7 335 32.1 67.0 3.1 275 21.6 78.4 0.0
18 SO 295 34.5 56.1 9.4 374 38.0 53.0 9.0 374 26.0 74.0 0.0
19 SZ 384 36.2 55.2 8.6 323 39.8 59.2 9.4 261 26.0 74.0 0.0
20 TG 234 28.7 68.9 2.5 344 27.4 68.9 3.7 364 21.6 78.4 0.0
22 UR 289 40.3 51.8 7.9 211 42.3 55.2 2.5 259 30.9 69.1 0.0
23 VD 363 55.3 40.8 3.9 - - - - - - - -
24 VS 352 50.4 49.6 0.0 291 52.7 42.8 4.5 321 40.8 55.1 4.0
25 ZG 253 46.8 50.0 3.3 120 44.3 47.8 7.9 59 21.7 78.3 0.0
26 ZH 345 39.8 60.2 0.0 510 37.8 57.5 4.7 429 30.6 66.4 3.0
21 TI - - - - - - - - - - - -
27 CH 7851 41.7 54.7 3.6 6876 37.9 57.8 4.3 6313 30.9 67.4 1.7
BE, TI, VD: not information since questionnaires were not used with the school children.  
TI toddlers: this question was not included in the questionnaire.
Annex M.1.   School Vaccination Policy
Canton TIME OF ROUTINE HEALTH WITH/ SCHOOL TYPE OF HEPATITIS B CANTONALLY    DATA COLLECTION FOR SURVEY
WITHOUT VAX CARD CHECK-UP VAX? VAX CARD CAMPAIGN EMPLOYED NURSES SCHOOL YEAR PRIMARY MODE
AG 1/2 KL 5KL 7/8KL Y SBC Y Y (LL) 2000-2002 Nurses
AI 1KL - 6KL N SBC N N 2000-2001 Doctors
AR 1KL - 8KL Y SBC Y N 2001-2002 Doctors
BE KG 4KL 8KL Y SBC Y N 2001 Municipal
BL 1KL 4KL 7KL N SBC N Y (LL) 2000-2001 Nurses
BS KG 3KL 9KL Y SBC Y Y (SHS) 2001-2002 Nurses
FR 1KL 5KL 8KL Y SBC Y N 2000-2001 School authorities
GE 1KL 3KL 8KL N SBC Y Y (SHS) 2001-2002 Nurses
GL KG/1KL 5KL 9KL Y GL blue booklet N N 2000-2001 Doctors
GR 1KL 4KL 9KL Y SBC N N 2001-2002 Doctors
JU 1KL 5KL 8KL Y SBC N Y (LL) 2001-2002 Nurses
LU 1KL 4KL 8KL N SBC Y N 2000-2001 School authorities
NE 1KL 3/4KL 9KL Y NE yellow booklet N N 2000-2001 Municipal
NW 1KL - 8KL Y SBC N Y 2001-2002 School authorities
OW KG 4KL 9KL N SBC N N 2001-2002 School authorities
SG KG 5KL 8KL Y SBC N N 2001-2002 Doctors
SH KG 5KL 8KL Y SBC N N 2000-2001 Doctors
SO 1KL 4KL 8/9KL N SBC N N 2000-2001 School authorities
SZ 1KL 4KL 8KL Y SBC Y Y (SHS) 2001-2002 Nurses
TG KG 4KL 8KL Y SBC Y N 2000-2001 School authorities
TI 1KL 5KL 8KL N SBC Y N 2002-2003 Doctors
UR KG 4KL 8KL N SBC N N 2001-2002 Doctors
VD 1KL 5KL 8KL Y SBC Y Y (SHS) 2001-2003 Nurses
VS 1KL 5KL 8KL Y VS blue booklet Y Y (LL) 1998-1999 Nurses
ZG KG 4KL 8KL N SBC N N 2001-2002 School authorities
ZH KG/1KL 5KL 7/8KL Y SBC Y/N N 1998-1999 Doctors
Y: Yes.   N: No.   VAX: Vaccination.   KG: Kindergarten.  SBC: standard blue card.  LL: LungenLiga.   SHS: School Health Service with nurses.  
Hepatitis B campaign:  Hep B information distributed in addition to the standard letter to the parents informing them of the different vaccine-preventable diseases since 1999.
AG: within 2 years all children in these grades are examined. BS: in the 7KL, there is also a big vaccination campaign. BL, GE: the doctors and 
nurses do not vaccinate, except for Hep B.  OW: in KG, a certificate is distributed for a health exam to be redeemed by the family doctor. 
In 4Kl, there is a health exam in the school. In the 8KL, the "Gemeinde doctor" holds a 2hr health discussion in the class with the students,
who receive a certificate for a more personal one on one talk with the doctors.
T17.schoolvax.xls   GENERAL VAX  28.9.2007
Annex M.2.   Hepatitis B Vaccination Policy
Canton SCHOOL HEPB YEAR SCHOOL VACCINATION VACCINATION DATA COLLECTION FOR SURVEY
CAMPAIGN BEGAN YES / NO GRADE VACCINE PERSON SCHOOL YEAR MONTH GRADE PRIMARY MODE
AG YES 99/00 YES 7/8 Engerix / GenHB LL /SDR 2000-2002 school year 8 Nurses
AI NO 99 NO - - GP 2000-2001 school year 6 Doctors
AR YES 99 YES 8 Engerix SDR 2001-2002 school year 8 Doctors
BE YES 98/99 YES 8 Engerix / GenHB SDR 2001 5/01-10/01 8 Municipal
BL NO 98/99 YES / NO 9 Heprecomb GP/LL 2000-2001 5/01-7/01 9 Nurses
BS YES 99/00 YES 7 Engerix / GenHB SHS 2001-2002 school year 9 Nurses
FR YES 99/00 YES 7 GenHB SDR 2000-2001 5/01-7/01 8 School authorities
GE YES 98/99 YES 7/8 Engerix / GenHB SHS 2001-2002 school year 8 Nurses
GL NO 99 YES 9 Engerix / GenHB SDR/GP 2000-2001 1/01-7/01 8/9 Doctors
GR NO 99 YES 9 GenHB GP 2001-2002 school year 9 Doctors
JU NO 99 YES 8 GenHB LL 2001-2002 school year 8 Nurses
LU YES 99 NO 8 - GP 2000-2001 5/01-7/01 9 School authorities
NE NO 98/99 NO - - GP 2000-2001 school year 8 Municipal
NW NO 99 YES 8 Engerix SHS 2001-2002 2/02-7/02 9 School authorities
OW NO 99 NO - - GP 2001-2002 2/02-7/02 8 School authorities
SG NO 99 YES 5-8 Engerix / GenHB SDR 2001-2002 school year 8 Doctors
SH NO 98/99 YES 5-8 Engerix / GenHB SDR 2000-2001 2/01-7/01 8 Doctors
SO YES 99 NO - Engerix GP 2000-2001 9/00-12/00 8 School authorities
SZ YES 99 NO 8 - GP 2001-2002 2/02-7/02 8 Nurses
TG YES 99 YES 5-8 Engerix GP 2000-2001 9/00-12/00 8 School authorities
TI YES 99 NO - - GP 2002-2003 11/02-12/02 9 Doctors
UR NO 99 NO 7 - GP 2001-2002 school year 8 Doctors
VD YES 98/99 YES 7 GenHB SHS 2001-2003 12/02-8/03 8 Nurses
VS YES 99 YES 7 Engerix / GenHB LL 1998-1999 5/99 8 Nurses
ZG NO 98 NO - - GP 2001-2002 2/02-7/02 9 School authorities
ZH YES/NO 98/99 YES 7/8 Engerix / GenHB SDR/GP 1998-1999 2/99-7/99 8 Doctors
LL: Lungenliga.   SDR: school doctor. GP: family physician.  SHS: School Health Service with nurses.  
Hepatitis B campaign:  Hep B information distributed in addition to the standard letter to the parents informing them of the different vaccine-preventable diseases since 1999.
AG: within 2 years all children in these grades are examined.
BL: GP vaccinate first, and catch-up shots are done by LL in the 9th grade.
ZH: there is a HepB campaign in the city, but none in the rural areas.
School vaccination policy: applies for period of data collection.  In some cantons, it have changed since then.
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Übertragbare Krankheiten
Durchimpfung in der Schweiz 1999–2003
sung der Durchimpfung in allen 
26 Kantonen in Auftrag gegeben.
Im Weiteren ging es darum, Metho-
den für ein regelmässiges Monito-
ring auszuarbeiten.
Dieser zusammenfassende Be-
richt vergleicht das Impfniveau bei
drei Altersgruppen in den 26 Kan-
tonen. Die Einflussfaktoren, welche
das Impfverhalten beeinflussen,
werden in einer zweiten Publikation
diskutiert. Für mehr Informationen
über die Methoden und Analysen
siehe detaillierter Bericht vom April
2005 [4].
METHODE
Aufgrund der unterschiedlichen Mög-
lichkeiten eine Stichprobe zu ziehen
und der vorhandenen Infrastruktur
wurden zwei Methoden benutzt: 
In 15 Kantonen war eine Liste 
von Kleinkindern eines bestimmten
Jahrgangs von den ausgewählten
Gemeinden erhältlich. Diese Liste
enthielt Name des Kindes und der
Eltern, Geburtsdatum, Geschlecht,
Adresse, Nationalität und Telefon-
nummer. Wegen der relativ kleinen
Einwohnerzahl in den Kantonen AI,
GL, NW, OW und UR wurden alle
Kinder im Alter zwischen 24 und 35
Monaten, die zur Zeit der Studien-
erhebung in diesen Kantonen wohn-
haft waren, befragt. In den Kanto-
nen BS und NE wurde eine einfache
Zufallsstichprobe erhoben, da es
dort jeweils eine zentrale Daten-
bank gibt. Weil die Diphtherieimp-
fung im Kanton GE obligatorisch 
ist, schreibt der kantonsärztliche
Dienst regelmässig allen Eltern, 
deren Kleinkinder das Alter von 28
Monaten erreicht haben, und fordert
diese auf, die Impfausweise einzu-
senden. Freundlicherweise hat der
Kanton Genf dem Institut für Sozial-
und Präventivmedizin (ISPM) er-
möglicht, diese Studie mit der Rou-
tineüberprüfung der Impfausweise
zu verbinden, damit die Eltern nicht
mehrmals befragt werden muss-
ten. Im Kanton VD wurde die Aus-
wahl der Stichprobengruppe dem
«Bureau Vaudois d’Adresses» an-
vertraut, welches die Verantwor-
tung für den Unterhalt des zentralen
Registers des Kantons hat.
Die Familien der ausgewählten
Kleinkinder wurden mit einem Brief,
welcher ein Erklärungsschreiben,
EINLEITUNG
Obwohl Impfungen als eine der 
effektivsten Gesundheitsmassnah-
men gelten, sind die Meinungen 
darüber teilweise kontrovers. Zahl-
reiche Eltern und einzelne Ärzte 
bezweifeln den Nutzen und die 
Wirkungsweise dieser präventiven
Massnahme und heben mögliche
Nebeneffekte hervor [1–3]. Um die
Bedrohung von Epidemien, die aus
mangelnder Impfcompliance resul-
tiert, einschätzen zu können, hat das
Bundesamt für Gesundheit (BAG) in
den Jahren 1999–2003 eine Erfas-
Obwohl Impfungen als eine der wirk-
samsten Massnahmen zur Förderung der öffentlichen
Gesundheit gelten, hat ein Teil der Bevölkerung diesbe-
züglich Bedenken. Deshalb wurde das Institut für Sozial-
und Präventivmedizin der Universität Zürich beauftragt,
die Durchimpfung von Kindern in drei verschiedenen
Altersgruppen in allen Kantonen zwischen 1999 und
2003 anhand der Impfausweise zu erheben und die
Faktoren, welche das Impfverhalten beeinflussen, mit-
tels Fragebogen zu untersuchen. Die durchschnittliche
nationale Durchimpfung mit drei Dosen Diphtherie- (Di),
Tetanus- (Te), Pertussis- (Per), Poliomyelitis- (Pol) und
Haemophilus influenzae Typ b- (Hib) sowie einer Dosis
Masern-, Mumps- und Röteln- (MMR-) Impfung war wie
folgt: über 91% bei Di, Te, Per, Pol und Hib und rund
81% bei MMR bei den Kleinkindern, und mit vier Dosen
über 92% bei Di, Te und Pol, 60,9% bei Per, 26,6% bei
Hib und 87% bei einer Dosis MMR bei Schuleintrittskin-
dern. Bei den Schulaustretenden war die Durchimpfung
mit fünf Dosen Di, Te und Pol über 81% und rund 50%
bei zwei Dosen MMR (rund 93% bei einer Dosis). Bei
dieser Altersgruppe schwankte die Deckung für Hepati-
tis B zwischen  2,3% und 88,3% mit dem Mittelwert für
eine Dosis bei 46,3%, für zwei Dosen bei 40,8% und drei
Dosen bei 25,9%. Aufgrund methodischer Schwierigkei-
ten ist der Vergleich bei Schulkindern zwischen den
verschiedenen Kantonen mit Vorsicht zu betrachten. Der
Vergleich der Durchimpfung von Kleinkindern mit einer
Dosis MMR und je drei Dosen von Di, Te und Pol zwi-
schen den Jahren 1999 und 2003 (diese Studie) und den
Jahren 1991 und 1998 zeigt, dass die Durchimpfung
ungefähr gleich blieb. Für drei und vier Dosen Per und
Hib und vier Dosen Di, Te, und Pol ist die Durchimpfung
gestiegen, wobei Hib am offensichtlichsten von 77% im
Jahr 1998 auf 91% in unserer Erhebung bei drei Dosen
und von 47% auf 79% bei vier Dosen gestiegen ist.
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einen Fragebogen in der Sprache
der Region (wenn nötig in der
Fremdsprache der Familie)  und ei-
nen vorfrankierten Briefumschlag
enthielt, aufgefordert an der Studie
teilzunehmen. Wenn innerhalb von
3–4 Wochen keine Antwort erfolgte,
erhielten die Eltern ein Erinnerungs-
schreiben. Wurde darauf ebenfalls
nicht reagiert, kontaktierte man die
Eltern telefonisch (ca. 3–4 Versuche
zu verschiedenen Tageszeiten). 
Als Datenerhebungsgrundlage für
die Schulkinder diente überall, aus-
ser in den Kantonen BE und NE,
eine Liste der Schulen und der An-
zahl der Klassen mit Kindern der
Zielgruppe. Von dieser Liste wurden
zwischen 30 und 50 Schulklassen,
gemäss der durchschnittlichen Klas-
sengrösse des Kantons, ausge-
wählt. Alle Schüler in den ausge-
wählten Klassen wurden für die
Studie rekrutiert. Nachdem die Klas-
sen ausgewählt waren, variierte die
Datenerhebungsmethode entspre-
chend der vorhandenen Infrastruk-
tur. In den Kantonen FR, LU, NW,
OW, SO, TG und ZG wurden Schul-
direktoren und Lehrer gebeten, bei
der Studie mitzuhelfen. Sie wurden
ersucht, Fragebogen zu verteilen
und das Original oder eine Kopie
des Impfausweises einzusammeln
und direkt an das ISPM weiterzulei-
ten. In den Kantonen AI, AR, GL,
GR, SG, SH, TI, UR und ZH wurden
die Informationen direkt an die
Schulärzte gesandt, welche die 
Studie mit der routinemässigen
Schularztuntersuchung koordinier-
ten. Aufgrund der kleinen Kantons-
grösse von AI, GL und UR wurden
die Schulärzte gebeten die Daten
von allen Schulanfängern und Schul-
austretenden, für die sie zuständig
waren, einzusammeln. In den Kan-
tonen AG, BL, BS, GE, JU, SZ, VD
wurde die Studie mit den Kranken-
schwestern des Schulgesundheits-
dienstes oder mit der Lungenliga,
welche für alle Phasen der Daten-
erhebung zuständig waren, koordi-
niert. Da die Studie mit den schul-
ärztlichen Untersuchungen koordi-
niert wurde, variieren die ausge-
wählten Stufen: beim Schuleintritts-
alter wurden Kindergärtler (zweites
Jahr), Erst-, Zweit- oder Drittkläss-
ler, und beim Schulaustrittsalter
Sechst-, Siebt-, Acht- oder Neunt-
klässler ausgewählt. In den Kanto-
nen BE und NE wurde die Kleinkin-
der-Methode auch für die Schulkin-
der angewendet: Die Familien wur-
den direkt aufgefordert, an der Stu-
die teilzunehmen, indem, wie bei
den Kleinkindern, jede/r Schüler/in
der ausgewählten Klasse einen
Brief erhielt, welcher ein Erklä-
rungsschreiben und einen Fragebo-
gen enthielt. 
In den Kantonen BE, SO, TG und
TI wurden alle Phasen der Daten-
erhebung durch die entsprechenden
kantonalen Dienste organisiert und
durchgeführt; die Kantone SO und
TG sammelten die Daten ein, nach-
dem die Auswahl vom ISPM durch-
geführt wurde. In den Kantonen BE
und TI erfolgte die Erhebung unab-
hängig vom ISPM [5; A. Galfetti,
Bellinzona, persönliche Mitteilung,
2003]. Die Daten wurden danach
freundlicherweise dem ISPM für die
Datenanalyse zur Verfügung gestellt.
Datenanalyse
Die Daten für Kleinkinder und Schul-
kinder wurden in Abhängigkeit von
der Erfassungswahrscheinlichkeit
bei der Stichprobe gewichtet und
für den Anteil der nicht Antworten-
den ausgeglichen. Mit Ausnahme
der Kantone BE, TI und VD erfolgte
nachträglich eine Stratifikation nach
Nationalität (Schweizer/Ausländer)
und Geschlecht [4]. Bei Kleinkin-
dern wurde als weiteres Kriterium
neben Geschlecht und Nationalität
auch die Wohnsituation (Stadt/
Land), gemäss Definition des Bun-
desamtes für Statistik (1999–2003),
berücksichtigt. Infolge von Missver-
ständnissen wurde im Kanton JU
die Durchimpfung nicht für jede Do-
sis einer Impfung ermittelt. Das Sig-
nifikanzniveau wurde  bei  p < 0,05
festgelegt.
RESULTATE
Beteiligung
Die Studie wurde zwischen 1999
und 2003 für alle drei Altersgruppen
in allen Kanton abgeschlossen. Die
meisten Kantone leisteten einen
Beitrag zur Datenerfassung, vor al-
lem bei den Schulkindern, indem
sie finanzielle oder personelle Res-
sourcen zur Verfügung stellten und
administrative Hilfe beim Daten-
schutz und beim Verfassen der
Briefe an die Eltern, Gemeinden
und Schulbehörden leisteten. 
In 25 Kantonen wurden Kleinkinder
zwischen 24 und 35 Monaten aus-
gewählt. Im Kanton TI wurden die
Daten von Kindern im ersten Kin-
dergartenjahr (34–81 Monate, Mit-
telwert 46,7 Monate) untersucht.
Bei den Kleinkindern hatten wir
durchschnittlich 62,3% der Impf-
ausweise erhalten. Die Beteiligung
bei den Schulkindern variierte in Ab-
hängigkeit von der Art der Daten-
erhebung (siehe Tabelle 1). In Kan-
tonen, in welchen kantonale Schul-
krankenschwestern oder Gesund-
heitsinstitutionen die Schulärzte bei
den Schuluntersuchungen unter-
stützten, betrug die Beteiligungs-
rate durchschnittlich 79,2% für Kin-
der bei Schuleintritt und 77,9% für
Kinder bei Schulaustritt. Bei der Zu-
sammenarbeit mit Schulärzten be-
trug die Antwortrate 56,6% (Schul-
eintritt) und 63,1% (Schulaustritt).
Bei der Zusammenarbeit mit Leh-
rern lag die Beteiligungsrate bei
      Übertragbare Krankheiten
Tabelle 1
Durchimpfung in der Schweiz 1999–2003: Rücklauf (%) der Impfausweise nach Art
der Datenerhebung und kantonale Spannweite1)
N2) Mittelwert Spannweite
Kleinkinder 14017 62,3 42,0–82,8
Schuleintritt: 8480 59,8 10,6–96,3
– Schulschwester 3303 79,2 55,2–96,3
– Schulärzte 2423 56,6 40,1–80,6
– Lehrerschaft 1754 37,1 10,6–67,0
Schulaustritt: 7623 57,6 6,8–91,7
– Schulschwester 3489 77,9 57,5–91,7
– Schulärzte 2558 63,1 51,1–79,3
– Lehrerschaft 1576 33,4 6,8–58,9
1) Ohne BE, JU, NE, TI
2) N: Stichprobengrösse
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37,1% (Schuleintritt) und 33,4%
(Schulaustritt). In NE, wo die Fami-
lien der ausgewählten Schüler ohne
Hilfe von Schulärzten oder offiziel-
len Stellen direkt kontaktiert wur-
den, lag der Beteiligungsgrad bei
69,6% für Schuleintrittskinder und
63,5% für Kinder bei Schulaustritt.
In BE war die Beteiligung nach ma-
ximal 4 Kontakten per Brief mit
89,5% (Schuleintritt) und 90,6%
(Schulaustritt) sehr hoch [5]. Dank
der Hilfe von Schulärzten war im
Kanton TI die Antwortrate mit
84,2% resp. 83,7% ebenfalls sehr
hoch [A. Galfetti, Bellinzona, per-
sönliche Mitteilung, 2003].
Durchimpfung
Tabelle 2 zeigt eine Zusammenfas-
sung der nationalen Durchimpfung,
detailliert nach Anzahl Impfungen
und  Altersgruppe. Die Durchimp-
fung mit den ersten drei Dosen Di,
Te und Pol bei allen drei Altersgrup-
pen sowie Per und Hib bei den
Kleinkindern ist hoch (>90%). Für
die weiteren Dosen fällt das Impf-
niveau, z.B. bei Kleinkindern, bis auf
83,6% für vier Dosen Di, auf 60,0%
für fünf Dosen Di bei Kindern im
Schuleintrittsalter und auf 51,4%
für sechs Dosen bei Jugendlichen.
Die Impfdichte für eine Masern-,
Mumps- und Rötelnimpfung ist
82,3%, 81,1% und 80,8% bei Klein-
kindern und steigt auf 88,4%, 87,0%
und 86,6% bei Kindern bei Schul-
eintritt und  93,8%, 93,1% und
90,6% bei Schulabgängern. Mit
zwei Dosen MMR waren nur noch
ca. 50% geimpft. Die Rötelndurch-
impfung war höher bei Mädchen als
bei Knaben (92,5% vs. 88,3% mit
einer Dosis und 49,5% vs. 44,5%
mit zwei Dosen, p<0,05). Bei Schul-
austritt zeigte die HepB-Durchimp-
fung eine grosse Spannweite von
7,5% bis 88,3% (Mittelwert 46,3%)
für eine Dosis, 6,7% bis 82,0%
(Mittelwert 40,8%) für zwei Dosen
und 2,3% bis 68,3% (Mittelwert
25,9%) für drei Dosen. Die Anzahl
der Kinder, welche nicht geimpft
wurden, ist klein und betrifft eher
Kleinkinder als Schulkinder. Die
MMR- und HepB-Impfungen wur-
den öfters weggelassen als andere
Impfungen. 
Tabelle 3 erlaubt einen detaillierte-
ren Vergleich der Durchimpfung von
Kleinkindern mit drei und vier Do-
sen von Di, Te, Per, Pol, Hib sowie
mit einer Dosis MMR zwischen den
einzelnen Kantonen. Bei drei Dosen
von Di, Te, Per, Pol und Hib hat OW
die tiefste Impfdichte von allen Kan-
tonen, für vier Dosen (ausser Pol)
hat Kanton AI die niedrigste Impf-
dichte. Für Masern und Mumps 
hat der Kanton AR die tiefste Durch-
impfung. Für Röteln ist der Kanton
SH am tiefsten mit 51,3%. Der Kan-
ton TI hat, möglicherweise wegen
des höheren Alters der erfassten
Kinder (durchschnittlich 46,7 Mo-
nate), die höchsten Raten für alle
Impfungen.
Im Weiteren zeigt Tabelle 3 einen
nationalen Vergleich der Durchimp-
fung von Kleinkindern zwischen den
Jahren 1991, 1998 und 1999–2003.
Die erfassten Impfdichten für eine
Dosis MMR und drei Dosen Di, Te
und Pol waren vergleichbar zwischen
der vorliegenden Studie (1999–2003)
und früheren Studien (1998 und
1991); für drei und vier Dosen Per
und Hib und vier Dosen Di, Te, und
Pol, hat sich die Durchimpfung er-
höht, mit einer markanten Zunahme
bei Hib, welche mit drei Dosen von
77% im Jahre 1998 auf 91% in un-
serer Erhebung und mit vier Dosen
von 47% auf 79% gestiegen ist.
DISKUSSION
Die zur Herdenimmunität nötige
Durchimpfung (Immunität) liegt bei
80–85% für Di und Pol, 92–95% 
für Per und Masern, 90–92% für
Mumps und 85–87% für Röteln [6].
Diese Erhebung zeigt, dass die
Durchimpfung bei Kindern in der
Schweiz deutlich unter dem vom
BAG und der WHO empfohlenen
Niveau liegt [7]. Die für eine Her-
denimmunität erforderliche Durch-
impfung wird zwar für Di und Pol 
erreicht, für Masern, Mumps und
Röteln liegt sie hingegen um 11, 10
resp. 5 Prozentpunkte darunter. Die
Impfrate ist bezüglich den empfoh-
lenen zwei Dosen MMR sowie den
fünf oder sechs empfohlenen Do-
sen von  Di und Te bei Schulein-
trittskindern respektive Schulabgän-
gern ebenfalls deutlich reduziert.
Diese tiefe Durchimpfung zeigt,
dass mehr Massnahmen erforder-
lich sind, um das von der WHO fest-
gelegte Ziel eines optimalen Impf-
schutzes zu erreichen, Immunität
zu gewährleisten und unkontrol-
lierte Virusverbreitungen zu verhin-
dern. 
Verglichen mit den Jahren 1991
und 1998 ist die Durchimpfung für
Per und Hib gestiegen. Dies ist der
Tatsache zu verdanken, dass immer
öfters kombinierte Impfungen an-
gewendet werden. Die bessere
Aufklärung über die Gefahren von
Hib ist ein weiterer möglicher
Grund für die gestiegene Rate der
Hib-Impfung, welche erst seit 1991
im Impfplan empfohlen ist. Seit
1987 wird die MMR-Impfung teil-
weise kontrovers diskutiert, wes-
halb die Impfdichte auf tiefen 80%
bleibt.
Der Einfluss von kombinierten
Impfungen wird auch durch die sehr
ähnlichen Durchimpfungswerte mit
Di, Te, Pol und auch MMR, sowie
Hib und Per bei Kleinkindern, be-
legt. Eine bemerkenswerte Aus-
nahme zeigt sich im Kanton SH, wo
die Durchimpfung für Röteln bei
Kleinkindern viel tiefer ist als jene
für Masern und Mumps. Diskussio-
nen mit dem Kantonsarzt zeigten,
dass Kinderärzte in diesem relativ
kleinen Kanton die Rötelnimpfung
bei Kleinkindern nicht empfehlen,
weshalb die Impfung dann erst im
Kindergartenalter nachgeholt wird.
Die Kantone GE und TI haben 
die höchste Durchimpfung bei den
meisten Impfungen. Dies ist wahr-
scheinlich darauf zurückzuführen,
dass in diesen Kantonen die Di-Imp-
fung obligatorisch ist und somit
eine hohe Durchimpfung auch für
Te, Per, Hib und Pol nach sich zieht,
da immer öfters kombinierte Imp-
fungen gebraucht werden. Obwohl
nur die Di-Impfung obligatorisch ist,
meinen viele Eltern, dies sei auch
bei der MMR-Impfung der Fall, was
sie oft veranlasst, ihre Kinder auch
gegen MMR impfen zu lassen. Weil
obligatorische Impfungen nur in ei-
nigen französischsprachigen Kanto-
nen (GE, FR, NE) und im TI existie-
ren, variiert der Impfgrad regional
sehr stark. Kleinkinder in italienisch-
und französischsprachigen Regio-
nen sind deutlich besser geimpft als
ihre Altersgenossen in der Deutsch-
schweiz. Dieses Phänomen muss
jedoch im Kanton TI mit Vorsicht in-
terpretiert werden, da in diesem
Kanton die Kinder erst im ersten
Kindergartenjahr erfasst wurden
und nicht wie in den übrigen Kanto-
nen im Alter von 24–35 Monaten. 
      Übertragbare Krankheiten
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      Übertragbare Krankheiten
Tabelle 2
Durchimpfung (%) bei Kleinkindern und Schulkindern in der Schweiz 1999–2003 nach Anzahl Dosen (kantonale Spannweite)
a) Kleinkinder (24–35 Monate; n=8729) 
Impfung Anzahl Dosen
0 1 2 3 4 5 6
Diphtherie 2,8 97,2 96,6 95,4 83,6
0–9,3 90,7–100,0 89,5–99,2 88,7–98,5 66,8–92,4
Tetanus 2,1 97,9 97,3 95,9 83,7
0–7,8 92,2–100,0 91,1–99,5 89,9–98,5 67,2–92,4
Pertussis 5,3 94,7 94,1 92,9 81,3
0,7–13,2 86,8–99,3 86,4–98,2 86,0–97,8 63,7–92,0 
Poliomyelitis 2,8 97,2 96,6 95,3 82,7
0,3–8,9 91,1–99,7 90,3–99,5 89,1–97,8 61,1–90,8
H. influenzae 5,9 94,1 92,8 91,1 79,3
1,1–12,4 87,6–98,9 87,6–97,0 86,0–96,0 60,8–87,1
Masern 17,7 82,3 7,8
6,3–31,4 68,6–93,7 0–48,2
Mumps 18,9 81,1 7,7
6,7–33,2 66,8–93,3 0–47,8
Röteln 19,2 80,8 7,7
6,7–48,7 51,3–93,3 0–47,8
b) Schuleintritt (Kindergarten, 1.–3. Klasse; n=8660)
Impfung Anzahl Dosen
0 1 2 3 4 5 6
Diphtherie 0,9 99,1 98,0 97,1 92,5 60,0
0–2,9 97,1–100,0 95,8–100,0 94,1–98,8 83,2–95,6 14,6–80,9
Tetanus 0,6 99,4 98,3 97,3 92,7 60,2
0–2,2 97,8–100,0 98,8–100,0 94,1–98,8 85,6–98,9 14,6–80,9
Pertussis 6,6 93,4 91,0 88,9 60,9 19,4
1,1–15,7 84,3–98,9 69,9–97,7 64,0–96,8 32,1–92,8 1,2–51,5
Poliomyelitis 0,9 99,1 98,0 97,0 92,0 59,6
0–2,4 97,6–100,0 96,0–100,0 93,5–98,8 73,6–95,9 9,2–78,8
H. influenzae 9,9 90,1 86,6 78,3 26,6
3,3–15,6 84,4–96,7 79,5–96,6 67,5–91,3 3,0–80,1
Masern 11,6 88,4 36,6
6,2–19,3 80,7–93,8 3,5–69,6
Mumps 13,0 87,0 36,0
6,3–23,6 76,4–93,7 3,0–69,4
Röteln 13,4 86,6 35,9
6,3–38,1 61,9–93,7 3,0–69,6
c) Schulaustritt (6.–9. Klasse; n=8277)
Impfung Anzahl Dosen
0 1 2 3 4 5 6
Diphtherie 1,1 98,9 95,5 93,1 90,2 81,6 51,4
0–5,1 94,9–100,0 87,7–99,2 86,3–99,2 81,6–95,9 56,3–94,0 15,8–78,7
Tetanus 1,0 99,0 95,7 93,3 90,5 82,2 52,1
0–5,1 94,9–100,0 87,9–100,0 86,7–99,2 82,8–96,2 58,9–94,0 17,3–78,8
Pertussis 12,5 87,5 86,0 83,5 12,9 3,4
2,1–55,8 44,2–97,9 42,4–96,2 41,1–95,0 0,7–28,7 0,0–22,5
Poliomyelitis 1,1 98,9 95,7 93,0 90,0 80,7
0–6,8 93,2–100,0 89,2–100,0 86,0–98,4 84,1–96,2 64,0–91,7
Masern 6,2 93,8 54,0
0,9–16,0 84,0–99,1 13,5–82,6
Mumps 6,9 93,1 52,7
0,9–18,2 81,8–99,1 12,3–82,6
Röteln 9,4 90,6 49,8
0–20,5 79,5–100,0 12,3–82,6
Hepatitis B 53,7 46,3 40,8 25,9
11,7–92,5 7,5–88,3 6,7–82,0 2,3–68,3
JU: ohne Schulkinder. BE: Per 4 Dosen und MMR 2 Dosen wurden nicht erfasst [5]. TI: Daten erfasst vom Kantonsärtzlichen
Dienst. Statt bei Kindern im Alter 24–35 Monate erfolgte die Erhebung  bei Kindern im 1. Kindergartenjahr.
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      Übertragbare Krankheiten
Tabelle 3
Durchimpfung der Kleinkinder (24–35 Monate) in der Schweiz nach Kantonen, 1999–2003
Kanton Jahr N Di3 Di4 Te3 Te4 Per3 Per4 Pol3 Pol4 Hib3 Hib4 Ma1 Mu1 Rö1
AG 2000 321 95,0 83,1 95,5 82,9 91,9 81,0 96,6 83,5 89,9 80,7 82,5 79,7 78,4
AI 2000 270 90,9 66,8 92,4 67,2 89,8 63,7 92,4 70,7 87,3 60,8 71,3 71,3 71,3
AR 2002 185 91,1 78,7 91,1 78,7 88,7 77,6 90,8 77,8 88,5 76,2 68,6 66,8 66,8
BE 2001 291 95,2 84,2 95,4 84,8 92,8 82,4 94,6 86,1 90,7 80,0 77,6 77,6 77,6
BL 2000 460 95,4 78,2 96,4 78,2 89,8 75,1 94,6 75,3 86,3 68,3 75,6 73,7 73,6
BS 2000 337 94,7 78,7 95,0 79,3 90,4 76,8 94,6 77,3 87,8 71,8 78,5 74,3 74,1
FR 2001 281 98,2 83,5 98,2 83,5 95,9 82,9 97,6 81,9 92,5 83,6 86,0 84,6 84,6
GE 2002 702 97,9 89,8 98,2 89,5 96,9 89,2 96,7 89,5 93,8 86,2 92,7 90,3 90,4
GL 2001 272 95,1 86,2 95,8 86,6 94,8 86,2 95,5 84,9 93,8 81,1 77,9 77,6 77,6
GR 2002 278 94,7 82,5 95,0 82,5 92,4 81,9 93,4 82,2 91,0 82,0 78,7 76,6 76,1
JU 2002 237 95,8 90,4 95,8 90,0 94,5 89,1 95,0 88,1 92,5 85,7 83,5 83,3 83,3
LU 2001 356 90,4 76,2 90,6 76,7 86,2 72,8 90,6 75,3 86,1 73,9 71,4 69,6 68,8
NE 2000 335 96,7 87,9 97,9 87,7 94,9 85,9 96,7 86,8 90,8 75,5 89,4 89,0 89,4
NW 2001 296 92,2 82,2 92,2 82,2 90,3 79,6 91,9 80,2 88,7 74,8 80,2 75,6 76,2
OW 2002 240 88,7 78,8 89,9 79,1 86,0 76,8 89,1 78,0 86,0 76,4 73,7 73,3 73,3
SG 2002 387 93,6 83,8 93,8 84,3 91,9 82,6 93,7 83,8 89,7 79,2 76,1 75,8 75,8
SH 2001 278 95,4 79,0 96,3 79,0 93,1 64,5 94,3 61,1 91,1 78,6 75,0 69,2 51,3
SO 2000 295 97,1 82,4 97,5 82,4 94,9 80,2 96,8 80,1 93,5 76,1 81,0 79,9 79,9
SZ 2001 365 93,0 79,4 93,4 79,8 90,8 77,9 93,0 78,9 91,3 77,3 80,0 79,1 79,3
TG 2000 235 95,7 84,1 95,7 84,1 92,9 80,5 95,8 79,1 90,9 77,8 84,1 82,2 81,7
TI1) 2002 684 98,5 92,4 98,5 92,4 97,8 92,0 97,8 90,8 96,0 87,1 93,7 93,3 93,3
UR 2001 289 96,4 87,1 96,4 87,1 93,4 84,8 96,4 85,2 91,4 84,8 83,2 81,5 81,8
VD 2003 353 97,8 84,9 98,5 84,9 95,5 84,3 96,9 82,7 94,4 81,1 89,7 88,7 88,7
VS 1999 382 96,2 88,2 98,1 88,9 95,6 82,7 97,8 87,0 93,6 78,7 92,9 92,6 92,6
ZG 2002 255 92,9 82,2 93,2 82,2 91,0 81,7 91,6 81,2 90,5 79,8 77,1 77,1 76,9
ZH 1999 345 95,1 82,7 95,6 82,7 91,9 78,6 95,3 82,0 91,1 78,8 81,4 81,1 81,1
CH 1999–
2003 8729 95,4 83,6 95,9 83,7 92,9 81,3 95,3 82,7 91,1 79,3 82,3 81,1 80,8
CH 19982) 403 94,3 71,7 93,3 71,5 88,1 68,2 92,1 76,2 76,9 47,4 81,4 78,9 78,7
CH 19913) 401 95,0 71,1 93,3 70,9 88,8 – 94,8 70,4 – – 83,1 80,1 79,6
Di3: Diphtherie (3 Dosen), Te: Tetanus, Per: Pertussis, Pol: Poliomyelitis, Hib: Haemophilus influenzae Typ b, Ma: Masern, 
Mu: Mumps, Rö: Röteln.
1)1. Jahr Kindergarten;  2)[8];  3)[9]
Die relativ hohe Nichtbeantwor-
tungsrate bei den Kleinkindern und
Schulkindern schränkt die Aussage-
kraft der Ergebnisse ein. Da anzu-
nehmen ist, dass Eltern, welche
Impfungen ablehnen, weniger be-
reit sind, an Impfstudien teilzuneh-
men, kann es zur Überschätzung
der effektiven Durchimpfung  kom-
men. Dieser Einfluss wurde jedoch
teilweise bei der Auswertung be-
rücksichtigt.  Eine weitere Optimie-
rung der Datenqualität könnte durch
differenziertere Statistikmodelle so-
wie eine erhöhte Antwortrate er-
langt werden.
Die Datenerfassung bei den Schul-
kindern ist so unterschiedlich, dass
ein Vergleich zwischen den Kanto-
nen und den Altersgruppen inner-
halb der Kantone schwierig ist. 
Aufgrund unterschiedlicher Organi-
sationsstrukturen in den Schulge-
sundheitsdiensten war das Vorge-
hen bei der Datenerhebung sehr un-
terschiedlich. Ebenfalls trugen die
grossen Spannweiten im Alter der
untersuchten Schüler bei den Ge-
sundheitsuntersuchungen und die
unterschiedlichen Impfleitlinien dazu
bei, dass Unterschiede bei den
Impfraten zwischen den Kantonen
schwer interpretierbar sind. Wei-
tere Faktoren, welche die Vergleich-
barkeit zwischen den Kantonen be-
einträchtigen, sind: der Zeitpunkt
der Routineuntersuchungen, wel-
che Impfungen werden in der
Schule angeboten, dürfen Schul-
ärzte Impfungen selbst durchfüh-
ren, wurde eine HepB-Kampagne 
in der Schule durchgeführt? Die
Durchimpfung wurde aber haupt-
sächlich durch die Beteiligungsrate
und die Art der Datenerhebung 
beeinflusst, wovon Letztere den
grösseren Einfluss hatte. Zusätzlich
ist häufig unklar, ob die Datener-
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hebung und die Schulimpfungen
gleichzeitig stattfanden, was wie-
derum zu ungenauen Schätzungen
führen kann. Nachimpfungen, die
durch Hausärzte durchgeführt wur-
den, konnten ebenfalls nicht be-
rücksichtigt werden. Zusätzlich er-
schwerten (durch Ärzte und Kran-
kenschwestern) unvollständig aus-
gefüllte Impfformulare einen Ver-
gleich innerhalb der einzelnen Kan-
tone. Die Gründe für die Nichtbe-
antwortung bei den Schulen sind
nicht bekannt.
Aufgrund dieser Einschränkungen
und um die Vergleichbarkeit zwi-
schen den Kantonen, im Speziellen
bei Schulkindern, zu verbessern,
wurde die Methode geändert. Es
wird empfohlen, dass die Methode
zur Erfassung der Daten der Klein-
kinder auch bei den Schulkindern
angewendet wird. Eine Zusammen-
arbeit mit kantonalen Schulge-
sundheitsdiensten ist nur sinnvoll,
wenn diese sehr gut etabliert sind
und von kantonalen Schulkranken-
schwestern unterstützt werden.
Des Weiteren wird ein Elternbrief
durch den kantonsärztlichen Dienst
empfohlen, um die Rückantwort-
rate weiter zu erhöhen. Das Über-
wachungssystem wird von 2004–
2007 jeweils in neun Kantonen pro
Jahr eingeführt und wird unterstützt
durch die Schweizerische Konfe-
renz der kantonalen Gesundheits-
direktorinnen und -direktoren. Im
Jahre 2005 wurden in folgenden
Kantonen die Daten erhoben: AI,
AG, BL, BS, SH, SO, SZ und ZH. Der
Kanton BE hat die Studie bereits
2004 selbstständig durchgeführt.
Es wird erwartet, dass die 17 weite-
ren Kantone in den Jahren 2006/
2007 teilnehmen werden.
Mitgeteilt von: Phung Lang und
Robert Steffen, Institut für Sozial-
und Präventivmedizin, Universität
Zürich
Dank: Wir bedanken uns bei allen
kantonsärztlichen Diensten, den
Schulärzten, Schulärztinnen, Schul-
schwestern und allen weiteren Per-
sonen, die uns bezüglich unserer
Impfstudie unterstützten. Ein be-
sonderer Dank für die Erlaubnis,
von den Kantonen bereits erhobene
Daten zu verwenden, geht an Frau
Anne-Marie Maurer vom  Kantons-
arztamt der Gesundheits- und Für-
sorgedirektion des Kantons Bern,
an Frau Alessandra Galfetti vom Uf-
fico del medico cantonale in Bellin-
zona und Herrn Philippe Sudre vom
Office du médecin cantonal Ge-
nève. 
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Abteilung Übertragbare Krankheiten
Telefon 031 323 87 06
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Übertragbare Krankheiten
Durchimpfung in der Schweiz 2005
EINLEITUNG
Die Durchimpfung bei in der Schweiz
wohnhaften Kindern wurde von
1999 bis 2003 auf nationaler und
kantonaler Ebene erhoben [1]. Mit
der Unterstützung der Schweizeri-
schen Konferenz der kantonalen
Gesundheitsdirektorinnen und -di-
rektoren sollen diese Erhebungen in
Zukunft regelmässig alle drei Jahre
in allen Kantonen durchgeführt wer-
den. Gegenwärtig erfolgt die Daten-
erhebung für die Periode 2005–07.
Dieser Bericht informiert über den
erreichten Impfgrad in neun Kanto-
nen (AI, AG, BL, BS, NE, SH, SO,
SZ, ZH), die 2005 an der nationalen
Erhebung teilgenommen haben. Der
Kanton BE hat die Daten bereits
2004 selbstständig erhoben und
wird sie dem ISPM Zürich zu einem
späteren Zeitpunkt zur Verfügung
stellen. In den übrigen Kantonen er-
folgt die Datenerhebung 2006–07.
METHODE
Wiederum wurden drei verschie-
dene Altersgruppen untersucht:
Kleinkinder im Alter zwischen 24
und 35 Monaten sowie 8-jährige
und 16-jährige Kinder. Im Kanton BS
wurden 2005 nur Daten von Klein-
kindern erhoben. Für alle drei Al-
tersgruppen wurde dieselbe Me-
thode benutzt.
Je nach vorhandener Datenerhe-
bungsgrundlage wurde ein unter-
schiedliches Vorgehen angewandt.
In den Kantonen AG, BL, SO und
ZH, wo von jeder Gemeinde eine
Liste mit allen im Jahre 2002 gebo-
renen Kindern erhältlich war, wurde
die Clusterstichprobe verwendet.
Zuerst wurden die Gemeinden und
danach die Kinder ausgewählt. Da
in den Kantonen AI, BS und NE ein
zentrales Register existiert, wurden
die Kinder hier nach dem Zufalls-
prinzip ausgewählt. Die Gemeinden
der restlichen beiden Kantone (SH
und SZ) wurden angefragt, eine
Liste mit allen Einwohnern der be-
treffenden Altersgruppen zu liefern
und die Kinder dann ebenfalls nach
dem Zufallsprinzip ausgewählt. 
Die von den Gemeinden oder den
zentralen Registern erhobenen In-
formationen beinhalteten den Na-
men des Kindes und der Eltern, das
Geburtsdatum, das Geschlecht, die
Zwischen 1999 und 2003 wurde die
Durchimpfung bei in der Schweiz wohnhaften Kindern
auf nationaler und kantonaler Ebene ermittelt und die
Grundlagen für ein regelmässiges Monitoring erarbeitet
[1]. Bis 2007 soll die nationale Durchimpfung zum zwei-
ten Mal umfassend erhoben werden, um Veränderun-
gen erfassen zu können. In den Jahren 2004 und 2005
wiederholten neun Kantone (AI, AG, BL, BS, NE, SH,
SO, SZ, ZH) die Erhebung für drei verschiedene Alters-
gruppen: Kleinkinder im Alter von 24 bis 35 Monaten
sowie 8 und 16 Jahre alte Kinder. Die Daten für diese
neun Kantone lassen auf folgende durchschnittliche
nationale Durchimpfung bei Kleinkindern schliessen: Mit
drei Dosen Diphtherie (Di), Tetanus (Te), Pertussis (Per),
Poliomyelitis (Pol) und Haemophilus influenzae Typ B
(Hib) 95,6%, 95,9%, 93,8%, 94,4% und 93,0% sowie
mit einer Dosis Masern (Ma), Mumps (Mu) und Röteln
(Ro) 86,2%, 84,9% und 84,9%. Ein Vergleich mit den
Ergebnissen der Erhebung 1999–2003 zeigt, dass die
Durchimpfung gegen Di, Te und Pol auf nationaler
Ebene unverändert geblieben ist, hingegen die Impfrate
gegen MMR mit einer und zwei Dosen und gegen Hib
und Per mit vier Dosen signifikant angestiegen ist. Mög-
liche Erklärungen für diese Zunahmen sind die Applika-
tion kombinierter Impfstoffe, der Wechsel vom zellulä-
ren zum azellulären Per-Impfstoff sowie mehrere Ma-
sernausbrüche seit 2003. Von den neun Kantonen ver-
zeichneten  acht einen generellen Anstieg der Durch-
impfung, währenddem im Kanton Schwyz ein deutlicher
Rückgang zu registrieren war. 
In acht Kantonen betrug die Durchimpfung mit vier
Dosen Di, Te, Per, Pol und Hib bei den 8-Jährigen
95,1%, 95,4%, 87,3%, 94,1% und 89,2% und mit einer
Dosis MMR 89,5%, 88,2% und 88,0%. Bei den 16-
Jährigen lag das Impfniveau mit fünf Dosen Di, Te und
Pol bei 85,9%, 86,2% und 91,7% und mit zwei Dosen
MMR bei 75,0%, 73,1% und 72,6%. Die Impfquote von
Schulkindern ist bei allen Impfungen stark angestiegen.
Der Grund hierfür könnte jedoch in erster Linie das
höhere Alter der für diese Studie erfassten Kinder sein.
Auch die Durchimpfung gegen Hepatitis B hat deutlich
zugenommen: auf 65,3% mit einer Dosis, 60,8% mit
zwei Dosen und 36,8% mit drei Dosen.
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Adresse, die Nationalität und, nach
Möglichkeit, den Beruf der Eltern
und die Telefonnummer.
Alle Familien der ausgewählten
Kinder wurden mit einem Brief, der
ein Erklärungsschreiben und einen
vorfrankierten Briefumschlag ent-
hielt, aufgefordert an der Studie teil-
zunehmen und eine Kopie oder den
Originalimpfausweis einzusenden.
Vier bis fünf Wochen später er-
hielten die Eltern, die noch nicht ge-
antwortet hatten, ein Erinnerungs-
schreiben. Wurde darauf ebenfalls
nicht reagiert, erfolgte eine telefo-
nische Kontaktaufnahme (fünf bis
sechs Versuche zu verschiedenen
Tageszeiten an verschiedenen Wo-
chentagen). 
Datenanalyse
Die Stichproben wurden zuerst ge-
wichtet, für den Anteil der nicht
Antwortenden ausgeglichen und
nach Nationalität, Geschlecht und
Wohnsituation (Stadt/Land) stratifi-
ziert. Die Wohnsituation wurde ge-
mäss Richtlinien des Bundesamtes
für Statistik definiert. Der Chi-Qua-
drat-Test wurde mit Hilfe der Statis-
tiksoftware Stata®, Version 7.0 durch-
geführt und das Signifikanzniveau
bei p <0,05 festgelegt.
RESULTATE
Beteiligung
Tabelle 1 stellt die Beteiligung an
den Erhebungen von 2005 und
1999–2003 nach Art der Datenerhe-
bung dar. Im Vergleich zur vorher-
gehenden Studie nahm die Beteili-
gung um ca. 20% zu; die durch-
schnittliche Antwortrate lag 2005 je
nach Altersgruppe zwischen 81 und
85%. Der Rücklauf war wie zu er-
warten am höchsten nach dem ers-
ten Brief (46–59%), am zweithöchs-
ten nach dem zweiten Schreiben
(19–23%) und am geringsten nach
dem dritten Kontakt (6–12%) (Abbil-
dung 1). Dieses Schema lässt sich
bei allen drei Altersgruppen erken-
nen. Der telefonische Kontakt war
am erfolgreichsten bei Eltern von
Kleinkindern, da diese öfters zu
Hause sind. 
Durchimpfung
Tabellen 2 und 3 detaillieren die
Durchimpfung von allen drei Alters-
gruppen. Obwohl sich generell in
vielen Kantonen eine leichte Zu-
nahme abzeichnet, hat sich das
Impfniveau bei Kleinkindern gegen
Di, Te, Pol und drei Dosen Per in
den letzten sechs Jahren kaum ver-
ändert (Tabelle 2). Dennoch ist die
Durchimpfung für einige Impfungen
signifikant angestiegen: für Hib mit
drei Dosen von 90,4% auf 93,0%,
mit vier Dosen von 77,2% auf
82,3%, für MMR mit einer Dosis
von 81,1% auf 86,2% (Masern),
von 79,7% auf 84,9% (Mumps) und
von 79,1% auf 84,9% (Röteln) und
mit vier Dosen Per von 78,8% auf
83,1%. In beinahe allen Kantonen
lässt sich derselbe Trend erkennen.
Einzig im Kanton SZ nahm die
Durchimpfung gegen Di, Te, Per, Pol
und Hib markant und diejenige ge-
gen MMR in geringem Masse ab.
Im Kanton BL hingegen erhöhte
sich die Durchimpfungsquote für
alle empfohlenen Impfungen sehr
deutlich. Erwähnenswert ist auch
die von 51,3% auf 84,9% gestie-
gene Durchimpfungsrate für Röteln
im Kanton SH.
Der durchschnittliche nationale Impf-
grad von Schulkindern hat sich bei
allen Impfungen verbessert (Tabelle
3). Die Durchimpfung mit fünf Do-
sen Di, Te und Pol bei 8-Jährigen ist
von 65–66% auf beinahe 80% ge-
stiegen. Der Anstieg für die zweite
Dosis MMR, die vierte und fünfte
Dosis Per und die dritte und vierte
Dosis Hib ist sogar noch markan-
ter, nämlich von 46,3% auf 73,9%
(Ma2), von 45,4% auf 72,6% (Mu2),
von 45,2% auf 71,8% (Ro2), von
54,7% auf 87,3% (Pe4), von 14,6%
auf 67,6% (Pe5), von 74,1% auf
89,2% (Hib3) und von 14,8% auf
73,6% (Hib4). Auch die Impfquote
von Jugendlichen hat seit dem letz-
ten Erhebungszeitraum deutlich zu-
genommen. Die Durchimpfung mit
sechs Dosen Di stieg von 50,0%
auf 62,3%, mit sechs Dosen Te von
51,1% auf 63,7%, mit vier Dosen
Per von 10,7% auf 24,4%, mit fünf
Dosen Pol von 78,2% auf 83,6%
und mit zwei Dosen MMR von
51,0% auf 75,0%, von 49,9% auf
73,1% respektive von 46,4% auf
72,6%. Die Durchimpfung mit einer
Dosis Hepatitis B (HB) stieg von
29,7% auf 65,3%, mit zwei Dosen
von 24,9% auf 60,8% und mit drei
Dosen von 13,2% auf 36,8%.
Im Gegensatz zu den Schulkin-
dern der anderen sieben Kantone,
die 2005 teilgenommen haben, hat
die Durchimpfungsrate auch bei 
Jugendlichen im Kanton SZ stark
abgenommen. Bei den 8-Jährigen
stieg das Impfniveau nur mit drei
und vier Dosen Hib von 76,2% auf
88,1% und von 33,5% auf 68,5%;
mit vier Dosen Per nahm es von
76,7% auf 63,2% signifikant ab.
      Übertragbare Krankheiten
Tabelle 1
Rücklauf (%) der Impfausweise nach Art der Datenerhebung und kantonale
Spannweite, 1999–2002 und 2005
Mittelwert Spannweite
N (%) (%)
Kleinkinder
– Gemeinden (1999–2001) 4853 65 56–80
– Gemeinden (2005) 3398 82 75–88
Schuleintritt
– Schulschwestern (1999–2002) 1876 75 73–78
– Schulärzte (1999–2002) 1532 71 57–81
– Lehrer (2000) 712 53 53
– Gemeinden (2000) 605 61 61
– Gemeinden (2005) 3192 85 76–91
Schulaustritt
– Schulschwestern (1999–2002) 1859 71 58–92
– Schulärzte (1999-2002) 1520 68 60–79
– Lehrer (2000) 725 52 52
– Gemeinden (2000) 600 47 47
– Gemeinden (2005) 3181 81 72–88
Kantone: AG, AI, BL, BS, NE, SH, SZ, SO, ZH. Schulkindern: ohne BS. N: Stichproben-
grösse. Anzahl der Kantone 1999–2002 mit Erhebung durch Schulschwestern: 3;
Schulärzte: 3; Lehrer: 1; Gemeinden: 1.
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DISKUSSION 
Ein Vergleich der aktuellen nationa-
len Durchimpfung von Kleinkindern
mit derjenigen von 1999–2001, ver-
deutlicht, dass sich die Impfquote
für MMR, Hib und vier Dosen Per
signifikant erhöht hat [1]. Während
der Impfgrad in acht von neun im
Jahre 2005 teilnehmenden Kanto-
nen generell angestiegen ist, lässt
sich im Kanton SZ ein deutlicher
Rückgang erkennen. 
Die Impfrate für Di, Pol und R hat
bei Kleinkindern das von der WHO
und dem BAG empfohlene Niveau
erreicht, um Ausbrüche in der Be-
völkerung zu vermeiden [4, 5]. Da-
mit dieses Niveau aber auch für die
anderen Impfungen erreicht wer-
den kann, wären mehr Massnah-
men erforderlich. Kürzliche Masern-
ausbrüche in den Kantonen GE, VD
und LU zeigten, dass die Durchimp-
fung gegen Masern zwar hoch ge-
nug ist, um die Krankheit im Zaum
zu halten, dass die Anzahl Krank-
heitsfälle in Gebieten mit ungenü-
gendem Impfniveau jedoch plötz-
lich zunehmen kann [6, 7].
Unterschiedliche Faktoren könn-
ten für den Anstieg der Impfrate
verantwortlich sein. Bei Hib ist die
Zunahme möglicherweise auf die
Applikation kombinierter Impfungen
zurückzuführen. Bei Pertussis hat
wahrscheinlich der Wechsel vom
zellulären zum azellulären Impfstoff
aufgrund seiner reduzierten Reakto-
genizität zu einer vermehrten Ak-
zeptanz bei Ärzten und Eltern ge-
führt [8, 9]. Lokale Masernausbrü-
che in der Schweiz in den Jahren
2003–2004 könnten unschlüssige
Eltern zudem dazu bewogen haben,
ihre Kinder doch noch impfen zu 
lassen [6, 7, 10]. Des Weiteren hat
möglicherweise auch die Impfkam-
pagne des BAG zum verbesserten
Impfniveau beigetragen. Zu guter
Letzt braucht es nach der Einfüh-
rung von neuen Empfehlungen häu-
fig auch eine gewisse Zeitspanne,
bis sie vom medizinischen Personal
und von der Bevölkerung voll akzep-
tiert werden.
Seit ihrer Einführung 1998 hat die
HB-Impfung an Akzeptanz gewon-
nen und das Wissen über die Krank-
heit zugenommen. Diese beiden
Faktoren sowie verbesserte Impf-
kampagnen in den Schulen haben
wahrscheinlich zu der höheren HB-
Durchimpfung geführt. Ein weiterer
Grund für die erhöhte Impfrate
könnte der Wechsel des Impfsche-
mas bei Jugendlichen von 3 auf 2
Dosen für einzelne HB-Impfstoffe
sein. Die gestiegene Impfquote bei
      Übertragbare Krankheiten
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      Übertragbare Krankheiten
Schulkindern dürfte zusätzlich auch
auf das höhere Alter der an dieser
Studie teilnehmenden Kinder zu-
rückzuführen sein. In der Studie von
1999–2003 wurden die Impfinfor-
mationen bei Kindergärtlern bis zu
Zweitklässlern (in einem Kanton bei
Drittklässlern) und bei Siebt- bis
Neuntklässlern (in einem Kanton bei
Sechstklässlern) erhoben. Im 2005
waren die Kinder 8 und 16 Jahre alt.
Weil in den Zielgruppen der aktuel-
len Erhebung Kinder vertreten sind,
die ein Jahr älter sind als das im
Schweizerischen Impfplan vorgese-
hene maximale Alter, dürften nun
auch ein grosser Teil der Nachhol-
impfungen erfasst worden sein [11].
Im Gegensatz zu den übrigen Kan-
tonen hat im Kanton SZ die Durch-
impfungsrate für Di, Te, Per, Pol und
in einem geringeren Masse für
MMR bei Kleinkindern und Jugend-
lichen abgenommen. Diese Tatsa-
che lässt darauf schliessen, dass
viele Eltern Impfungen im Allgemei-
nen für ihre Kinder ablehnen und
nicht, wie früher, nur die MMR-Imp-
fung. Ein Hauptgrund für die Ab-
nahme könnte der starke Einfluss
von Alternativmedizinern sein, wel-
che junge Eltern möglicherweise
unempfänglich machen für Impfin-
formationen und Impfkampagnen.
Gemäss einem Kinderarzt im Kan-
ton SZ verfügt die Region Einsie-
deln über deutlich mehr Homöopa-
then als andere Gebiete im Kanton,
was dazu führt, dass die Durchimp-
fung in Einsiedeln viel tiefer ist als in
anderen Regionen [S. Rupp, Kinder-
arzt, persönliche Mitteilung]. Auch
eine aktuelle Erhebung im Kanton
VD bestätigt, dass Kinder, die haupt-
sächlich von Homöopathen behan-
delt werden, weniger oft gegen
MMR geimpft sind als Kinder, die
von Kinderärzten behandelt werden
[8]. Ausserdem nahm die MMR-
Impfrate im Kanton SZ vor ein paar
Jahren wider Erwarten leicht ab,
nachdem in den Schulen die Impf-
broschüren des BAG verteilt wur-
den [M. Hofstra, Schulgesundheits-
dienst SZ, persönliche Mitteilung,
2006]. Der Kanton SZ hat sich die
Priorität gesetzt, die Durchimpfung
bei Schulkindern in den nächsten
Jahren zu steigern.
Bei den Jugendlichen hat die Na-
tionalität einen starken Einfluss auf
das Impfniveau: Ausländische Kin-
der verfügen über eine deutlich
niedrigere Durchimpfung als Schwei-
zer Kinder. Dies muss jedoch mit
Vorsicht betrachtet werden. Es be-
steht die Möglichkeit, dass die
Impfquote von ausländischen Kin-
dern in Realität höher ist, weil die
Daten nur die in den Impfauswei-
sen dokumentierten Impfungen wi-
derspiegeln. In den Heimatländern
dieser Kinder wurden aber vielleicht
Impfungen verabreicht und nicht
vermerkt oder der Impfausweis ging
verloren. 
Obwohl der Rücklauf mit über 80%
deutlich zugenommen hat, kann eine
Nichtbeantwortungsrate von 20%
immer noch zu einer Fehleinschät-
zung der erhobenen Durchimpfung
führen. Die Gründe für eine Nicht-
beantwortung wurden erfasst, und
weniger als 1% haben eine nega-
tive Haltung Impfungen gegenüber
als Ursache dafür angegeben, nicht
an der Studie teilgenommen zu 
haben. Trotzdem muss die Nichtbe-
antwortungsrate ernst genommen
werden, da nicht alle ausgewählten
Familien kontaktiert werden konn-
ten und die Resultate zeigen, dass
der Zeitpunkt der Antwort deutlich
mit dem Grad der Durchimpfung
korreliert: Die Kinder von Eltern, die
erst auf den telefonischen Kontakt
hin reagiert hatten, weisen ein tiefe-
res Impfniveau auf als jene Kinder
von Familien, die bereits auf den
ersten oder zweiten Brief geant-
wortet hatten. Schon früher hatte
eine Studie im Kanton BL gezeigt,
dass der Zeitpunkt der Antwort in
einer Erhebung mit dem Grad der
Durchimpfung verbunden ist [12].
Um das Kooperationsniveau zu er-
höhen, ist es folglich wichtig, die
Methode zu verbessern. Die Beteili-
gung hat von 1999/2003 bis 2005
um ca. 20% zugenommen, was
wahrscheinlich dem Weglassen ei-
nes zusätzlichen Fragebogens und
der besseren Datenerhebungsme-
thode zu verdanken ist. 
Bis Dezember 2007 wird die Da-
tenerhebung in 25 Kantonen been-
det sein. Ein Kanton beteiligt sich
noch nicht an der aktuellen na-
tionalen Erhebung. Die Daten zur
nationalen Durchimpfung werden
im 2008 veröffentlicht. Viele der
Einschränkungen in der Studie von
1999–2003, v.a. die Vergleichbarkeit
zwischen den 26 Kantonen, wurden
im Erhebungszeitraum 2005–2007
eliminiert. Die Zusammenarbeit mit
den Kantonen war hervorragend, und
die meisten Kantone werden für
alle drei Altersgruppen dieselbe Me-
thode anwenden. Aufgrund logisti-
scher und finanzieller Gründe wer-
den drei Kantone die Datenerhe-
bung von Schulkindern weiterhin
Tabelle 3
Durchimpfung (%) von Schulkindern in 8 Kantonen, 1999–2002 und 2005
a) Schuleintritt b) Schulaustritt
Jahr 1999–02 2005 Jahr 1999-02 2005
n 3227 2685 n 3004 2541
Di4 93.3 95.1 Di5* 81.2 85.9
Di5* 66.4 77.9 Di6* 50.0 62.3
Te4 93.5 95.4 Te5* 81.9 86.2
Te5* 66.5 77.9 Te6* 51.1 63.7
Per4* 54.7 87.3 Per3 82.6 83.1
Per5* 14.6 67.6 Per4* 10.7 24.4
Pol4 92.4 94.1 Pol4* 88.5 91.7
Pol5* 65.0 75.4 Pol5* 78.2 83.6
Hib3* 74.1 89.2 HB1* 29.7 65.3
Hib4* 14.8 73.6 HB2* 24.9 60.8
HB3* 13.2 36.8
Ma1 88.7 89.5 Ma1 94.4 94.8
Ma2* 46.3 73.9 Ma2* 51.0 75.0 
Mu1 87.4 88.2 Mu1 94.0 93.9
Mu2* 45.4 72.6 Mu2* 49.9 73.1
Ro1 86.6 88.0 Ro1 92.0 93.9
Ro2* 45.2 71.8 Ro2* 46.4 72.6
Kantone: AG, AI, BL, NE, SH, SZ, SO, ZH. 1999–2002: 1.–2. und 6.–9. Klassen; 
2005: 8- und 16-Jährige. 
*p < 0.05.
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mit den Schulkrankenschwestern
der gut organisierten Schulgesund-
heitsdienste durchführen.
Mitgeteilt von: Phung Lang, Ursula
Piller and Robert Steffen, Institut für
Sozial- und Präventivmedizin, Uni-
versität Zürich. 
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